Compounds > fluorescein
Page last updated: 2024-09-22

fluorescein

Description

Fluorescein: A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium such as the aqueous humor. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

fluorescein (lactone form) : A xanthene dye that is highly fluorescent, detectable even when present in minute quantities. Used forensically to detect traces of blood, in analytical chemistry as an indicator in silver nitrate titrations and in microscopy. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16850
CHEMBL ID1057
CHEBI ID31624
SCHEMBL ID16533
MeSH IDM0029368

Synonyms (159)

Synonym
c.i. solvent yellow 94
d and c yellow no. 7
3',6'-dihydroxyspiro[isobenzofuran-3,9'-xanthene]-1-one
2321-07-5
fluorescein
3',6'-dihydroxyspiro(isobenzofuran-1(3h),9'-(9h)xanthen)-3-one
CHEMBL1057 ,
c20h12o5
fluorescein (free acid)
diofluor
nsc667256
nsc-667256
brn 0094324
fluorescein acid
fluorescein red
soap yellow f
11712 yellow
nsc 667256
d+c yellow no. 7
3',6'-dihydroxyspiro(isobenzofuran-1(3h),9'(9h)-xanthen)-3-one
japan yellow no. 201
benzoic acid, o-(6-hydroxy-3-oxo-3h-xanthen-9-yl)-
einecs 219-031-8
c.i. 45350:1
hsdb 2128
fluoran, 3',6'-dihydroxy-
spiro(isobenzofuran-1(3h),9'-(9h)xanthen)-3-one,3'6'-dihydroxy-
3,6-dihydroxyspiro(xanthene-9,3'-phthalide)
3h-xanthen-3-one, 9-(o-carboxyphenyl)-6-hydroxy-
ci 45350:1
d & c yellow no. 7
benzoic acid, 2-(6-hydroxy-3-oxo-3h-xanthen-9-yl)-
zlut kysela 73 [czech]
ccris 7076
spiro(isobenzofuran-1(3h),9'-(9h)xanthen)-3-one, 3',6'-dihydroxy-
2-(6-hydroxy-3-oxo-(3h)-xanthen-9-yl)benzoic acid
hidacid fluorescein
resorcinolphthalein
3',6'-dihydroxy-3h-spiro[2-benzofuran-1,9'-xanthen]-3-one
9-(o-carboxyphenyl)-6-hydroxy-3-isoxanthenone
d&c yellow no. 7
3',6'-dihydroxyfluoran
CHEBI:31624 ,
yellow fluorescein
japan yellow 201
9-(o-carboxyphenyl)-6-hydroxy-3h-xanthen-3-one
3,6-fluorandiol
solvent yellow 94
fluoresceine
fluoreszein
UPCMLD-DP087:001
MOLI001003
fluorescein (free acid), dye content 95 %
DB00693
UPCMLD-DP087
NCGC00161643-02
fluorescite (tn)
D01261
fluorescein (jan/usp)
NCGC00161643-01
HMS2093F21
E89FA0B4-4844-46A2-AF9B-29ECA50E5599
inchi=1/c20h12o5/c21-11-5-7-15-17(9-11)24-18-10-12(22)6-8-16(18)20(15)14-4-2-1-3-13(14)19(23)25-20/h1-10,21-22h
gnbhrkfjiuuoqi-uhfffaoysa-
3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one
FT-0668579
F0095
NCGC00161643-03
5-19-06-00456 (beilstein handbook reference)
ec 219-031-8
tpy09g7xir ,
unii-tpy09g7xir
zlut kysela 73
fluorescein [usp:ban:jan]
dtxsid0038887 ,
tox21_303508
dtxcid8018887
NCGC00257491-01
cas-2321-07-5
tox21_113500
pharmakon1600-01505396
nsc759114
nsc-759114
3',6'-dihydroxy-3h-spiro[isobenzofuran-1,9'-xanthen]-3-one
fluorescein [usp-rs]
yellow 7 [inci]
fluorescein [ep monograph]
fluorescein [vandf]
ki201 [inci]
fluorescein [hsdb]
fluorescein [who-dd]
fluorescein [ii]
d & c yellow no. 7 k7133
acid yellow 73 [inci]
fluorescein [mart.]
fluorescein [usp monograph]
fluorescein [jan]
ki201
fluorescein [mi]
EPITOPE ID:137337
AKOS015903296
S5488
CCG-213417
SCHEMBL16533
W-107417
CS-7537
spiro[isobenzofuran-1(3h),9'-[9h]xanthen]-3-one, 3',6'-dihydroxy-
3,6-dihydroxyspiro[xanthene-9,3'-phthalide]
c.i. 45350 (salt/mix)
c.i. acid yellow 73 (salt/mix)
dihydroxyfluorane
3',6'-fluorandiol
fluorescite (salt/mix)
c.i. 45350a
diresorcinolphthalein
AB00643381_02
mfcd00005050
bdbm50237588
resorcinol phthalein
SR-05000001696-1
sr-05000001696
fluorescein, for fluorescence, free acid
fluorescein low range dna standard, fluorescein-labeled marker for dna electrophoresis
fluorescein, united states pharmacopeia (usp) reference standard
fluorescein, european pharmacopoeia (ep) reference standard
SBI-0206827.P001
HY-D0251
Q410922
3',6' dihydroxyfluoran
3',6'-dihydroxy-3h-spiro[isobenzo[b]furan-1,9'-xanthen]-3-one
AMY22388
BRD-K21913543-001-01-6
HMS3744C17
D70685
fluorescein (solvent yellow 94)
SY012645
EN300-702817
spiro[isobenzofuran-1(3h),9'-[9h]xanthene]-ar-carboxylicacid, 3',6'-dihydroxy-3-oxo-
BP-31220
3',6'-dihydroxyspiro(isobenzofuran-1(3h), 9'(9h)-xanthen)-3-one
o-(6-hydroxy-3-oxo-3h-xanthen-9-yl)benzoic acid
fluorescein (lactone form)
benzoic acid, o-(6-hydroxy-3-oxo-3h-xanthen-9-yl)-,
fluorescein lactone
spiro(isobenzofuran-1(3h),9'-(9h)xanthen-3-one, 3',6'-dihydroxy-
fluoresceina
fluorescein (mart.)
fluorescein (usp:ban:jan)
3',6'-dihydroxyfluorane
fluorescein (usp monograph)
fluorescein (usp-rs)
3',4'-dehydroxyfluoran
fluorescein (ep monograph)
fluorescein (ii)
d&c yellow no 7
11712 yellow9-(o-carboxyphenyl)-6-hydroxy-3h-xanthen-3-one
c.i. 45350 (free acid)
3',6'-dihydroxy-3h-spiro(2-benzofuran-1,9'-xanthen)-3-one
benzoic acid, 2-(6-hydroxy-3-oxo-3h-xanthen-9-yl)-,

Research Excerpts

Overview

ExcerptReference
"Fluorescein is an agent that accumulates in areas of blood-brain barrier breakdown and is commonly used in neurosurgical oncology to assist with lesion localization and visualizing the extent of resection. "( Amankulor, NM; Habib, A; Jaman, E; Mallela, AN; Zhang, X; Zinn, PO, 2023)
"Fluorescein is a helpful microsurgical tool in guiding surgical resection and in the localization of intramedullary spinal lesions."( Chatain, GP; Finn, M; Serva, S; Ung, TH; Witt, JP, 2022)
"Fluorescein fluorescence is a handy tool to detect the pathological tissue in stereotactic brain biopsy and may improve its diagnostic accuracy and expedite the procedure."( Ahmad, F; Kaif, M; Khan, KA; Kumar Singh, R; Singh, AK; Singh, DK; Yadav, K, 2023)
"Fluorescein is a fluorescent dye used as a diagnostic tool in various fields of medicine. "( Dvořák, A; Klán, P; Martínek, M; Muchová, L; Šebej, P; Šranková, M; Vítek, L, 2022)
"Fluorescein angiography is an important and frequently used diagnostic tool in ophthalmological practice. "( Bouman, AC; de Kruijf, D; Emmen, JMA; Faes, MC; Groot, MJCK; Rettig, TCD, 2019)
"Fluorescein is an inexpensive fluorescent lymphatic tracer."( Agarwal, A; Agarwal, G; Agrawal, V; Chand, G; Gambhir, S; Mayilvaganan, S; Mishra, A; Mishra, SK; Valiveru, RC, 2020)
"Fluorescein is a helpful supplement in the neurosurgical treatment of cerebral metastases."( Halle, B; Hansen, RW; Kofoed, MS; Kristensen, BW; Markovic, L; Pedersen, CB; Poulsen, FR; Schulz, MK, 2022)
"Fluorescein guidance is a feasible tool for defining surgical entry zones when aiming for surgical removal of spinal cord and brain stem lesions. "( Stummer, W; Suero Molina, E, 2018)
"Fluorescein sodium is a safe dye; it can be used to aid in precise localization and safe maximal resection of the pathologic tissue with the help of a blue light source at any center with challenged resources. "( Ginjupally, DR; Gollapudi, PR; Kotha, AR; Mohammed, I; Pittala, SR; Reddycherla, NR, 2018)
"Fluorescein is a chemical dye frequently used in eye diseases to assess blood flow in the retina, choroid tissue, and iris. "( Aydin, I; Kalkan, A; Turedi, S, 2015)
"Fluorescein sodium is a fluorescent tracer used for retinal and neurosurgical angiography but not yet for lymphatic supermicrosurgery."( Ayestaray, B; Bekara, F, 2015)
"Fluorescein is a representative green fluorophore that has been widely used as a scaffold of practically useful green fluorescent probes. "( Egawa, T; Hanaoka, K; Hirabayashi, K; Kamiya, M; Komatsu, T; Nagano, T; Takayanagi, T; Terai, T; Toki, Y; Uchiyama, M; Ueno, T; Urano, Y; Yoshida, K, 2015)
"Fluorescein dye is a sensitive test for determining native mastectomy skin flap viability after autologous reconstruction; however, viability is underpredicted. "( Carlson, GW; Losken, A; Schaefer, TG; Styblo, TM, 2008)
"Fluorescein is a fluorochrome dye occasionally administered by intrathecal injection to identify and localize cerebrospinal fluid leaks. "( Dilger, JA; Hebl, JR; Jacob, AK, 2008)
"Fluorescein sodium is a fluorescent molecule that has been used specifically in ophthalmology for the treatment of retinal angiography. "( Cohen-Gadol, AA; Rey-Dios, R, 2013)
"Fluorescein is a marker-dye customary applied to the evaluation of tight-junctional permeability of epithelial cell monolayers. "( Hagiwara, K; Konishi, Y; Shimizu, M, 2002)
"Fluorescein is a widely used fluorescent probe in DNA analysis. "( Gryczynski, I; Lakowicz, JR; Malicka, J, 2003)
"Fluorescein is a simple and rapid means of evaluating traumatized intestine, and it may prove to be a useful adjunct to the clinical examination."( Brotman, S; Cowley, RA; Marzella, L; Mayer, J, 1984)
"[fluorescein Lys3]SP is an agonist at the human NK1 receptor, with an affinity for both the high-affinity and low-affinity binding states of the receptor approximately 6-fold lower than that of substance P."( Daniel, S; Fong, TM; Longmore, J; Mazina, KE; Sirotina, A; Strader, CD; Tota, MR, 1994)
"Fluorescein is an effective dye for immediate and transient localization of trans-scleral transplants to the subretinal space. "( Cox, C; Das, T; del Cerro, C; del Cerro, M; DiLoreto, DA, 1997)
"Fluorescein and Cy3 are an important donor-acceptor pair of fluorophores; the characteristic Förster length for this pair on DNA is 56 A, so the pair can be used to study relatively long distances."( Grainger, RJ; Lilley, DM; Norman, DG; Uhrín, D, 2000)
"Oral fluorescein angiography is an efficient and highly sensitive tool for the detection of macular oedema. "( Kritzinger, EE; Razvi, FM; Ryder, RE; Tsaloumas, MD, 2001)
"Fluorescein angiography is a routine procedure in ophthalmology. "( Mole, T, 1991)
"Fluorescein angiography is an application of the physical phenomenon of fluorescence, which is phosphorescence in which the quantum mechanical decay curve is so rapid that it appears instantaneous, and it consequently has no afterglow. "( Wolfe, DR, 1986)

Effects

ExcerptReference
"Fluorescein has a significantly low distribution in the brain (contrast with the level in adipose tissue indicates the low ability to penetrate the blood-brain barrier)."( Bures, J; Kopacova, M; Kunes, M; Kvetina, J; Malakova, J; Rejchrt, S, 2010)
"Fluorescein has an extremely low luminescence intensity in acidic aqueous media. "( Jung, DY; Kang, C; Kang, D; Kim, HJ; Suh, M, 2003)
"Fluorescein dye has been used for tumour detection in colon, stomach, breast and brain."( Bhatt, K; Gupta, SD; Kharbanda, OP; Kumawat, R; Mishra, D; Pandey, RM; Qaiser, D; Sood, A; Srivastava, A; Yadav, R, 2020)
"Fluorescein has recently been reintroduced into neurosurgery, and novel microscope systems are available for visualizing this fluorochrome, which highlights all perfused tissues but has limited selectivity for tumor detection."( Brokinkel, B; Ehrhardt, A; Ewelt, C; Stummer, W; Suero Molina, E; Wölfer, J, 2018)
"Fluorescein has been found as an efficient visible-light-induced oxidase mimic and its catalytic performance is group-dependent. "( Gao, C; Liao, B; Liu, L; Shi, Y; Sun, C; Tang, M; Zhang, X; Zheng, H, 2019)
"Fluorescein has been used for rapid and sensitive detection of fish skin and corneal ulceration. "( Davis, MW; Noga, EJ; Stephenson, J, 2008)
"This fluorescein variant has two readily accessible functional groups (aniline NH2 and phenol OH) that can be activated or blocked independently and can serve, for instance, as a fluorescent bridge between two different recognition motifs."( Avadisian, M; Fletcher, S; Gradinaru, CC; Gunning, PT; Liu, B, 2009)
"Fluorescein has a significantly low distribution in the brain (contrast with the level in adipose tissue indicates the low ability to penetrate the blood-brain barrier)."( Bures, J; Kopacova, M; Kunes, M; Kvetina, J; Malakova, J; Rejchrt, S, 2010)
"Fluorescein has also been conjugated to rat plasma proteins."( HESS, EL; SCHAYER, RW; SCHILLER, AA, 1953)
"Fluorescein has an extremely low luminescence intensity in acidic aqueous media. "( Jung, DY; Kang, C; Kang, D; Kim, HJ; Suh, M, 2003)
"Fluorescein has been used for many years in medicine for diagnostic purposes and is widely safe, albeit intravenous bolus injection may cause serious adverse reactions. "( O'goshi, K; Serup, J, 2006)
"Fluorescein sodium has been used in 13 cases, and achieved effective stainability in all cases."( Kataoka, K; Okuda, T; Taneda, M, 2007)
"Fluorescein staining has been used to assess the viability of many tissues, and in the present study discolouration was compared with fluorescein staining."( Holmström, A, 1984)
"Fluorescein has been shown to meet these requirements."( Brunning, S; Chadwick, P; Cunningham, M; Durrant, I; Eccleston, L, 1995)
"Fluorescein has been shown not to hinder the hairpin formation and to give an additional protection against nucleases."( Chinsky, L; Jollès, B; Laigle, A; Réfrégiers, M, 1996)
"Fluorescein has been used in the field of neurosurgery; however, fluorescein enhancement or contrast proved to be inadequate because of a lack of appropriate light sources or filters. "( Kajimoto, Y; Kuroiwa, T; Ohta, T, 1998)
"Fluorescein has proved to be consistent and reliable, and the dermofluorometer has the advantage of using smaller fluorescein doses that can be frequently repeated."( Reinisch, JF; Sloan, GM, 1985)

Actions

ExcerptReference
"Fluorescein did not cause any significant change in the NITBUT of HK-Chinese and the instillation of fluorescein in one eye does not affect the NITBUT of the fellow eye."( Brown, B; Cho, P; Lau, C, 1996)

Roles (2)

RoleDescription
radioopaque mediumA substance having the property of absorbing, and therefore being opaque to, electromagnetic radiation, particularly X-rays.
fluorescent dyenull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
xanthene dyeA dye derived by condensation of phthalic anhydride with resorcinol (and derivatives) or m-aminophenol (and derivatives).
gamma-lactoneA lactone having a five-membered lactone ring.
polyphenolMembers of the class of phenols that contain 2 or more benzene rings each of which is substituted by at least one hydroxy group.
oxaspiro compoundA spiro compound in which at least one of the cyclic components is an oxygen heterocyle.
2-benzofurans
organic heteropentacyclic compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (35)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency29.90330.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency0.00940.004023.8416100.0000AID485290
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency47.55950.125919.1169125.8920AID2549; AID504841
Chain A, Ferritin light chainEquus caballus (horse)Potency35.48135.623417.292931.6228AID485281
acetylcholinesteraseHomo sapiens (human)Potency0.56380.002541.796015,848.9004AID1347398
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency43.64653.189029.884159.4836AID1224846
SMAD family member 2Homo sapiens (human)Potency35.59640.173734.304761.8120AID1346859; AID1346924; AID1347035
SMAD family member 3Homo sapiens (human)Potency35.59640.173734.304761.8120AID1346859; AID1346924; AID1347035
Microtubule-associated protein tauHomo sapiens (human)Potency0.63100.180013.557439.8107AID1460
AR proteinHomo sapiens (human)Potency22.34000.000221.22318,912.5098AID743035; AID743036; AID743040; AID743053; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency54.48270.000657.913322,387.1992AID1259377; AID1259378
progesterone receptorHomo sapiens (human)Potency54.48270.000417.946075.1148AID1346784; AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency30.27980.000214.376460.0339AID720691; AID720692; AID720719
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency76.95880.003041.611522,387.1992AID1159553
retinoid X nuclear receptor alphaHomo sapiens (human)Potency28.21450.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency5.53780.001530.607315,848.9004AID1224841; AID1224842; AID1259401
farnesoid X nuclear receptorHomo sapiens (human)Potency25.71160.375827.485161.6524AID743217; AID743220; AID743239
pregnane X nuclear receptorHomo sapiens (human)Potency21.68990.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency27.58530.000229.305416,493.5996AID743069; AID743075; AID743078; AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency26.10140.001024.504861.6448AID743212; AID743215; AID743227
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency25.98500.001019.414170.9645AID743094; AID743140; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency17.63000.023723.228263.5986AID743222; AID743223; AID743241
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency10.00000.035520.977089.1251AID504332
aryl hydrocarbon receptorHomo sapiens (human)Potency21.68990.000723.06741,258.9301AID743085
activating transcription factor 6Homo sapiens (human)Potency41.24340.143427.612159.8106AID1159516; AID1159519
thyrotropin-releasing hormone receptorHomo sapiens (human)Potency0.34550.154917.870243.6557AID1346877; AID1346891
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency48.972219.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency34.09540.057821.109761.2679AID1159526; AID1159528
Bloom syndrome protein isoform 1Homo sapiens (human)Potency28.93420.540617.639296.1227AID2528
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency51.05300.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency29.97580.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency25.55730.000627.21521,122.0200AID743202; AID743219
DNA polymerase kappa isoform 1Homo sapiens (human)Potency30.77890.031622.3146100.0000AID588579
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency29.90330.251215.843239.8107AID504327
Cellular tumor antigen p53Homo sapiens (human)Potency38.18180.002319.595674.0614AID651631; AID720552
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (124)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1422649Binding affinity to Escherichia coli SurA at 5 nM by fluorescence anisotropy2018Bioorganic & medicinal chemistry letters, 12-01, Volume: 28, Issue:22
Identification of inhibitors of the E. coli chaperone SurA using in silico and in vitro techniques.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5,873)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990828 (14.10)18.7374
1990's1072 (18.25)18.2507
2000's1707 (29.07)29.6817
2010's1738 (29.59)24.3611
2020's528 (8.99)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials283 (4.55%)5.53%
Reviews148 (2.38%)6.00%
Case Studies224 (3.60%)4.05%
Observational30 (0.48%)0.25%
Other5,529 (88.98%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
fluorescein 5-maleimide[no description available]medium10
cyclosporine[no description available]medium419
indigo carmine[no description available]medium41
phenazopyridine[no description available]medium52diaminopyridine;
monoazo compound		anticoronaviral agent;
carcinogenic agent;
local anaesthetic;
non-narcotic analgesic
zineb[no description available]medium10dithiocarbamate salt;
macromolecule;
zinc coordination entity		antifungal agrochemical
maneb[no description available]medium10
nabam[no description available]medium10dithiocarbamic acids
silver[no description available]medium150copper group element atom;
elemental silver		Escherichia coli metabolite
indocyanine green[no description available]medium11531,1-diunsubstituted alkanesulfonate;
benzoindole;
cyanine dye
sodium hydroxide[no description available]medium50alkali metal hydroxide
rhodamine b[no description available]medium550organic chloride salt;
xanthene dye		fluorescent probe;
fluorochrome;
histological dye
sulfuric acid[no description available]medium20sulfur oxoacidcatalyst
perfluorophenanthrene[no description available]medium10fluorocarbonradioopaque medium
rhodamine 123[no description available]medium210organic cation;
xanthene dye		fluorochrome
colistin[no description available]medium10
glycerol[no description available]medium170alditol;
triol		algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
hydrogen sulfide[no description available]medium110gas molecular entity;
hydracid;
mononuclear parent hydride;
sulfur hydride		Escherichia coli metabolite;
genotoxin;
metabolite;
signalling molecule;
toxin;
vasodilator agent
fluorescein-5-isothiocyanate[no description available]medium1351fluorescein isothiocyanate
nadp[no description available]medium50
benoxinate[no description available]medium82amino acid ester;
benzoate ester;
substituted aniline;
tertiary amino compound		drug allergen;
local anaesthetic;
topical anaesthetic
procaine[no description available]medium132benzoate ester;
substituted aniline;
tertiary amino compound		central nervous system depressant;
drug allergen;
local anaesthetic;
peripheral nervous system drug
trehalose[no description available]medium91trehaloseEscherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pilocarpine[no description available]medium131pilocarpineantiglaucoma drug
eosine yellowish-(ys)[no description available]medium240organic sodium salt;
organobromine compound		fluorochrome;
histological dye
gadolinium[no description available]medium70f-block element atom;
lanthanoid atom
cobalt[no description available]medium70cobalt group element atom;
metal allergen		micronutrient
xanthenes[no description available]medium630xanthene
diethyl chlorophosphate[no description available]medium10
mitomycin[no description available]medium80mitomycinalkylating agent;
antineoplastic agent
singlet oxygen[no description available]medium110chalcogen;
monoatomic oxygen;
nonmetal atom		macronutrient
carbon monoxide[no description available]medium40carbon oxide;
gas molecular entity;
one-carbon compound		biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent
picric acid[no description available]medium30C-nitro compoundantiseptic drug;
explosive;
fixative
yttrium[no description available]medium20d-block element atom;
rare earth metal atom;
scandium group element atom
acrylamide[no description available]medium30acrylamides;
N-acylammonia;
primary carboxamide		alkylating agent;
carcinogenic agent;
Maillard reaction product;
mutagen;
neurotoxin
yttria[no description available]medium10
evans blue[no description available]medium400organic sodium saltfluorochrome;
histological dye;
sodium channel blocker;
teratogenic agent
aminolevulinic acid[no description available]medium1804-oxo monocarboxylic acid;
amino acid zwitterion;
delta-amino acid		antineoplastic agent;
dermatologic drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
atropine[no description available]medium40
delphinidin[no description available]medium50anthocyanidin chloride
berberine[no description available]medium20alkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound		antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker
betadex[no description available]medium110cyclodextrin
peroxynitrous acid[no description available]medium120nitrogen oxoacid
ruthenium[no description available]medium60iron group element atom;
platinum group metal atom
calixarenes[no description available]medium40
calix(4)arene[no description available]medium10
gamma-aminobutyric acid[no description available]medium70amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid		human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule
glutamic acid[no description available]medium170glutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
methotrexate[no description available]medium180dicarboxylic acid;
monocarboxylic acid amide;
pteridines		abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
betamethasone[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		anti-asthmatic agent;
anti-inflammatory drug;
immunosuppressive agent
diquafosol[no description available]medium167pyrimidine ribonucleoside 5'-tetraphosphate;
uridine 5'-phosphate		mouse metabolite;
P2Y2 receptor agonist
warfarin[no description available]medium390benzenes;
hydroxycoumarin;
methyl ketone
gold[no description available]medium600copper group element atom;
elemental gold
scopolamine hydrobromide[no description available]medium20
isothiocyanic acid[no description available]medium390hydracid;
one-carbon compound
tetracycline[no description available]medium40
levofloxacin[no description available]medium109-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;
fluoroquinolone antibiotic;
quinolone antibiotic		antibacterial drug;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
varenicline[no description available]medium11
cellulose[no description available]medium190glycoside
methamphetamine[no description available]medium40amphetamines;
secondary amine		central nervous system stimulant;
environmental contaminant;
neurotoxin;
psychotropic drug;
xenobiotic
alpha-synuclein[no description available]medium20
hypochlorous acid[no description available]medium50chlorine oxoacid;
reactive oxygen species		EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
human metabolite
silicon[no description available]medium200carbon group element atom;
metalloid atom;
nonmetal atom
acridine orange[no description available]medium130aminoacridines;
aromatic amine;
tertiary amino compound		fluorochrome;
histological dye
azides[no description available]medium190pseudohalide anionmitochondrial respiratory-chain inhibitor
fluorine[no description available]medium40diatomic fluorine;
gas molecular entity		NMR chemical shift reference compound
fluorides[no description available]medium50halide anion;
monoatomic fluorine
folic acid[no description available]medium161folic acids;
N-acyl-amino acid		human metabolite;
mouse metabolite;
nutrient
benzotriazole[no description available]medium10benzotriazolesenvironmental contaminant;
xenobiotic
thiophenes[no description available]medium116mancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound		non-polar solvent
cysteine[no description available]medium420cysteiniumfundamental metabolite
rivaroxaban[no description available]medium10aromatic amide;
lactam;
monocarboxylic acid amide;
morpholines;
organochlorine compound;
oxazolidinone;
thiophenes		anticoagulant;
EC 3.4.21.6 (coagulation factor Xa) inhibitor
paraquat[no description available]medium50organic cationgeroprotector;
herbicide
cyanamide[no description available]medium20nitrile;
one-carbon compound		EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor
riboflavin[no description available]medium141flavin;
vitamin B2		anti-inflammatory agent;
antioxidant;
cofactor;
Escherichia coli metabolite;
food colouring;
fundamental metabolite;
human urinary metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite
furosemide[no description available]medium61chlorobenzoic acid;
furans;
sulfonamide		environmental contaminant;
loop diuretic;
xenobiotic
dodecaborate[no description available]medium10
interleukin-8[no description available]medium50
hydrazine[no description available]medium150azane;
hydrazines		EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
ketoprofen[no description available]medium40benzophenones;
oxo monocarboxylic acid		antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
naproxen[no description available]medium10methoxynaphthalene;
monocarboxylic acid		antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
lactoferrin[no description available]medium20
lysophosphatidic acid[no description available]medium201-acyl-sn-glycerol 3-phosphate
chitosan[no description available]medium290
erythrosine[no description available]medium1,47538
tellurium[no description available]medium20chalcogen;
metalloid atom
cadmium telluride[no description available]medium20
opc 12759[no description available]medium72secondary carboxamide
methylene blue[no description available]medium242organic chloride saltacid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer
lidocaine[no description available]medium61benzenes;
monocarboxylic acid amide;
tertiary amino compound		anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
lysine[no description available]medium141aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid		algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
phenylalanine[no description available]medium121amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid		algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
tryptophan[no description available]medium160erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan		antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
okadaic acid[no description available]medium20ketal
malondialdehyde[no description available]medium50dialdehydebiomarker
ovalbumin[no description available]medium140
d-alpha tocopherol[no description available]medium60alpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
tocophersolan[no description available]medium10tocol
benzophenoneidum[no description available]medium10hydrochloridefluorochrome;
histological dye
biotin[no description available]medium1020biotins;
vitamin B7		coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite
2-propanol[no description available]medium210secondary alcohol;
secondary fatty alcohol		protic solvent
2-propanol[no description available]medium211secondary alcohol;
secondary fatty alcohol		protic solvent
ochratoxin a[no description available]medium30isochromanes;
monocarboxylic acid amide;
N-acyl-L-phenylalanine;
organochlorine compound;
phenylalanine derivative		Aspergillus metabolite;
calcium channel blocker;
carcinogenic agent;
mycotoxin;
nephrotoxin;
Penicillium metabolite;
teratogenic agent
2,4-dichlorophenoxyacetic acid[no description available]medium30chlorophenoxyacetic acid;
dichlorobenzene		agrochemical;
defoliant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
environmental contaminant;
phenoxy herbicide;
synthetic auxin
tobramycin[no description available]medium31amino cyclitol glycosideantibacterial agent;
antimicrobial agent;
toxin
arginyl-glycyl-aspartic acid[no description available]medium50oligopeptide
heptanol[no description available]medium20heptanol;
primary alcohol		flavouring agent;
fragrance;
gap junctional intercellular communication inhibitor;
plant metabolite
vancomycin[no description available]medium30glycopeptideantibacterial drug;
antimicrobial agent;
bacterial metabolite
methane[no description available]medium110alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound		bacterial metabolite;
fossil fuel;
greenhouse gas
deoxyuridine[no description available]medium40pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pifithrin[no description available]medium10aromatic ketone
curcumin[no description available]medium50aromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
deoxycytidine[no description available]medium20pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
diclofenac[no description available]medium74amino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound		antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
ferrous chloride[no description available]medium10iron coordination entity
safranine t[no description available]medium20organic chloride saltfluorochrome;
histological dye
nile red[no description available]medium120aromatic amine;
cyclic ketone;
organic heterotetracyclic compound;
tertiary amino compound		fluorochrome;
histological dye
oligonucleotides[no description available]medium730
coumarin[no description available]medium210coumarinsfluorescent dye;
human metabolite;
plant metabolite
arginine[no description available]medium330arginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
glycyrrhizic acid[no description available]medium41enone;
glucosiduronic acid;
pentacyclic triterpenoid;
tricarboxylic acid;
triterpenoid saponin		EC 3.4.21.5 (thrombin) inhibitor;
plant metabolite
phosphatidylcholines[no description available]medium2801,2-diacyl-sn-glycero-3-phosphocholine
cerium[no description available]medium20f-block element atom;
lanthanoid atom
pyridine[no description available]medium20azaarene;
mancude organic heteromonocyclic parent;
monocyclic heteroarene;
pyridines		environmental contaminant;
NMR chemical shift reference compound
cocaine[no description available]medium50benzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid		adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
orabase[no description available]medium82
sphingosine[no description available]medium50sphing-4-eninehuman metabolite;
mouse metabolite
sphingosine 1-phosphate[no description available]medium40sphingoid 1-phosphatemouse metabolite;
signalling molecule;
sphingosine-1-phosphate receptor agonist;
T-cell proliferation inhibitor;
vasodilator agent
rhodamine 6g[no description available]medium320
sepharose[no description available]medium70
ibuprofen[no description available]medium60monocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
omega-n-methylarginine[no description available]medium130amino acid zwitterion;
arginine derivative;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
agar[no description available]medium30
caffeine[no description available]medium40purine alkaloid;
trimethylxanthine		adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
n-acetylneuraminic acid[no description available]medium40N-acetylneuraminic acidsantioxidant;
bacterial metabolite;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
human metabolite;
mouse metabolite
erucyl amide[no description available]medium2013-docosenamideEC 3.1.1.7 (acetylcholinesterase) inhibitor;
human metabolite;
mammalian metabolite;
plant metabolite;
rat metabolite
fullerene c60[no description available]medium30fullerenegeroprotector
cyanides[no description available]medium60pseudohalide anionEC 1.9.3.1 (cytochrome c oxidase) inhibitor
carbocyanines[no description available]medium380cyanine dye;
organic iodide salt		fluorochrome
1-anilino-8-naphthalenesulfonate[no description available]medium70aminonaphthalene;
naphthalenesulfonic acid		fluorescent probe
digoxigenin[no description available]medium25012beta-hydroxy steroid;
14beta-hydroxy steroid;
3beta-hydroxy steroid;
3beta-sterol		hapten;
plant metabolite
transforming growth factor beta[no description available]medium70
dithiothreitol[no description available]medium701,4-dimercaptobutane-2,3-diol;
butanediols;
dithiol;
glycol;
thiol		chelator;
human metabolite;
reducing agent
sodium dodecyl sulfate[no description available]medium70organic sodium saltdetergent;
protein denaturant
thiazoles[no description available]medium1201,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
mirabegron[no description available]medium101,3-thiazoles;
aromatic amide;
ethanolamines;
monocarboxylic acid amide		beta-adrenergic agonist
osmium[no description available]medium10iron group element atom;
platinum group metal atom
dapi[no description available]medium110indolesfluorochrome
acetylcysteine[no description available]medium20acetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid		antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
europium[no description available]medium80f-block element atom;
lanthanoid atom
terbium[no description available]medium70f-block element atom;
lanthanoid atom
curium[no description available]medium10actinoid atom;
f-block element atom
enterobactin[no description available]medium20catechols;
crown compound;
macrotriolide;
polyphenol		bacterial metabolite;
siderophore
4,4'-bipyridyl[no description available]medium10bipyridine
3,3',5,5'-tetramethylbenzidine[no description available]medium30
uridine triphosphate[no description available]medium120pyrimidine ribonucleoside 5'-triphosphate;
uridine 5'-phosphate		Escherichia coli metabolite;
mouse metabolite
rg108[no description available]medium10indolyl carboxylic acid
homocysteine[no description available]medium60amino acid zwitterion;
homocysteine;
serine family amino acid		fundamental metabolite;
mouse metabolite
sulfites[no description available]medium20divalent inorganic anion;
sulfur oxide;
sulfur oxoanion
dalteparin[no description available]medium10
cyclic gmp[no description available]medium1703',5'-cyclic purine nucleotide;
guanyl ribonucleotide		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
muramidase[no description available]medium240
(3-mercaptopropyl)trimethoxysilane[no description available]medium10
limestone[no description available]medium10calcium salt;
carbonate salt;
inorganic calcium salt;
one-carbon compound		antacid;
fertilizer;
food colouring;
food firming agent
phosphine[no description available]medium20mononuclear parent hydride;
phosphanes;
phosphine		carcinogenic agent;
fumigant insecticide
n-methyladenosine[no description available]medium10methyladenosine
adenosine[no description available]medium130adenosines;
purines D-ribonucleoside		analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
pyrroles[no description available]medium50pyrrole;
secondary amine
sodium sulfide[no description available]medium20
sodium bisulfide[no description available]medium10
tricyclazole[no description available]medium10triazolobenzothiazoleantifungal agrochemical;
melanin synthesis inhibitor
glucose, (beta-d)-isomer[no description available]medium50D-glucopyranoseepitope;
mouse metabolite
ascorbic acid[no description available]medium150ascorbic acid;
vitamin C		coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline[no description available]medium20naphthalenes;
sulfonic acid derivative
quinoxalines[no description available]medium62mancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene
thiazolyl blue[no description available]medium60organic bromide saltcolorimetric reagent;
dye
ammonium sulfate[no description available]medium10ammonium salt;
inorganic sulfate salt		fertilizer
ammonium peroxydisulfate[no description available]medium10
durapatite[no description available]medium71
n,n,n',n'-tetramethylethylenediamine[no description available]medium10ethylenediamine derivativecatalyst;
chelator
6-carboxyfluorescein[no description available]medium280monocarboxylic acid
texas red[no description available]medium250organic heteroheptacyclic compoundfluorochrome
fluorouracil[no description available]medium50nucleobase analogue;
organofluorine compound		antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
coenzyme q10[no description available]medium10ubiquinonesantioxidant;
ferroptosis inhibitor;
human metabolite
ubiquinone[no description available]medium10
dehydroepiandrosterone[no description available]medium1017-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
androstanoid		androgen;
human metabolite;
mouse metabolite
tropicamide[no description available]medium52acetamides
propoxycaine[no description available]medium112benzoate ester
proxymetacaine[no description available]medium112benzoate ester
phenyl acetate[no description available]medium61benzenes;
phenyl acetates
glycine[no description available]medium61alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid		EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
aluminum phthalocyanine[no description available]medium10organic molecular entity
phthalocyanine[no description available]medium20phthalocyanines;
tetrapyrrole fundamental parent
proflavine[no description available]medium10aminoacridinesantibacterial agent;
antiseptic drug;
carcinogenic agent;
chromophore;
intercalator
protoporphyrin ix[no description available]medium60
acetic acid[no description available]medium60monocarboxylic acidantimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent
iodine[no description available]medium40halide anion;
monoatomic iodine		human metabolite
zithromax[no description available]medium33macrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
esculin[no description available]medium11beta-D-glucoside;
hydroxycoumarin		antioxidant;
metabolite
pectins[no description available]medium20D-galactopyranuronic acid
ethyl cellulose[no description available]medium40glycoside
lactic acid[no description available]medium2802-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
capsaicin[no description available]medium50capsaicinoidnon-narcotic analgesic;
TRPV1 agonist;
voltage-gated sodium channel blocker
5-aminolevulinic acid hexyl ester[no description available]medium10organonitrogen compound;
organooxygen compound
selenocysteine[no description available]medium20
lissamine rhodamine b[no description available]medium110
deoxycholic acid[no description available]medium50bile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid		human blood serum metabolite
1,2-dilauroylphosphatidylcholine[no description available]medium201,2-diacyl-sn-glycero-3-phosphocholine(1+)
zinc sulfate[no description available]medium10metal sulfate;
zinc molecular entity		fertilizer
oregon green 488 carboxylic acid[no description available]medium80xanthene dyeepitope;
fluorochrome
tetracaine[no description available]medium30benzoate ester;
tertiary amino compound		local anaesthetic
mercury[no description available]medium110elemental mercury;
zinc group element atom		neurotoxin
4,5-diaminofluorescein diacetate[no description available]medium860
ferric chloride[no description available]medium20iron coordination entityastringent;
Lewis acid
chlorine[no description available]medium120halide anion;
monoatomic chlorine		cofactor;
Escherichia coli metabolite;
human metabolite
balafilcon a[no description available]medium10
methylcellulose[no description available]medium93
enkephalin, leucine[no description available]medium30pentapeptide;
peptide zwitterion		analgesic;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist;
neurotransmitter;
rat metabolite
biphalin[no description available]medium10
maleimide[no description available]medium50dicarboximide;
maleimides		EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
enkephalin, d-penicillamine (2,5)-[no description available]medium10heterodetic cyclic peptidedelta-opioid receptor agonist
heparitin sulfate[no description available]medium30
bromodeoxyuridine[no description available]medium50pyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
stilbenes[no description available]medium50stilbene
mannitol[no description available]medium181mannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
cobaltous chloride[no description available]medium20cobalt salt;
inorganic chloride		allergen;
calcium channel blocker;
sensitiser;
two-colour indicator
hydralazine[no description available]medium30azaarene;
hydrazines;
ortho-fused heteroarene;
phthalazines		antihypertensive agent;
vasodilator agent
2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein[no description available]medium10
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid[no description available]medium40
salicylates[no description available]medium60monohydroxybenzoateplant metabolite
gamma-glycidoxypropyltrimethoxysilane[no description available]medium20
bromodeoxyuridine triphosphate[no description available]medium10
triamcinolone acetonide[no description available]medium6111beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone		anti-allergic agent;
anti-inflammatory drug
plastoquinone[no description available]medium32plastoquinone
epichlorohydrin[no description available]medium30epoxide;
organochlorine compound
arsenic[no description available]medium100metalloid atom;
pnictogen		micronutrient
2',7'-dichlorofluorescein[no description available]medium602-benzofuransfluorochrome
alanine[no description available]medium81alanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
carbostyril[no description available]medium71monohydroxyquinoline;
quinolone		bacterial xenobiotic metabolite
piperidines[no description available]medium40
tetramethylrhodamine[no description available]medium410xanthene dye
dipicolinic acid[no description available]medium10pyridinedicarboxylic acidbacterial metabolite
tromethamine[no description available]medium20primary amino compound;
triol		buffer
5-carboxytetramethylrhodamine succinimidyl ester[no description available]medium120
neutral red[no description available]medium30hydrochlorideacid-base indicator;
dye;
two-colour indicator
glycolipids[no description available]medium30
naphthalimides[no description available]medium20
9,10-diphenylanthracene[no description available]medium10anthracenesfluorochrome;
photosensitizing agent
phenylacetylene[no description available]medium10benzenes
benzeneboronic acid[no description available]medium20boronic acids
acetylene[no description available]medium20alkyne;
gas molecular entity;
terminal acetylenic compound
naphthoquinones[no description available]medium20
lycorine[no description available]medium10indolizidine alkaloidanticoronaviral agent;
antimalarial;
plant metabolite;
protein synthesis inhibitor
acrylic acid[no description available]medium80alpha,beta-unsaturated monocarboxylic acidmetabolite
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid[no description available]medium30azamacrocyclechelator;
copper chelator
loteprednol etabonate[no description available]medium2211beta-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
etabonate ester;
organochlorine compound;
steroid acid ester;
steroid ester		anti-inflammatory drug
diphenylamine[no description available]medium10aromatic amine;
bridged diphenyl fungicide;
secondary amino compound		antifungal agrochemical;
antioxidant;
carotogenesis inhibitor;
EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor;
ferroptosis inhibitor;
radical scavenger
robenacoxib[no description available]medium10aromatic amino acid;
monocarboxylic acid;
organofluorine compound;
phenylacetic acids;
secondary amino compound		cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
lucifer yellow[no description available]medium150organic lithium saltfluorochrome
potassium periodate[no description available]medium10
metaperiodate[no description available]medium30iodine oxoacid
catechol[no description available]medium10catecholsallelochemical;
genotoxin;
plant metabolite
tinopal[no description available]medium10
triethoxysilane[no description available]medium10
mobic[no description available]medium101,3-thiazoles;
benzothiazine;
monocarboxylic acid amide		analgesic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
propidium[no description available]medium90phenanthridines;
quaternary ammonium ion		fluorochrome;
intercalator
deuterium oxide[no description available]medium20deuterated compound;
water		NMR solvent
choline[no description available]medium20cholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
sinapine[no description available]medium10acylcholineantioxidant;
photosynthetic electron-transport chain inhibitor;
plant metabolite
xenon[no description available]medium40monoatomic xenon;
noble gas atom;
p-block element atom
thiourea[no description available]medium60one-carbon compound;
thioureas;
ureas		antioxidant;
chromophore
fipronil[no description available]medium10(trifluoromethyl)benzenes;
dichlorobenzene;
nitrile;
primary amino compound;
pyrazoles;
sulfoxide
aflatoxin b1[no description available]medium40aflatoxin;
aromatic ether;
aromatic ketone		carcinogenic agent;
human metabolite
furaldehyde[no description available]medium10aldehyde;
furans		Maillard reaction product;
metabolite
5-hydroxymethylfurfural[no description available]medium10arenecarbaldehyde;
furans;
primary alcohol		indicator;
Maillard reaction product
quinine[no description available]medium30cinchona alkaloidantimalarial;
muscle relaxant;
non-narcotic analgesic
resveratrol[no description available]medium40resveratrolantioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger
quercetin[no description available]medium407-hydroxyflavonol;
pentahydroxyflavone		antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
inosine[no description available]medium20inosines;
purines D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
concanavalin a[no description available]medium120
sulforhodamine 101[no description available]medium50organic heteroheptacyclic compoundfluorochrome
cellulase[no description available]medium30cellotriose
lignin[no description available]medium20
prednisolone[no description available]medium5111beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
prednisolone acetate[no description available]medium10corticosteroid hormone
morphine[no description available]medium50morphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
chondroitin sulfates[no description available]medium60
substance p[no description available]medium110peptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
sq-23377[no description available]medium20cyclic ether;
enol;
polyunsaturated fatty acid;
very long-chain fatty acid		calcium ionophore;
metabolite
dermatan sulfate[no description available]medium30amino disaccharide;
glycosylgalactose derivative;
iduronic acids;
oligosaccharide sulfate
ebselen[no description available]medium20benzoselenazoleanti-inflammatory drug;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 3.5.4.1 (cytosine deaminase) inhibitor;
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor;
enzyme mimic;
ferroptosis inhibitor;
genotoxin;
hepatoprotective agent;
neuroprotective agent;
radical scavenger
trimethyloxamine[no description available]medium10tertiary amine oxideEscherichia coli metabolite;
metabolite;
osmolyte
1,1-diphenyl-2-picrylhydrazyl[no description available]medium30
fluorexon[no description available]medium130xanthene dyefluorochrome
fluorexon[no description available]medium131xanthene dyefluorochrome
deferoxamine[no description available]medium40acyclic desferrioxaminebacterial metabolite;
ferroptosis inhibitor;
iron chelator;
siderophore
9-(dicyanovinyl)julolidine[no description available]medium10
n-hydroxysuccinimide[no description available]medium30
ophiobolin a[no description available]medium10cyclic ketone;
enal;
oxaspiro compound;
sesterterpenoid;
tertiary alcohol
urea[no description available]medium60isourea;
monocarboxylic acid amide;
one-carbon compound		Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
glucosamine[no description available]medium10D-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
nile blue[no description available]medium20
latanoprost[no description available]medium72isopropyl ester;
prostaglandins Falpha;
triol		antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor;
prodrug
tetramethylrhodamine isothiocyanate[no description available]medium70
n-(4-(7-(diethylamino)-4-methylcoumarin-3-yl))maleimide[no description available]medium20
benzothiazoline[no description available]medium10
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene[no description available]medium160BODIPY compound
metazachlor[no description available]medium10aromatic amide;
organochlorine compound;
pyrazoles		environmental contaminant;
herbicide;
xenobiotic
oxalic acid[no description available]medium40alpha,omega-dicarboxylic acidalgal metabolite;
human metabolite;
plant metabolite
bromide[no description available]medium50halide anion;
monoatomic bromine
ozone[no description available]medium20elemental molecule;
gas molecular entity;
reactive oxygen species;
triatomic oxygen		antiseptic drug;
disinfectant;
electrophilic reagent;
greenhouse gas;
mutagen;
oxidising agent;
tracer
formaldehyde[no description available]medium100aldehyde;
one-carbon compound		allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
platinum[no description available]medium40elemental platinum;
nickel group element atom;
platinum group metal atom
dinoprostone[no description available]medium80prostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
pyrogallol[no description available]medium10benzenetriol;
phenolic donor		plant metabolite
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid[no description available]medium100chromanol;
monocarboxylic acid;
phenols		antioxidant;
ferroptosis inhibitor;
neuroprotective agent;
radical scavenger;
Wnt signalling inhibitor
pyrogallol sulfonphthalein[no description available]medium10
isoborneol[no description available]medium10borneol
oxazoles[no description available]medium201,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
guanosine triphosphate[no description available]medium40guanosine 5'-phosphate;
purine ribonucleoside 5'-triphosphate		Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
bourgeonal[no description available]medium10
paclitaxel[no description available]medium90taxane diterpenoid;
tetracyclic diterpenoid		antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
quinone methide[no description available]medium10quinomethane
metformin[no description available]medium10guanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
n-methylaspartate[no description available]medium60amino dicarboxylic acid;
D-alpha-amino acid;
D-aspartic acid derivative;
secondary amino compound		neurotransmitter agent
ifenprodil[no description available]medium10piperidines
ambroxol[no description available]medium11aromatic amine
propyl gallate[no description available]medium20trihydroxybenzoic acid
rhodamine 110[no description available]medium70
fibrin[no description available]medium50peptide
glucuronic acid[no description available]medium70D-glucuronic acidalgal metabolite
luminol[no description available]medium90
proline[no description available]medium41amino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid		algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
leucine[no description available]medium31amino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1-monooleoyl-rac-glycerol[no description available]medium201-acylglycerol 18:1;
monooleoylglycerol		plant metabolite
erythrosine[no description available]medium160
pyronine[no description available]medium20iminium salt;
organic chloride salt		histological dye
rhinacanthin-c[no description available]medium10
camptothecin[no description available]medium20delta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol		antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
rifampin[no description available]medium10cyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion		angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
torsemide[no description available]medium10aminopyridine;
N-sulfonylurea;
secondary amino compound		antihypertensive agent;
loop diuretic
transferrin[no description available]medium160
hepes[no description available]medium20HEPES;
organosulfonic acid
lithium[no description available]medium40alkali metal atom
3,3'-dioctadecylindocarbocyanine[no description available]medium30Cy5 dye;
indolium ion		fluorochrome
octaarginine[no description available]medium30
glycosides[no description available]medium10
afimoxifene[no description available]medium30phenols;
tertiary amino compound		antineoplastic agent;
estrogen receptor antagonist;
metabolite
tamoxifen[no description available]medium30stilbenoid;
tertiary amino compound		angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
gamma-linolenic acid[no description available]medium64linolenic acid;
omega-6 fatty acid		human metabolite;
mouse metabolite;
plant metabolite
sybr green i[no description available]medium60benzothiazolium ion;
cyanine dye;
quinolines;
tertiary amine		fluorescent dye
resazurin[no description available]medium60phenoxazine
1-bromohexadecane[no description available]medium10
2-(dimethylamino)ethyl methacrylate[no description available]medium10
1-bromohexane[no description available]medium10
1-bromopropane[no description available]medium10bromoalkane;
bromohydrocarbon		neurotoxin;
solvent
dimethylaminododecyl methacrylate[no description available]medium10
xanthene-9-carboxylic acid[no description available]medium10xanthenes
apaflurane[no description available]medium10
y 27632[no description available]medium20aromatic amide
mci 9038[no description available]medium10peptide
trichloroacetic acid[no description available]medium30monocarboxylic acid;
organochlorine compound		carcinogenic agent;
metabolite;
mouse metabolite
anthracene[no description available]medium40acene;
anthracenes;
ortho-fused tricyclic hydrocarbon
benzoic acid[no description available]medium50benzoic acidsalgal metabolite;
antimicrobial food preservative;
drug allergen;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
human xenobiotic metabolite;
plant metabolite
amyloid beta-peptides[no description available]medium20
acriflavine[no description available]medium60
cyclopentolate[no description available]medium10carboxylic ester;
tertiary alcohol;
tertiary amino compound		diagnostic agent;
muscarinic antagonist;
mydriatic agent;
parasympatholytic
glyburide[no description available]medium30monochlorobenzenes;
N-sulfonylurea		anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
dorzolamide[no description available]medium96sulfonamide;
thiophenes		antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
timolol[no description available]medium103timololanti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
triethylene glycol dimethacrylate[no description available]medium20
cefotaxime[no description available]medium201,3-thiazoles;
cephalosporin;
oxime O-ether		antibacterial drug;
drug allergen
sar 1118[no description available]medium111-benzofurans;
isoquinolines;
L-phenylalanine derivative;
N-acyl-L-alpha-amino acid;
sulfone		anti-inflammatory drug;
lymphocyte function-associated antigen-1 antagonist
cryptophane a[no description available]medium10
dexamethasone 21-phosphate[no description available]medium1011beta-hydroxy steroid;
17-hydroxy steroid;
3-oxo-Delta(4) steroid;
fluorinated steroid;
steroid phosphate;
tertiary alpha-hydroxy ketone		glucocorticoid receptor agonist
ethyldimethylaminopropyl carbodiimide[no description available]medium20
phosphoric acid[no description available]medium30phosphoric acidsalgal metabolite;
fertilizer;
human metabolite;
NMR chemical shift reference compound;
solvent
kainic acid[no description available]medium10dicarboxylic acid;
L-proline derivative;
non-proteinogenic L-alpha-amino acid;
pyrrolidinecarboxylic acid		antinematodal drug;
excitatory amino acid agonist
natriuretic peptide, c-type[no description available]medium10
phenolsulfonphthalein[no description available]medium1112,1-benzoxathiole;
arenesulfonate ester;
phenols;
sultone		acid-base indicator;
diagnostic agent;
two-colour indicator
elastin[no description available]medium40oligopeptide
hydrochloric acid[no description available]medium40chlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride		mouse metabolite
prisma-fil[no description available]medium10
thrombin aptamer[no description available]medium10
kanamycin a[no description available]medium10kanamycinsbacterial metabolite
octadecyl palmitate[no description available]medium21hexadecanoate ester;
wax ester		coral metabolite;
cosmetic
povidone-iodine[no description available]medium51
nicotine[no description available]medium603-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate[no description available]medium10
triclosan[no description available]medium11aromatic ether;
dichlorobenzene;
monochlorobenzenes;
phenols		antibacterial agent;
antimalarial;
drug allergen;
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
fungicide;
persistent organic pollutant;
xenobiotic
acetone[no description available]medium30ketone body;
methyl ketone;
propanones;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
fenton's reagent[no description available]medium30
pyruvaldehyde[no description available]medium402-oxo aldehyde;
propanals		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
4,5-diaminofluorescein[no description available]medium851
perfluorodecalin[no description available]medium10fluorocarbonblood substitute;
solvent
1,2-oleoylphosphatidylcholine[no description available]medium40phosphatidylcholine(1+)
qx-314[no description available]medium10monocarboxylic acid amidelocal anaesthetic
titanium[no description available]medium40titanium group element atom
wortmannin[no description available]medium40acetate ester;
cyclic ketone;
delta-lactone;
organic heteropentacyclic compound		anticoronaviral agent;
antineoplastic agent;
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector;
Penicillium metabolite;
radiosensitizing agent
mk 2206[no description available]medium10organic heterotricyclic compoundEC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
caprylates[no description available]medium20fatty acid anion 8:0;
straight-chain saturated fatty acid anion		human metabolite;
Saccharomyces cerevisiae metabolite
oleic acid[no description available]medium30octadec-9-enoic acidantioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent
dipalmitoylphosphatidic acid[no description available]medium10phosphatidic acid
1,2-dipalmitoylphosphatidylcholine[no description available]medium40
deoxyguanosine triphosphate[no description available]medium10deoxyguanosine phosphate;
guanyl deoxyribonucleotide;
purine 2'-deoxyribonucleoside 5'-triphosphate		Arabidopsis thaliana metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
isosorbide dinitrate[no description available]medium10glucitol derivative;
nitrate ester		nitric oxide donor;
vasodilator agent
isosorbide-5-mononitrate[no description available]medium10glucitol derivative;
nitrate ester		nitric oxide donor;
vasodilator agent
mocetinostat[no description available]medium80aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline		antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
n-vinyl-2-pyrrolidinone[no description available]medium82pyrrolidin-2-ones
methanol[no description available]medium110alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound		amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
ethidium[no description available]medium230phenanthridinesfluorochrome;
intercalator
hydroxide ion[no description available]medium30oxygen hydridemouse metabolite
calcium phosphate, dibasic, dihydrate[no description available]medium10calcium salt;
hydrate
tricalcium phosphate[no description available]medium50calcium phosphate
salicylaldehyde[no description available]medium10hydroxybenzaldehydenematicide;
plant metabolite
ferulic acid[no description available]medium30ferulic acidsanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
MALDI matrix material;
plant metabolite
didodecyldimethylammonium[no description available]medium10
citrulline[no description available]medium20amino acid zwitterion;
citrulline		Daphnia magna metabolite;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
protective agent;
Saccharomyces cerevisiae metabolite
toluene 2,4-diisocyanate[no description available]medium10toluene meta-diisocyanateallergen;
hapten
2-hydroxyethyl acrylate[no description available]medium10
cytidine monophosphate[no description available]medium20cytidine 5'-phosphate;
pyrimidine ribonucleoside 5'-monophosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
hydrogen[no description available]medium60elemental hydrogen;
elemental molecule;
gas molecular entity		antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
sodium iodide[no description available]medium20inorganic sodium salt;
iodide salt
1,1'-diethyl-2,2'-cyanine[no description available]medium101,1'-diethyl-2,2'-cyanine;
quinolines
thyronines[no description available]medium10thyronine
imidazole[no description available]medium30imidazole
2-naphthol[no description available]medium40naphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
procyanidin[no description available]medium10proanthocyanidin
palladium[no description available]medium40metal allergen;
nickel group element atom;
platinum group metal atom
thioctic acid[no description available]medium10dithiolanes;
heterocyclic fatty acid;
thia fatty acid		fundamental metabolite;
geroprotector
vitamin b 12[no description available]medium70
colchicine[no description available]medium30alkaloid;
colchicine		anti-inflammatory agent;
gout suppressant;
mutagen
catechin[no description available]medium50catechinantioxidant;
plant metabolite
gallic acid[no description available]medium30trihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite
alkenes[no description available]medium30
thiacalix(4)arene[no description available]medium10
3-nitrotyrosine[no description available]medium102-nitrophenols;
C-nitro compound;
nitrotyrosine;
non-proteinogenic alpha-amino acid
tyrosine[no description available]medium140amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine		EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
pyrene[no description available]medium70ortho- and peri-fused polycyclic arenefluorescent probe;
persistent organic pollutant
zoledronic acid[no description available]medium101,1-bis(phosphonic acid);
imidazoles		bone density conservation agent
taurocholic acid[no description available]medium40amino sulfonic acid;
bile acid taurine conjugate		human metabolite
7-aminocoumarin[no description available]medium10
toluene[no description available]medium20methylbenzene;
toluenes;
volatile organic compound		cholinergic antagonist;
fuel additive;
neurotoxin;
non-polar solvent
bafilomycin a1[no description available]medium10cyclic hemiketal;
macrolide antibiotic;
oxanes		apoptosis inducer;
autophagy inhibitor;
bacterial metabolite;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor;
ferroptosis inhibitor;
fungicide;
potassium ionophore;
toxin
simvastatin[no description available]medium20delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic)		EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug
lovastatin[no description available]medium10delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)		anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug
omeprazole[no description available]medium10aromatic ether;
benzimidazoles;
pyridines;
sulfoxide
heme[no description available]medium20
thiocyanate[no description available]medium20pseudohalide anion;
sulfur molecular entity		human metabolite
l-lysine methyl ester[no description available]medium10L-lysyl ester
gliotoxin[no description available]medium10dipeptide;
organic disulfide;
organic heterotetracyclic compound;
pyrazinoindole		antifungal agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
immunosuppressive agent;
mycotoxin;
proteasome inhibitor
dihydrotestosterone[no description available]medium1017beta-hydroxy steroid;
17beta-hydroxyandrostan-3-one;
3-oxo-5alpha-steroid		androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
naphthofluorescein[no description available]medium10xanthenes
4-dimethylaminopyridine[no description available]medium10dialkylarylamine;
tertiary amino compound
4-aminopyridine[no description available]medium20aminopyridine;
aromatic amine		avicide;
orphan drug;
potassium channel blocker
azetidine[no description available]medium10azacycloalkane;
azetidines;
saturated organic heteromonocyclic parent
hexachlorocyclotriphosphazene[no description available]medium10
n-acetylhistidine[no description available]medium10L-histidine derivative;
N-acetyl-L-amino acid;
N-acetylhistidine		animal metabolite
4-hydroxyphenylacetic acid[no description available]medium10monocarboxylic acid;
phenols		fungal metabolite;
human metabolite;
mouse metabolite;
plant metabolite
histidine[no description available]medium110amino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
imidazoleacetic acid[no description available]medium10imidazoles;
monocarboxylic acid		metabolite;
mouse metabolite
1-methyl-3-ethylimidazolium[no description available]medium101-alkyl-3-methylimidazolium
fluorosulfonic acid[no description available]medium10sulfur oxoacidNMR solvent
fluorometholone[no description available]medium4211beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
tertiary alpha-hydroxy ketone		anti-inflammatory drug
gemcitabine[no description available]medium10organofluorine compound;
pyrimidine 2'-deoxyribonucleoside		antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
thymosin beta(4)[no description available]medium11
thymosin[no description available]medium11
gentian violet[no description available]medium80organic chloride saltanthelminthic drug;
antibacterial agent;
antifungal agent;
antiseptic drug;
histological dye
thiosemicarbazide[no description available]medium20hydrazines;
thiocarboxamide;
thioureas
metaperiodate[no description available]medium20iodine oxoanion;
monovalent inorganic anion
bpc 157[no description available]medium10
2-aminopurine[no description available]medium202-aminopurines;
nucleobase analogue		antimetabolite
laponite[no description available]medium20
lead[no description available]medium20carbon group element atom;
elemental lead;
metal atom		neurotoxin
sanguinarine[no description available]medium10alkaloid antibiotic;
benzophenanthridine alkaloid;
botanical anti-fungal agent
chelerythrine[no description available]medium10benzophenanthridine alkaloid;
organic cation		antibacterial agent;
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
cascade blue[no description available]medium10aminonaphthalenefluorochrome
amiloride[no description available]medium60aromatic amine;
guanidines;
organochlorine compound;
pyrazines		diuretic;
sodium channel blocker
atorvastatin[no description available]medium10aromatic amide;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrroles;
statin (synthetic)		environmental contaminant;
xenobiotic
thioridazine[no description available]medium10phenothiazines;
piperidines		alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
n-isopropylacrylamide[no description available]medium10
citric acid, anhydrous[no description available]medium20tricarboxylic acidantimicrobial agent;
chelator;
food acidity regulator;
fundamental metabolite
ajoene[no description available]medium10sulfoxide
sarcosine[no description available]medium20N-alkylglycine zwitterion;
N-alkylglycine;
N-methyl-amino acid;
N-methylglycines		Escherichia coli metabolite;
glycine receptor agonist;
glycine transporter 1 inhibitor;
human metabolite;
mouse metabolite
efinaconazole[no description available]medium11conazole antifungal drug;
olefinic compound;
organofluorine compound;
piperidines;
tertiary alcohol;
tertiary amino compound;
triazole antifungal drug		EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
triazoles[no description available]medium921,2,3-triazole
pulmicort[no description available]medium3011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic acetal;
glucocorticoid;
primary alpha-hydroxy ketone		anti-inflammatory drug;
bronchodilator agent;
drug allergen
budesonide, formoterol fumarate drug combination[no description available]medium10
pyridoxine[no description available]medium20hydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6		cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
retinol[no description available]medium20retinol;
vitamin A		human metabolite;
mouse metabolite;
plant metabolite
retinol palmitate[no description available]medium20all-trans-retinyl ester;
retinyl palmitate		antioxidant;
Escherichia coli metabolite;
human xenobiotic metabolite
glyoxal[no description available]medium10dialdehydeagrochemical;
allergen;
pesticide;
plant growth regulator
guanidine[no description available]medium10carboxamidine;
guanidines;
one-carbon compound
adenosine monophosphate[no description available]medium50adenosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate		adenosine A1 receptor agonist;
cofactor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.11 (fructose-bisphosphatase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
guanosine monophosphate[no description available]medium10guanosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate		biomarker;
Escherichia coli metabolite;
metabolite;
mouse metabolite
tyramine[no description available]medium80monoamine molecular messenger;
primary amino compound;
tyramines		EC 3.1.1.8 (cholinesterase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter
chromium[no description available]medium30chromium group element atom;
metal allergen		micronutrient
glycerylphosphorylcholine[no description available]medium10glycerophosphocholine
sodium borohydride[no description available]medium10inorganic sodium salt;
metal tetrahydridoborate
melamine[no description available]medium20triamino-1,3,5-triazinexenobiotic metabolite
cimetidine[no description available]medium50aliphatic sulfide;
guanidines;
imidazoles;
nitrile		adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
valproic acid[no description available]medium50branched-chain fatty acid;
branched-chain saturated fatty acid		anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
benzoylphenylalanine[no description available]medium102-(benzoylamino)-3-phenylpropanoic acid;
N-acyl-L-phenylalanine
cytochrome c-t[no description available]medium60
dimethylsulfonioacetate[no description available]medium10sulfonium betaine
betaine[no description available]medium20amino-acid betaine;
glycine derivative		fundamental metabolite
n-methylolacrylamide[no description available]medium10secondary carboxamide
holmium[no description available]medium10f-block element atom;
lanthanoid atom
epidermal growth factor[no description available]medium30
framycetin[no description available]medium30aminoglycosideallergen;
antibacterial drug;
Escherichia coli metabolite
firefly luciferin[no description available]medium301,3-thiazolemonocarboxylic acid;
benzothiazoles;
imidothioate		luciferin
2-cyanobenzothiazole[no description available]medium10
limonene[no description available]medium40cycloalkene;
p-menthadiene		human metabolite
3-mercaptopropionic acid[no description available]medium10mercaptopropanoic acidalgal metabolite
cysteamine[no description available]medium30amine;
thiol		geroprotector;
human metabolite;
mouse metabolite;
radiation protective agent
baicalein[no description available]medium10trihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger
baicalin[no description available]medium10dihydroxyflavone;
glucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative		antiatherosclerotic agent;
antibacterial agent;
anticoronaviral agent;
antineoplastic agent;
antioxidant;
cardioprotective agent;
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
ferroptosis inhibitor;
neuroprotective agent;
non-steroidal anti-inflammatory drug;
plant metabolite;
prodrug
verapamil[no description available]medium60aromatic ether;
nitrile;
polyether;
tertiary amino compound
nitroxyl[no description available]medium10nitrogen oxoacid
mebeverine[no description available]medium10
3-hydroxybutyric acid[no description available]medium11(omega-1)-hydroxy fatty acid;
3-hydroxy monocarboxylic acid;
hydroxybutyric acid		human metabolite
caseins[no description available]medium60
iodoacetamide[no description available]medium40
cadaverine[no description available]medium60alkane-alpha,omega-diamineDaphnia magna metabolite;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite
phencyclidine[no description available]medium40benzenes;
piperidines		anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
mesalamine[no description available]medium10amino acid;
aromatic amine;
monocarboxylic acid;
monohydroxybenzoic acid;
phenols		non-steroidal anti-inflammatory drug
azathioprine[no description available]medium20aryl sulfide;
C-nitro compound;
imidazoles;
thiopurine		antimetabolite;
antineoplastic agent;
carcinogenic agent;
DNA synthesis inhibitor;
hepatotoxic agent;
immunosuppressive agent;
prodrug
neurokinin b[no description available]medium10polypeptide
dihydroethidium[no description available]medium40
benzofurans[no description available]medium10
gw9508[no description available]medium10aromatic amine
flag peptide[no description available]medium10peptide
tak-875[no description available]medium10biphenyls
terbinafine[no description available]medium10acetylenic compound;
allylamine antifungal drug;
enyne;
naphthalenes;
tertiary amine		EC 1.14.13.132 (squalene monooxygenase) inhibitor;
P450 inhibitor;
sterol biosynthesis inhibitor
adenosine-5'-(n-ethylcarboxamide)[no description available]medium30adenosines;
monocarboxylic acid amide		adenosine A1 receptor agonist;
adenosine A2A receptor agonist;
antineoplastic agent;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
daptomycin[no description available]medium10
formazans[no description available]medium20
tyrosinamide[no description available]medium10amino acid amide;
L-tyrosine derivative
corticosterone[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone		human metabolite;
mouse metabolite
methylamine[no description available]medium20methylamines;
one-carbon compound;
primary aliphatic amine		mouse metabolite
cobrotoxin[no description available]medium10
neurotoxin ii, naja naja oxiana[no description available]medium10
brilliant green[no description available]medium10organic hydrogensulfate saltantibacterial agent;
antiseptic drug;
environmental contaminant;
fluorochrome;
histological dye;
poison
palmitic acid[no description available]medium10long-chain fatty acid;
straight-chain saturated fatty acid		algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite
nickel[no description available]medium40metal allergen;
nickel group element atom		epitope;
micronutrient
metronidazole[no description available]medium10C-nitro compound;
imidazoles;
primary alcohol		antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic
hydroxyl radical[no description available]medium60oxygen hydride;
oxygen radical;
reactive oxygen species
tretinoin[no description available]medium60retinoic acid;
vitamin A		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
imiquimod[no description available]medium10imidazoquinolineantineoplastic agent;
interferon inducer
technetium[no description available]medium30manganese group element atom
ro13-9904[no description available]medium10
trimethoxyvinylsilane[no description available]medium10
tribromoethanol[no description available]medium10alcohol;
organobromine compound
xylazine[no description available]medium101,3-thiazine;
methylbenzene;
secondary amino compound		alpha-adrenergic agonist;
analgesic;
emetic;
muscle relaxant;
sedative
ketamine[no description available]medium10cyclohexanones;
monochlorobenzenes;
secondary amino compound		analgesic;
environmental contaminant;
intravenous anaesthetic;
neurotoxin;
NMDA receptor antagonist;
xenobiotic
butyltriphenylphosphonium[no description available]medium10
sulfur[no description available]medium20chalcogen;
nonmetal atom		macronutrient
nitrobenzene[no description available]medium10nitroarene;
nitrobenzenes
cytarabine[no description available]medium20beta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside		antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
kp372-1[no description available]medium10
maltodextrin[no description available]medium10
pyrethrins[no description available]medium20
cyfluthrin[no description available]medium10aromatic ether;
cyclopropanecarboxylate ester;
nitrile;
organochlorine compound;
organofluorine compound		agrochemical;
pyrethroid ester insecticide
cephalosporin c[no description available]medium50cephalosporinfungal metabolite
p-dimethylaminoazobenzene[no description available]medium80azobenzenes
4-(4-dimethylaminophenylazo)benzoic acid[no description available]medium80
c.i. 42510[no description available]medium110
iso-sulfan blue[no description available]medium50
kresoxim-methyl[no description available]medium10aromatic ether;
methoxyiminoacetate strobilurin antifungal agent;
methyl ester;
oxime O-ether		antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
xenobiotic
trifloxystrobin[no description available]medium10
picoxystrobin[no description available]medium10aromatic ether;
enoate ester;
enol ether;
methoxyacrylate strobilurin antifungal agent;
organofluorine compound;
pyridines		antifungal agrochemical;
mitochondrial cytochrome-bc1 complex inhibitor
furan[no description available]medium10furans;
mancude organic heteromonocyclic parent;
monocyclic heteroarene		carcinogenic agent;
hepatotoxic agent;
Maillard reaction product
salen[no description available]medium10
salophen[no description available]medium10
cresyl violet[no description available]medium10
fasudil[no description available]medium10isoquinolines;
N-sulfonyldiazepane		antihypertensive agent;
calcium channel blocker;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
geroprotector;
neuroprotective agent;
nootropic agent;
vasodilator agent
1-(5-isoquinolinesulfonyl)-2-methylpiperazine[no description available]medium30isoquinolines;
N-sulfonylpiperazine		EC 2.7.11.13 (protein kinase C) inhibitor
sucrose[no description available]medium100glycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
1,2-diaminoanthraquinone[no description available]medium10
5-dimethylaminonaphthalene-1-sulfonamide[no description available]medium10
ethylene glycol[no description available]medium51ethanediol;
glycol		metabolite;
mouse metabolite;
solvent;
toxin
2-aminoisobutyric acid[no description available]medium102,2-dialkylglycine zwitterion;
2,2-dialkylglycine
emerimicins[no description available]medium10
adenosine diphosphate[no description available]medium120adenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate		fundamental metabolite;
human metabolite
docetaxel anhydrous[no description available]medium20secondary alpha-hydroxy ketone;
tetracyclic diterpenoid		antimalarial;
antineoplastic agent;
photosensitizing agent
cholesteryl succinate[no description available]medium10cholestane ester;
dicarboxylic acid monoester;
hemisuccinate		detergent
indomethacin[no description available]medium181aromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole		analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
1,2-dioleoyloxy-3-(trimethylammonium)propane[no description available]medium40
resorcinarene[no description available]medium10
almagate[no description available]medium10
helium[no description available]medium20monoatomic helium;
noble gas atom;
s-block element atom		food packaging gas
ng-nitroarginine methyl ester[no description available]medium270alpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor
7-nitroindazole[no description available]medium20
indazoles[no description available]medium41indazole
meso-chlorin e(6) monoethylene diamine[no description available]medium10
n-(2-hydroxypropyl)methacrylamide[no description available]medium10
benzene[no description available]medium30aromatic annulene;
benzenes;
volatile organic compound		carcinogenic agent;
environmental contaminant;
non-polar solvent
resorufin[no description available]medium40phenoxazine
flash-edt2[no description available]medium10
naringenin[no description available]medium10(2S)-flavan-4-one;
naringenin		expectorant;
plant metabolite
phalloidine[no description available]medium50homodetic cyclic peptide
tricaine[no description available]medium10methanesulfonate saltgeneral anaesthetic
diphenylhexatriene[no description available]medium20alkatrienefluorochrome
etodolac[no description available]medium20monocarboxylic acid;
organic heterotricyclic compound		antipyretic;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
(hexadecanoyl)aminofluorescein[no description available]medium30
1-(4'-carboxyethyl)-6-diphenyl-1,3,5-hexatriene[no description available]medium10
vanadates[no description available]medium20trivalent inorganic anion;
vanadium oxoanion		EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
chlorhexidine[no description available]medium31biguanides;
monochlorobenzenes		antibacterial agent;
antiinfective agent
phenylthiourea[no description available]medium10thioureasEC 1.14.18.1 (tyrosinase) inhibitor
thymidine[no description available]medium50pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
benzamidine[no description available]medium10benzenes;
carboxamidine		serine protease inhibitor
ergonovine[no description available]medium10ergot alkaloid;
monocarboxylic acid amide;
organic heterotetracyclic compound;
primary alcohol;
secondary amino compound;
tertiary amino compound		diagnostic agent;
fungal metabolite;
oxytocic;
toxin
dicumarol[no description available]medium10hydroxycoumarinanticoagulant;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
Hsp90 inhibitor;
vitamin K antagonist
aniline[no description available]medium20anilines;
primary arylamine
phenolphthalein[no description available]medium30phenols
galactose[no description available]medium60D-galactose;
galactopyranose		Escherichia coli metabolite;
mouse metabolite
hirudin[no description available]medium30
niobium[no description available]medium10vanadium group element atom
sulfur hexafluoride[no description available]medium40sulfur coordination entitygreenhouse gas;
NMR chemical shift reference compound;
ultrasound contrast agent
coomassie brilliant blue[no description available]medium20
gadolinium dtpa[no description available]medium60gadolinium coordination entityMRI contrast agent
taxane[no description available]medium10diterpene;
terpenoid fundamental parent
cephalomannine[no description available]medium10
eosine i bluish[no description available]medium80organic sodium saltfluorescent dye;
histological dye
ciprofloxacin[no description available]medium31aminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion		antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
sodium fluoride[no description available]medium53fluoride saltmutagen
guanine[no description available]medium502-aminopurines;
oxopurine;
purine nucleobase		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
8-hydroxyguanine[no description available]medium10oxopurine
sodium nitrate[no description available]medium10inorganic nitrate salt;
inorganic sodium salt		fertilizer;
NMR chemical shift reference compound
alitretinoin[no description available]medium10retinoic acidantineoplastic agent;
keratolytic drug;
metabolite;
retinoid X receptor agonist
nitrates[no description available]medium81monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
cyanine dye 3[no description available]medium180
aspartic acid[no description available]medium50aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
3-(2-furoyl)quinoline-2-carbaldehyde[no description available]medium20
phenylephrine[no description available]medium50phenols;
phenylethanolamines;
secondary amino compound		alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
potassium nitrate[no description available]medium11inorganic nitrate salt;
potassium salt		fertilizer
theophylline[no description available]medium80dimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
s-(2,4-dinitrophenyl)glutathione[no description available]medium10glutathione conjugate
zinc oxide[no description available]medium30zinc molecular entity
all-bond 2[no description available]medium10
zearalenone[no description available]medium10macrolide;
resorcinols		fungal metabolite;
mycoestrogen
oxytetracycline, anhydrous[no description available]medium10
nitroarginine[no description available]medium40guanidines;
L-arginine derivative;
N-nitro compound;
non-proteinogenic L-alpha-amino acid
prednisolone hemisuccinate[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
hemisuccinate;
tertiary alpha-hydroxy ketone		anti-inflammatory drug
erythromycin[no description available]medium10cyclic ketone;
erythromycin
quinidine[no description available]medium10cinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
hydrogen carbonate[no description available]medium61carbon oxoanioncofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pentylenetetrazole[no description available]medium10organic heterobicyclic compound;
organonitrogen heterocyclic compound
piracetam[no description available]medium20organonitrogen compound;
organooxygen compound
levetiracetam[no description available]medium20pyrrolidin-2-onesanticonvulsant;
environmental contaminant;
xenobiotic
s-nitrosoglutathione[no description available]medium20glutathione derivative;
nitrosothio compound		bronchodilator agent;
nitric oxide donor;
platelet aggregation inhibitor;
signalling molecule
uric acid[no description available]medium20uric acidEscherichia coli metabolite;
human metabolite;
mouse metabolite
s-nitrosocysteinylglycine[no description available]medium10dipeptide;
nitroso compound;
nitrosothio compound
1-palmitoyl-2-oleoylphosphatidylcholine[no description available]medium40
dodecyltrimethylammonium[no description available]medium10quaternary ammonium ion
bisindolylmaleimide iii[no description available]medium10indoles;
maleimides		EC 2.7.11.13 (protein kinase C) inhibitor
staurosporine[no description available]medium30ammonium ion derivative
azobenzene[no description available]medium10azobenzenes
nitrites[no description available]medium90monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species		human metabolite
pyrophosphate[no description available]medium10diphosphate ion
edetic acid[no description available]medium150ethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid		anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector
5-(n-dodecanoyl)aminofluorescein[no description available]medium40
propranolol[no description available]medium40naphthalenes;
propanolamine;
secondary amine		anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
genistein[no description available]medium107-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
phytoestrogens[no description available]medium10
molybdenum[no description available]medium10chromium group element atommicronutrient
1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt[no description available]medium20organic molecular entity
molybdate ion[no description available]medium10divalent inorganic anion;
molybdenum oxoanion		Escherichia coli metabolite
triphenylphosphine[no description available]medium10benzenes;
tertiary phosphine		NMR chemical shift reference compound;
reducing agent
colforsin[no description available]medium50acetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol		adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist
egtazic acid[no description available]medium60diether;
tertiary amino compound;
tetracarboxylic acid		chelator
kinetensin[no description available]medium10oligopeptidehistamine releasing agent;
human metabolite
saccharin[no description available]medium111,2-benzisothiazole;
N-sulfonylcarboxamide		environmental contaminant;
sweetening agent;
xenobiotic
titanium dioxide[no description available]medium20titanium oxidesfood colouring
nifedipine[no description available]medium21C-nitro compound;
dihydropyridine;
methyl ester		calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
dimethyl sulfoxide[no description available]medium80sulfoxide;
volatile organic compound		alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger
sulfonyl chloride[no description available]medium10sulfuryl halide
n-methylpyrrole[no description available]medium10pyrroles
1-methylimidazole[no description available]medium10imidazoles
silicon nitride[no description available]medium20
combretastatin[no description available]medium10
alizarin[no description available]medium10dihydroxyanthraquinonechromophore;
dye;
plant metabolite
iloprost[no description available]medium30carbobicyclic compound;
monocarboxylic acid;
secondary alcohol		platelet aggregation inhibitor;
vasodilator agent
u 62840[no description available]medium10carbotricyclic compound;
carboxylic acid		antihypertensive agent;
cardiovascular drug;
human blood serum metabolite;
platelet aggregation inhibitor;
vasodilator agent;
vitamin K antagonist
n-methylpyrrolidone[no description available]medium20lactam;
N-alkylpyrrolidine;
pyrrolidin-2-ones		polar aprotic solvent
aluminum oxide[no description available]medium40
1-propyl-2-methyl-3-hydroxypyrid-4-one[no description available]medium10
hydroxyethylcellulose[no description available]medium40
acid green 50[no description available]medium92
5-aminofluorescein[no description available]medium10primary amino compound
1,2-diphytanoylphosphatidylcholine[no description available]medium10
copper sulfate[no description available]medium20metal sulfateemetic;
fertilizer;
sensitiser
protectin d1[no description available]medium10dihydroxydocosahexaenoic acid;
protectin;
secondary allylic alcohol		anti-inflammatory agent;
apoptosis inhibitor;
hepatoprotective agent;
human xenobiotic metabolite;
neuroprotective agent;
PPARgamma agonist;
specialised pro-resolving mediator
cyclofenil[no description available]medium10organic molecular entity
ethinyl estradiol[no description available]medium1017-hydroxy steroid;
3-hydroxy steroid;
terminal acetylenic compound		xenoestrogen
octane[no description available]medium10alkanexenobiotic
cetyltrimethylammonium ion[no description available]medium60quaternary ammonium ion
docusate[no description available]medium10diester;
organosulfonic acid
n-pentanol[no description available]medium10pentanol;
short-chain primary fatty alcohol		human metabolite;
plant metabolite
vantocil[no description available]medium32
biguanides[no description available]medium42guanidines
neostigmine[no description available]medium20quaternary ammonium ionantidote to curare poisoning;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
physostigmine[no description available]medium20carbamate ester;
indole alkaloid		antidote to curare poisoning;
EC 3.1.1.8 (cholinesterase) inhibitor;
miotic
2,3-naphthalenedicarboxaldehyde[no description available]medium10
sodium cyanide[no description available]medium10cyanide salt;
one-carbon compound;
sodium salt		EC 1.15.1.1 (superoxide dismutase) inhibitor
aspirin[no description available]medium51benzoic acids;
phenyl acetates;
salicylates		anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
vitamin k semiquinone radical[no description available]medium10
aluminum[no description available]medium30boron group element atom;
elemental aluminium;
metal atom
ag 1879[no description available]medium10aromatic amine;
monochlorobenzenes;
pyrazolopyrimidine		beta-adrenergic antagonist;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector
as 1411[no description available]medium10
spermine[no description available]medium60polyazaalkane;
tetramine		antioxidant;
fundamental metabolite;
immunosuppressive agent
ofloxacin[no description available]medium103-oxo monocarboxylic acid;
N-arylpiperazine;
N-methylpiperazine;
organofluorine compound;
oxazinoquinoline
selenium[no description available]medium40chalcogen;
nonmetal atom		micronutrient
nitrogen trioxide[no description available]medium10nitrogen oxide
trypan blue[no description available]medium191
acid phosphatase[no description available]medium10
sulfaphenazole[no description available]medium10primary amino compound;
pyrazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antibacterial drug;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor;
P450 inhibitor
lanthanum[no description available]medium30f-block element atom;
lanthanoid atom;
scandium group element atom
strontium[no description available]medium10alkaline earth metal atom
dronabinol[no description available]medium21benzochromene;
diterpenoid;
phytocannabinoid;
polyketide		cannabinoid receptor agonist;
epitope;
hallucinogen;
metabolite;
non-narcotic analgesic
cytosine[no description available]medium40aminopyrimidine;
pyrimidine nucleobase;
pyrimidone		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
quinoline[no description available]medium10azaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinolines
ammonium hydroxide[no description available]medium10inorganic hydroxy compoundfood acidity regulator
hyaluronoglucosaminidase[no description available]medium90
mannose[no description available]medium70D-aldohexose;
D-mannose;
mannopyranose		metabolite
fluorene[no description available]medium10ortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon
salicylic acid[no description available]medium70monohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
salicylic acid[no description available]medium71monohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
leucogentian violet[no description available]medium20benzenoid aromatic compound
thyroxine[no description available]medium702-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine		antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
fluorodeoxyglucose f18[no description available]medium202-deoxy-2-((18)F)fluoro-D-glucose;
2-deoxy-2-fluoro-aldehydo-D-glucose
maraviroc[no description available]medium10tropane alkaloid
vicriviroc[no description available]medium10(trifluoromethyl)benzenes
niacinamide[no description available]medium30pyridine alkaloid;
pyridinecarboxamide;
vitamin B3		anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor
aminophylline[no description available]medium10mixturebronchodilator agent;
cardiotonic drug
aluminum chloride[no description available]medium10aluminium coordination entityLewis acid
prednisone[no description available]medium1011-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
miltefosine[no description available]medium10phosphocholines;
phospholipid		anti-inflammatory agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antiprotozoal drug;
apoptosis inducer;
immunomodulator;
protein kinase inhibitor
phosphorylcholine[no description available]medium20phosphocholinesallergen;
epitope;
hapten;
human metabolite;
mouse metabolite
antimony potassium tartrate[no description available]medium10
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole[no description available]medium60benzoic acid;
imidazolines;
organic radical		apoptosis inhibitor;
radical scavenger
technetium tc 99m exametazime[no description available]medium10
carboxypolymethylene[no description available]medium10
propylene glycol[no description available]medium10glycol;
propane-1,2-diols		allergen;
human xenobiotic metabolite;
mouse metabolite;
protic solvent
roussin's red salt[no description available]medium10
propylene[no description available]medium10alkene;
gas molecular entity		refrigerant;
xenobiotic
myristamidopropyl dimethylamine[no description available]medium11
gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate[no description available]medium10
tacrolimus[no description available]medium20macrolide lactambacterial metabolite;
immunosuppressive agent
decanoic acid[no description available]medium20medium-chain fatty acid;
straight-chain saturated fatty acid		algal metabolite;
anti-inflammatory agent;
antibacterial agent;
human metabolite;
plant metabolite;
volatile oil component
propionic acid[no description available]medium20saturated fatty acid;
short-chain fatty acid		antifungal drug
1,2-dipalmitoyl-3-phosphatidylethanolamine[no description available]medium50
6-cyano-7-nitroquinoxaline-2,3-dione[no description available]medium10quinoxaline derivative
clofibric acid[no description available]medium10aromatic ether;
monocarboxylic acid;
monochlorobenzenes		anticholesteremic drug;
antilipemic drug;
antineoplastic agent;
herbicide;
marine xenobiotic metabolite;
PPARalpha agonist
adamantane[no description available]medium20adamantanes;
polycyclic alkane
sphingosine kinase[no description available]medium30
stearylamine[no description available]medium10primary aliphatic aminefilm-forming compound
oseltamivir[no description available]medium10acetamides;
amino acid ester;
cyclohexenecarboxylate ester;
primary amino compound		antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
environmental contaminant;
prodrug;
xenobiotic
iridium[no description available]medium10cobalt group element atom;
platinum group metal atom
13,19-didesmethyl spirolide c[no description available]medium10
hexadecanethiol[no description available]medium10
dimercaprol[no description available]medium10dithiol;
primary alcohol		chelator
8-aminohexylamino camp[no description available]medium10
leucomalachite green[no description available]medium10benzenoid aromatic compound
irsogladine[no description available]medium10dichlorobenzene
allopurinol[no description available]medium60nucleobase analogue;
organic heterobicyclic compound		antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
xanthine[no description available]medium20xanthineSaccharomyces cerevisiae metabolite
fusidic acid[no description available]medium3011alpha-hydroxy steroid;
3alpha-hydroxy steroid;
alpha,beta-unsaturated monocarboxylic acid;
steroid acid;
steroid antibiotic;
sterol ester		EC 2.7.1.33 (pantothenate kinase) inhibitor;
Escherichia coli metabolite;
protein synthesis inhibitor
potassium chloride[no description available]medium70inorganic chloride;
inorganic potassium salt;
potassium salt		fertilizer
triethanolamine[no description available]medium10amino alcohol;
tertiary amino compound;
triol		buffer;
surfactant
1,2-dimethylhydrazine[no description available]medium10hydrazinesalkylating agent;
carcinogenic agent
epigallocatechin gallate[no description available]medium20flavans;
gallate ester;
polyphenol		antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
norvancomycin[no description available]medium10
glycogen[no description available]medium20
sansalvamide a[no description available]medium10
sodium sulfite[no description available]medium10inorganic sodium salt;
sulfite salt		food preservative;
reducing agent
cesium[no description available]medium10alkali metal atom
cesium chloride[no description available]medium10inorganic caesium salt;
inorganic chloride		phase-transfer catalyst;
vasoconstrictor agent
g(m1) ganglioside[no description available]medium40alpha-N-acetylneuraminosyl-(2->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine;
sialotetraosylceramide
tartrazine[no description available]medium20
tetrahydrozoline[no description available]medium11carboxamidine;
imidazolines		nasal decongestant;
sympathomimetic agent
pyocyanine[no description available]medium20iminium betaine;
phenazines		antibacterial agent;
bacterial metabolite;
biological pigment;
virulence factor
fenofibrate[no description available]medium10aromatic ether;
chlorobenzophenone;
isopropyl ester;
monochlorobenzenes		antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
captopril[no description available]medium62alkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
neodymium[no description available]medium10f-block element atom;
lanthanoid atom
ytterbium[no description available]medium10f-block element atom;
lanthanoid atom
epiglucan[no description available]medium20
acetonitrile[no description available]medium30aliphatic nitrile;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
NMR chemical shift reference compound;
polar aprotic solvent
rimantadine[no description available]medium10alkylamine
3,5-diiodothyronine[no description available]medium10organonitrogen compound;
organooxygen compound
inositol 1,4,5-trisphosphate[no description available]medium30myo-inositol trisphosphatemouse metabolite
triiodothyronine[no description available]medium202-halophenol;
amino acid zwitterion;
iodophenol;
iodothyronine		human metabolite;
mouse metabolite;
thyroid hormone
2-aminoadipic acid[no description available]medium10amino dicarboxylic acid;
dicarboxylic fatty acid;
non-proteinogenic alpha-amino acid		Caenorhabditis elegans metabolite;
mammalian metabolite
7-aminocephalosporanic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acid;
amino acid zwitterion
1,7-phenanthroline[no description available]medium10phenanthroline
tris(4,7-diphenyl-1,10-phenanthroline)ruthenium (ii)[no description available]medium10ruthenium coordination entityfluorochrome
ethylene dichloride[no description available]medium10chloroethaneshepatotoxic agent;
mutagen;
non-polar solvent
methylene chloride[no description available]medium10chloromethanes;
volatile organic compound		carcinogenic agent;
polar aprotic solvent;
refrigerant
trifluoroacetic acid[no description available]medium10fluoroalkanoic acidhuman xenobiotic metabolite;
NMR chemical shift reference compound;
reagent
nitisinone[no description available]medium10(trifluoromethyl)benzenes;
C-nitro compound;
cyclohexanones;
mesotrione		EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor
tiletamine hydrochloride[no description available]medium20
serine[no description available]medium50L-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pyridoxal phosphate[no description available]medium10methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6 phosphate		coenzyme;
cofactor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
alloxan[no description available]medium10pyrimidonehyperglycemic agent;
metabolite
pimagedine[no description available]medium10guanidines;
one-carbon compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
EC 1.4.3.4 (monoamine oxidase) inhibitor
sodium tungstate(vi)[no description available]medium10inorganic sodium saltreagent
2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide[no description available]medium20
barium chloride[no description available]medium10barium salt;
inorganic chloride		potassium channel blocker
methyl-thiohydantoin-tryptophan[no description available]medium10organonitrogen compound;
organooxygen compound
geraniol[no description available]medium103,7-dimethylocta-2,6-dien-1-ol;
monoterpenoid;
primary alcohol		allergen;
fragrance;
plant metabolite;
volatile oil component
eucalyptol[no description available]medium10
cyclohexanol[no description available]medium10cyclohexanols;
secondary alcohol		solvent
brass[no description available]medium10
diaminorhodamine-4m[no description available]medium20
fibrinogen[no description available]medium50iditolfungal metabolite
alpha-cyano-4-hydroxycinnamate[no description available]medium60
1-propanol[no description available]medium30propan-1-ols;
short-chain primary fatty alcohol		metabolite;
protic solvent
ketorolac[no description available]medium10amino acid;
aromatic ketone;
monocarboxylic acid;
pyrrolizines;
racemate		analgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
nepafenac[no description available]medium10monocarboxylic acid amidecyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
lysophosphatidylcholines[no description available]medium301-O-acyl-sn-glycero-3-phosphocholine
carbonates[no description available]medium10carbon oxoanion
quinacrine[no description available]medium40acridines;
aromatic ether;
organochlorine compound;
tertiary amino compound		antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
daunorubicin[no description available]medium30aminoglycoside antibiotic;
anthracycline;
p-quinones;
tetracenequinones		antineoplastic agent;
bacterial metabolite
phosphoric acid, trisodium salt[no description available]medium20sodium phosphate
thromboplastin[no description available]medium40
arginyl-glycyl-aspartyl-phenylalanine[no description available]medium10
fura-2[no description available]medium80
threonine[no description available]medium10amino acid zwitterion;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
threonine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
fura-2-am[no description available]medium10
arsenic trioxide[no description available]medium10
2',7'-dichlorodihydrofluorescein diacetate[no description available]medium20
puromycin[no description available]medium30puromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
4-butyrolactone[no description available]medium10butan-4-olidemetabolite;
neurotoxin
sulfan blue[no description available]medium20organic molecular entity
antipyrine[no description available]medium30pyrazoloneantipyretic;
cyclooxygenase 3 inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
edaravone[no description available]medium20pyrazoloneantioxidant;
radical scavenger
pentetic acid[no description available]medium50pentacarboxylic acidcopper chelator
gramicidin a[no description available]medium10
diacetyldichlorofluorescein[no description available]medium30
diphenyleneiodonium[no description available]medium10organic cation
metallothionein[no description available]medium10
phosphorylethanolamine[no description available]medium20phosphoethanolamine;
primary amino compound		algal metabolite;
human metabolite;
mouse metabolite
cumene hydroperoxide[no description available]medium20peroxolenvironmental contaminant;
Mycoplasma genitalium metabolite;
oxidising agent
angiotensin i[no description available]medium20angiotensin;
peptide zwitterion		human metabolite;
neurotransmitter agent
angiotensin ii, des-phe(8)-[no description available]medium10amino acid zwitterion;
angiotensin		vasodilator agent
epalrestat[no description available]medium11monocarboxylic acid;
thiazolidines		EC 1.1.1.21 (aldehyde reductase) inhibitor
rhodanine[no description available]medium11thiazolidinone
thiazolidines[no description available]medium21thiazolidine
5-methylcytosine[no description available]medium10methylcytosine;
pyrimidines		human metabolite
antimony[no description available]medium10metalloid atom;
pnictogen
quinic acid[no description available]medium10
shikimic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acid;
cyclohexenecarboxylic acid;
hydroxy monocarboxylic acid		Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
diethylhexyl phthalate[no description available]medium10diester;
phthalate ester		androstane receptor agonist;
apoptosis inhibitor;
plasticiser
2-ethylhexanol[no description available]medium10primary alcoholplant metabolite;
volatile oil component
4-nonylphenol[no description available]medium10phenolsenvironmental contaminant
1-hexanol[no description available]medium20hexanol;
primary alcohol		alarm pheromone;
antibacterial agent;
fragrance;
plant metabolite
flutax 2[no description available]medium20
dehydroascorbic acid[no description available]medium10dehydroascorbic acid;
vitamin C		coenzyme;
mouse metabolite
dibutyl phthalate[no description available]medium10diester;
phthalate ester		EC 3.2.1.20 (alpha-glucosidase) inhibitor;
environmental contaminant;
metabolite;
plasticiser;
teratogenic agent
butylbenzyl phthalate[no description available]medium10benzyl ester
sodium azide[no description available]medium20inorganic sodium saltantibacterial agent;
explosive;
mitochondrial respiratory-chain inhibitor;
mutagen
epibatidine[no description available]medium20
3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate[no description available]medium101,1-diunsubstituted alkanesulfonate
u 78517f[no description available]medium20
2,2-dimethyl-5-hydroxy-1-pyrrolidinyloxy[no description available]medium10
buthionine sulfoximine[no description available]medium30diastereoisomeric mixture;
homocysteines;
non-proteinogenic alpha-amino acid;
sulfoximide		EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor;
ferroptosis inducer
phosphorus radioisotopes[no description available]medium51
oxalates[no description available]medium50
bis(2,4,6-trichlorophenyl)oxalate[no description available]medium10
calcimycin[no description available]medium40benzoxazole
thapsigargin[no description available]medium10butyrate ester;
organic heterotricyclic compound;
sesquiterpene lactone		calcium channel blocker;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
diquat[no description available]medium10organic cationdefoliant;
herbicide
mesotrione[no description available]medium10aromatic ketone;
beta-triketone;
C-nitro compound;
sulfone		carotenoid biosynthesis inhibitor;
EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor;
environmental contaminant;
herbicide;
xenobiotic
hexaconazole[no description available]medium10dichlorobenzene;
tertiary alcohol;
triazoles		chelator
indo-1[no description available]medium30indolesfluorochrome
suramin[no description available]medium20naphthalenesulfonic acid;
phenylureas;
secondary carboxamide		angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
ethidium homodimer[no description available]medium20
levobunolol[no description available]medium20aromatic ether;
cyclic ketone;
propanolamine		antiglaucoma drug;
beta-adrenergic antagonist
5-dimethylamiloride[no description available]medium10
proxyl nitroxide[no description available]medium10aminoxyls;
pyrrolidines		radical scavenger
edda[no description available]medium10amino dicarboxylic acid;
ethylenediamine derivative;
glycine derivative;
polyamino carboxylic acid		bacterial xenobiotic metabolite;
chelator
linoleic acid[no description available]medium53octadecadienoic acid;
omega-6 fatty acid		algal metabolite;
Daphnia galeata metabolite;
plant metabolite
gefarnate[no description available]medium10organic molecular entity
verlukast[no description available]medium20
n-formylmethionine leucyl-phenylalanine[no description available]medium40tripeptide
fluorescein-di-beta-d-galactopyranoside[no description available]medium10
angiotensin ii[no description available]medium90amino acid zwitterion;
angiotensin II		human metabolite
adenine[no description available]medium506-aminopurines;
purine nucleobase		Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
kinetin[no description available]medium106-aminopurines;
furans		cytokinin;
geroprotector
endothelin-1[no description available]medium40
6-ketocholestanol[no description available]medium10cholestanoid
phloretin[no description available]medium20dihydrochalconesantineoplastic agent;
plant metabolite
yohimbine[no description available]medium10methyl 17-hydroxy-20xi-yohimban-16-carboxylatealpha-adrenergic antagonist;
dopamine receptor D2 antagonist;
serotonergic antagonist
n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide[no description available]medium10aminoquinoline
alprostadil[no description available]medium42prostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
magnesium sulfate[no description available]medium20magnesium salt;
metal sulfate;
organic magnesium salt		anaesthetic;
analgesic;
anti-arrhythmia drug;
anticonvulsant;
calcium channel blocker;
cardiovascular drug;
fertilizer;
tocolytic agent
butaprost[no description available]medium10
leptin[no description available]medium30
carbocysteine[no description available]medium20L-cysteine thioether;
non-proteinogenic L-alpha-amino acid		mucolytic
thymine[no description available]medium10pyrimidine nucleobase;
pyrimidone		Escherichia coli metabolite;
human metabolite;
mouse metabolite
epsilon-(gamma-glutamyl)-lysine[no description available]medium10L-alpha-amino acid zwitterion;
N(6)-acyl-L-lysine
bromosuccinimide[no description available]medium20dicarboximide;
organobromine compound;
pyrrolidinone		reagent
ribose[no description available]medium20D-ribose;
ribopyranose
methyl red[no description available]medium30
isoproterenol[no description available]medium60catechols;
secondary alcohol;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
pentobarbital[no description available]medium10barbituratesGABAA receptor agonist
mustard gas[no description available]medium10ethyl sulfide;
organochlorine compound		alkylating agent;
carcinogenic agent;
vesicant
acridines[no description available]medium70acridines;
mancude organic heterotricyclic parent;
polycyclic heteroarene		genotoxin
iodine[no description available]medium80diatomic iodinenutrient
histamine[no description available]medium131aralkylamino compound;
imidazoles		human metabolite;
mouse metabolite;
neurotransmitter
phosphorus[no description available]medium20monoatomic phosphorus;
nonmetal atom;
pnictogen		macronutrient
cyanates[no description available]medium20
2-diethylaminoethanol[no description available]medium20ethanolamines;
primary alcohol;
tertiary amino compound
ethacridine[no description available]medium10acridines
osmium tetroxide[no description available]medium10osmium coordination entityfixative;
histological dye;
oxidising agent;
poison
chlorine[no description available]medium30diatomic chlorine;
gas molecular entity		bleaching agent
barium sulfate[no description available]medium10barium salt;
inorganic barium salt;
metal sulfate		radioopaque medium
barium[no description available]medium20alkaline earth metal atom;
elemental barium
dehydrocholic acid[no description available]medium2012-oxo steroid;
3-oxo-5beta-steroid;
7-oxo steroid;
oxo-5beta-cholanic acid		gastrointestinal drug
alcian blue[no description available]medium10
reserpine[no description available]medium10alkaloid ester;
methyl ester;
yohimban alkaloid		adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
hydrochlorothiazide[no description available]medium10benzothiadiazine;
organochlorine compound;
sulfonamide		antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
griseofulvin[no description available]medium101-benzofurans;
antibiotic antifungal drug;
benzofuran antifungal drug;
organochlorine compound;
oxaspiro compound		antibacterial agent;
Penicillium metabolite
chlortetracycline[no description available]medium10
butacaine[no description available]medium10benzoate ester
4-aminobenzoic acid[no description available]medium30aminobenzoate;
aromatic amino-acid anion		Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
nitrofurazone[no description available]medium10
atractyloside[no description available]medium10
flurbiprofen[no description available]medium65fluorobiphenyl;
monocarboxylic acid		antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
phosphothreonine[no description available]medium10L-threonine derivative;
non-proteinogenic L-alpha-amino acid;
O-phosphoamino acid		Escherichia coli metabolite
phorbol-12-myristate[no description available]medium10
ibopamine[no description available]medium11benzoate ester;
phenols
deoxyepinephrine[no description available]medium11catecholamine
dapiprazole[no description available]medium11N-alkylpiperazine;
N-arylpiperazine;
pyridines		alpha-adrenergic antagonist;
antipsychotic agent;
miotic;
ophthalmology drug
xylometazoline[no description available]medium10alkylbenzene
1-o-pentylglycerol[no description available]medium10
tocopherols[no description available]medium10
2,2'-azobis(2-amidinopropane)[no description available]medium30monoazo compound
tocotrienols[no description available]medium10diterpenoid
carbachol[no description available]medium20ammonium salt;
carbamate ester		cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic
trans-2,3',4,5'-tetrahydroxystilbene[no description available]medium10stilbenoid
chlorobutanol[no description available]medium30tertiary alcohol
epicatechin gallate[no description available]medium10catechin;
gallate ester;
polyphenol		EC 3.2.1.1 (alpha-amylase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
bimatoprost[no description available]medium11monocarboxylic acid amideantiglaucoma drug;
antihypertensive agent
cloprostenol[no description available]medium11prostanoid
travoprost[no description available]medium11(trifluoromethyl)benzenes;
isopropyl ester;
prostaglandins Falpha		antiglaucoma drug;
antihypertensive agent;
ophthalmology drug;
prodrug;
prostaglandin receptor agonist
2,4-pyridinedicarboxylic acid[no description available]medium10pyridinedicarboxylic acid
potassium permanganate[no description available]medium10
potassium chromate(vi)[no description available]medium10potassium saltcarcinogenic agent;
oxidising agent
phenytoin[no description available]medium20imidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
silver nitrate[no description available]medium20inorganic nitrate salt;
silver salt		astringent
chromates[no description available]medium10chromium oxoanion;
divalent inorganic anion		oxidising agent
masoprocol[no description available]medium10nordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite
brefeldin a[no description available]medium30macrolide antibioticPenicillium metabolite
yo-pro 1[no description available]medium10cyanine dye;
organic iodide salt;
quaternary ammonium salt		fluorochrome
gamma-cyclodextrin[no description available]medium10cyclodextrin
benzoxazoles[no description available]medium101,3-benzoxazoles;
mancude organic heterobicyclic parent
3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol[no description available]medium10
pyrazines[no description available]medium10diazine;
pyrazines		Daphnia magna metabolite
2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one[no description available]medium10
chitotriose[no description available]medium10
triptolide[no description available]medium10diterpenoid;
epoxide;
gamma-lactam;
organic heteroheptacyclic compound		antispermatogenic agent;
plant metabolite
phenanthrenes[no description available]medium20
brimonidine tartrate[no description available]medium42
cortisone[no description available]medium1011-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		human metabolite;
mouse metabolite
dichlorvos[no description available]medium10alkenyl phosphate;
dialkyl phosphate;
organochlorine acaricide;
organophosphate insecticide		anthelminthic drug;
antibacterial agent;
antifungal agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor
carbofuran[no description available]medium101-benzofurans;
carbamate ester		acaricide;
agrochemical;
avicide;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
nematicide
1,2-dielaidoylphosphatidylethanolamine[no description available]medium20
o(6)-benzylguanine[no description available]medium10
flavin-adenine dinucleotide[no description available]medium10flavin adenine dinucleotide;
vitamin B2		cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prosthetic group
flavin mononucleotide[no description available]medium20
gemfibrozil[no description available]medium10aromatic etherantilipemic drug
acyclovir[no description available]medium202-aminopurines;
oxopurine		antimetabolite;
antiviral drug
dinitrobenzenes[no description available]medium10
wrenchnolol[no description available]medium10
adamanolol[no description available]medium10
mifepristone[no description available]medium103-oxo-Delta(4) steroid;
acetylenic compound;
tertiary amino compound		abortifacient;
contraceptive drug;
hormone antagonist;
synthetic oral contraceptive
pimonidazole[no description available]medium10
o-(chloroacetylcarbamoyl)fumagillol[no description available]medium10carbamate ester;
organochlorine compound;
semisynthetic derivative;
sesquiterpenoid;
spiro-epoxide		angiogenesis inhibitor;
antineoplastic agent;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
methionine aminopeptidase 2 inhibitor;
retinoic acid receptor alpha antagonist
sesquiterpenes[no description available]medium10
azomycin[no description available]medium10C-nitro compound;
imidazoles		antitubercular agent
midazolam[no description available]medium10imidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound		anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
p-aminohippuric acid[no description available]medium130N-acylglycineDaphnia magna metabolite
clarithromycin[no description available]medium10macrolide antibioticantibacterial drug;
environmental contaminant;
protein synthesis inhibitor;
xenobiotic
phenformin[no description available]medium10biguanidesantineoplastic agent;
geroprotector;
hypoglycemic agent
tetrodotoxin[no description available]medium20azatetracycloalkane;
oxatetracycloalkane;
quinazoline alkaloid		animal metabolite;
bacterial metabolite;
marine metabolite;
neurotoxin;
voltage-gated sodium channel blocker
estrone sulfate[no description available]medium1017-oxo steroid;
steroid sulfate		human metabolite;
mouse metabolite
estrone[no description available]medium1017-oxo steroid;
3-hydroxy steroid;
phenolic steroid;
phenols		antineoplastic agent;
bone density conservation agent;
estrogen;
human metabolite;
mouse metabolite
sea 0400[no description available]medium10
7-methylguanosine-5'-monophosphate[no description available]medium10organophosphate oxoanion
ccf 2[no description available]medium10
caffeic acid[no description available]medium10caffeic acidgeroprotector;
mouse metabolite
chlorogenic acid[no description available]medium10cinnamate ester;
tannin		food component;
plant metabolite
sildenafil citrate[no description available]medium10citrate saltEC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
1-methyl-3-isobutylxanthine[no description available]medium203-isobutyl-1-methylxanthine
dizocilpine maleate[no description available]medium20maleate salt;
tetracyclic antidepressant		anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist
fast green fcf[no description available]medium10organic sodium saltfluorochrome;
food colouring;
histological dye
amido black[no description available]medium10
tetraethylammonium[no description available]medium20quaternary ammonium ion
phosphotyrosine[no description available]medium40L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid;
O(4)-phosphotyrosine		Escherichia coli metabolite;
immunogen
chloramphenicol[no description available]medium40C-nitro compound;
carboxamide;
diol;
organochlorine compound		antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
technetium tc 99m sulfur colloid[no description available]medium20
11-cis-retinal[no description available]medium40retinalchromophore;
human metabolite;
mouse metabolite
trinitrotoluene[no description available]medium10trinitrotolueneexplosive
imatinib mesylate[no description available]medium10methanesulfonate saltanticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
hoe 33342[no description available]medium40
thromboxane b2[no description available]medium20thromboxanes Bhuman metabolite;
mouse metabolite
nocodazole[no description available]medium60aromatic ketone;
benzimidazoles;
carbamate ester;
thiophenes		antimitotic;
antineoplastic agent;
microtubule-destabilising agent;
tubulin modulator
tetradecanoylphorbol acetate[no description available]medium110acetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester		antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator
chlorpromazine[no description available]medium40organochlorine compound;
phenothiazines;
tertiary amine		anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug
cyclopentane[no description available]medium20cycloalkane;
cyclopentanes;
volatile organic compound		non-polar solvent
6-mercapto-1-hexanol[no description available]medium10
alpha-chymotrypsin[no description available]medium40
4-chloro-7-nitrobenzofurazan[no description available]medium30benzoxadiazole;
C-nitro compound;
organochlorine compound		EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.6.1.3 (adenosinetriphosphatase) inhibitor;
fluorescent probe;
fluorochrome
morpholinopropane sulfonic acid[no description available]medium10MOPS;
morpholines;
organosulfonic acid
mercuric oxide[no description available]medium10
bromine[no description available]medium20diatomic bromine
flavone[no description available]medium10flavonesmetabolite;
nematicide
amphotericin b[no description available]medium10antibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic		antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
cyclothiazide[no description available]medium10benzothiadiazineantihypertensive agent;
diuretic
picrotoxin[no description available]medium10
strychnine[no description available]medium10monoterpenoid indole alkaloid;
organic heteroheptacyclic compound		avicide;
cholinergic antagonist;
glycine receptor antagonist;
neurotransmitter agent;
rodenticide
gyki 53655[no description available]medium10
carmustine[no description available]medium10N-nitrosoureas;
organochlorine compound		alkylating agent;
antineoplastic agent
bradykinin[no description available]medium60oligopeptidehuman blood serum metabolite;
vasodilator agent
lysyl-aspartyl-glutamyl-leucine[no description available]medium10
zeolites[no description available]medium10
mercuric chloride[no description available]medium20mercury coordination entitysensitiser
Brilliant Blue[no description available]medium10organic molecular entity
cytidine[no description available]medium10cytidinesEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
cresol red[no description available]medium102,1-benzoxathiole;
arenesulfonate ester;
polyphenol;
sultone		acid-base indicator;
dye;
two-colour indicator
phosphoramidite[no description available]medium10
h 89[no description available]medium10N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide
risarestat[no description available]medium11thiazolidinone
guanosine[no description available]medium20guanosines;
purines D-ribonucleoside		fundamental metabolite
ribosomal protein l7-l12[no description available]medium20
nateglinide[no description available]medium30phenylalanine derivative
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide[no description available]medium10benzamides;
benzodioxoles;
imidazoles;
pyridines		EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
1,2-diaminobenzene[no description available]medium10phenylenediaminehydrogen donor
1,3-dipropyl-8-cyclopentylxanthine[no description available]medium10oxopurineadenosine A1 receptor antagonist;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
fluorescein glucuronide[no description available]medium321
zm 241385[no description available]medium10diamino-1,3,5-triazine
mrs 1191[no description available]medium10cinnamate ester
dihydropyridines[no description available]medium10
benzenesulfonyl chloride[no description available]medium10
dithionitrobenzoic acid[no description available]medium10nitrobenzoic acid;
organic disulfide		indicator
guanosine diphosphate[no description available]medium10guanosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate		Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
glycidyl methacrylate[no description available]medium10enoate ester;
epoxide
ethylene dimethacrylate[no description available]medium10enoate esterallergen;
cross-linking reagent;
polymerisation monomer
4-carboxyfluorescein[no description available]medium50monocarboxylic acidfluorochrome
2-nitrophenyl-egta[no description available]medium10
carbobenzoxyproline[no description available]medium10
isoleucine[no description available]medium10aspartate family amino acid;
isoleucine;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
ethylnitrosourea[no description available]medium10N-nitrosoureasalkylating agent;
carcinogenic agent;
genotoxin;
mutagen
trimethoprim[no description available]medium20aminopyrimidine;
methoxybenzenes		antibacterial drug;
diuretic;
drug allergen;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
environmental contaminant;
xenobiotic
pyrimethamine[no description available]medium10aminopyrimidine;
monochlorobenzenes		antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
transportan[no description available]medium20
4-nitrophenol[no description available]medium104-nitrophenolshuman xenobiotic metabolite;
mouse metabolite
nitrophenols[no description available]medium10
beryllium[no description available]medium10alkaline earth metal atom;
elemental beryllium;
metal allergen		adjuvant;
carcinogenic agent;
epitope
beryllium fluoride[no description available]medium10beryllium molecular entity;
fluoride salt
putrescine[no description available]medium30alkane-alpha,omega-diamineantioxidant;
fundamental metabolite
trinitrobenzenesulfonic acid[no description available]medium20arenesulfonic acid;
C-nitro compound		epitope;
explosive;
reagent
sinistrin[no description available]medium20
6-carboxy-x-rhodamine[no description available]medium10
probenecid[no description available]medium181benzoic acids;
sulfonamide		uricosuric drug
digitoxin[no description available]medium10cardenolide glycosideEC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
digoxin[no description available]medium30cardenolide glycoside;
steroid saponin		anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope
dimethyldioctadecylammonium[no description available]medium10
curdlan[no description available]medium10hexose
nitrilotriacetic acid[no description available]medium30NTA;
tricarboxylic acid		carcinogenic agent;
nephrotoxic agent
beta-lactams[no description available]medium10beta-lactam antibiotic allergen;
beta-lactam
adenosine 5'-o-(3-thiotriphosphate)[no description available]medium20nucleoside triphosphate analogue
suberic acid[no description available]medium10alpha,omega-dicarboxylic acid;
dicarboxylic fatty acid		human metabolite
quinalphos[no description available]medium10organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
carmine[no description available]medium10
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide[no description available]medium10aromatic ether;
C-nitro compound;
sulfonamide		antineoplastic agent;
cyclooxygenase 2 inhibitor
isoprene[no description available]medium10alkadiene;
hemiterpene;
volatile organic compound		plant metabolite
urethane[no description available]medium10carbamate esterfungal metabolite;
mutagen
1-octanol[no description available]medium20octanol;
primary alcohol		antifungal agent;
bacterial metabolite;
fuel additive;
kairomone;
plant metabolite
sapropterin[no description available]medium105,6,7,8-tetrahydrobiopterincoenzyme;
cofactor;
diagnostic agent;
human metabolite
calmidazolium[no description available]medium10imidazolium ionapoptosis inducer;
calmodulin antagonist
melatonin[no description available]medium10acetamides;
tryptamines		anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
uridine diphosphate[no description available]medium10pyrimidine ribonucleoside 5'-diphosphate;
uridine 5'-phosphate		Escherichia coli metabolite;
mouse metabolite
apyrase[no description available]medium10
zinc chloride[no description available]medium10inorganic chloride;
zinc molecular entity		astringent;
disinfectant;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
Lewis acid
5'-adenylyl (beta,gamma-methylene)diphosphonate[no description available]medium10nucleoside triphosphate analogue
arl-67156[no description available]medium10
bilirubin[no description available]medium40biladienes;
dicarboxylic acid		antioxidant;
human metabolite;
mouse metabolite
7432 s[no description available]medium10cephalosporin;
dicarboxylic acid		antibacterial drug
4-aminobenzoic acid[no description available]medium60aminobenzoic acid;
aromatic amino-acid zwitterion		allergen;
Escherichia coli metabolite;
plant metabolite
succinic acid[no description available]medium20alpha,omega-dicarboxylic acid;
C4-dicarboxylic acid		anti-ulcer drug;
fundamental metabolite;
micronutrient;
nutraceutical;
radiation protective agent
polyethylene glycol 300[no description available]medium10poly(ethylene glycol)
n-heptane[no description available]medium10alkane;
volatile organic compound		non-polar solvent;
plant metabolite
ethylene oxide[no description available]medium10gas molecular entity;
oxacycle;
saturated organic heteromonocyclic parent		allergen;
mouse metabolite;
mutagen
nystatin a1[no description available]medium30nystatins
glyoxal bis(2-hydroxyanil)[no description available]medium10
aminocaproic acid[no description available]medium10amino acid zwitterion;
epsilon-amino acid;
omega-amino fatty acid		antifibrinolytic drug;
hematologic agent;
metabolite
ethylmaleimide[no description available]medium20maleimidesanticoronaviral agent;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.1.1 (hexokinase) inhibitor
phenylmethylsulfonyl fluoride[no description available]medium10acyl fluorideserine proteinase inhibitor
pitavastatin[no description available]medium10cyclopropanes;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
quinolines;
statin (synthetic)		antioxidant
calcium dobesilate[no description available]medium11
chondroitin[no description available]medium10
pyranine[no description available]medium70organic sodium saltfluorochrome
hexacyanoferrate iii[no description available]medium10
diethylstilbestrol[no description available]medium10olefinic compound;
polyphenol		antifungal agent;
antineoplastic agent;
autophagy inducer;
calcium channel blocker;
carcinogenic agent;
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
endocrine disruptor;
xenoestrogen
metoprolol[no description available]medium10aromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound		antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
fulvestrant[no description available]medium1017beta-hydroxy steroid;
3-hydroxy steroid;
organofluorine compound;
sulfoxide		antineoplastic agent;
estrogen antagonist;
estrogen receptor antagonist
sr 59230a[no description available]medium10
metoclopramide[no description available]medium20benzamides;
monochlorobenzenes;
substituted aniline;
tertiary amino compound		antiemetic;
dopaminergic antagonist;
environmental contaminant;
gastrointestinal drug;
xenobiotic
su 11248[no description available]medium10monocarboxylic acid amide;
pyrroles		angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
immunomodulator;
neuroprotective agent;
vascular endothelial growth factor receptor antagonist
s-acetylmercaptosuccinic anhydride[no description available]medium10
beta-escin[no description available]medium10
tetraethoxysilane[no description available]medium10
celecoxib[no description available]medium10organofluorine compound;
pyrazoles;
sulfonamide;
toluenes		cyclooxygenase 2 inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
gallein[no description available]medium102-benzofurans;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
polyphenol;
xanthene dye		fluorochrome;
G-protein-coupled receptor antagonist;
histological dye
adenosine diphosphate ribose[no description available]medium10ADP-sugarEscherichia coli metabolite;
mouse metabolite
valine[no description available]medium20L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
8-aminoquinoline[no description available]medium10
bisphenol a-glycidyl methacrylate[no description available]medium10diarylmethane
tetramethoxysilane[no description available]medium10
methyltrimethoxysilane[no description available]medium10
ammonium hydroxide[no description available]medium20azane;
gas molecular entity;
mononuclear parent hydride		EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
methanethiosulfonate[no description available]medium10
divinyl sulfone[no description available]medium10sulfonecross-linking reagent
cystine[no description available]medium10
s-nitroso-n-acetylpenicillamine[no description available]medium30nitroso compound;
nitrosothio compound		nitric oxide donor;
vasodilator agent
hydroxyethyl methacrylate[no description available]medium30enoate esterallergen;
polymerisation monomer
pregnanolone[no description available]medium103-hydroxy-5beta-pregnan-20-one;
3alpha-hydroxy steroid		human metabolite;
intravenous anaesthetic;
sedative
brl 37344[no description available]medium10monocarboxylic acid
rhod-2[no description available]medium10
1-ethyl-3-(3-dimethylaminoethyl)carbodiimide[no description available]medium10
carbodiimides[no description available]medium20carbodiimide
indapamide[no description available]medium10indoles;
organochlorine compound;
sulfonamide		antihypertensive agent;
diuretic
lactose[no description available]medium40lactose
3-azidotyrosine[no description available]medium10
ethacrynic acid[no description available]medium10aromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid		EC 2.5.1.18 (glutathione transferase) inhibitor;
ion transport inhibitor;
loop diuretic
1-methyl-4-phenylpyridinium[no description available]medium10pyridinium ionapoptosis inducer;
herbicide;
human xenobiotic metabolite;
neurotoxin
leukotriene c4[no description available]medium10leukotrienebronchoconstrictor agent;
human metabolite;
mouse metabolite
methacrylic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acid
ethyl acrylate[no description available]medium10enoate ester
tetrahydrofuran[no description available]medium10cyclic ether;
oxolanes;
saturated organic heteromonocyclic parent;
volatile organic compound		polar aprotic solvent
papa nonoate[no description available]medium10alkylamine
sodium hypochlorite[no description available]medium10inorganic sodium saltbleaching agent;
disinfectant
pd 98059[no description available]medium10aromatic amine;
monomethoxyflavone		EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
bromochloroacetic acid[no description available]medium402-bromocarboxylic acid;
monocarboxylic acid;
organochlorine compound
methacholine chloride[no description available]medium10quaternary ammonium salt
acetovanillone[no description available]medium10acetophenones;
aromatic ketone;
methyl ketone		antirheumatic drug;
EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug;
plant metabolite
oxypurinol[no description available]medium10pyrazolopyrimidinedrug metabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor
glutathione disulfide[no description available]medium20glutathione derivative;
organic disulfide		Escherichia coli metabolite;
mouse metabolite
methylprednisolone[no description available]medium106-methylprednisolone;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antiemetic;
environmental contaminant;
neuroprotective agent;
xenobiotic
boric acid[no description available]medium10boric acidsastringent
thalidomide[no description available]medium10phthalimides;
piperidones
spermidine[no description available]medium20polyazaalkane;
triamine		autophagy inducer;
fundamental metabolite;
geroprotector
cytochalasin d[no description available]medium40
ethylene[no description available]medium10alkene;
gas molecular entity		plant hormone;
refrigerant
naltrexone[no description available]medium30cyclopropanes;
morphinane-like compound;
organic heteropentacyclic compound		antidote to opioid poisoning;
central nervous system depressant;
environmental contaminant;
mu-opioid receptor antagonist;
xenobiotic
naloxone[no description available]medium30morphinane alkaloid;
organic heteropentacyclic compound;
tertiary alcohol		antidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist
3-(trimethoxysilyl)propylamine[no description available]medium10
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester[no description available]medium10
abscisic acid[no description available]medium302-trans-abscisic acid
dihydrorhodamine 123[no description available]medium10
dihydrorhodamine 6g[no description available]medium10
4-bis(2-methylstyryl)benzene[no description available]medium10
sarkosyl[no description available]medium10
rotenone[no description available]medium30organic heteropentacyclic compound;
rotenones		antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin
diacetyl[no description available]medium20alpha-diketoneEscherichia coli metabolite;
Saccharomyces cerevisiae metabolite
diacetylmonoxime[no description available]medium20
etoposide[no description available]medium20beta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound		antineoplastic agent;
DNA synthesis inhibitor
glycopyrrolate[no description available]medium10organic bromide salt;
quaternary ammonium salt
methylphosphonic acid[no description available]medium10one-carbon compound;
phosphonic acids
alpha-linolenic acid[no description available]medium10linolenic acid;
omega-3 fatty acid		micronutrient;
mouse metabolite;
nutraceutical
7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole[no description available]medium10
pyrrhocoricin protein, pyrrhocoris apterus[no description available]medium10
myelin basic protein[no description available]medium10
2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid[no description available]medium10
pinocembrin[no description available]medium10(2S)-flavan-4-one;
dihydroxyflavanone		antineoplastic agent;
antioxidant;
metabolite;
neuroprotective agent;
vasodilator agent
losartan potassium[no description available]medium10
acetyl phosphate[no description available]medium20acyl monophosphateEscherichia coli metabolite;
human metabolite;
mouse metabolite
cholecystokinin[no description available]medium20
diacetylfluorescein[no description available]medium50
triethyltin sulfate[no description available]medium10
trimethoprim, sulfamethoxazole drug combination[no description available]medium10
crotamiton[no description available]medium10
malathion[no description available]medium20diester;
ethyl ester;
organic thiophosphate
sulfamethoxazole[no description available]medium10isoxazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antibacterial agent;
antiinfective agent;
antimicrobial agent;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
epitope;
P450 inhibitor;
xenobiotic
1-naphthylphenylamine[no description available]medium30naphthalenes
1-naphthylamine[no description available]medium30naphthylaminehuman xenobiotic metabolite
rhodamine wt[no description available]medium10
f-chemotactic peptide[no description available]medium20
6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione[no description available]medium10phthalazines
4-aminopropiophenone[no description available]medium10
cystamine[no description available]medium10organic disulfide;
primary amino compound		EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor
amifostine anhydrous[no description available]medium10diamine;
organic thiophosphate		antioxidant;
prodrug;
radiation protective agent
nad[no description available]medium40organophosphate oxoanioncofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite
isoluminol[no description available]medium10
fluvoxamine[no description available]medium10(trifluoromethyl)benzenes;
5-methoxyvalerophenone O-(2-aminoethyl)oxime		antidepressant;
anxiolytic drug;
serotonin uptake inhibitor
citalopram[no description available]medium102-benzofurans;
cyclic ether;
nitrile;
organofluorine compound;
tertiary amino compound
methysergide[no description available]medium10ergoline alkaloid
ouabain[no description available]medium7011alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone		anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite
potassium cyanide[no description available]medium40cyanide salt;
one-carbon compound;
potassium salt		EC 1.15.1.1 (superoxide dismutase) inhibitor;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
neurotoxin
gentamicin[no description available]medium60
dimethadione[no description available]medium10oxazolidinone
ammonium chloride[no description available]medium30ammonium salt;
inorganic chloride		ferroptosis inhibitor
chloroquine[no description available]medium40aminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
ampicillin[no description available]medium10beta-lactam antibiotic;
penicillin allergen;
penicillin		antibacterial drug
phenobarbital[no description available]medium10barbituratesanticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative
2-acetylaminofluorene[no description available]medium102-acetamidofluorenesantimitotic;
carcinogenic agent;
epitope;
mutagen
diethylnitrosamine[no description available]medium10nitrosaminecarcinogenic agent;
hepatotoxic agent;
mutagen
digitonin[no description available]medium40
nigericin[no description available]medium10polycyclic etherantibacterial agent;
antimicrobial agent;
bacterial metabolite;
potassium ionophore
monensin[no description available]medium40cyclic hemiketal;
monocarboxylic acid;
polyether antibiotic;
spiroketal		antifungal agent;
coccidiostat;
ionophore
mezerein[no description available]medium10diterpenoid
dimethylformamide[no description available]medium10formamides;
volatile organic compound		geroprotector;
hepatotoxic agent;
polar aprotic solvent
iprazochrome[no description available]medium10
adrenochrome[no description available]medium10indoles
meperidine[no description available]medium10ethyl ester;
piperidinecarboxylate ester;
tertiary amino compound		antispasmodic drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
carbamazepine[no description available]medium10dibenzoazepine;
ureas		analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic
dactinomycin[no description available]medium20actinomycinmutagen
acetaldehyde[no description available]medium10aldehydecarcinogenic agent;
EC 3.5.1.4 (amidase) inhibitor;
electron acceptor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
mutagen;
oxidising agent;
Saccharomyces cerevisiae metabolite;
teratogenic agent
fucose[no description available]medium30fucopyranose;
L-fucose		Escherichia coli metabolite;
mouse metabolite
deoxyuridine triphosphate[no description available]medium30deoxyuridine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-triphosphate		Arabidopsis thaliana metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite
sodium salicylate[no description available]medium10organic molecular entity
tauro-24,25-dihydrofusidate[no description available]medium20
raffinose[no description available]medium10raffinose family oligosaccharide;
trisaccharide		mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
l 703606[no description available]medium10
quinuclidines[no description available]medium10quinuclidines;
saturated organic heterobicyclic parent
1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium[no description available]medium10cyanine dye;
organic iodide salt		fluorochrome
sorbitol[no description available]medium10glucitolcathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent
sulfapyridine[no description available]medium10pyridines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antiinfective agent;
dermatologic drug;
drug allergen;
environmental contaminant;
xenobiotic
aminooxyacetic acid[no description available]medium10amino acid;
hydroxylamines;
monocarboxylic acid		anticonvulsant;
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor;
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor;
nootropic agent
ranitidine[no description available]medium11C-nitro compound;
furans;
organic sulfide;
tertiary amino compound		anti-ulcer drug;
drug allergen;
environmental contaminant;
H2-receptor antagonist;
xenobiotic
astemizole[no description available]medium11benzimidazoles;
piperidines		anti-allergic agent;
anticoronaviral agent;
H1-receptor antagonist
eicosapentaenoic acid ethyl ester[no description available]medium10
8,11,14-eicosatrienoic acid[no description available]medium10fatty acid 20:3;
long-chain fatty acid		fungal metabolite;
human metabolite;
nutraceutical
eicosapentaenoic acid[no description available]medium10icosapentaenoic acid;
omega-3 fatty acid		anticholesteremic drug;
antidepressant;
antineoplastic agent;
Daphnia galeata metabolite;
fungal metabolite;
micronutrient;
mouse metabolite;
nutraceutical
arachidonic acid[no description available]medium40icosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid		Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
benzoylecgonine[no description available]medium10benzoate ester;
tropane alkaloid		epitope;
human xenobiotic metabolite;
marine xenobiotic metabolite;
plant metabolite
tranilast[no description available]medium10amidobenzoic acid;
cinnamamides;
dimethoxybenzene;
secondary carboxamide		anti-allergic agent;
anti-asthmatic drug;
antineoplastic agent;
aryl hydrocarbon receptor agonist;
calcium channel blocker;
hepatoprotective agent;
nephroprotective agent
cromolyn sodium[no description available]medium40organic sodium saltanti-asthmatic drug;
drug allergen
diphenhydramine[no description available]medium20ether;
tertiary amino compound		anti-allergic agent;
antidyskinesia agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
antitussive;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
oneirogen;
sedative
triphenyltetrazolium[no description available]medium10organic cation
4-(dicyanomethylene)-2-methyl-6-(4-(dimethylamino)styryl)-4h-pyran[no description available]medium10
cefmenoxime[no description available]medium20cephalosporinantibacterial drug
fluorescein dilaurate[no description available]medium70
1,5-aedans[no description available]medium10aminonaphthalenesulfonic acidfluorescent probe
1,5-i-aedans[no description available]medium20aminonaphthalenesulfonic acidfluorescent probe
dansylaziridine[no description available]medium10
malonic acid[no description available]medium20alpha,omega-dicarboxylic acidhuman metabolite
1-butanol[no description available]medium20alkyl alcohol;
primary alcohol;
short-chain primary fatty alcohol		human metabolite;
mouse metabolite;
protic solvent
technetium tc 99m pentetate[no description available]medium10
ck 17[no description available]medium10
2'-deoxyadenosine triphosphate[no description available]medium202'-deoxyadenosine 5'-phosphate;
purine 2'-deoxyribonucleoside 5'-triphosphate		Escherichia coli metabolite;
mouse metabolite
pindolol[no description available]medium10indoles;
secondary amine		antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent
phenoxybenzamine[no description available]medium20aromatic amine
sulfasalazine[no description available]medium10
calpastatin[no description available]medium10polypeptideEC 3.4.22.52 (calpain-1) inhibitor;
EC 3.4.22.53 (calpain-2) inhibitor
calpain[no description available]medium10
impromidine[no description available]medium10
promethazine[no description available]medium10phenothiazines;
tertiary amine		anti-allergic agent;
anticoronaviral agent;
antiemetic;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
sedative
eflornithine[no description available]medium20alpha-amino acid;
fluoroamino acid		trypanocidal drug
bromhexine[no description available]medium10organobromine compound;
substituted aniline;
tertiary amino compound		mucolytic
albuterol[no description available]medium10phenols;
phenylethanolamines;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
environmental contaminant;
xenobiotic
azelastine[no description available]medium10monochlorobenzenes;
phthalazines;
tertiary amino compound		anti-allergic agent;
anti-asthmatic drug;
bronchodilator agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
H1-receptor antagonist;
platelet aggregation inhibitor
potassium iodide[no description available]medium10potassium saltexpectorant;
radical scavenger
terbutaline[no description available]medium10phenylethanolamines;
resorcinols		anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hypoglycemic agent;
sympathomimetic agent;
tocolytic agent
malic acid[no description available]medium302-hydroxydicarboxylic acid;
C4-dicarboxylic acid		food acidity regulator;
fundamental metabolite
cadmium[no description available]medium20cadmium molecular entity;
zinc group element atom
phenylpyruvic acid[no description available]medium302-oxo monocarboxylic acidchromogenic compound;
EC 6.4.1.1 (pyruvate carboxylase) inhibitor;
fundamental metabolite
methylphenazonium methosulfate[no description available]medium10azaheterocycle sulfate salt;
phenazines
pyrazole[no description available]medium10pyrazole
quinolinic acid[no description available]medium10pyridinedicarboxylic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite;
NMDA receptor agonist
pyruvic acid[no description available]medium202-oxo monocarboxylic acidcofactor;
fundamental metabolite
9-amino-6-chloro-2-methoxyacridine[no description available]medium10
glycolic acid[no description available]medium202-hydroxy monocarboxylic acid;
primary alcohol		keratolytic drug;
metabolite
lacto-n-neotetraose[no description available]medium10
cc 1065[no description available]medium10
saxitoxin[no description available]medium10alkaloid;
carbamate ester;
guanidines;
ketone hydrate;
paralytic shellfish toxin;
pyrrolopurine		cyanotoxin;
marine metabolite;
neurotoxin;
sodium channel blocker;
toxin
2,4-dinitrophenol[no description available]medium30dinitrophenolallergen;
antiseptic drug;
bacterial xenobiotic metabolite;
geroprotector;
oxidative phosphorylation inhibitor
1,2-dioxetane[no description available]medium20
filipin[no description available]medium20
glutamine[no description available]medium20amino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
perfluorooctane[no description available]medium10fluoroalkane;
fluorocarbon
enbucrilate[no description available]medium10alpha,beta-unsaturated monocarboxylic acid;
nitrile
ethyl 2-cyanoacrylate[no description available]medium10
aminopenicillanic acid[no description available]medium10amino acid zwitterion;
penicillanic acids		allergen
penicillanic acid[no description available]medium10penicillanic acids
penicillin g[no description available]medium20penicillin allergen;
penicillin		antibacterial drug;
drug allergen;
epitope
c-peptide[no description available]medium21
glucagon[no description available]medium11peptide hormone
fructosamine[no description available]medium11
pentoxifylline[no description available]medium10oxopurine
indoleacetic acid[no description available]medium10indole-3-acetic acids;
monocarboxylic acid		auxin;
human metabolite;
mouse metabolite;
plant hormone;
plant metabolite
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a[no description available]medium10
chlorophyll a[no description available]medium10chlorophyll;
methyl ester		cofactor
stallimycin[no description available]medium10
chromomycins[no description available]medium10
cyanuric chloride[no description available]medium10chloro-1,3,5-triazine;
organochlorine compound		cross-linking reagent
suprofen[no description available]medium20aromatic ketone;
monocarboxylic acid;
thiophenes		antirheumatic drug;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
tolmetin[no description available]medium10aromatic ketone;
monocarboxylic acid;
pyrroles		EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
cadmium chloride[no description available]medium10cadmium coordination entity
dipivefrin[no description available]medium10ethanolamines;
pivalate ester		adrenergic agonist;
antiglaucoma drug;
ophthalmology drug;
prodrug;
sympathomimetic agent
monochlorobimane[no description available]medium10organochlorine compound;
pyrazolopyrazole		fluorochrome
cytochalasin b[no description available]medium30cytochalasin;
lactam;
lactone;
organic heterotricyclic compound		actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor
cetirizine[no description available]medium11ether;
monocarboxylic acid;
monochlorobenzenes;
piperazines		anti-allergic agent;
environmental contaminant;
H1-receptor antagonist;
xenobiotic
tetrandrine[no description available]medium10bisbenzylisoquinoline alkaloid;
isoquinolines
phenanthrene[no description available]medium10ortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon;
phenanthrenes		environmental contaminant;
mouse metabolite
diazomethane[no description available]medium10diazo compoundalkylating agent;
antineoplastic agent;
carcinogenic agent;
poison
biocytin[no description available]medium10azabicycloalkane;
L-alpha-amino acid zwitterion;
L-lysine derivative;
monocarboxylic acid amide;
non-proteinogenic L-alpha-amino acid;
thiabicycloalkane;
ureas		mouse metabolite
dinoprost[no description available]medium30monocarboxylic acid;
prostaglandins Falpha		human metabolite;
mouse metabolite
prostaglandin f2 isopropyl ester[no description available]medium10prostanoid
carbamates[no description available]medium20amino-acid anion
atrial natriuretic factor[no description available]medium10polypeptide
natriuretic peptide, brain[no description available]medium10polypeptide
methionine[no description available]medium20aspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid		antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
naphthalan[no description available]medium10
acetazolamide[no description available]medium64monocarboxylic acid amide;
sulfonamide;
thiadiazoles		anticonvulsant;
diuretic;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
1,3-dimethylthiourea[no description available]medium10
fomepizole[no description available]medium10pyrazolesantidote;
EC 1.1.1.1 (alcohol dehydrogenase) inhibitor;
protective agent
beta-naltrexamine[no description available]medium10
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole[no description available]medium10aromatic primary alcohol;
furans;
indazoles		antineoplastic agent;
apoptosis inducer;
platelet aggregation inhibitor;
soluble guanylate cyclase activator;
vasodilator agent
cathepsin g[no description available]medium10
organophosphonates[no description available]medium20divalent inorganic anion;
phosphite ion
bendazac lysine[no description available]medium11
iodonaphthylazide[no description available]medium10
5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein[no description available]medium10
gallium[no description available]medium20boron group element atom
cyclonite[no description available]medium101,3,5-triazinanes;
N-nitro compound		explosive
keratan sulfate[no description available]medium10
rolitetracycline[no description available]medium10
xenon radioisotopes[no description available]medium10
6-aminoquinolyl-n-hydroxysuccinimidyl carbamate[no description available]medium10
neuropeptide y[no description available]medium30
pyrimidine dimers[no description available]medium10
chromomycin a3[no description available]medium10
5'-s-(2-aminoethyl)-n(6)-(4-nitrobenzyl)-5'-thioadenosine[no description available]medium10
ethoxyresorufin[no description available]medium10phenoxazine
phytic acid[no description available]medium10inositol phosphate
maleic acid[no description available]medium10butenedioic acidalgal metabolite;
mouse metabolite;
plant metabolite
5-methyldeoxycytidine triphosphate[no description available]medium102'-deoxycytidine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-triphosphate
deoxyguanosine[no description available]medium20purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
bromphenol blue[no description available]medium102,1-benzoxathiole;
arenesulfonate ester;
organobromine compound;
phenols;
sultone		acid-base indicator;
dye;
two-colour indicator
titan yellow[no description available]medium10
u 74006f[no description available]medium10corticosteroid hormone
glutaral[no description available]medium40dialdehydecross-linking reagent;
disinfectant;
fixative
gluma[no description available]medium10
procion green h-e4bd[no description available]medium10
3,3'-diaminobenzidine[no description available]medium30biphenyls;
substituted aniline		histological dye
rh 421[no description available]medium10
maclurin[no description available]medium20benzophenones
azoxymethane[no description available]medium20
pentamidine[no description available]medium10aromatic ether;
carboxamidine;
diether		anti-inflammatory agent;
antifungal agent;
calmodulin antagonist;
chemokine receptor 5 antagonist;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
NMDA receptor antagonist;
S100 calcium-binding protein B inhibitor;
trypanocidal drug;
xenobiotic
tytin[no description available]medium10
casein kinase ii[no description available]medium10
s-nitrosopenicillamine[no description available]medium10
melphalan[no description available]medium10L-phenylalanine derivative;
nitrogen mustard;
non-proteinogenic L-alpha-amino acid;
organochlorine compound		alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
argon[no description available]medium20monoatomic argon;
noble gas atom;
p-block element atom		food packaging gas;
neuroprotective agent
porphobilinogen[no description available]medium10aralkylamino compound;
dicarboxylic acid;
pyrroles		Escherichia coli metabolite;
metabolite;
mouse metabolite
lewis x antigen[no description available]medium10
inositol[no description available]medium10cyclitol;
hexol
enkephalin, methionine[no description available]medium10
trypsinogen[no description available]medium10
potassium hydroxide[no description available]medium10alkali metal hydroxide
nitrogenase[no description available]medium20
biotinyltyramide[no description available]medium10
chlorfenvinphos[no description available]medium10dichlorobenzene;
organic phosphate;
organochlorine acaricide;
organochlorine insecticide;
organophosphate insecticide		agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor
dimethoate[no description available]medium10monocarboxylic acid amide;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
rolipram[no description available]medium10pyrrolidin-2-onesantidepressant;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
iodoantipyrine[no description available]medium10
thionine[no description available]medium10
calcitonin[no description available]medium10
nonoxynol[no description available]medium10
ganciclovir[no description available]medium102-aminopurines;
oxopurine		antiinfective agent;
antiviral drug
estriol[no description available]medium1016alpha-hydroxy steroid;
17beta-hydroxy steroid;
3-hydroxy steroid		estrogen;
human metabolite;
human xenobiotic metabolite;
mouse metabolite
oxazolone[no description available]medium30
sybr green ii[no description available]medium10
n-succinyl-chitosan[no description available]medium10
methylprednisolone hemisuccinate[no description available]medium11corticosteroid hormone;
hemisuccinate
benzoporphyrin d[no description available]medium10
manganese[no description available]medium10elemental manganese;
manganese group element atom		Escherichia coli metabolite;
micronutrient
rutin[no description available]medium10disaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone		antioxidant;
metabolite
cardiovascular agents[no description available]medium10
1,4-dioxane[no description available]medium10dioxane;
volatile organic compound		carcinogenic agent;
metabolite;
NMR chemical shift reference compound;
non-polar solvent
theobromine[no description available]medium20dimethylxanthineadenosine receptor antagonist;
bronchodilator agent;
food component;
human blood serum metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
fluo-3[no description available]medium10xanthene dyefluorochrome
2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid[no description available]medium10
2-phenyloxazolone[no description available]medium101,3-oxazoles
4-(2-aminoethyl)benzenesulfonylfluoride[no description available]medium10
glycocholic acid[no description available]medium30bile acid glycine conjugatehuman metabolite
florfenicol[no description available]medium11organochlorine compound;
organofluorine compound;
secondary alcohol;
secondary carboxamide;
sulfone		antimicrobial agent
thiamphenicol[no description available]medium11monocarboxylic acid amide;
sulfone		antimicrobial agent;
immunosuppressive agent
beta-endorphin[no description available]medium10
calcium oxalate[no description available]medium10organic calcium salt
acetaminophen[no description available]medium10acetamides;
phenols		antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
zidovudine[no description available]medium10azide;
pyrimidine 2',3'-dideoxyribonucleoside		antimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
loperamide[no description available]medium10monocarboxylic acid amide;
monochlorobenzenes;
piperidines;
tertiary alcohol		anticoronaviral agent;
antidiarrhoeal drug;
mu-opioid receptor agonist
brinzolamide[no description available]medium11sulfonamide;
thienothiazine		antiglaucoma drug;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
s-(2-chloro-1,1,2-trifluoroethyl)cysteine[no description available]medium10
idoxuridine[no description available]medium10organoiodine compound;
pyrimidine 2'-deoxyribonucleoside		antiviral drug;
DNA synthesis inhibitor
enalapril[no description available]medium11dicarboxylic acid monoester;
dipeptide		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
geroprotector;
prodrug
acetic anhydride[no description available]medium10acyclic carboxylic anhydridemetabolite;
reagent
2,3-diaminonaphthalene[no description available]medium10
2-naphthylamine[no description available]medium10naphthylaminecarcinogenic agent
oleanolic acid[no description available]medium10hydroxy monocarboxylic acid;
pentacyclic triterpenoid		plant metabolite
s 0139[no description available]medium10
diphenylguanidine[no description available]medium10guanidinesallergen
diphenylthiourea[no description available]medium10thioureasallergen
kemptide[no description available]medium10
thiophosphoric acid[no description available]medium10phosphorothioic acid
tesmilifene[no description available]medium10diarylmethane
thioguanine anhydrous[no description available]medium102-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent
2-phenylsuccinate[no description available]medium10
lutetium[no description available]medium10d-block element atom;
lanthanoid atom
motexafin lutetium[no description available]medium10
motexafin gadolinium[no description available]medium10
betaxolol[no description available]medium11propanolamineantihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
carvedilol[no description available]medium10carbazoles;
secondary alcohol;
secondary amino compound		alpha-adrenergic antagonist;
antihypertensive agent;
beta-adrenergic antagonist;
cardiovascular drug;
vasodilator agent
noc-5[no description available]medium10
naphthalene[no description available]medium10naphthalenes;
ortho-fused bicyclic arene		apoptosis inhibitor;
carcinogenic agent;
environmental contaminant;
mouse metabolite;
plant metabolite;
volatile oil component
phosphoserine[no description available]medium10non-proteinogenic alpha-amino acid;
O-phosphoamino acid;
serine derivative		human metabolite
latrunculin a[no description available]medium10cyclic hemiketal;
macrolide;
oxabicycloalkane;
thiazolidinone		actin polymerisation inhibitor;
metabolite;
toxin
latrunculin b[no description available]medium10cyclic hemiketal;
macrolide;
oxabicycloalkane;
thiazolidinone		actin polymerisation inhibitor;
metabolite;
toxin
morphine-6-glucuronide[no description available]medium10morphinane alkaloid
codeine[no description available]medium10morphinane alkaloid;
organic heteropentacyclic compound		antitussive;
drug allergen;
environmental contaminant;
opioid analgesic;
opioid receptor agonist;
prodrug;
xenobiotic
oxycodone[no description available]medium10organic heteropentacyclic compound;
semisynthetic derivative		antitussive;
mu-opioid receptor agonist;
opioid analgesic
lanthiopeptin[no description available]medium10heterodetic cyclic peptide;
L-cysteine thioether;
macrocycle;
type B lantibiotic
ethanolamine[no description available]medium30ethanolamines;
primary alcohol;
primary amine		Escherichia coli metabolite;
human metabolite;
mouse metabolite
4-methylumbelliferyl phosphate[no description available]medium10
hymecromone[no description available]medium20hydroxycoumarinantineoplastic agent;
hyaluronic acid synthesis inhibitor
5-cyano-2,3-ditolyltetrazolium chloride[no description available]medium10
rutecarpine[no description available]medium10beta-carbolines
quinazolines[no description available]medium30azaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinazolines
ml 7[no description available]medium10N-sulfonyldiazepane;
organoiodine compound		EC 2.7.11.18 (myosin-light-chain kinase) inhibitor
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid[no description available]medium10non-proteinogenic alpha-amino acid
pirenoxine[no description available]medium10organic molecular entity
pyrithione[no description available]medium10monohydroxypyridine;
pyridinethione		ionophore
peridinin[no description available]medium10
7-aminoactinomycin d[no description available]medium10
angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-[no description available]medium10organic molecular entity
fumonisin b1[no description available]medium10diester;
fumonisin;
primary amino compound;
triol		carcinogenic agent;
metabolite
ethyl oleate[no description available]medium10long-chain fatty acid ethyl esteracaricide;
plant metabolite
oleylamine[no description available]medium10
deferiprone[no description available]medium104-pyridonesiron chelator;
protective agent
methylnitrosourea[no description available]medium10N-nitrosoureasalkylating agent;
carcinogenic agent;
mutagen;
teratogenic agent
perylene[no description available]medium10ortho- and peri-fused polycyclic arene;
perylenes
hypericin[no description available]medium10
hydroxypropylmethylcellulose acetate succinate[no description available]medium10
uridine[no description available]medium10uridinesdrug metabolite;
fundamental metabolite;
human metabolite
4-iodoacetamidosalicylic acid[no description available]medium10
5-iodoacetamidofluorescein[no description available]medium10
oxadiazoles[no description available]medium10
4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole[no description available]medium10
8-azidoethidium[no description available]medium10
hematoxylin[no description available]medium20organic heterotetracyclic compound;
oxacycle;
polyphenol;
tertiary alcohol		histological dye;
plant metabolite
tyrosine[no description available]medium10alpha-amino-acid radical
penicillamine[no description available]medium20non-proteinogenic alpha-amino acid;
penicillamine		antirheumatic drug;
chelator;
copper chelator;
drug allergen
s-nitro-n-acetylpenicillamine[no description available]medium20
n-(((4-benzoylamino)phenyl)sulfonyl)glycine[no description available]medium10
enkephalin, ala(2)-mephe(4)-gly(5)-[no description available]medium10
ellagic acid[no description available]medium10catechols;
cyclic ketone;
lactone;
organic heterotetracyclic compound;
polyphenol		antioxidant;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor;
EC 2.4.1.1 (glycogen phosphorylase) inhibitor;
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor;
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor;
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
food additive;
fungal metabolite;
geroprotector;
plant metabolite;
skin lightening agent
phosphorodithioic acid[no description available]medium10phosphorothioic acid
bafilomycin a[no description available]medium10
1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid[no description available]medium10polyamino carboxylic acid;
tetracarboxylic acid		chelator
noc 9[no description available]medium10
thiazole orange[no description available]medium10cyanine dyefluorochrome
desciclovir[no description available]medium10
clonidine[no description available]medium43clonidine;
imidazoline
tosylphenylalanyl chloromethyl ketone[no description available]medium10alpha-chloroketone;
sulfonamide		alkylating agent;
serine proteinase inhibitor
tosyllysine chloromethyl ketone[no description available]medium10sulfonic acid derivative
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone[no description available]medium10
oregon green 514[no description available]medium10xanthene dyefluorochrome
diuron[no description available]medium103-(3,4-substituted-phenyl)-1,1-dimethylurea;
dichlorobenzene		environmental contaminant;
mitochondrial respiratory-chain inhibitor;
photosystem-II inhibitor;
urea herbicide;
xenobiotic
sodium nitrite[no description available]medium10inorganic sodium salt;
nitrite salt		antidote to cyanide poisoning;
antihypertensive agent;
antimicrobial food preservative;
food antioxidant;
poison
cycloheximide[no description available]medium10antibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol		anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
sincalide[no description available]medium10oligopeptide
1-palmitoyl-2-(6-(n-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine[no description available]medium101,2-diacyl-sn-glycero-3-phosphocholine(1+)fluorescent probe
dihydrotetramethylrosamine[no description available]medium10
2,2,5,7,8-pentamethyl-1-hydroxychroman[no description available]medium10
propargylamine[no description available]medium10
pargyline[no description available]medium10aromatic amine
propynyloxy-2'-deoxyuridine[no description available]medium10
sorbic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acid;
sorbic acid
1,3-dibromo-5,5-dimethylhydantoin[no description available]medium10
flucytosine[no description available]medium10aminopyrimidine;
nucleoside analogue;
organofluorine compound;
pyrimidine antifungal drug;
pyrimidone		prodrug
cinnarizine[no description available]medium10diarylmethane;
N-alkylpiperazine;
olefinic compound		anti-allergic agent;
antiemetic;
calcium channel blocker;
geroprotector;
H1-receptor antagonist;
histamine antagonist;
muscarinic antagonist
hydantoins[no description available]medium10imidazolidine-2,4-dione
7-benzyloxy-4-trifluoromethylcoumarin[no description available]medium10
phosphorodiamidic acid[no description available]medium10
unithiol[no description available]medium10
deuterium[no description available]medium20dihydrogen
2,2,6,6-tetramethylpiperidine-n-oxide-4-amino-4-carboxylic acid[no description available]medium10aminoxyls;
piperidinemonocarboxylic acid
rubidium[no description available]medium20alkali metal atom
oligomycins[no description available]medium10
mannans[no description available]medium10
hirugen[no description available]medium10
moxalactam[no description available]medium10cephalosporin;
oxacephem		antibacterial drug
cefotetan[no description available]medium10
cefoxitin[no description available]medium10beta-lactam antibiotic allergen;
cephalosporin;
cephamycin;
semisynthetic derivative		antibacterial drug
1-n-methyl-5-thiotetrazole[no description available]medium10
perflutren[no description available]medium20fluoroalkane;
fluorocarbon
7-amino-4-methylcoumarin-3-acetate[no description available]medium30
9-hydroxyphenylfluoron[no description available]medium20
pyrenedecanoic acid[no description available]medium10
poloxalene[no description available]medium10epoxide
lithium chloride[no description available]medium10inorganic chloride;
lithium salt		antimanic drug;
geroprotector
glutaric acid[no description available]medium10alpha,omega-dicarboxylic acid;
dicarboxylic fatty acid		Daphnia magna metabolite;
human metabolite
apraclonidine[no description available]medium22dichlorobenzene;
guanidines;
imidazolines		alpha-adrenergic agonist;
antiglaucoma drug;
beta-adrenergic agonist;
diagnostic agent;
ophthalmology drug
eledoisin[no description available]medium10peptide
piroxicam[no description available]medium10benzothiazine;
monocarboxylic acid amide;
pyridines		analgesic;
antirheumatic drug;
cyclooxygenase 1 inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
azinphosmethyl[no description available]medium10benzotriazines;
organic thiophosphate;
organothiophosphate insecticide		agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor
4-nitroquinoline-1-oxide[no description available]medium10C-nitro compound;
quinoline N-oxide		carcinogenic agent
flutropium bromide[no description available]medium10
ketotifen[no description available]medium10cyclic ketone;
olefinic compound;
organic heterotricyclic compound;
organosulfur heterocyclic compound;
piperidines;
tertiary amino compound		anti-asthmatic drug;
H1-receptor antagonist
alpha-phenylcinnamate[no description available]medium10
normetanephrine[no description available]medium10catecholamine
sulpiride[no description available]medium10benzamides;
N-alkylpyrrolidine;
sulfonamide		antidepressant;
antiemetic;
antipsychotic agent;
dopaminergic antagonist
epsilon-dinitrophenyllysine[no description available]medium10N(6)-(2,4-dinitrophenyl)lysine
hematoporphyrin[no description available]medium10
nitroblue tetrazolium[no description available]medium10organic cation
lauric acid[no description available]medium10medium-chain fatty acid;
straight-chain saturated fatty acid		algal metabolite;
antibacterial agent;
plant metabolite
nortriptyline[no description available]medium10organic tricyclic compound;
secondary amine		adrenergic uptake inhibitor;
analgesic;
antidepressant;
antineoplastic agent;
apoptosis inducer;
drug metabolite
10-hydroxynortriptyline[no description available]medium10
rubidium chloride[no description available]medium10inorganic chloride;
rubidium molecular entity		antidepressant;
biomarker
tin[no description available]medium10carbon group element atom;
elemental tin;
metal atom		micronutrient
pituitrin[no description available]medium10
arginine vasopressin[no description available]medium10vasopressincardiovascular drug;
hematologic agent;
mitogen
neon[no description available]medium10monoatomic neon;
noble gas atom;
p-block element atom
hexylene glycol[no description available]medium20glycol
trimetrexate[no description available]medium20
piritrexim[no description available]medium10
arotinolol[no description available]medium11aromatic amide;
thiophenes
carteolol[no description available]medium11quinolone;
secondary alcohol		anti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
c.i. fluorescent brightening agent 28[no description available]medium10
bendroflumethiazide[no description available]medium10benzothiadiazine;
sulfonamide		antihypertensive agent;
diuretic
dipyridamole[no description available]medium10piperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol		adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
pentazocine[no description available]medium10benzazocine
buprenorphine[no description available]medium10morphinane alkaloiddelta-opioid receptor antagonist;
kappa-opioid receptor antagonist;
mu-opioid receptor agonist;
opioid analgesic
n-formylmethionylphenylalanine[no description available]medium10peptide
n-formylnorleucyl-leucyl-4-phenylalanine[no description available]medium10
octamethylenediamine[no description available]medium10alkane-alpha,omega-diamine
nimodipine[no description available]medium102-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester		antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
sulindac[no description available]medium11monocarboxylic acid;
organofluorine compound;
sulfoxide		analgesic;
antineoplastic agent;
antipyretic;
apoptosis inducer;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug;
tocolytic agent
anthroylouabain[no description available]medium10
merocyanine dye[no description available]medium10
pyrimidinones[no description available]medium10
valinomycin[no description available]medium10cyclodepsipeptide;
macrocycle		antimicrobial agent;
antiviral agent;
bacterial metabolite;
potassium ionophore
acridine yellow[no description available]medium10aminoacridines;
hydrochloride		fluorochrome
1-oleoyl-2-acetylglycerol[no description available]medium101,2-diglyceride
pyoverdin[no description available]medium10
sodium iodate[no description available]medium20organic molecular entity
galactose[no description available]medium10
bentiromide[no description available]medium20dipeptidediagnostic agent;
indicator;
reagent
4-methylumbelliferyl heptanoate[no description available]medium10
diatrizoate meglumine[no description available]medium10monocarboxylic acid anionradioopaque medium
urografin 76[no description available]medium10
diatrizoic acid[no description available]medium10acetamides;
benzoic acids;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
nitrohydroxyiodophenylacetate[no description available]medium102-nitrophenols;
organoiodine compound;
phenylacetic acids		antigen
sorbinil[no description available]medium10azaspiro compound;
chromanes;
imidazolidinone;
organofluorine compound;
oxaspiro compound		antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor
sorbinil[no description available]medium11azaspiro compound;
chromanes;
imidazolidinone;
organofluorine compound;
oxaspiro compound		antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor
imidazolidines[no description available]medium11azacycloalkane;
imidazolidines;
saturated organic heteromonocyclic parent
amphetamine[no description available]medium10primary amine
dextroamphetamine[no description available]medium101-phenylpropan-2-amineadrenergic agent;
adrenergic uptake inhibitor;
dopamine uptake inhibitor;
dopaminergic agent;
neurotoxin;
sympathomimetic agent
acetylglucosamine[no description available]medium10N-acetyl-D-glucosamineepitope
acetylgalactosamine[no description available]medium10N-acetyl-D-hexosamine;
N-acetylgalactosamine		Escherichia coli metabolite;
human metabolite;
mouse metabolite
5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)[no description available]medium10
dodecyl sulfate[no description available]medium10alkyl sulfate
ceruletide[no description available]medium10oligopeptidediagnostic agent;
gastrointestinal drug
4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid[no description available]medium10stilbenoid
2-keto-4-methylvalerate[no description available]medium102-oxo monocarboxylic acid;
branched-chain keto acid		algal metabolite;
human metabolite
thioflavin t[no description available]medium10organic chloride saltfluorochrome;
geroprotector;
histological dye
4-methylhistamine[no description available]medium10aralkylamino compound;
imidazoles		histamine agonist;
metabolite
pyrilamine[no description available]medium10aromatic ether;
ethylenediamine derivative		H1-receptor antagonist
metiamide[no description available]medium10imidazoles
glucuronyl glucosamine glycan sulfate[no description available]medium20
phenylephrine hydrochloride[no description available]medium60hydrochloride
eye[no description available]medium8412
isomethyleugenol[no description available]medium60isomethyleugenol
oxybutynin[no description available]medium10acetylenic compound;
carboxylic ester;
racemate;
tertiary alcohol;
tertiary amino compound		antispasmodic drug;
calcium channel blocker;
local anaesthetic;
muscarinic antagonist;
muscle relaxant;
parasympatholytic
guaifenesin[no description available]medium100methoxybenzenes
fenoxycarb[no description available]medium30aromatic ether;
carbamate ester		environmental contaminant;
insecticide;
juvenile hormone mimic;
xenobiotic
trazodone hydrochloride[no description available]medium60hydrochlorideadrenergic antagonist;
antidepressant;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
methyl salicylate[no description available]medium20benzoate ester;
methyl ester;
salicylates		flavouring agent;
insect attractant;
metabolite
fomesafen[no description available]medium30aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols		agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
propiconazole[no description available]medium50conazole fungicide;
cyclic ketal;
dichlorobenzene;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
environmental contaminant;
xenobiotic
iodinated glycerol[no description available]medium10dioxolane
torpedo[no description available]medium30
exudates[no description available]medium10
fusarium[no description available]medium20
isoniazid[no description available]medium10carbohydrazideantitubercular agent;
drug allergen
bassianolide[no description available]medium10cyclodepsipeptide;
cyclooctadepsipeptide		antineoplastic agent;
fungal metabolite;
insecticide
nociceptin[no description available]medium10organic molecular entity;
polypeptide		human metabolite;
rat metabolite
egg white[no description available]medium10
trolamine salicylate[no description available]medium20
inositol 3-phosphate[no description available]medium41
ants[no description available]medium10
sodium ethylxanthate[no description available]medium10
vendex[no description available]medium10organotin acaricide
1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone[no description available]medium10dichlorobenzene;
differentiation-inducing factor;
monomethoxybenzene;
resorcinols		eukaryotic metabolite;
signalling molecule
metrizoate[no description available]low00monocarboxylic acidradioopaque medium
fluorescite[no description available]medium00benzoic acids;
cyclic ketone;
hydroxy monocarboxylic acid;
organic heterotricyclic compound;
phenols;
xanthene dye		fluorescent dye;
radioopaque medium
iodamide[no description available]low00benzoic acids;
organoiodine compound		radioopaque medium
iodixanol[no description available]low00organoiodine compoundradioopaque medium
iohexol[no description available]low00benzenedicarboxamide;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
iomeprol[no description available]low00benzenedicarboxamide;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
iopromide[no description available]low00dicarboxylic acid diamide;
organoiodine compound		environmental contaminant;
nephrotoxic agent;
radioopaque medium;
xenobiotic
iodipamide[no description available]low00benzoic acids;
organoiodine compound;
secondary carboxamide		radioopaque medium
ioxaglate[no description available]low00benzenedicarboxamide;
benzoic acids;
organoiodine compound		radioopaque medium
perflexane[no description available]low00fluoroalkane;
fluorocarbon;
volatile organic compound		non-polar solvent;
radioopaque medium
perflubron[no description available]low00haloalkane;
organobromine compound;
perfluorinated compound		blood substitute;
radioopaque medium
perfluoropentane[no description available]low00fluoroalkane;
fluorocarbon		radioopaque medium;
ultrasound contrast agent
ioxitalamic acid[no description available]low00acetamides;
benzoic acids;
dicarboxylic acid monoamide;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
iopamidol[no description available]low00benzenedicarboxamide;
organoiodine compound;
pentol		environmental contaminant;
radioopaque medium;
xenobiotic
iobitridol[no description available]low00benzenedicarboxamide;
hexol;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
meglumine iodipamide[no description available]low00organoammonium saltradioopaque medium
amidotrizoic acid dihydrate[no description available]low00hydrateradioopaque medium
sodium diatrizoate[no description available]low00organic sodium salt;
organoiodine compound		radioopaque medium
aminacrine[no description available]low00aminoacridines;
primary amino compound		acid-base indicator;
antiinfective agent;
antiseptic drug;
fluorescent dye;
MALDI matrix material;
mutagen
n-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide[no description available]low00benzenes;
coumarins;
maleimides;
tertiary amino compound		fluorescent dye
picogreen[no description available]low00benzothiazoles;
cyanine dye;
quinolines;
tertiary amine		fluorescent dye
(E,E)-1-bromo-2,5-bis-(4-hydroxystyryl)benzene[no description available]medium00organobromine compound;
polyphenol		fluorescent dye
rhodamine 123[no description available]low00organic chloride salt;
xanthene dye		fluorochrome
calcein am[no description available]low002-benzofurans;
acetate ester;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
xanthene dye		fluorochrome
rose bengal(2-)[no description available]low00monocarboxylic acid anion;
xanthene dye		fluorochrome
calcium orange[no description available]low00xanthene dyefluorochrome
glucono-1,4-lactone[no description available]low00gamma-lactone
patulin[no description available]low00furopyran;
gamma-lactone;
lactol		antimicrobial agent;
Aspergillus metabolite;
carcinogenic agent;
mutagen;
mycotoxin;
Penicillium metabolite
phthalide[no description available]low002-benzofurans;
gamma-lactone
2-acetylbutyrolactone[no description available]low00gamma-lactone
decan-4-olide[no description available]low00gamma-lactone;
tetrahydrofuranone		anticonvulsant;
flavouring agent;
food additive
gamma-dodecalactone[no description available]low00gamma-lactonebacterial metabolite;
fungal metabolite;
volatile oil component
helenalin[no description available]low00cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
secondary alcohol;
sesquiterpene lactone		anti-inflammatory agent;
antineoplastic agent;
metabolite;
plant metabolite
4,5,6,7-tetrachlorophthalide[no description available]low00gamma-lactone;
organic heterobicyclic compound;
propan-1-ol;
tetrachlorobenzene		antifungal agrochemical;
melanin synthesis inhibitor
zaluzanin C[no description available]low00gamma-lactone;
guaiane sesquiterpenoid;
organic heterotricyclic compound;
secondary alcohol;
sesquiterpene lactone		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite
dehydrocostus lactone[no description available]low00gamma-lactone;
guaiane sesquiterpenoid;
organic heterotricyclic compound;
sesquiterpene lactone		antimycobacterial drug;
antineoplastic agent;
apoptosis inducer;
cyclooxygenase 2 inhibitor;
metabolite;
trypanocidal drug
marrubiin[no description available]low00gamma-lactone
tutin[no description available]low00gamma-lactone
asperuloside[no description available]low00acetate ester;
beta-D-glucoside;
gamma-lactone;
iridoid monoterpenoid;
monosaccharide derivative		metabolite
beta-peltatin[no description available]low00furonaphthodioxole;
gamma-lactone;
lignan;
organic heterotetracyclic compound;
phenols		antineoplastic agent;
plant metabolite
alpha-peltatin[no description available]low00furonaphthodioxole;
gamma-lactone;
lignan;
organic heterotetracyclic compound;
phenols		antineoplastic agent;
metabolite
matairesinol[no description available]low00gamma-lactone;
lignan;
polyphenol		angiogenesis inhibitor;
anti-asthmatic agent;
phytoestrogen;
plant metabolite
4'-demethyldesoxypodophyllotoxin[no description available]low00furonaphthodioxole;
gamma-lactone;
lignan;
methoxybenzenes;
phenols		antineoplastic agent;
antioxidant;
immunosuppressive agent;
plant metabolite
gulonolactone[no description available]low00gamma-lactone
confertin[no description available]low00cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
pseudoguaianolide		anti-inflammatory agent;
metabolite;
plant metabolite
2-ethyl-2-methyl-4-butyrolactone[no description available]low00gamma-lactone
inuviscolide[no description available]low00gamma-lactone;
organic heterotricyclic compound;
sesquiterpene lactone;
tertiary alcohol		anti-inflammatory agent;
plant metabolite
top 53[no description available]low00furonaphthodioxole;
gamma-lactone;
organic heterotetracyclic compound;
phenols;
tertiary amino compound		antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
spirodiclofen[no description available]low00dichlorobenzene;
gamma-lactone;
organochlorine acaricide;
oxaspiro compound
ergolide[no description available]low00acetate ester;
cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
sesquiterpene lactone		anti-inflammatory agent;
antineoplastic agent;
metabolite;
NF-kappaB inhibitor;
plant metabolite
aromaticin[no description available]low00cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
sesquiterpene lactone		anti-inflammatory agent;
metabolite;
plant metabolite
anthricin[no description available]low00furonaphthodioxole;
gamma-lactone;
lignan;
methoxybenzenes		antineoplastic agent;
apoptosis inducer;
plant metabolite
picrotin[no description available]low00diol;
epoxide;
gamma-lactone;
organic heteropentacyclic compound;
picrotoxane sesquiterpenoid;
tertiary alcohol		plant metabolite
picrotoxinin[no description available]low00epoxide;
gamma-lactone;
organic heteropentacyclic compound;
picrotoxane sesquiterpenoid;
tertiary alcohol		GABA antagonist;
plant metabolite;
serotonergic antagonist
hinokinin[no description available]low00benzodioxoles;
gamma-lactone;
lignan		trypanocidal drug
eplerenone[no description available]low003-oxo-Delta(4) steroid;
epoxy steroid;
gamma-lactone;
methyl ester;
organic heteropentacyclic compound;
oxaspiro compound;
steroid acid ester		aldosterone antagonist;
antihypertensive agent
mycophenolic acid[no description available]low002-benzofurans;
gamma-lactone;
monocarboxylic acid;
phenols		anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
environmental contaminant;
immunosuppressive agent;
mycotoxin;
Penicillium metabolite;
xenobiotic
teniposide[no description available]low00aromatic ether;
beta-D-glucoside;
cyclic acetal;
furonaphthodioxole;
gamma-lactone;
monosaccharide derivative;
phenols;
thiophenes		antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
butylidenephthalide[no description available]low002-benzofurans;
gamma-lactone		EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hypoglycemic agent;
metabolite
bigelovin[no description available]low00acetate ester;
cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
sesquiterpene lactone		antineoplastic agent;
apoptosis inducer;
immunomodulator;
plant metabolite
heparin[no description available]low00gamma-lactone
4-methylene-2-octyl-5-oxo-3-oxolanecarboxylic acid[no description available]low00gamma-lactone;
monocarboxylic acid;
tetrahydrofuranone
mycophenolate mofetil[no description available]low00carboxylic ester;
ether;
gamma-lactone;
phenols;
tertiary amino compound		anticoronaviral agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
immunosuppressive agent;
prodrug
eupatolide[no description available]low00gamma-lactone;
germacranolide;
homoallylic alcohol;
secondary alcohol		antineoplastic agent;
plant metabolite
pyrethrosin[no description available]low00gamma-lactone
savinin[no description available]low00benzodioxoles;
gamma-lactone;
lignan		anti-inflammatory agent;
anticoronaviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
plant metabolite;
T-cell proliferation inhibitor
andrographolide[no description available]low00carbobicyclic compound;
gamma-lactone;
labdane diterpenoid;
primary alcohol;
secondary alcohol		anti-HIV agent;
anti-inflammatory drug;
antineoplastic agent;
metabolite
arglabin[no description available]low00epoxide;
gamma-lactone;
organic heterotetracyclic compound;
sesquiterpene lactone		antineoplastic agent;
metabolite
himbacine[no description available]low00gamma-lactone;
organic heterotricyclic compound;
piperidine alkaloid		muscarinic antagonist
thunberginol f[no description available]low00catechols;
gamma-lactone;
isobenzofuranone		metabolite;
plant metabolite
chaetoviridin a[no description available]low00azaphilone;
beta-hydroxy ketone;
enone;
gamma-lactone;
organic heterotricyclic compound;
organochlorine compound;
secondary alcohol		antifungal agent;
Chaetomium metabolite
hydroxyachillin[no description available]low00gamma-lactone
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid[no description available]low004-methylidene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid;
gamma-lactone
lactonamycin[no description available]low00gamma-lactone;
organic heterohexacyclic compound;
phenols;
trideoxyhexose derivative		antibacterial agent;
antimicrobial agent;
metabolite
sporothriolide[no description available]low00furofuran;
gamma-lactone		antifungal agent;
fungal metabolite
bielschowskysin[no description available]low00acetate ester;
cyclic acetal;
diterpenoid;
gamma-lactone;
organic heterohexacyclic compound		antimalarial;
antineoplastic agent;
metabolite
monascin[no description available]low00alpha,beta-unsaturated ketone;
gamma-lactone;
organic heterotricyclic compound;
polyketide		antilipemic drug;
antineoplastic agent;
fungal metabolite;
PPARgamma agonist
monascorubrin[no description available]low00azaphilone;
enone;
gamma-lactone;
polyketide;
triketone		anti-inflammatory agent;
antineoplastic agent;
biological pigment;
food colouring;
fungal metabolite;
Hsp90 inhibitor
3-furancarboxylic acid, tetrahydro-4-methylene-5-oxo-2-propyl-, (2r,3s)-rel-[no description available]low00gamma-lactone
4'-epichaetoviridin A[no description available]low00azaphilone;
beta-hydroxy ketone;
enone;
gamma-lactone;
organic heterotricyclic compound;
organochlorine compound;
secondary alcohol		Chaetomium metabolite
albiflorin[no description available]low00benzoate ester;
beta-D-glucoside;
bridged compound;
gamma-lactone;
monoterpene glycoside;
secondary alcohol		neuroprotective agent;
plant metabolite
(3S,3Ar,4S,9aS,9bR)-4-hydroxy-3,6,9-trimethyl-3,3a,4,5-tetrahydroazuleno[4,5-b]furan-2,7(9aH,9bH)-dione hydrate[no description available]low00gamma-lactone
chaetoviridin E[no description available]low00azaphilone;
enone;
gamma-lactone;
organic heterotricyclic compound;
organochlorine compound		Chaetomium metabolite
salvileucalin b[no description available]low00bridged compound;
diterpenoid;
furans;
gamma-lactone		antineoplastic agent;
metabolite
fumimycin[no description available]low001-benzofurans;
dicarboxylic acid monoamide;
gamma-lactone;
monocarboxylic acid;
polyphenol		antibacterial agent;
Aspergillus metabolite;
EC 3.5.1.88 (peptide deformylase) inhibitor
sphaeropsidin a[no description available]low00gamma-lactonemetabolite
carlactone[no description available]low00cyclic acetal;
gamma-lactone		plant hormone
lancifodilactone g[no description available]low00cyclic ether;
diol;
enol;
gamma-lactone;
oxaspiro compound;
triterpenoid		anti-HIV agent;
metabolite
nephrosteranic acid[no description available]low00gamma-lactone
4',7-dihydroxyflavanone[no description available]low004'-hydroxyflavanones;
dihydroxyflavanone;
polyphenol		Brassica napus metabolite;
fungal xenobiotic metabolite
bithionol[no description available]low00aryl sulfide;
bridged diphenyl antifungal drug;
bridged diphenyl fungicide;
dichlorobenzene;
organochlorine pesticide;
polyphenol		antifungal agrochemical;
antiplatyhelmintic drug
hexachlorophene[no description available]low00bridged diphenyl fungicide;
polyphenol;
trichlorobenzene		acaricide;
antibacterial agent;
antifungal agrochemical;
antiseptic drug
probucol[no description available]low00dithioketal;
polyphenol		anti-inflammatory drug;
anticholesteremic drug;
antilipemic drug;
antioxidant;
cardiovascular drug
resveratrol[no description available]low00polyphenol;
resorcinols;
stilbenol		antioxidant;
geroprotector;
glioma-associated oncogene inhibitor;
phytoalexin
bromthymol blue[no description available]low002,1-benzoxathiole;
arenesulfonate ester;
organobromine compound;
polyphenol;
sultone		acid-base indicator;
dye;
two-colour indicator
fentichlor[no description available]low00aryl sulfide;
bridged diphenyl antifungal drug;
monochlorobenzenes;
polyphenol		antiinfective agent;
drug allergen
bromcresol purple[no description available]low002,1-benzoxathiole;
arenesulfonate ester;
organobromine compound;
polyphenol;
sultone		acid-base indicator;
dye;
two-colour indicator
usnic acid[no description available]low00dibenzofurans;
methyl ketone;
polyphenol		acaricide;
antifungal agent;
lichen metabolite
silybin[no description available]low00aromatic ether;
benzodioxine;
flavonolignan;
polyphenol;
secondary alpha-hydroxy ketone		antineoplastic agent;
antioxidant;
hepatoprotective agent;
plant metabolite
du-21220[no description available]low00benzyl alcohols;
polyphenol;
secondary alcohol;
secondary amino compound
ractopamine[no description available]low00benzyl alcohols;
polyphenol;
secondary alcohol;
secondary amino compound
epicatechin[no description available]low00catechin;
polyphenol		antioxidant
9,9-bis(4-hydroxyphenyl)fluorene[no description available]low00fluorenes;
polyphenol		anti-estrogen
eupatorin[no description available]low00dihydroxyflavone;
polyphenol;
trimethoxyflavone		anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
Brassica napus metabolite;
calcium channel blocker;
P450 inhibitor;
vasodilator agent
atromentin[no description available]low00dihydroxy-1,4-benzoquinones;
polyphenol		antibacterial agent;
anticoagulant;
antineoplastic agent;
apoptosis inducer;
biological pigment;
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor;
fungal metabolite
rhodomycinone[no description available]low00carbopolycyclic compound;
methyl ester;
polyphenol;
tetracenequinones;
tetracenomycin
syringaresinol[no description available]low00aromatic ether;
furofuran;
lignan;
polyether;
polyphenol		plant metabolite
versicolorin c[no description available]low00cyclic acetal;
organic heteropentacyclic compound;
p-quinones;
polyphenol		Aspergillus metabolite
versiconal hemiacetal acetate[no description available]low00acetate ester;
anthrafuran;
lactol;
palmitoyl amino acid;
polyphenol		metabolite
ecteinascidin 743[no description available]low00acetate ester;
azaspiro compound;
bridged compound;
hemiaminal;
isoquinoline alkaloid;
lactone;
organic heteropolycyclic compound;
organic sulfide;
oxaspiro compound;
polyphenol;
tertiary amino compound		alkylating agent;
angiogenesis modulating agent;
anti-inflammatory agent;
antineoplastic agent;
marine metabolite
procyanidin b2[no description available]low00biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		antioxidant;
metabolite
procyanidin b5[no description available]low00biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		metabolite
swertisin[no description available]low00dihydroxyflavone;
flavone C-glycoside;
monomethoxyflavone;
monosaccharide derivative;
polyphenol		adenosine A1 receptor antagonist;
anti-inflammatory agent;
antioxidant;
hypoglycemic agent;
plant metabolite
tetrahydrocurcumin[no description available]low00beta-diketone;
diarylheptanoid;
polyphenol		metabolite
alteichin[no description available]low00polyphenol
cercosporamide[no description available]low00dibenzofurans;
methyl ketone;
monocarboxylic acid amide;
polyphenol		antifungal agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
fungal metabolite;
phytotoxin
marsupsin[no description available]low001-benzofurans;
aromatic ether;
polyphenol		antilipemic drug;
hypoglycemic agent;
metabolite
procyanidin b3[no description available]low00biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		anti-inflammatory agent;
antioxidant;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
metabolite
acrovestone[no description available]low00acetophenones;
aromatic ether;
olefinic compound;
polyphenol		antioxidant;
EC 1.14.18.1 (tyrosinase) inhibitor;
plant metabolite
corytuberine[no description available]low00aporphine alkaloid;
aromatic ether;
organic heterotetracyclic compound;
polyphenol;
tertiary amino compound		plant metabolite
isolariciresinol[no description available]low00guaiacols;
lignan;
polyphenol;
primary alcohol		plant metabolite
2',6'-dihydroxy-4'-methoxydihydrochalcone[no description available]low00dihydrochalcones;
monomethoxybenzene;
polyphenol		antiplasmodial drug;
radical scavenger
procyanidin C1[no description available]low00hydroxyflavan;
polyphenol;
proanthocyanidin		anti-inflammatory agent;
antioxidant;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
lipoxygenase inhibitor;
metabolite
medioresinol[no description available]low00dimethoxybenzene;
furofuran;
lignan;
polyphenol		plant metabolite
(+)-epicatechin[no description available]low00catechin;
polyphenol		cyclooxygenase 1 inhibitor;
plant metabolite
chloroorienticin b[no description available]low00cyclic ether;
glycopeptide;
heterodetic cyclic peptide;
monosaccharide derivative;
organochlorine compound;
polyphenol		antimicrobial agent;
bacterial metabolite
(-)-gallocatechin gallate[no description available]low00catechin;
gallate ester;
polyphenol		antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human xenobiotic metabolite;
plant metabolite
norbelladine[no description available]low00catechols;
phenethylamine alkaloid;
polyphenol;
secondary amino compound		plant metabolite
silychristin[no description available]low001-benzofurans;
aromatic ether;
flavonolignan;
polyphenol;
secondary alpha-hydroxy ketone		lipoxygenase inhibitor;
metabolite;
prostaglandin antagonist;
radical scavenger
davidigenin[no description available]low00dihydrochalcones;
polyphenol		anti-allergic agent;
anti-asthmatic agent;
antioxidant;
metabolite
knipholone[no description available]low00aromatic ketone;
dihydroxyanthraquinone;
methoxybenzenes;
methyl ketone;
polyphenol;
resorcinols		antineoplastic agent;
antioxidant;
antiplasmodial drug;
leukotriene antagonist;
metabolite
aglucovancomycin b[no description available]low00cyclic ether;
heterodetic cyclic peptide;
peptide antibiotic;
peptide zwitterion;
polyphenol		metabolite
5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol[no description available]low00carbotetracyclic compound;
polyphenol		estrogen receptor agonist;
estrogen receptor antagonist;
geroprotector;
neuroprotective agent
pallidol[no description available]low00carbopolycyclic compound;
polyphenol;
stilbenoid		antifungal agent;
antioxidant;
plant metabolite
averufin[no description available]low00cyclic ketal;
organic heteropentacyclic compound;
polyketide;
polyphenol		fungal metabolite
versicolorin a[no description available]low00cyclic acetal;
organic heteropentacyclic compound;
p-quinones;
polyphenol		Aspergillus metabolite;
carcinogenic agent
xanthohumol[no description available]low00aromatic ether;
chalcones;
polyphenol		anti-HIV-1 agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor;
metabolite
3,3',4,5'-tetrahydroxystilbene[no description available]low00catechols;
polyphenol;
resorcinols;
stilbenol		antineoplastic agent;
apoptosis inducer;
geroprotector;
hypoglycemic agent;
plant metabolite;
protein kinase inhibitor;
tyrosine kinase inhibitor
adefovir[no description available]low00aromatic ether;
aromatic ketone;
biaryl;
cyclic ketone;
naphtho-gamma-pyrone;
organooxygen heterocyclic antibiotic;
polyphenol		antimalarial;
Aspergillus metabolite;
marine metabolite
catechin gallate[no description available]low00flavans;
gallate ester;
polyphenol		metabolite
gallocatechin-3-gallate[no description available]low00catechin;
gallate ester;
polyphenol		plant metabolite
naringenin chalcone[no description available]low00chalcones;
polyphenol		anti-allergic agent;
anti-inflammatory agent;
metabolite
butein[no description available]low00chalcones;
polyphenol		antineoplastic agent;
antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
geroprotector;
hypoglycemic agent;
plant metabolite;
radiosensitizing agent;
tyrosine kinase inhibitor
isobavachalcone[no description available]low00chalcones;
polyphenol		antibacterial agent;
metabolite;
platelet aggregation inhibitor
bellidifolin[no description available]low00polyphenol;
xanthones		EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hypoglycemic agent;
metabolite
gartanin[no description available]low00polyphenol;
xanthones		antineoplastic agent;
plant metabolite
gentiacaulein[no description available]low00aromatic ether;
polyphenol;
xanthones		plant metabolite
gentisein[no description available]low00polyphenol;
xanthones		plant metabolite
gentisin[no description available]low00aromatic ether;
polyphenol;
xanthones		plant metabolite
isogentisin[no description available]low00aromatic ether;
polyphenol;
xanthones		EC 1.4.3.4 (monoamine oxidase) inhibitor;
plant metabolite
1,8-dihydroxy-3,7-dimethoxyxanthone[no description available]low00aromatic ether;
polyphenol;
xanthones		plant metabolite
norathyriol[no description available]low00polyphenol;
xanthones		antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
plant metabolite
norlichexanthone[no description available]low00polyphenol;
xanthones		antimalarial;
fungal metabolite
1,2,8-trihydroxy-6-methoxyxanthone[no description available]low00aromatic ether;
polyphenol;
xanthones		antioxidant;
plant metabolite
coumestrol[no description available]low00coumestans;
delta-lactone;
polyphenol		anti-inflammatory agent;
antioxidant;
plant metabolite
astringin[no description available]low00beta-D-glucoside;
monosaccharide derivative;
polyphenol;
stilbenoid		antineoplastic agent;
antioxidant;
metabolite
polydatin[no description available]low00beta-D-glucoside;
monosaccharide derivative;
polyphenol;
stilbenoid		anti-arrhythmia drug;
antioxidant;
geroprotector;
hepatoprotective agent;
metabolite;
nephroprotective agent;
potassium channel modulator
epsilon-viniferin[no description available]low001-benzofurans;
polyphenol;
stilbenoid		metabolite
acteoside[no description available]low00catechols;
cinnamate ester;
disaccharide derivative;
glycoside;
polyphenol		anti-inflammatory agent;
antibacterial agent;
antileishmanial agent;
neuroprotective agent;
plant metabolite
psoralidin[no description available]low00coumestans;
delta-lactone;
polyphenol		estrogen receptor agonist;
plant metabolite
wedelolactone[no description available]low00aromatic ether;
coumestans;
delta-lactone;
polyphenol		antineoplastic agent;
apoptosis inducer;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
hepatoprotective agent;
metabolite
(+)-trans-epsilon-viniferin[no description available]low001-benzofurans;
polyphenol;
stilbenoid
bisdemethoxycurcumin[no description available]low00beta-diketone;
diarylheptanoid;
enone;
polyphenol		EC 3.2.1.1 (alpha-amylase) inhibitor;
metabolite
rosmarinic acid[no description available]low00carboxylic ester;
monocarboxylic acid;
phenylpropanoid;
polyphenol		antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug;
plant metabolite;
serine proteinase inhibitor
quadrangularin a[no description available]low00indanes;
polyphenol;
stilbenoid		antioxidant;
plant metabolite
isomangiferin[no description available]low00C-glycosyl compound;
polyphenol;
xanthones		anti-HSV-1 agent;
plant metabolite
neoglycyrol[no description available]low00aromatic ether;
coumestans;
delta-lactone;
polyphenol		antineoplastic agent;
plant metabolite
benanomicin b[no description available]low00aromatic ether;
disaccharide derivative;
L-alanine derivative;
polyketide;
polyphenol;
pradimicin;
secondary alcohol
pradimicin b[no description available]low00aromatic ether;
L-alanine derivative;
monosaccharide derivative;
polyketide;
polyphenol;
pradimicin;
secondary alcohol
demethoxycurcumin[no description available]low00beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antineoplastic agent;
metabolite
tetrahydroxycurcumin[no description available]low00beta-diketone;
catechols;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
neuroprotective agent;
plant metabolite
pradimicin a[no description available]low00aromatic ether;
carboxylic acid;
disaccharide derivative;
L-alanine derivative;
p-quinones;
polyphenol;
pradimicin;
secondary alcohol
lespenefril[no description available]low00alpha-L-rhamnoside;
dihydroxyflavone;
glycosyloxyflavone;
monosaccharide derivative;
polyphenol		anti-inflammatory agent;
antidepressant;
antineoplastic agent;
apoptosis inducer;
bone density conservation agent;
hypoglycemic agent;
immunomodulator;
plant metabolite
4-hydroxycordoin[no description available]low00aromatic ether;
chalcones;
polyphenol		anti-inflammatory agent;
antibacterial agent;
plant metabolite
rifamycin sv[no description available]low00acetate ester;
cyclic ketal;
lactam;
macrocycle;
organic heterotetracyclic compound;
polyphenol;
rifamycins		antimicrobial agent;
antitubercular agent;
bacterial metabolite
(-)-catechin-3-O-gallate[no description available]low00flavans;
gallate ester;
polyphenol		metabolite
salvianolic acid B[no description available]low001-benzofurans;
catechols;
dicarboxylic acid;
enoate ester;
polyphenol		anti-inflammatory agent;
antidepressant;
antineoplastic agent;
antioxidant;
apoptosis inducer;
autophagy inhibitor;
cardioprotective agent;
hepatoprotective agent;
hypoglycemic agent;
neuroprotective agent;
osteogenesis regulator;
plant metabolite
altenusin[no description available]low00aromatic ether;
carboxybiphenyl;
catechols;
hydroxybiphenyls;
polyphenol		antifungal agent;
fungal metabolite
rubraxanthone[no description available]low00aromatic ether;
polyphenol;
xanthones		antibacterial agent;
antineoplastic agent;
metabolite
hetacillin[no description available]low00guaiacols;
lignan;
oxolanes;
polyphenol;
tetrol		plant metabolite
delta-viniferin[no description available]low001-benzofurans;
polyphenol;
stilbenoid
fonsecinone a[no description available]low00aromatic ether;
aromatic ketone;
biaryl;
cyclic ketone;
naphtho-gamma-pyrone;
polyphenol		antibacterial agent;
Aspergillus metabolite
dihydroxanthohumol[no description available]low00aromatic ether;
dihydrochalcones;
polyphenol		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite
(+)-lyoniresinol-3-alpha-O-beta-D-glucopyranoside[no description available]low00beta-D-glucoside;
dimethoxybenzene;
lignan;
monosaccharide derivative;
polyphenol;
primary alcohol;
tetralins		antibacterial agent;
antifungal agent;
metabolite
2,3,6,8-tetrahydroxy-1-(3-methylbut-2-enyl)-5-(2-methylbut-3-en-2-yl)-9h-xanthen-9-one[no description available]low00polyphenol;
xanthones		anti-inflammatory agent;
antineoplastic agent;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite
procyanidin b1[no description available]low00biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		anti-inflammatory agent;
EC 3.4.21.5 (thrombin) inhibitor;
metabolite
aspalathin[no description available]low00C-glycosyl compound;
catechols;
dihydrochalcones;
polyketide;
polyphenol		antioxidant;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
hypoglycemic agent;
plant metabolite
liphagal[no description available]low00aldehyde;
cyclic ether;
meroterpenoid;
organic heterotetracyclic compound;
polyphenol		EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
metabolite
lyoniresinol[no description available]low00dimethoxybenzene;
lignan;
polyphenol;
primary alcohol;
tetralins		antineoplastic agent;
metabolite
complestatin[no description available]low00cyclic ether;
heterodetic cyclic peptide;
indoles;
organic heterobicyclic compound;
organochlorine compound;
peptide antibiotic;
polyphenol		anti-HIV-1 agent;
antimicrobial agent;
HIV-1 integrase inhibitor;
metabolite
neuroprotectin a[no description available]low00cyclic ether;
heterodetic cyclic peptide;
indoles;
organochlorine compound;
polyphenol		HIV-1 integrase inhibitor;
metabolite
tricin 4'-o-(threo-beta-guaiacylglyceryl) ether[no description available]low00dimethoxybenzene;
flavonolignan;
polyphenol;
primary alcohol;
secondary alcohol		plant metabolite
5,7-dihydroxy-3-(3-hydroxy-4-methoxybenzyl)-6-methoxychroman-4-one[no description available]low00aromatic ether;
homoisoflavonoid;
polyphenol		angiogenesis modulating agent;
plant metabolite
mycocyclosin[no description available]low002,5-diketopiperazines;
organic heterotetracyclic compound;
polyphenol		metabolite
scytonemin[no description available]low00enone;
organic heterotricyclic compound;
organonitrogen heterocyclic compound;
polyphenol;
ring assembly		bacterial metabolite;
biological pigment;
ultraviolet filter
hydrazinocurcumin[no description available]low00aromatic ether;
olefinic compound;
polyphenol;
pyrazoles		angiogenesis modulating agent;
antineoplastic agent;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
spironolactone[no description available]low003-oxo-Delta(4) steroid;
oxaspiro compound;
steroid lactone;
thioester		aldosterone antagonist;
antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
tomatidine[no description available]low003beta-hydroxy steroid;
azaspiro compound;
oxaspiro compound
fluoran[no description available]low002-benzofurans;
oxaspiro compound;
xanthenes
remikiren[no description available]low00azaspiro compound;
oxaspiro compound;
steroid
u 69593[no description available]low00monocarboxylic acid amide;
N-alkylpyrrolidine;
organic heterobicyclic compound;
oxaspiro compound		anti-inflammatory agent;
diuretic;
kappa-opioid receptor agonist
hippurin[no description available]low00oxaspiro compound;
steroid
bisdechlorogeodin[no description available]low001-benzofurans;
cyclohexadiene;
methyl ester;
oxaspiro compound		antimicrobial agent
solasodine[no description available]low00alkaloid antibiotic;
azaspiro compound;
hemiaminal ether;
oxaspiro compound;
sapogenin;
steroid alkaloid		anticonvulsant;
antifungal agent;
antiinfective agent;
antioxidant;
antipyretic;
antispermatogenic agent;
apoptosis inducer;
cardiotonic drug;
central nervous system depressant;
diuretic;
immunomodulator;
plant metabolite;
teratogenic agent
6-amino-3-(methoxymethyl)-5-spiro[2H-pyrano[2,3-c]pyrazole-4,4'-thiane]carbonitrile[no description available]low00nitrile;
organic sulfide;
organosulfur heterocyclic compound;
oxaspiro compound
pseurotin[no description available]low00azaspiro compound;
lactam;
oxaspiro compound		metabolite
estin[no description available]low001-benzofurans;
ether;
methyl ester;
organochlorine compound;
oxaspiro compound;
phenols		Aspergillus metabolite;
Penicillium metabolite
trachyspic acid[no description available]low00oxaspiro compound;
tricarboxylic acid		EC 3.2.1.166 (heparanase) inhibitor;
fungal metabolite
esculeoside a[no description available]low00azaspiro compound;
oxaspiro compound;
saponin;
steroid alkaloid;
steroid saponin		antineoplastic agent;
metabolite
fumiquinazoline c[no description available]low00azaspiro compound;
fumiquinazoline;
imidazoindole;
organic heteroheptacyclic compound;
oxaspiro compound
avilamycin a[no description available]low00benzoate ester;
cyclic acetal;
dichlorobenzene;
oligosaccharide derivative;
ortho ester;
oxaspiro compound;
phenols;
tertiary alpha-hydroxy ketone		antimicrobial agent;
bacterial metabolite
AZD1979[no description available]low00aromatic ether;
azaspiro compound;
carboxamide;
N-acylazetidine;
oxadiazole;
oxaspiro compound;
oxetanes		melanin-concentrating hormone receptor antagonist
boromycin[no description available]low00macrodiolide;
macrolide antibiotic;
organoboron compound;
oxaspiro compound;
zwitterion		anti-HIV agent;
antibacterial agent;
bacterial metabolite
marineosin a[no description available]low00azaspiro compound;
ether;
macrocycle;
oxaspiro compound;
pyrroles		antineoplastic agent;
metabolite
marineosin b[no description available]low00azaspiro compound;
ether;
macrocycle;
oxaspiro compound;
pyrroles		antineoplastic agent;
metabolite
6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester[no description available]low002-benzofurans
6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid[no description available]low002-benzofurans
sulfobromophthalein[no description available]low002-benzofurans;
organobromine compound;
organosulfonic acid;
phenols		dye
phthalic anhydride[no description available]low002-benzofurans;
cyclic dicarboxylic anhydride		allergen
trimellitic anhydride[no description available]low002-benzofurans;
cyclic dicarboxylic anhydride;
dioxo monocarboxylic acid		allergen;
epitope;
hapten
tetrabromophthalic anhydride[no description available]low002-benzofurans;
cyclic dicarboxylic anhydride
meconin[no description available]low002-benzofurans
fraxinellone[no description available]low002-benzofurans
5,6-dimethoxy-3H-isobenzofuran-1-one[no description available]low002-benzofurans
3-Furan-3-yl-3a,7-dimethyl-3a,4,5,6-tetrahydro-3H-isobenzofuran-1-one[no description available]low002-benzofurans
4,6-Dimethoxy-phthalide[no description available]low002-benzofurans
(3z,6alpha,7alpha)-isomer of 3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3h)-isobenzofuranone[no description available]low002-benzofurans
deberza[no description available]low002-benzofurans
asperfuranone[no description available]low002-benzofurans;
cyclic ketone;
diol;
polyketide;
secondary alcohol;
tertiary alcohol;
tertiary alpha-hydroxy ketone		antineoplastic agent;
fungal metabolite
chetomin[no description available]low00indoles;
organic disulfide;
organic heteropentacyclic compound		Chaetomium metabolite;
immunosuppressive agent
amberlite cg 400[no description available]low00methyl ester;
organic heteropentacyclic compound;
yohimban alkaloid
vincristine[no description available]low00acetate ester;
formamides;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
tertiary alcohol;
tertiary amino compound;
vinca alkaloid		antineoplastic agent;
drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
fluocinolone acetonide[no description available]low0011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
organic heteropentacyclic compound;
primary alpha-hydroxy ketone		anti-inflammatory drug;
antipruritic drug
gibberellic acid[no description available]low00C19-gibberellin;
gibberellin monocarboxylic acid;
lactone;
organic heteropentacyclic compound		mouse metabolite;
plant metabolite
deserpidine[no description available]low00alkaloid ester;
benzoate ester;
methyl ester;
organic heteropentacyclic compound;
yohimban alkaloid
liriodenine[no description available]low00alkaloid antibiotic;
cyclic ketone;
organic heteropentacyclic compound;
oxacycle;
oxoaporphine alkaloid		antifungal agent;
antimicrobial agent;
antineoplastic agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
vincamine[no description available]low00alkaloid ester;
hemiaminal;
methyl ester;
organic heteropentacyclic compound;
vinca alkaloid		antihypertensive agent;
metabolite;
vasodilator agent
tabersonine[no description available]low00alkaloid ester;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound		antineoplastic agent;
metabolite
stanozolol[no description available]low0017beta-hydroxy steroid;
anabolic androgenic steroid;
organic heteropentacyclic compound;
tertiary alcohol		anabolic agent;
androgen
canadine[no description available]low00aromatic ether;
berberine alkaloid;
organic heteropentacyclic compound;
oxacycle
butaclamol[no description available]low00organic heteropentacyclic compound
butaclamol[no description available]low00amino alcohol;
organic heteropentacyclic compound;
tertiary alcohol;
tertiary amino compound		dopaminergic antagonist
vindesine[no description available]low00methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
primary carboxamide;
tertiary alcohol;
tertiary amino compound;
vinca alkaloid		antineoplastic agent
cephalotaxine[no description available]low00benzazepine alkaloid fundamental parent;
benzazepine alkaloid;
cyclic acetal;
enol ether;
organic heteropentacyclic compound;
secondary alcohol;
tertiary amino compound
siccanin[no description available]low00organic heteropentacyclic compoundantifungal drug;
fungal metabolite
tetrahydroalstonine[no description available]low00methyl ester;
organic heteropentacyclic compound;
yohimban alkaloid		plant metabolite
voacamine[no description available]low00alkaloid ester;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		angiogenesis inhibitor;
antineoplastic agent;
plant metabolite
tylophorine[no description available]low00organic heteropentacyclic compound;
organonitrogen heterocyclic compound
cryptopleurine[no description available]low00alkaloid antibiotic;
alkaloid;
aromatic ether;
organic heteropentacyclic compound		antineoplastic agent;
antiviral agent;
protein synthesis inhibitor
sporidesmin[no description available]low00aromatic ether;
cyclic ketone;
diketone;
organic disulfide;
organic heteropentacyclic compound;
organochlorine compound;
secondary alcohol;
tertiary alcohol;
tertiary amino compound		mycotoxin;
Wnt signalling activator
fumitremorgin b[no description available]low00indole alkaloid;
organic heteropentacyclic compound		mycotoxin
deguelin[no description available]low00aromatic ether;
diether;
organic heteropentacyclic compound;
rotenones		angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
mitochondrial NADH:ubiquinone reductase inhibitor;
plant metabolite
cafestol[no description available]low00diterpenoid;
furans;
organic heteropentacyclic compound;
primary alcohol;
tertiary alcohol		angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
hypoglycemic agent;
plant metabolite
kahweol[no description available]low00diterpenoid;
furans;
organic heteropentacyclic compound;
primary alcohol;
tertiary alcohol		angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
plant metabolite
tephrosin[no description available]low00aromatic ether;
cyclic ketone;
organic heteropentacyclic compound;
rotenones		antineoplastic agent;
metabolite;
pesticide
actinodaphine[no description available]low00aporphine alkaloid;
aromatic ether;
organic heteropentacyclic compound;
phenols;
secondary amino compound		antibacterial agent;
antifungal agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite;
platelet aggregation inhibitor;
topoisomerase inhibitor
anonaine[no description available]low00aporphine alkaloid;
organic heteropentacyclic compound;
oxacycle		antineoplastic agent;
antiplasmodial drug;
trypanocidal drug
glyceollin[no description available]low00organic heteropentacyclic compound
diflomotecan[no description available]low00epsilon-lactone;
organic heteropentacyclic compound;
organofluorine compound;
organonitrogen heterocyclic compound;
tertiary alcohol		antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
vincaleukoblastine[no description available]low00acetate ester;
indole alkaloid fundamental parent;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
tertiary alcohol;
tertiary amino compound;
vinca alkaloid		antineoplastic agent;
immunosuppressive agent;
microtubule-destabilising agent;
plant metabolite
homoharringtonine[no description available]low00alkaloid ester;
enol ether;
organic heteropentacyclic compound;
tertiary alcohol		anticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
protein synthesis inhibitor
tryptoquivaline[no description available]low00aromatic ether;
indole alkaloid;
organic heteropentacyclic compound		breast cancer resistance protein inhibitor;
mycotoxin
hippeastrine[no description available]low00delta-lactone;
indole alkaloid;
organic heteropentacyclic compound;
secondary alcohol		antineoplastic agent;
metabolite
glaucarubinone[no description available]low00carboxylic ester;
organic heteropentacyclic compound;
quassinoid;
secondary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone;
tetrol		antimalarial;
antineoplastic agent;
geroprotector;
plant metabolite
raubasine[no description available]low00methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound		alpha-adrenergic antagonist;
antihypertensive agent;
vasodilator agent
antofine[no description available]low00alkaloid antibiotic;
alkaloid;
aromatic ether;
organic heteropentacyclic compound		angiogenesis inhibitor;
anti-inflammatory agent;
antimicrobial agent;
antineoplastic agent;
antiviral agent;
phytotoxin;
plant metabolite
noribogaine[no description available]low00monoterpenoid indole alkaloid;
organic heteropentacyclic compound;
secondary amino compound;
tertiary amino compound		kappa-opioid receptor agonist;
NMDA receptor antagonist;
psychotropic drug;
serotonin uptake inhibitor
rescinnamine[no description available]low00indole alkaloid;
methyl ester;
organic heteropentacyclic compound		antihypertensive agent
geissospermine[no description available]low00indole alkaloid;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound		EC 3.1.1.7 (acetylcholinesterase) inhibitor
hydrocodone[no description available]low00morphinane-like compound;
organic heteropentacyclic compound		antitussive;
mu-opioid receptor agonist;
opioid analgesic
hydromorphone[no description available]low00morphinane alkaloid;
organic heteropentacyclic compound		mu-opioid receptor agonist;
opioid analgesic
nalbuphine[no description available]low00organic heteropentacyclic compoundmu-opioid receptor antagonist;
opioid analgesic
pholcodine[no description available]low00morphinane alkaloid;
organic heteropentacyclic compound		antitussive;
drug allergen;
mu-opioid receptor agonist;
opioid analgesic
vinorelbine[no description available]low00acetate ester;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
ring assembly;
vinca alkaloid		antineoplastic agent;
photosensitizing agent
oridonin[no description available]low00cyclic hemiketal;
enone;
ent-kaurane diterpenoid;
organic heteropentacyclic compound;
secondary alcohol		angiogenesis inhibitor;
anti-asthmatic agent;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite
thebaine[no description available]low00morphinane alkaloid;
organic heteropentacyclic compound
catharanthine[no description available]low00alkaloid ester;
bridged compound;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound;
tertiary amino compound
oripavine[no description available]low00ether;
morphinane alkaloid;
organic heteropentacyclic compound;
organic hydroxy compound;
tertiary amino compound		bacterial xenobiotic metabolite;
opioid analgesic
neopine[no description available]low00morphinane alkaloid;
organic heteropentacyclic compound
resiniferatoxin[no description available]low00carboxylic ester;
diterpenoid;
enone;
monomethoxybenzene;
organic heteropentacyclic compound;
ortho ester;
phenols;
tertiary alpha-hydroxy ketone		analgesic;
neurotoxin;
plant metabolite;
TRPV1 agonist
coronardine[no description available]low00alkaloid ester;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound		antileishmanial agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite
salannin[no description available]low00acetate ester;
furans;
limonoid;
methyl ester;
organic heteropentacyclic compound		antifeedant;
insect growth regulator;
plant metabolite
muromonab-cd3[no description available]low00alkaloid;
macrocycle;
organic heteropentacyclic compound;
organonitrogen heterocyclic compound;
oxacycle;
tertiary amino compound		antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
IP3 receptor antagonist;
marine metabolite
akuammicine[no description available]low00methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		plant metabolite
demethoxyfumitremorgin c[no description available]low00indole alkaloid;
organic heteropentacyclic compound		mycotoxin
eckstolonol[no description available]low00organic heteropentacyclic compound;
oxacycle;
phlorotannin		metabolite;
radical scavenger
vinflunine[no description available]low00acetate ester;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
semisynthetic derivative;
vinca alkaloid		antineoplastic agent
homocamptothecin[no description available]low00epsilon-lactone;
organic heteropentacyclic compound;
organonitrogen heterocyclic compound;
tertiary alcohol		antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
triphosphate[no description available]low00aldehyde;
indole alkaloid;
organic heteropentacyclic compound		plant metabolite
gedunin[no description available]low00acetate ester;
enone;
epoxide;
furans;
lactone;
limonoid;
organic heteropentacyclic compound;
pentacyclic triterpenoid		antimalarial;
antineoplastic agent;
Hsp90 inhibitor;
plant metabolite
simalikalactone D[no description available]low00cyclic ether;
delta-lactone;
enone;
organic heteropentacyclic compound;
quassinoid;
secondary alcohol;
secondary alpha-hydroxy ketone;
triol		antimalarial;
antineoplastic agent;
antiviral agent;
metabolite
interiotherin b[no description available]low00aromatic ether;
fatty acid ester;
lignan;
organic heteropentacyclic compound;
oxacycle		anti-HIV agent;
metabolite
vindolinine[no description available]low00methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		plant metabolite
alexa fluor 546[no description available]low00organic heteropentacyclic compoundfluorochrome
jadomycin b[no description available]low00glycoside;
jadomycin;
organic heteropentacyclic compound		antibacterial agent;
antineoplastic agent;
apoptosis inducer;
Aurora kinase inhibitor;
bacterial metabolite
picrinine[no description available]low00alkaloid ester;
indole alkaloid;
methyl ester;
organic heteropentacyclic compound;
polycyclic ether		analgesic;
anti-asthmatic agent;
anti-inflammatory agent;
antitussive;
plant metabolite
eurycomanone[no description available]low00cyclic ether;
delta-lactone;
enone;
organic heteropentacyclic compound;
pentol;
quassinoid;
secondary alcohol;
secondary alpha-hydroxy ketone;
tertiary alcohol		antimalarial;
antineoplastic agent;
metabolite
crambescidin 800[no description available]low00alkaloid;
carboxylic ester;
guanidines;
monocarboxylic acid amide;
organic heteropentacyclic compound;
primary amino compound;
secondary alcohol;
spiro compound		anti-HIV-1 agent;
anti-HSV-1 agent;
antimalarial;
marine metabolite
naloxegol[no description available]low00aromatic ether;
organic heteropentacyclic compound;
phenols;
polyether;
tertiary alcohol		cathartic;
mu-opioid receptor antagonist
gs-5816[no description available]low00carbamate ester;
ether;
imidazoles;
L-valine derivative;
N-acylpyrrolidine;
organic heteropentacyclic compound;
ring assembly		antiviral drug;
hepatitis C virus nonstructural protein 5A inhibitor
ebc-46[no description available]low00diester;
diterpenoid;
organic heteropentacyclic compound;
phorbol ester		antineoplastic agent;
plant metabolite;
protein kinase C agonist
chrodrimanin b[no description available]low00organic heteropentacyclic compound
wilforgine[no description available]low00acetate ester;
dihydroagarofuran sesquiterpenoid;
furans;
macrocyclic lactone;
organic heteropentacyclic compound;
pyridine alkaloid		plant metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
2019 Novel Coronavirus Disease0low80
2019 Novel Coronavirus Infection0low80
2019-nCoV Disease0low80
2019-nCoV Infection0low80
4 Hydroxyphenylpyruvate Dioxygenase Deficiency Disease0low20
4-Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease0low20
4-Hydroxyphenylpyruvate Dioxygenase Deficiency0low20
4-Hydroxyphenylpyruvic Acid Oxidase Deficiency0low20
47,XX,+210low10
47,XY,+210low10
Abdomen, Acute0low10
Abdominal Injuries0low10
Aberrant Tissue0low10
Abnormalities, Autosome0low10
Abnormalities, Chromosomal0low10
Abnormalities, Chromosome0low10
Abnormalities, Multiple0low10
Abnormality, Heart0low20
Abnormality, Torsion0low10
Abscess0low10
Abscess, Intracranial, Subdural0low10
Absence Seizure0low100
Absence Seizure Disorder0low10
Absence Seizures0low100
Absence Status0low40
Acanthamoeba Keratitis0low20
Acariasis0low10
Ache0medium91
Achromatopsia0low10
Acid beta-Glucosidase Deficiency0low10
Acid beta-Glucosidase Deficiency Disease0low10
Acidosis0low20
Acne Rosacea0low10
Acoustic Neuroma0low30
Acoustic Neuroma, Cerebellopontine Angle0low30
Acoustic Trauma0low10
Acoustic Tumor0low30
Acquired Autoimmune Hemolytic Anemia0low10
Acquired Immune Deficiency Syndrome0low30
Acquired Immuno-Deficiency Syndrome0low30
Acquired Immunodeficiency Syndrome0low30
Acquired Meningomyelocele0low10
Acrania0low10
Acrocephaly0low10
Actinic Reticuloid Syndrome0low10
Actinobacillus Infections0low10
Active Hyperemia0medium62
Acute Bacterial Prostatitis0low10
Acute Brain Injuries0low40
Acute Confusional Senile Dementia0low30
Acute Disease0medium161
Acute Edematous Pancreatitis0low30
Acute Ischemic Stroke0low20
Acute Kidney Failure0low30
Acute Kidney Injury0low30
Acute Kidney Insufficiency0low30
Acute Liver Injury, Drug-Induced0low10
Acute Lymphoid Leukemia0low10
Acute Myelogenous Leukemia0low10
Acute Myeloid Leukemia0low10
Acute Myeloid Leukemia with Maturation0low10
Acute Myeloid Leukemia without Maturation0low10
Acute Necrotizing Pancreatitis0low10
Acute Neuronopathic Gaucher Disease0low10
Acute Pancreatitis0low30
Acute Promyelocytic Leukemia0low20
Acute Renal Failure0low30
Acute Renal Injury0low30
Acute Renal Insufficiency0low30
Adamantiades-Behcet Disease0low10
Adenocarcinoma0low80
Adenocarcinoma Of Kidney0medium21
Adenocarcinoma of Lung0low10
Adenocarcinoma, Basal Cell0low80
Adenocarcinoma, Granular Cell0low80
Adenocarcinoma, Oxyphilic0low80
Adenocarcinoma, Renal0medium21
Adenocarcinoma, Renal Cell0medium21
Adenocarcinoma, Tubular0low80
Adenocystic Carcinoma0low10
Adenoma0medium42
Adenoma, Basal Cell0medium42
Adenoma, beta-Cell0low10
Adenoma, Follicular0medium42
Adenoma, Malignant0low80
Adenoma, Microcystic0medium42
Adenoma, Monomorphic0medium42
Adenoma, Papillary0medium42
Adenoma, Prostatic0low10
Adenoma, Trabecular0medium42
Adie Pupil0low10
Adie's Pupil0low10
Adipocere0low10
Adnexal Diseases0low10
Adrenal Cancer0low10
Adrenal Gland Cancer0low10
Adrenal Gland Neoplasms0low10
Adrenal Neoplasm0low10
Adverse Drug Event0medium21
Adverse Drug Reaction0medium21
African Lymphoma0low20
African Sleeping Sickness0low10
African Trypanosomiasis0low10
Agammaglobulinemia0low10
Age-Related Macular Degeneration0medium286
Age-Related Maculopathies0medium286
Age-Related Maculopathy0medium286
Age-Related Memory Disorders0low10
Age-Related Osteoporosis0low20
Aggression0low10
Aging0medium351
AIDS0low30
AIDS-Related Complex0low10
AIDS-Related Opportunistic Infections0low10
AIDS, Simian0low10
Airflow Obstruction, Chronic0medium21
Akinetic Petit Mal0low10
Albinism0low10
Albuminuria0medium63
Alcoholic Intoxication0low10
Algor Mortis0low10
ALL, Childhood0low10
Allergic Conjunctivitis0low110
Allergic Contact Dermatitis0medium11
Allergic Encephalomyelitis0low50
Allergic Encephalomyelitis, Experimental0low50
Allergic Reaction0low30
Allergy0low30
Allergy, Drug0medium183
Allergy, Food0low10
Allodynia0low10
Allodynia, Mechanical0low10
Allodynia, Tactile0low10
Allodynia, Thermal0low10
Alloxan Diabetes0low110
Alopecia0low10
Alopecia Areata0low10
Alopecia Cicatrisata0low10
Alopecia Circumscripta0low10
Alopecia, Androgenetic0low10
Alopecia, Male Pattern0low10
Alpha Virus Infections0low10
Alphavirus Infections0low10
Alzheimer Dementia0low30
Alzheimer Disease0low30
Alzheimer Disease, Early Onset0low30
Alzheimer Disease, Late Onset0low30
Alzheimer Sclerosis0low30
Alzheimer Syndrome0low30
Alzheimer Type Senile Dementia0low30
Alzheimer-Type Dementia (ATD)0low30
Alzheimer's Disease0low30
Alzheimer's Disease, Focal Onset0low30
Alzheimer's Diseases0low30
Amaurosis0low10
Amentia0low10
Ametropia0medium62
AML M30low20
Amnesia0low10
Amnesia-Memory Loss0low10
Amnesia, Dissociative0low10
Amnesia, Global0low10
Amnesia, Hysterical0low10
Amnesia, Tactile0low10
Amnesia, Temporary0low10
Amnestic State0low10
Amyloid Deposits0low20
Amyloid Plaques0low20
Amyloidosis0low20
Amyoplasia Congenita0low10
Anaphylactic Reaction0medium232
Anaphylactoid Reaction0medium232
Anaphylactoid Shock0medium232
Anaphylaxis0medium232
Anaplastic Astrocytoma0low110
Anaplastic Ependymoma0low40
Anaplastic Oligodendroglioma0low10
Anasarca0low120
Androgenetic Alopecia0low10
Androgenic Alopecia0low10
Anemia0low10
Anemia, Hemolytic0low10
Anemia, Hemolytic, Acquired0low10
Anemia, Hemolytic, Autoimmune0low10
Anemia, Hemolytic, Cold Antibody0low10
Anemia, Hemolytic, Idiopathic Acquired0low10
Anemia, Iron-Deficiency0low10
Anemia, Microangiopathic0low10
Anemias, Iron-Deficiency0low10
Anesthesia0low20
Aneuploid0low10
Aneuploid Cell0low10
Aneuploidy0low10
Aneurysm0low120
Aneurysm, Anterior Cerebral Artery0low140
Aneurysm, Anterior Communicating Artery0low140
Aneurysm, Arteriovenous0low20
Aneurysm, Basilar Artery0low140
Aneurysm, Cerebral0low140
Aneurysm, Intracranial0low140
Aneurysm, Middle Cerebral Artery0low140
Aneurysm, Posterior Cerebral Artery0low140
Aneurysm, Posterior Communicating Artery0low140
Aneurysm, Ruptured0low40
Angiitis0low10
Angiitis, Central Nervous System0low10
Angioblastic Meningioma0low80
Angiogenesis, Pathologic0medium271
Angiogenesis, Pathological0medium271
Angioid Streaks0low20
Angioma0low20
Angiomatous Meningioma0low80
Angle Tumor0low30
Animal Mammary Carcinoma0low10
Anisocoria0low10
Anisocoria, Physiologic0low10
ANLL0low10
Anoxemia0medium223
Anoxia0medium223
Anoxia-Ischemia, Brain0low10
Anoxia-Ischemia, Cerebral0low10
Anoxia, Brain0low10
Anoxia, Cerebral0low10
Anoxic Brain Damage0low10
Anoxic Encephalopathy0low10
Anoxic-Ischemic Encephalopathy0low10
Anterior Cerebral Artery Aneurysm0low140
Anterior Cerebral Circulation Infarction0low20
Anterior Choroidal Artery Infarction0low20
Anterior Circulation Brain Infarction0low20
Anterior Circulation Infarction, Brain0low20
Anterior Circulation Transient Ischemic Attack0low10
Anterior Communicating Artery Aneurysm0low140
Anterior Ischemic Optic Neuropathy0low20
Anthrax0low10
Anti-Phospholipid Antibody Syndrome0low10
Anti-Phospholipid Syndrome0low10
Antiphospholipid Antibody Syndrome0low10
Antiphospholipid Syndrome0low10
Anxiety0low20
Aortic Arteritis, Giant Cell0low20
Aortic Coarctation0low10
Aortitis, Giant Cell0low20
Aphakia0low10
Aphakia, Postcataract0low40
Aphakic Eye0low10
Aphakic Eye, Post-traumatic0low10
Aphakic Eye, Postcataract0low40
Aphakic Eye, Traumatic0low10
Apoplexy0low30
Aqueductal Stenosis0low20
Arachnoidal Cerebellar Sarcoma, Circumscribed0low10
ARC0low10
Argentaffinoma0low10
Arterial Diseases, Carotid0low30
Arterial Diseases, Common Carotid0low30
Arterial Diseases, External Carotid0low30
Arterial Diseases, Internal Carotid0low30
Arterial Hyperemia0medium62
Arterial Inflammation0low10
Arterial Obstructive Diseases0medium61
Arterial Occlusive Diseases0medium61
Arteriosclerosis0low20
Arteriosclerosis, Coronary0medium11
Arteriovenous Aneurysm0low20
Arteriovenous Fistula0low20
Arteriovenous Fistulas0low20
Arteriovenous Malformations0low10
Arteriovenous Malformations, Cerebral0low30
Arteritis0low10
Arteritis, Giant Cell, Horton0low20
Arteritis, Giant Cell, Horton's0low20
Arteritis, Temporal0low20
Arthritis0low10
Arthritis, Degenerative0low10
Arthritis, Rheumatoid0low50
Arthrogryposis0low10
Arthrogryposis Multiplex Congenita0low10
Arthrogryposis Multiplex Congenita (AMC)0low10
Arthromyodysplasia, Congenital0low10
Arthroses0low10
Arthrosis0low10
Arthus Phenomenon0low10
Arthus Reaction0low10
Ascites0low20
Asialia0low10
Asphyxia0low20
Asthenopia0medium11
Astigmatism0low60
Astroblastoma0low10
Astrocytoma0low110
Astrocytoma, Grade I0low110
Astrocytoma, Grade II0low110
Astrocytoma, Grade III0low110
Astrocytoma, Grade IV0medium201
Astrocytoma, Protoplasmic0low110
Astrocytoma, Subependymal Giant Cell0low110
Astroglioma0low110
Asymmetric Diabetic Proximal Motor Neuropathy0low20
Asymptomatic Inflammatory Prostatitis0low10
Asystole0low20
Atherogenesis0low30
Atheroma0low20
Atheromatous Plaque0low20
Atheromatous Plaques0low20
Atherosclerosis0low30
Atherosclerosis, Coronary0medium11
Atherosclerotic Disease, Carotid0low30
Atherosclerotic Plaque0low20
Atherosclerotic Plaques0low20
Atonic Absence Seizure0low100
Atonic Absence Seizures0low100
Atonic Seizure0low100
Atonic Seizures0low100
Atopic Hypersensitivity0low10
Atrial Fibrillation0low10
Atrophy0low50
Atypical Mycobacterial Infection, Disseminated0low10
Atypical Mycobacterial Infection, Familial Disseminated0low10
Atypical Mycobacteriosis, Familial0low10
Atypical Mycobacteriosis, Familial Disseminated0low10
Atypical Mycobacterium Infections0low10
Aura0low10
Auricular Fibrillation0low10
Autoimmune Diabetes0medium408
Autoimmune Disease0low80
Autoimmune Diseases0low80
Autoimmune Encephalomyelitis, Experimental0low50
Autoimmune Experimental Encephalomyelitis0low50
Autoimmune Haemolytic Anaemia0low10
Autoimmune Hemolytic Anemia0low10
Autoimmune Pancreatitis0low10
Autoimmune Thrombocytopenia0low10
Autoimmune Thrombocytopenic Purpura0low10
Autonomic Dysfunction, Paraneoplastic0low10
Autosomal Dominant Striatonigral Degeneration0low10
Autosomal Recessive Chronic Granulomatous Disease0low10
Autosome Abnormalities0low10
Avian Diseases0medium11
AVM (Arteriovenous Malformation) Intracranial0low30
Awakening Epilepsy0low10
Azorean Ataxia0low10
Azorean Disease0low10
Azorean Disease (Machado-Joseph)0low10
Azorean Disease, Nervous System0low10
Azorean Neurologic Disease0low10
B Virus Infection0low10
B-Cell Lymphoma0low10
B16 Melanoma0low40
Bacillus anthracis Infection0low10
Bacterial Eye Infections0low80
Bacterial Infections, Gram-Negative0low10
Bacterial Ocular Infections0low80
Bacteriuria0low20
Baldness0low10
Baldness, Male Pattern0low10
Bare Lymphocyte Syndrome0low10
Barmah Forest Virus Infection0low10
Barotrauma0low10
Barrett Epithelium0medium21
Barrett Esophagus0medium21
Barrett Metaplasia0medium21
Barrett Syndrome0medium21
Barrett's Esophagus0medium21
Barrett's Syndrome0medium21
Bartonella bacilliformis Infection0low10
Bartonella Infections0low10
Bartonellosis0low10
Basedow Disease0low10
Basedow's Disease0low10
Basilar Artery Aneurysm0low140
Basilar Skull Fracture0low10
Basophilic Leukemia, Acute0low10
Battle Sign0low10
Battle's Sign0low10
Becker Muscular Dystrophy0low20
Becker's Muscular Dystrophy0low20
Behcet Disease0low10
Behcet Syndrome0low10
Behcet Triple Symptom Complex0low10
Behcet's Disease0low10
Behcet's Syndrome0low10
Behu00E7et Disease0low10
Benign Cerebellar Neoplasms0low10
Benign Infratentorial Neoplasms0low30
Benign Meningeal Neoplasms0low80
Benign Meningioma0low80
Benign Mucosal Pemphigoid0low40
Benign Mucous Membrane Pemphigoid0low40
Benign Neoplasms0low670
Benign Neoplasms, Brain0medium1391
Benign Prostatic Hyperplasia0low10
Benign Psychomotor Epilepsy, Childhood0low10
Benign Supratentorial Neoplasms0low80
Berry Aneurysm0low140
Besnier-Boeck Disease0low30
Besnier-Boeck-Schaumann Syndrome0low30
beta-Cell Tumor0low10
Bewilderment0low10
Bilateral Blindness0low10
Bilateral Headache0low50
Bilateral Wilms Tumor0low10
Bile Duct Obstruction0low10
Bile Duct Obstruction, Extrahepatic0low10
Biliary Calculi0low10
Biliary Calculi, Common Bile Duct0low10
Biliary Stasis0low10
Biliary Stasis, Extrahepatic0low10
Bilirubin Encephalopathy0low10
Bird Diseases0medium11
Birdshot Chorioretinitis0low10
Birdshot Chorioretinopathy0low10
Birdshot Retinochoroiditis0low10
Birdshot Retinochoroidopathy0low10
Birth Weight0low20
Black Death0low10
Black Fever0low10
Black Plague0low10
Bladder Cancer0low50
Bladder Diseases0low10
Bladder Neoplasms0low50
Bladder Pain Syndrome0low30
Bladder Tumors0low50
Blastomycosis0low10
Blastomycosis, North American0low10
Bleb0medium41
Bleeding0low110
Blepharitis0medium71
Blepharospasm0low40
Blindness0low10
Blindness, Acquired0low10
Blindness, Bilateral0low10
Blindness, Complete0low10
Blindness, Hysterical0low10
Blindness, Legal0low10
Blindness, Monocular0low10
Blindness, Transient0low10
Blindness, Unilateral0low10
Blister0medium41
Bloch-Siemens Syndrome0low10
Bloch-Siemens-Sulzberger Syndrome0low10
Bloch-Sulzberger Syndrome0low10
Blood Clot0low180
Blood Loss, Surgical0low10
Blood Platelet Disorders0low30
Blood Poisoning0low40
Blood Pressure, High0medium101
Blood Pressure, Low0low40
Bloodstream Infection0low40
Blunt Injuries0low40
Body Weight0low70
Body Weight, Fetal0low30
Boeck Disease0low30
Boeck's Disease0low30
Boeck's Sarcoid0low30
Bone Cancer0low40
Bone Fractures0low10
Bone Loss, Age-Related0low20
Bone Loss, Osteoclastic0low10
Bone Neoplasms0low40
Bone Resorption0low10
Bordetella pertussis Infection, Respiratory0medium11
Borrelia Infections0low10
Bovine Diseases0medium11
Bowel Diseases, Inflammatory0low20
Brachial Paresis0low10
Brachycephaly0low10
Brain Abscess0low10
Brain Abscess, Child0low10
Brain Abscess, Multiple0low10
Brain Abscess, Pyogenic0low10
Brain Abscess, Sterile0low10
Brain Aneurysm0low140
Brain Anoxia0low10
Brain Anoxia-Ischemia0low10
Brain Cancer0medium1391
Brain Concussion0low10
Brain Diseases0low60
Brain Disorders0low60
Brain Edema0low140
Brain Emboli0low10
Brain Embolism0low10
Brain Embolism and Thrombosis0low10
Brain Hemorrhage, Cerebral0low10
Brain Hypoxia0low10
Brain Hypoxia-Ischemia0low10
Brain Infarct0low20
Brain Infarction0low20
Brain Infarction, Anterior Circulation0low20
Brain Infarction, Posterior Circulation0low20
Brain Infarction, Venous0low20
Brain Inflammation0low20
Brain Injuries0low40
Brain Injuries, Acute0low40
Brain Injuries, Focal0low40
Brain Ischemia0low110
Brain Ischemia-Anoxia0low10
Brain Ischemia-Hypoxia0low10
Brain Lacerations0low40
Brain Metastases0medium1391
Brain Neoplasm, Primary0medium1391
Brain Neoplasms0medium1391
Brain Neoplasms, Benign0medium1391
Brain Neoplasms, Malignant0medium1391
Brain Neoplasms, Malignant, Primary0medium1391
Brain Neoplasms, Primary Malignant0medium1391
Brain Stem Ischemia, Transient0low10
Brain Stem Neoplasms0low30
Brain Stem Neoplasms, Primary0low30
Brain Stem Transient Ischemic Attack0low10
Brain Stem Tumors0low30
Brain Swelling0low140
Brain TIA0low10
Brain Tumor, Primary0medium1391
Brain Tumor, Recurrent0medium1391
Brain Tumors0medium1391
Brain Vascular Disorders0low40
Brain Ventricular Neoplasms0low10
Brainstem Ischemia, Transient0low10
Brainstem Neoplasms0low30
Brainstem Neoplasms, Primary0low30
Brainstem Transient Ischemic Attack0low10
Brainstem Tumors0low30
Branch Retinal Artery Occlusion0low30
Branch Vein Occlusion0low120
Breast Cancer0low320
Breast Carcinoma0low320
Breast Neoplasms0low320
Breast Tumors0low320
Bright Disease0low10
Brill Disease0low10
Brill-Zinsser Disease0low10
Brill's Disease0low10
Broken Bones0low10
Bronchial Neoplasms0low20
Bronze Diabetes0low10
Bronzed Cirrhosis0low10
Bruise0low20
Bubonic Plague0low10
Buerger Disease0low10
Buerger's Disease0low10
Bulla0medium41
Bullae0medium41
Bullous Lesion0medium41
Bunyaviridae Infections0low10
Bunyavirus Infections0low10
Buphthalmos0low10
Burkitt Cell Leukemia0low20
Burkitt Leukemia0low20
Burkitt Lymphoma0low20
Burkitt Tumor0low20
Burkitt's Leukemia0low20
Burkitt's Lymphoma0low20
Burkitt's Tumor0low20
Burns0low50
Burns, Chemical0low70
Cadaver0low140
Cafe-au-Lait Spots with Pulmonic Stenosis0low10
Cancer0low670
Cancer of Bladder0low50
Cancer of Bone0low40
Cancer of Brain0medium1391
Cancer of Breast0low320
Cancer of Cervix0low50
Cancer of Colon0medium223
Cancer of Digestive System0low10
Cancer of Esophagus0medium31
Cancer of Eye0low40
Cancer of Gastrointestinal Tract0low10
Cancer of Head0low60
Cancer of Head and Neck0low60
Cancer of Kidney0medium21
Cancer of Larynx0low20
Cancer of Liver0low170
Cancer of Lung0low80
Cancer of Mouth0low30
Cancer of Nasopharynx0low10
Cancer of Neck0low60
Cancer of Nose0low10
Cancer of Oropharnyx0low10
Cancer of Ovary0low80
Cancer of Pancreas0low30
Cancer of Paranasal Sinus0low10
Cancer of Pharynx0low20
Cancer of Prostate0low150
Cancer of Rectum0low20
Cancer of Skin0low70
Cancer of Stomach0medium101
Cancer of the Adrenal Gland0low10
Cancer of the Bladder0low50
Cancer of the Bone0low40
Cancer of the Brain0medium1391
Cancer of the Breast0low320
Cancer of the Cervix0low50
Cancer of the Colon0medium223
Cancer of the Digestive System0low10
Cancer of the Esophagus0medium31
Cancer of the Eye0low40
Cancer of the Gastrointestinal Tract0low10
Cancer of the Head0low60
Cancer of the Head and Neck0low60
Cancer of the Kidney0medium21
Cancer of the Larynx0low20
Cancer of the Liver0low170
Cancer of the Lung0low80
Cancer of the Mouth0low30
Cancer of the Nasopharynx0low10
Cancer of the Neck0low60
Cancer of the Nose0low10
Cancer of the Oropharynx0low10
Cancer of the Ovary0low80
Cancer of the Pancreas0low30
Cancer of the Pharynx0low20
Cancer of the Prostate0low150
Cancer of the Rectum0low20
Cancer of the Retina0low30
Cancer of the Skin0low70
Cancer of the Stomach0medium101
Cancer of the Thyroid0low10
Cancer of the Tongue0low10
Cancer of the Uterine Cervix0low50
Cancer of the Uterus0medium21
Cancer of the Vulva0low20
Cancer of Thyroid0low10
Cancer of Tongue0low10
Cancer of Uterus0medium21
Cancer of Vulva0low20
Cancer, Hepatocellular0low170
Cancer, Retinal0low30
Cancer, Supratentorial0low80
Candidiasis, Oral0low10
Cane-Cutter Fever0low10
Canicola Fever0low10
Canine Diseases0medium92
Canine Distemper0low20
Capillary Leak Syndrome0low20
Caprine Diseases0low10
Carcinoid0low10
Carcinoid Tumor0low10
Carcinoid, Goblet Cell0low10
Carcinoma0medium91
Carcinoma in Situ0medium32
Carcinoma, Adenoid Cystic0low10
Carcinoma, Anaplastic0medium91
Carcinoma, Basal Cell0low30
Carcinoma, Basal Cell, Pigmented0low30
Carcinoma, Bronchial0low10
Carcinoma, Bronchogenic0low10
Carcinoma, Cribriform0low80
Carcinoma, Ehrlich Tumor0low50
Carcinoma, Epidermoid0low120
Carcinoma, Granular Cell0low80
Carcinoma, Hepatocellular0low90
Carcinoma, Hypernephroid0medium21
Carcinoma, Intraepithelial0medium32
Carcinoma, Lewis Lung0low10
Carcinoma, Non-Small Cell Lung0low30
Carcinoma, Non-Small-Cell Lung0low30
Carcinoma, Planocellular0low120
Carcinoma, Preinvasive0medium32
Carcinoma, Renal Cell0medium21
Carcinoma, Signet Ring Cell0low10
Carcinoma, Spindle-Cell0medium91
Carcinoma, Squamous0low120
Carcinoma, Squamous Cell0low120
Carcinoma, Transitional Cell0low10
Carcinoma, Tubular0low80
Carcinoma, Undifferentiated0medium91
Carcinomatosis0medium91
Cardiac Arrest0low20
Cardiac Diseases0low20
Cardiac Disorders0low20
Cardiac Rupture, Traumatic0low10
Cardiomyopathy, Dilated, 3B0low20
Cardiomyopathy, Dilated, X-Linked0low20
Cardiopulmonary Arrest0low20
Cardiovascular Diseases0low50
Cardiovascular Stroke0low60
Caries, Cervical0low30
Caries, Dental0low60
Caries, Root0low30
Carious Dentin0low60
Carious Lesions0low60
Carotid Arteriopathies, Traumatic0low10
Carotid Artery Diseases0low30
Carotid Artery Disorders0low30
Carotid Artery Injuries0low10
Carotid Artery Narrowing0low10
Carotid Artery Plaque0low10
Carotid Artery Stenosis0low10
Carotid Artery Ulcerating Plaque0low10
Carotid Atherosclerosis0low30
Carotid Atherosclerotic Disease0low30
Carotid Circulation Transient Ischemic Attack0low10
Carotid False Aneurysm0low10
Carotid Pseudoaneurysm0low10
Carotid Stenosis0low10
Carotid Ulcer0low10
Carrion Disease0low10
Carrion's Disease0low10
Cartilage Diseases0low10
Cat Diseases0medium61
Cataract0low120
Cataract, Membranous0low120
Cattle Diseases0medium11
Celiac Disease0low10
Celiac Sprue0low10
Cell Transformation, Neoplastic0low30
Cell Transformation, Viral0low10
Cells, Neoplasm Circulating0low20
Cellular Ependymoma0low40
Cellulitis0low10
Central Nervous System Angiitis0low10
Central Nervous System Disease0low10
Central Nervous System Diseases0low10
Central Nervous System Disorder0low10
Central Nervous System Disorders0low10
Central Nervous System Disorders, Intracranial0low60
Central Nervous System Intracranial Disorders0low60
Central Nervous System Lupus0low10
Central Nervous System Lupus Vasculitis0low10
Central Nervous System Neoplasm0low50
Central Nervous System Neoplasms0low50
Central Nervous System Neoplasms, Primary0low50
Central Nervous System Systemic Lupus Erythematosis0low10
Central Nervous System Tumor0low50
Central Nervous System Tumors0low50
Central Nervous System Vasculitis0low10
Central Retinal Artery Occlusion0low30
Central Retinal Edema, Cystoid0medium232
Central Retinal Vein Occlusion0low120
Central Serous Chorioretinopathy0medium63
Central Serous Retinopathy0medium63
Centrala nervsystemets sjukdomar@sv0low10
Cephalalgia0low50
Cephalgia0low50
Cephalodynia0low50
Cerebellar Cancer0low10
Cerebellar Neoplasms0low10
Cerebellar Neoplasms, Benign0low10
Cerebellar Neoplasms, Malignant0low10
Cerebellar Neoplasms, Primary0low10
Cerebellar Tumors0low10
Cerebellopontine Angle Acoustic Neuroma0low30
Cerebellopontine Angle Tumor0low30
Cerebral Abscess0low10
Cerebral Aneurysm0low140
Cerebral Angiitis0low10
Cerebral Anoxia0low10
Cerebral Anoxia-Ischemia0low10
Cerebral Arteriovenous Malformations0low30
Cerebral Astrocytoma0low110
Cerebral Concussion0low10
Cerebral Convexity Meningioma0low80
Cerebral Cortical Dysplasia0low20
Cerebral Edema0low140
Cerebral Edema, Cytotoxic0low140
Cerebral Edema, Vasogenic0low140
Cerebral Emboli0low10
Cerebral Embolism0low10
Cerebral Embolism and Thrombosis0low10
Cerebral Hemorrhage0low10
Cerebral Hypoxia0low10
Cerebral Hypoxia-Ischemia0low10
Cerebral Infarct0low20
Cerebral Infarction0low20
Cerebral Infarction, Left Hemisphere0low20
Cerebral Infarction, Middle Cerebral Artery0low60
Cerebral Infarction, Right Hemisphere0low20
Cerebral Ischemia0low110
Cerebral Ischemia-Anoxia0low10
Cerebral Ischemia-Hypoxia0low10
Cerebral Ischemia, Transient0low10
Cerebral Malaria0low20
Cerebral Parenchymal Hemorrhage0low10
Cerebral Stroke0low30
Cerebral Vasculitis0low10
Cerebral Ventricle Neoplasms0low10
Cerebral Ventricle Tumors0low10
Cerebral Ventriculomegaly0low20
Cerebral, Left Hemisphere, Infarction0low20
Cerebral, Right Hemisphere, Infarction0low20
Cerebromeningitis0low10
Cerebroside Lipidosis Syndrome0low10
Cerebrospinal Fluid Drainage0low180
Cerebrospinal Fluid Drainage, Post-Traumatic0low180
Cerebrospinal Fluid Drainage, Spontaneous0low180
Cerebrospinal Fluid Drainage, Traumatic0low180
Cerebrospinal Fluid Effusion, Subdural0low20
Cerebrospinal Fluid Hypovolemia0low10
Cerebrospinal Fluid Leak0low180
Cerebrospinal Fluid Leak, Post-Traumatic0low180
Cerebrospinal Fluid Leak, Spontaneous0low180
Cerebrospinal Fluid Leak, Traumatic0low180
Cerebrospinal Fluid Leakage0low180
Cerebrospinal Fluid Leakage, Post-Traumatic0low180
Cerebrospinal Fluid Leakage, Spontaneous0low180
Cerebrospinal Fluid Leakage, Subdural0low20
Cerebrospinal Fluid Leakage, Traumatic0low180
Cerebrospinal Fluid Otorrhea0low110
Cerebrospinal Fluid Otorrhea, Post-Traumatic0low110
Cerebrospinal Fluid Otorrhea, Spontaneous0low110
Cerebrospinal Fluid Otorrhea, Traumatic0low110
Cerebrospinal Fluid Rhinorrhea0medium481
Cerebrospinal Fluid Rhinorrhea, Post-Traumatic0medium481
Cerebrospinal Fluid Rhinorrhea, Spontaneous0medium481
Cerebrospinal Fluid Rhinorrhea, Traumatic0medium481
Cerebrospinal Otorrhea0low110
Cerebrospinal Rhinorrhea0medium481
Cerebrovascular Accident0low30
Cerebrovascular Accident, Acute0low30
Cerebrovascular Apoplexy0low30
Cerebrovascular Diseases0low40
Cerebrovascular Disorders0low40
Cerebrovascular Insufficiency0low40
Cerebrovascular Moyamoya Disease0low10
Cerebrovascular Occlusion0low40
Cerebrovascular Stroke0low30
Cerebroventricular Neoplasms0low10
Cervical Cancer0low50
Cervical Caries0low30
Cervical Neoplasms0low50
Cervicitis0low10
Cervix Cancer0low50
Cervix Dysplasia0low20
Cervix Neoplasms0low50
Charcot-Bouchard Aneurysm0low10
Charcot-Bouchard Aneurysms0low10
Charcot-Marie-Tooth Disease, Demyelinating, Type 4f0low10
Charcot-Marie-Tooth Disease, Type 30low10
Chemical and Drug Induced Liver Injury0low10
Chemical Burns0low70
Chemically-Induced Liver Toxicity0low10
Chest Pain0low10
Childhood Absence Epilepsy0low10
Childhood Benign Psychomotor Epilepsy0low10
Childhood Cerebral Astrocytoma0low110
Childhood Muscular Dystrophy, Pseudohypertrophic0low20
Childhood Pseudohypertrophic Muscular Dystrophy0low20
Chlamydia Infections0low30
Chlamydia pneumoniae Infections0low20
Chlamydophila Infections0low20
Choked Disk0low30
Cholelithiasis0low10
Cholera0low10
Cholera Infantum0low10
Cholestasis0low10
Cholestasis, Extrahepatic0low10
Chondrodysplasia Punctata0low10
Chondrodysplasia Punctata 2, X-Linked0low10
Chondrodysplasia Punctata 2, X-Linked Dominant0low10
Chondrodystrophia Calcificans Congenita0low10
Chondromalacia0low10
Chondrosarcoma0low10
Chorangioma0low20
Chorioangioma0low20
Chorioretinitis0low30
Choristoma0low10
Choroby OUN@pl0low10
Choroid Diseases0low100
Choroid Neoplasms0low40
Choroid Neovascularization0medium275
Choroidal Diseases0low100
Choroidal Neoplasms0low40
Choroidal Neovascularization0medium275
Choroiditis0low40
Chromophil Renal Cell Carcinoma0medium21
Chromophobe Renal Cell Carcinoma0medium21
Chromosomal Aberrations0low10
Chromosomal Translocation0low30
Chromosome Aberrations0low10
Chromosome Abnormalities0low10
Chronic Actinic Dermatitis0low10
Chronic Airflow Obstruction0medium21
Chronic Bacterial Prostatitis0low10
Chronic Disease0medium235
Chronic Gaucher Disease0low10
Chronic Granulomatous Disease0low10
Chronic Granulomatous Disease, Atypical0low10
Chronic Granulomatous Disease, X-Linked0low10
Chronic Hepatitis C0low10
Chronic Illness0medium235
Chronic Interstitial Cystitis0low30
Chronic Kidney Diseases0low30
Chronic Kidney Failure0medium31
Chronic Kidney Insufficiency0low30
Chronic Obstructive Airway Disease0medium21
Chronic Obstructive Lung Disease0medium21
Chronic Obstructive Pulmonary Disease0medium21
Chronic Obstructive Pulmonary Diseases0medium21
Chronic Primary Open Angle Glaucoma0medium213
Chronic Prostatitis with Chronic Pelvic Pain Syndrome0low10
Chronic Renal Diseases0low30
Chronic Renal Insufficiency0low30
Chronically Ill0medium235
Cicatricial Pemphigoid, Ocular0low40
Cicatrix0medium41
Cicatrization0medium41
Circulating Cells, Neoplasm0low20
Circulating Neoplastic Cells0low20
Circulating Tumor Cells0low20
Circulatory Collapse0low50
Circulatory Failure0low50
Cirrhoses, Experimental Liver0low20
Cirrhosis0low40
Cirrhosis, Experimental Liver0low20
Clarkson Disease0low20
Clear Cell Ependymoma0low40
Clear Cell Meningioma0low80
Clear Cell Renal Carcinoma0medium21
Clear Cell Renal Cell Carcinoma0medium21
Clinical Capillary Leak Syndrome0low20
Clonic Seizure0low100
Clonic Seizures0low100
Clubfeet0low10
Clubfeet, Congenital0low10
Clubfoot0low10
Clubfoot, Congenital0low10
CMT4f0low10
CNS Disease0low10
CNS Diseases0low10
CNS Disorders, Intracranial0low60
CNS Neoplasm0low50
CNS Neoplasms0low50
CNS Vasculitis0low10
COAD0medium21
Coarctation of Aorta0low10
Coarctation of Aorta Dominant0low10
Coarctation of the Aorta0low10
Coats Disease0low10
Coats' Disease0low10
Cochlear Hearing Loss0low10
Cognition Disorders0low10
Cognitive Decline0low20
Cognitive Dysfunction0low20
Cognitive Impairments0low20
Cold Agglutinin Disease0low10
Cold Antibody Disease0low10
Cold Antibody Hemolytic Anemia0low10
Cold Fingers, Hereditary0low30
Colitis0low60
Colitis Gravis0medium113
Colitis, Granulomatous0medium92
Colitis, Ulcerative0medium113
Collagen Diseases0low10
Collecting Duct Carcinoma0medium21
Collecting Duct Carcinoma (Kidney)0medium21
Collecting Duct Carcinoma of the Kidney0medium21
Coloboma0low10
Coloboma Of Iris, Choroid, And Retina0low10
Coloboma, Ocular0low10
Coloboma, Uveoretinal0low10
Colon Cancer0medium223
Colon Neoplasms0medium223
Colonic Cancer0medium223
Colonic Neoplasms0medium223
Colonic Polyps0medium31
Color Blindness0low10
Color Blindness, Acquired0low10
Color Blindness, Blue0low10
Color Blindness, Green0low10
Color Blindness, Inherited0low10
Color Blindness, Red0low10
Color Blindness, Red-Green0low10
Color Vision Defects0low10
Color Vision Deficiency0low10
Colorectal Cancer0medium122
Colorectal Carcinoma0medium122
Colorectal Neoplasms0medium122
Colorectal Tumors0medium122
Coma0medium31
Comatose0medium31
Common Bile Duct Calculi0low10
Common Bile Duct Gall Stone0low10
Common Bile Duct Gall Stones0low10
Common Bile Duct Gallstone0low10
Common Bile Duct Gallstones0low10
Common Carotid Artery Diseases0low30
Common Carotid Artery Stenosis0low10
Commotio Cerebri0low10
Communicating Hydrocephalus0low20
Complex Partial Seizure0low100
Complex Partial Seizures0low100
Complex Partial Status Epilepticus0low40
Complication, Intraoperative0medium152
Complication, Peroperative0medium152
Complication, Postoperative0medium444
Complications of Diabetes Mellitus0low30
Complications, Pregnancy0low30
Concussion, Intermediate0low10
Concussion, Mild0low10
Concussion, Severe0low10
Condition, Preneoplastic0medium51
Conditions, Preneoplastic0medium51
Confusion0low10
Confusion, Post-Ictal0low10
Confusion, Reactive0low10
Confusional State0low10
Congenital Arthromyodysplasia0low10
Congenital Familial Lymphedema0low30
Congenital Heart Defect0low20
Congenital Heart Defects0low20
Congenital Heart Disease0low20
Congenital Hereditary Lymphedema0low30
Congenital Hydrocephalus0low20
Congenital Intracranial Arteriovenous Malformations0low30
Congenital Multiple Arthrogryposis0low10
Congenital Myotonic Dystrophy0medium21
Congenital Talipes Equinovarus0low10
Congestive Ophthalmopathy0low30
Conjunctival Diseases0medium301
Conjunctival Neoplasms0low20
Conjunctivitis0medium21
Conjunctivitis, Allergic0low110
Conjunctivitis, Atopic0low110
Conjunctivitis, Giant Papillary0low110
Conjunctivitis, Vernal0low110
Conjunctivitis, Viral0low10
Connective Tissue Disease, Mixed0low10
Conradi Hunermann Happle Syndrome0low10
Conradi-Hu00FCnermann Syndrome0low10
Conradi-Hu00FCnermann-Happle Syndrome0low10
Conradi-Hunermann Syndrome0low10
Conradi-Hunermann-Happle Syndrome0low10
Constricted Pupil0low10
Constriction, Pathologic0low10
Constriction, Pathological0low10
Contact Dermatitis0low30
Contusions0low20
Convulsion0low100
Convulsion, Non-Epileptic0low100
Convulsions0low100
Convulsions, Grand Mal0low20
Convulsive Seizure0low100
Convulsive Seizures0low100
COPD0medium21
Cornea Injuries0medium192
Corneal Abrasions0medium192
Corneal Angiogenesis0medium61
Corneal Damage0medium192
Corneal Diseases0medium612
Corneal Dystrophies0low60
Corneal Dystrophies, Hereditary0low60
Corneal Dystrophy, Juvenile Epithelial of Meesmann0low10
Corneal Dystrophy, Meesmann0low10
Corneal Dystrophy, Meesmann Epithelial0low10
Corneal Edema0medium93
Corneal Injuries0medium192
Corneal Neovascularization0medium61
Corneal Opacity0low60
Corneal Perforation0low20
Corneal Scar0medium192
Corneal Trauma0medium192
Corneal Ulcer0medium152
Coronary Arteriosclerosis0medium11
Coronary Artery Disease0medium11
Coronary Atherosclerosis0medium11
Coronary Disease0low10
Coronary Heart Disease0low10
Coronavirus Disease 20190low80
Coronavirus Disease-190low80
Coronavirus Infections0low30
Corpse0low140
Cortical Dysplasia0low20
Cortical Dysplasia, Cerebral0low20
Corynebacterium diphtheriae Infection0low10
Cough0low10
COVID-190low80
COVID-19 Pandemic0low80
COVID-19 Pandemics0low80
COVID-19 Virus Disease0low80
COVID-19 Virus Infection0low80
COVID190low80
Coxsackie Virus Infections0low10
Coxsackievirus Infections0low10
Cracked Tooth Syndrome0low10
Cranial Arteritis0low20
Cranial Nerve Diseases0medium21
Cranial Nerve Disorders0medium21
Cranial Nerve II Diseases0low60
Cranial Nerve II Disorder0low60
Cranial Nerve Palsies0medium21
Cranial Nerve V Diseases0low20
Cranial Nerve VII Injuries0low10
Cranial Neuropathies0medium21
Cranial Neuropathies, Multiple0medium21
Cranial Pain0low50
Craniocerebral Injuries0low30
Craniocerebral Trauma0low30
Craniorachischisis0low10
Craniostenosis0low10
Craniosynostoses0low10
Craniosynostosis0low10
Craniosynostosis, Lambdoidal0low10
Craniosynostosis, Type 10low10
Crescendo Transient Ischemic Attacks0low10
Critical Illness0medium11
Critically Ill0medium11
Crohn Disease0medium92
Crohn's Disease0medium92
Crohn's Enteritis0medium92
Cross Infection0low10
Cruor0low10
Crural Paresis0low10
Crushing Skull Injury0low30
Cryptogenic Embolism Stroke0low20
Cryptogenic Ischemic Stroke0low20
Cryptogenic Stroke0low20
Cryptogenic Tonic-Clonic Epilepsy0low20
CSF Hypovolemia0low10
CSF Rhinorrhea0medium481
Cutaneous Fistula0low10
Cutis Elastica0low10
CVA (Cerebrovascular Accident)0low30
Cylindroma0low10
Cyst0low30
Cystic Fibrosis0low60
Cystic Fibrosis of Pancreas0low60
Cystitis0low30
Cystitis, Chronic Interstitial0low30
Cystitis, Interstitial0low30
Cystoid Macular Dystrophy0medium232
Cystoid Macular Edema0medium232
Cystoid Macular Edema, Postoperative0medium232
Cysts0low30
Cytochrome B-Negative Granulomatous Disease, Chronic, X-Linked0low10
Cytochrome B-Positive Granulomatous Disease, Chronic, X-Linked0low10
Cytogenetic Aberrations0low10
Cytogenetic Abnormalities0low10
Cytomegaloviral Retinitis0low10
Cytomegalovirus0low50
Cytomegalovirus Retinitis0low10
Cytotoxic Brain Edema0low140
Cytotoxic Cerebral Edema0low140
Dacryoadenitis0low10
Dacryocystitis0low10
Day Blindness0low80
Deafness Neurosensory0low10
Deafness, Sudden0low10
Deafness, Transitory0low10
Death, Sudden0low10
Decay, Dental0low60
Decreased Intraocular Pressure-Associated Papilledema0low30
Deep Vein Thrombosis0low10
Deep Venous Thrombosis0low10
Deep-Vein Thrombosis0low10
Deep-Venous Thrombosis0low10
Defects, Congenital Heart0low20
Deficiency Disease, 4-Hydroxyphenol Pyruvic Acid Oxidase0low20
Deficiency Disease, Fumarylacetoacetase0low20
Deficiency Disease, Tyrosine Transaminase0low20
Deficiency, Oxygen0medium223
Deficiency, Vitamin D0low10
Deficiency, Vitamin E0low10
Degenerative Diseases, Central Nervous System0low20
Degenerative Diseases, Nervous System0low20
Degenerative Diseases, Neurologic0low20
Degenerative Diseases, Spinal Cord0low20
Degenerative Neurologic Diseases0low20
Degenerative Neurologic Disorders0low20
Dehiscence, Surgical Wound0low40
Dejerine-Sottas Disease0low10
Dejerine-Sottas Neuropathy0low10
Dejerine-Sottas Syndrome0low10
Dementia0low10
Dementia, Alzheimer Type0low30
Dementia, Presenile0low30
Dementia, Primary Senile Degenerative0low30
Dementia, Senile0low30
Dementias, Transmissible0low40
Demineralization, Tooth0low40
Dental Caries0low60
Dental Decay0low60
Dental Fissure0low30
Dental Fissures0low30
Dental Leakage0low10
Dental Leakages0low10
Dental Plaque0medium137
Dental White Spot0low60
Dental White Spots0low60
Dentin Hypersensitivity0low10
Dentin Sensitivity0low10
Dentine Hypersensitivity0low10
Dentine Sensitivity0low10
Depression0low30
Depression, Endogenous0low10
Depression, Neurotic0low10
Depression, Unipolar0low10
Depressive Disorder0low10
Depressive Syndrome0low10
Dermatitis0low10
Dermatitis Medicamentosa0low30
Dermatitis Seborrheica0low10
Dermatitis Venenata0low30
Dermatitis, Actinic0low10
Dermatitis, Adverse Drug Reaction0low30
Dermatitis, Allergic Contact0medium11
Dermatitis, Allergic Eczematous0medium11
Dermatitis, Atopic0low60
Dermatitis, Contact0low30
Dermatitis, Contact, Allergic0medium11
Dermatitis, Contact, Phototoxic0low20
Dermatitis, Eczematous0low10
Dermatitis, Phototoxic0low20
Dermatitis, Seborrheic0low10
Dermatoses0low50
Dermatosis0low50
Deutan Defect0low10
Developmental Defects, Neural Tube0low10
Developmental Neural Tube Defects0low10
Di Guglielmo Disease0low20
Di Guglielmo's Disease0low20
Diabetes Complications0low30
Diabetes Mellitus0medium242
Diabetes Mellitus, Adult-Onset0medium181
Diabetes Mellitus, Brittle0medium408
Diabetes Mellitus, Experimental0low110
Diabetes Mellitus, Insulin-Dependent0medium408
Diabetes Mellitus, Insulin-Dependent, 10medium408
Diabetes Mellitus, Juvenile-Onset0medium408
Diabetes Mellitus, Ketosis-Prone0medium408
Diabetes Mellitus, Ketosis-Resistant0medium181
Diabetes Mellitus, Maturity-Onset0medium181
Diabetes Mellitus, Non Insulin Dependent0medium181
Diabetes Mellitus, Non-Insulin-Dependent0medium181
Diabetes Mellitus, Noninsulin Dependent0medium181
Diabetes Mellitus, Noninsulin-Dependent0medium181
Diabetes Mellitus, Slow-Onset0medium181
Diabetes Mellitus, Stable0medium181
Diabetes Mellitus, Sudden-Onset0medium408
Diabetes Mellitus, Type 10medium408
Diabetes Mellitus, Type 20medium181
Diabetes Mellitus, Type I0medium408
Diabetes Mellitus, Type II0medium181
Diabetes-Related Complications0low30
Diabetes, Autoimmune0medium408
Diabetes, Bronze0low10
Diabetic Amyotrophy0low20
Diabetic Angiopathies0low60
Diabetic Asymmetric Polyneuropathy0low20
Diabetic Autonomic Neuropathy0low20
Diabetic Complications0low30
Diabetic Feet0low30
Diabetic Foot0low30
Diabetic Glomerulosclerosis0medium61
Diabetic Kidney Disease0medium61
Diabetic Mononeuropathy0low20
Diabetic Mononeuropathy Simplex0low20
Diabetic Nephropathies0medium61
Diabetic Nephropathy0medium61
Diabetic Neuralgia0low20
Diabetic Neuropathies0low20
Diabetic Neuropathy, Painful0low20
Diabetic Polyneuropathy0low20
Diabetic Retinopathy0medium8911
Diabetic Vascular Complications0low60
Diabetic Vascular Diseases0low60
Diaphragmatic Hernia0low10
Diarrhea0low50
Diastematomyelia0low10
Diathesis0low10
Diffuse Mixed Small and Large Cell Lymphoma0low10
Diffuse Mixed-Cell Lymphoma0low10
Diffuse Myofascial Pain Syndrome0low10
Diffuse Parenchymal Lung Disease0low10
Diffuse Parenchymal Lung Diseases0low10
Diffuse Small Cleaved-Cell Lymphoma0low10
Diffuse Undifferentiated Lymphoma0low10
Digestive System Cancer0low10
Digestive System Neoplasms0low10
Dilatation, Pathologic0low10
Dilatation, Pathological0low10
Dilatations, Pathologic0low10
Dilatations, Pathological0low10
Diphtheria0low10
Diplopia0medium21
Diplopia, Cortical0medium21
Diplopia, Horizontal0medium21
Diplopia, Intermittent0medium21
Diplopia, Monocular0medium21
Diplopia, Refractive0medium21
Diplopia, Unilateral0medium21
Diplopia, Vertical0medium21
Disease0low40
Disease Exacerbation0medium191
Disease Models, Animal0low1270
Disease Progression0medium191
Disease Susceptibility0low10
Diseases of Immune System0low30
Diseases, Occupational0low30
Diseases, Peripheral Vascular0low160
Disorientation0low10
Dissecting Vertebral Artery Aneurysm0low10
Distemper0low20
Distemper, Canine0low20
Doenu00E7as do Sistema Nervoso Central@pt0low10
Dog Diseases0medium92
Double Vision0medium21
Down Syndrome0low10
Down Syndrome, Partial Trisomy 210low10
Down's Syndrome0low10
Drop Attack0low10
Dropsy0low120
Drowning0low10
Drug Allergy0medium183
Drug Eruptions0low30
Drug Hypersensitivity0medium183
Drug Side Effects0medium21
Drug Toxicity0medium21
Drug-Induced Acute Liver Injury0low10
Drug-Induced Liver Disease0low10
Drug-Induced Liver Injury0low10
Drug-Induced Stevens Johnson Syndrome0low20
Drug-Induced Stevens-Johnson Syndrome0low20
Drug-Related Side Effects and Adverse Reactions0medium21
Drunkenness0low10
Drusen, Optic Disc0low10
Drusen, Optic Disk0low10
Drusen, Optic Nerve0low10
Drusen, Retinal0low40
Dry Eye0medium36375
Dry Eye Disease0medium36375
Dry Eye Syndromes0medium36375
Duchenne and Becker Muscular Dystrophy0low20
Duchenne Muscular Dystrophy0low20
Duchenne-Becker Muscular Dystrophy0low20
Duchenne-Type Progressive Muscular Dystrophy0low20
Duodenitis0low20
Dysesthesia0low10
Dysgeusia0low10
Dysplasia Epiphysialis Punctata0low10
Dysthyroid Ophthalmopathy0low30
Dystrophia Myotonica0medium21
Dystrophia Myotonica 10medium21
Dystrophia Myotonica 20medium21
E coli Infections0low30
E. coli Infection0low30
Ear Diseases0low20
Early Onset Alzheimer Disease0low30
Early Onset Lymphedema0low30
Ectasia0low10
Ectopic Tissue0low10
Ectropion0low10
Eczema0low10
Eczema, Atopic0low60
Eczema, Contact0low30
Eczema, Infantile0low60
Edema0low120
Edema of the Optic Disc0low30
Edema of the Optic Disk0low30
Edema-Proteinuria-Hypertension Gestosis0low30
Edema, Pulmonary0low10
Edemas, Pulmonary0low10
Edematous Ophthalmopathy0low30
EDS IV0low10
Ehlers Danlos Disease0low10
Ehlers Danlos Syndrome Type 4, Autosomal Dominant0low10
Ehlers Danlos Syndrome, Arterial Type0low10
Ehlers Danlos Syndrome, Ecchymotic Type0low10
Ehlers Danlos Syndrome, Sack-Barabas Type0low10
Ehlers-Danlos Disease0low10
Ehlers-Danlos Syndrome0low10
Ehlers-Danlos Syndrome, Arterial Type0low10
Ehlers-Danlos Syndrome, Ecchymotic Type0low10
Ehlers-Danlos Syndrome, Sack-Barabas Type0low10
Ehlers-Danlos Syndrome, Type IV0low10
Ehlers-Danlos Syndrome, Type IV, Autosomal Dominant0low10
Ehlers-Danlos Syndrome, Vascular Type0low10
Ehrlich Ascites Tumor0low50
EHS Tumor0low30
Electrolytes0low130
Electron Transport Chain Deficiencies, Mitochondrial0low10
Elephantiasis Neuromatosis0low10
Embolic Infarction, Middle Cerebral Artery0low60
Embolic Tumor Cells0low20
Embolism0low30
Embolism and Thrombosis, Brain0low10
Embolism, Brain0low10
Embolism, Intracranial0low10
Embolism, Pulmonary0low60
Embolism, Tumor0low20
Embolisms, Pulmonary0low60
Embolus0low30
Embolus, Middle Cerebral Artery0low60
Emesis0medium81
Empyema, Subdural0low10
Encephalitis0low20
Encephalitis, Rasmussen0low20
Encephalitis, Viral0low10
Encephalomeningitis0low10
Encephalomyelitis0low10
Encephalomyelitis, Allergic0low50
Encephalomyelitis, Autoimmune, Experimental0low50
Encephalomyelitis, Experimental Autoimmune0low50
Encephalomyelitis, Infectious, Viral0low10
Encephalomyelitis, Inflammatory0low10
Encephalon Diseases0low60
Encephalopathies, Spongiform, Transmissible0low40
Encephalopathy0low60
Encephalopathy, Anoxic-Ischemic0low10
Encephalopathy, Bilirubin0low10
Encephalopathy, Hyperbilirubinemic0low10
Encephalopathy, Hypoxic0low10
Encephalopathy, Hypoxic-Ischemic0low10
Encephalopathy, Ischemic0low110
Encephalopathy, Toxic0low20
End-Stage Kidney Disease0medium31
End-Stage Renal Disease0medium31
Endometrial Diseases0low10
Endometrioma0low10
Endometriosis0low10
Endophthalmitis0low40
Enfermedades del Sistema Nervioso Central@es0low10
Entamoeba histolytica Infection0low10
Entamoeba Infections0low10
Entamoebiasis0low10
Enteric Fever0low30
Enteritis, Granulomatous0medium92
Enteritis, Regional0medium92
Enterocolitis, Necrotizing0low20
Entrapment Neuropathies0low10
Ependymoastrocytoma0low10
Ependymoma0low40
Ependymoma, Myxopapillary0low40
Ependymoma, Papillary0low40
EPH Complex0low30
EPH Gestosis0low30
EPH Toxemias0low30
Epidemic Typhus0low10
Epidermal Necrolysis, Toxic0low20
Epilepsy0low10
Epilepsy Juvenile Absence0low10
Epilepsy, Absence0low10
Epilepsy, Absence, Atypical0low10
Epilepsy, Benign Psychomotor, Childhood0low10
Epilepsy, Cryptogenic0low10
Epilepsy, Grand Mal0low20
Epilepsy, Lateral Temporal0low10
Epilepsy, Major0low20
Epilepsy, Minor0low10
Epilepsy, Petit Mal0low10
Epilepsy, Temporal Lobe0low10
Epilepsy, Tonic-Clonic0low20
Epilepsy, Tonic-Clonic, Cryptogenic0low20
Epilepsy, Tonic-Clonic, Familial0low20
Epilepsy, Tonic-Clonic, Symptomatic0low20
Epilepsy, Uncinate0low10
Epileptic Seizure0low100
Epileptic Seizures0low100
Epiphora0medium242
Epiphyses, Stippled0low10
Epiretinal Membrane0low20
Episcleritis0low10
Epithelial Neoplasms, Malignant0medium91
Epithelial Tumors, Malignant0medium91
Epithelioma0medium91
Epithelioma, Basal Cell0low30
Equine Diseases0low30
Equinovarus0low10
Erosive Duodenitis0low20
Erythema0low20
Erythematotelangiectatic Rosacea0low10
Erythremic Myelosis0low20
Erythroblastic Leukemia, Acute0low20
Erythroleukemia0low20
Escherichia coli Infections0low30
Esophageal and Gastric Varices0low20
Esophageal Cancer0medium31
Esophageal Diseases0low10
Esophageal Neoplasms0medium31
Esophageal Perforation0low10
Esophageal Varices0low20
Esophageal Varix0low20
Esophagitis0low10
Esophagitis, Peptic0low10
Esophagitis, Reflux0low10
Esophagus Cancer0medium31
Esophagus Neoplasm0medium31
Esophagus, Barrett0medium21
ESRD0medium31
Evaporative Dry Eye0medium36375
Evaporative Dry Eye Disease0medium36375
Evaporative Dry Eye Syndrome0medium36375
Exanthem0low40
Exanthema0low40
Exencephaly0low10
Exfoliation Glaucoma0low20
Exfoliation Syndrome0low20
Exfoliative Syndrome0low20
Exocrine Pancreatic Insufficiency0low30
Exophthalmic Goiter0low10
Exophthalmos0low20
Experimental Allergic Encephalomyelitis0low50
Experimental Autoimmune Encephalomyelitis0low50
Experimental Diabetes Mellitus0low110
Experimental Hepatoma0low20
Experimental Hepatomas0low20
Experimental Liver Cirrhoses0low20
Experimental Liver Cirrhosis0low20
Experimental Liver Neoplasms0low20
Experimental Mammary Neoplasms0low30
Experimental Melanoma0low40
Experimental Melanomas0low40
Experimental Neoplasms0low150
Experimental Radiation Injuries0low50
Experimental Sarcoma0low30
Experimental Sarcomas0low30
External Carotid Artery Diseases0low30
External Carotid Artery Stenosis0low10
External Fistula0low10
External Nerve Compression Syndromes0low10
Extra-Mammary Paget Disease0low20
Extra-Mammary Paget's Disease0low20
Extrahepatic Cholestasis0low10
Extramammary Paget Disease0low20
Extramammary Paget's Disease0low20
Extravasation of Contrast Media0low90
Extravasation of Diagnostic and Therapeutic Materials0low90
Extravasation of Diagnostic, Therapeutic Materials0low90
Extravascular Hemolysis0low90
Eye Burns0low30
Eye Cancer0low40
Eye Diseases0medium403
Eye Disorders0medium403
Eye Fatigue0medium11
Eye Foreign Bodies0low30
Eye Foreign Object0low30
Eye Infections, Bacterial0low80
Eye Infections, Fungal0low20
Eye Infections, Parasitic0low10
Eye Infections, Viral0low40
Eye Injuries0medium172
Eye Injuries, Penetrating0low20
Eye Manifestations0low10
Eye Neoplasms0low40
Eye Pain0low30
Eyelid Diseases0medium346
Eyestrain0medium11
Facial Nerve Avulsion0low10
Facial Nerve Injuries0low10
Facial Nerve Trauma0low10
Facial Neuropathy, Traumatic0low10
Facial Palsy0low30
Facial Palsy, Lower Motor Neuron0low30
Facial Palsy, Upper Motor Neuron0low30
Facial Paralysis0low30
Facial Paralysis, Central0low30
Facial Paralysis, Peripheral0low30
Facial Paresis0low30
Facial Spasm, Unilateral0low10
Failure to Thrive0low10
Fainting0low10
False Aneurysm, Carotid0low10
Familial Alzheimer Disease (FAD)0low30
Familial Atrial Fibrillation0low10
Familial Dementia0low10
Familial Exudative Vitreoretinopathies0low10
Familial Exudative Vitreoretinopathy0low10
Familial Hemochromatosis0low10
Familial Tonic-Clonic Epilepsy0low20
Fasciitis0low10
Fascitis0low10
Fasting Hypoglycemia0low10
Fatigue, Visual0medium11
Fatty Liver0low10
Fatty Streak, Arterial0low20
Feline Diseases0medium61
Female Pattern Baldness0low10
Fetal Cerebral Ventriculomegaly0low20
Fetal Growth Restriction0low10
Fetal Growth Retardation0low10
Fetal Weight0low30
Fever0low30
Fibrillary Astrocytoma0low110
Fibroatheroma0low20
Fibroatheromatous Plaques0low20
Fibrocystic Disease of Pancreas0low60
Fibroid0medium11
Fibroid Tumor0medium11
Fibroid Uterus0medium11
Fibroids, Uterine0medium11
Fibroma, Shope0low30
Fibroma, Uterine0medium11
Fibromyalgia0low10
Fibromyalgia-Fibromyositis Syndrome0low10
Fibromyalgia, Primary0low10
Fibromyalgia, Secondary0low10
Fibromyoma0medium11
Fibromyositis-Fibromyalgia Syndrome0low10
Fibrosarcoma0low10
Fibrosis0low40
Fibrositis0low10
Fibrous Ankylosis of Multiple Joints0low10
Fibrous Meningioma0low80
Fifth Cranial Nerve Diseases0low20
Fish Diseases0low40
Fissure, Dental0low30
Fissures, Dental0low30
Fistula0low130
Flavivirus Infections0low10
FMR1-Related Primary Ovarian Insufficiency0low10
Focal Brain Injuries0low40
Focal Onset Alzheimer's Disease0low30
Food Allergy0low10
Food Hypersensitivity0low10
Foot Dermatoses0medium11
Foot Dermatosis0medium11
Foot Ulcer, Diabetic0low30
Forehead Trauma0low30
Foreign Bodies0low20
Foreign Objects0low20
Foreign-Body Reaction0low10
Formication0low10
Foster-Kennedy Syndrome0low60
Fractures, Bone0low10
Fractures, Compound0low10
Fractures, Open0low10
Fragile X Premature Ovarian Failure0low10
Fragile X-Associated Primary Ovarian Insufficiency0low10
Frontal Region Trauma0low30
Frostbite0low20
Fuch's Endothelial Dystrophy0low10
Fuchs Atrophy0low10
Fuchs Corneal Dystrophy0low10
Fuchs Dystrophy0low10
Fuchs Endothelial Corneal Dystrophy0low10
Fuchs Endothelial Dystrophy0low10
Fuchs' Endothelial Dystrophy0low10
Fumarylacetoacetase Deficiency0low20
Fumarylacetoacetase Deficiency Disease0low20
Functional Gastrointestinal Disorders0low10
Fungal Diseases0low20
Fungal Eye Infections0low20
Fungal Infections0low20
Fungus Diseases0low20
Fungus Infections0low20
Furrow Keratitis0low40
Fusiform Aneurysm0low120
Gall Stone0low10
Gall Stones0low10
Gall Stones, Common Bile Duct0low10
Gallstone0low10
Gallstone Disease0low10
Gallstones0low10
Gallstones, Common Bile Duct0low10
Ganglion Cysts0low10
Ganglionic Cysts0low10
Ganglions0low10
Gangrene0medium51
Gastric Cancer0medium101
Gastric Cancer, Familial Diffuse0medium101
Gastric Diseases0low10
Gastric Neoplasms0medium101
Gastric Ulcer0low10
Gastric Varices0low20
Gastric Varix0low20
Gastritis0low30
Gastroduodenal Ulcer0low10
Gastroenteritis0low10
Gastrointestinal Cancer0low10
Gastrointestinal Diseases0low10
Gastrointestinal Disorders0low10
Gastrointestinal Disorders, Functional0low10
Gastrointestinal Hemorrhage0low110
Gastrointestinal Neoplasms0low10
Gaucher Disease0low10
Gaucher Disease Type 10low10
Gaucher Disease Type 20low10
Gaucher Disease Type 30low10
Gaucher Disease, Acute Neuronopathic0low10
Gaucher Disease, Acute Neuronopathic Type0low10
Gaucher Disease, Chronic0low10
Gaucher Disease, Chronic Neuronopathic Type0low10
Gaucher Disease, Infantile0low10
Gaucher Disease, Infantile Cerebral0low10
Gaucher Disease, Juvenile0low10
Gaucher Disease, Juvenile and Adult, Cerebral0low10
Gaucher Disease, Neuronopathic0low10
Gaucher Disease, Non-Neuronopathic Form0low10
Gaucher Disease, Noncerebral Juvenile0low10
Gaucher Disease, Subacute Neuronopathic Form0low10
Gaucher Disease, Subacute Neuronopathic Type0low10
Gaucher Disease, Type 10low10
Gaucher Disease, Type 20low10
Gaucher Disease, Type 30low10
Gaucher Disease, Type I0low10
Gaucher Disease, Type II0low10
Gaucher Disease, Type III0low10
Gaucher Splenomegaly0low10
Gaucher Syndrome0low10
Gaucher's Disease0low10
Gauchers Disease0low10
GBA Deficiency0low10
Gemistocytic Astrocytoma0low110
Generalized Absence Seizure0low100
Generalized Absence Seizures0low100
Generalized Convulsive Status Epilepticus0low40
Generalized Headache0low50
Generalized Tonic-Clonic Seizures0low100
Genetic Hemochromatosis0low10
Genetic Predisposition0low10
Genetic Predisposition to Disease0low10
Genetic Susceptibility0low10
Germinoblastoma0low110
Gestosis, EPH0low30
Giant Cell Aortic Arteritis0low20
Giant Cell Aortitis0low20
Giant Cell Aortitis, Horton's0low20
Giant Cell Arteritis0low20
Giant Cell Arteritis, Horton0low20
Giant Cell Glioblastoma0medium201
Giant Intracranial Aneurysm0low140
Gilchrist Disease0low10
Gilchrist's Disease0low10
Glaucoma0medium291
Glaucoma Capsulare0low20
Glaucoma Simplex0medium213
Glaucoma, Angle Closure0low20
Glaucoma, Angle-Closure0low20
Glaucoma, Closed-Angle0low20
Glaucoma, Compensated0medium213
Glaucoma, Compensative0medium213
Glaucoma, Narrow-Angle0low20
Glaucoma, Neovascular0low10
Glaucoma, Open Angle0medium213
Glaucoma, Open-Angle0medium213
Glaucoma, Pigmentary0medium213
Glaucoma, Primary Open Angle0medium213
Glaucoma, Secondary Open Angle0medium213
Glaucoma, Simple0medium213
Glaucoma, Suspect0low90
Glaucoma, Uncompensated0low20
Glaucoma, Uncompensative0low20
Glial Cell Tumors0low650
Glioblastoma0medium201
Glioblastoma Multiforme0medium201
Glioma0low650
Glioma, Astrocytic0low110
Gliomatosis Cerebri0low10
Glomerulonephritis0low10
Glomerulosclerosis, Diabetic0medium61
Glucocerebrosidase Deficiency0low10
Glucocerebrosidase Deficiency Disease0low10
Glucocerebrosidosis0low10
Glucosyl Cerebroside Lipidosis0low10
Glucosylceramidase Deficiency0low10
Glucosylceramide Beta-Glucosidase Deficiency0low10
Glucosylceramide Beta-Glucosidase Deficiency Disease0low10
Glucosylceramide Lipidosis0low10
Gluten Enteropathy0low10
Gluten-Sensitive Enteropathy0low10
Glycosuria0low10
Goat Diseases0low10
Goiter, Exophthalmic0low10
Gonadotropin-Resistant Ovary Syndrome0low10
Gonorrhea0low10
Gossypiboma0low20
Graft vs Host Disease0medium153
Graft-Versus-Host Disease0medium153
Graft-vs-Host Disease0medium153
Gram-Negative Bacterial Infections0low10
Grand Mal Seizure Disorder0low20
Grand Mal Status Epilepticus0low40
Granular Dystrophy, Corneal0low60
Granulocytic Leukemia0low10
Granulocytic Leukemia, Chronic0low10
Granuloma0low10
Granulomas0low10
Granulomatous Angiitis0low10
Granulomatous Arteritis0low10
Granulomatous Disease, Chronic0low10
Granulomatous Disease, Chronic, X-Linked0low10
Granulomatous Disease, Chronic, X-Linked, Variant0low10
Granulomatous Rosacea0low10
Graves Disease0low10
Graves Ophthalmopathy0low30
Graves Orbitopathy0low30
Graves' Disease0low10
Grawitz Tumor0medium21
Great Pox0low10
Grippe0low30
Groenblad-Strandberg Syndrome0low10
Groenouw's Dystrophies0low60
Gronblad-Strandberg Syndrome0low10
Growth Retardation, Intrauterine0low10
Guerin-Stern Syndrome0low10
Guu00E9rin-Stern Syndrome0low10
Haemochromatosis0low10
Haemolysis0low90
Haemolytic Anaemia0low10
Haemonchiasis0low10
Hair Loss0low10
Hamartoma0low10
Happle Syndrome0low10
Harding Passey Melanoma0low40
Hay Fever0low10
Hayfever0low10
Head and Neck Cancer0low60
Head and Neck Neoplasm0low60
Head and Neck Neoplasms0low60
Head Cancer0low60
Head Injuries0low30
Head Injuries, Multiple0low30
Head Injury, Minor0low30
Head Injury, Open0low30
Head Injury, Superficial0low30
Head Neoplasm0low60
Head Neoplasms0low60
Head Pain0low50
Head Trauma0low30
Head, Neck Neoplasms0low60
Headache0low50
Health Care Associated Infection0low10
Health Care Associated Infections0low10
Healthcare Associated Infections0low10
Hearing Impairment0low10
Hearing Loss0low10
Hearing Loss, Cochlear0low10
Hearing Loss, Noise-Induced0low10
Hearing Loss, Sensorineural0low10
Hearing Loss, Sudden0low10
Hearing Loss, Transitory0low10
Heart Abnormalities0low20
Heart Arrest0low20
Heart Attack0low60
Heart Defect, Congenital0low20
Heart Defects, Congenital0low20
Heart Disease, Ischemic0low20
Heart Diseases0low20
Heart Disorders0low20
Heart Injuries0low10
Heart Rupture, Traumatic0low10
Heart Septal Defects, Ventricular0low40
Heart, Malformation Of0low20
Helicobacter Infections0low20
Hemangioblastic Meningioma0low80
Hemangioblastoma0low10
Hemangioma0low20
Hemangioma, Histiocytoid0low20
Hemangioma, Intramuscular0low20
Hemangiopericytic Meningioma0low80
Hematochezia0low110
Hematoma0low20
Hematoma, Subdural0low10
Hematuria0low10
Hemeralopia0low80
Hemicrania0low50
Hemifacial Myokymia0low10
Hemifacial Paralysis0low30
Hemifacial Spasm0low10
Hemiparesis0low10
Hemochromatoses0low10
Hemochromatosis0low10
Hemoglobinuria, Paroxysmal0low10
Hemolysis0low90
Hemolytic Anemia0low10
Hemolytic Anemia, Acquired0low10
Hemolytic Anemia, Autoimmune0low10
Hemorrhage0low110
Hemorrhage, Cerebral0low10
Hemorrhage, Cerebrum0low10
Hemorrhage, Gastrointestinal0low110
Hemorrhage, Peptic Ulcer0low10
Hemorrhage, Retinal0low80
Hemorrhage, Subarachnoid0low10
Hemorrhage, Subdural0low10
Hemorrhage, Surgical0low10
Hemorrhage, Uterine0medium11
Hemorrhage, Vitreous0low20
Hemorrhagic Diathesis0low10
Hemorrhagic Disorders0low10
Hemorrhagic Necrotic Pancreatitis0low10
Hemorrhagic Shock0low30
Hepatic Cancer0low170
Hepatic Cirrhosis, Experimental0low20
Hepatic Neoplasms0low170
Hepatitis B0low10
Hepatitis B Virus Infection0low10
Hepatitis C0low10
Hepatitis C, Chronic0low10
Hepatitis, Drug-Induced0low10
Hepatitis, Toxic0low10
Hepatitis, Viral, Human0low10
Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted0low10
Hepatoblastoma0low10
Hepatocellular Cancer0low170
Hepatocellular Carcinoma0low90
Hepatoma0low90
Hepatoma, Experimental0low20
Hepatoma, Morris0low20
Hepatoma, Novikoff0low20
Hepatomas, Experimental0low20
Hepatorenal Tyrosinemia0low20
Herditary Sensory and Motor Neuropathy0low10
Hereditary Hemorrhagic Telangiectasia0low10
Hereditary Lymphedema0low30
Hereditary Lymphedema 10low30
Hereditary Lymphedema Type I0low30
Hereditary Motor and Sensory Neuropathies0low10
Hereditary Motor and Sensory Neuropathy0low10
Hereditary Motor and Sensory Neuropathy 30low10
Hereditary Motor and Sensory Neuropathy Type III0low10
Hereditary Optic Atrophy0low20
Hereditary Sensory and Motor Neuropathy0low10
Hereditary Tyrosinemia, Type I0low20
Hereditary Tyrosinemia, Type II0low20
Hereditary Tyrosinemia, Type III0low20
Hereditary Tyrosinemias0low20
Hereditary, Type III, Motor and Sensory Neuropathy0low10
Hereditary, Type VII, Motor and Sensory Neuropathy0low10
Hernia, Diaphragmatic0low10
Herpes Simplex0low10
Herpes Simplex Keratitis0low80
Herpes Simplex Virus Infection0low10
Herpes Simplex, Ocular0low80
Herpes Zoster0low10
Herpes Zoster Ophthalmicus0low20
Herpes Zoster, Ocular0low20
Herpesviridae Infections0low10
Herpesvirus Infections0low10
Heterotopic Tissue0low10
Histoplasma capsulatum Infection0low10
Histoplasma Infection0low10
Histoplasmosis0low10
HIV0low10
HIV Coinfection0low40
HIV Infections0low40
HIV-Related Opportunistic Infections0low10
Hives0low90
HMSN0low10
HMSN Type III0low10
HMSN Type VII0low10
HMSN30low10
Homologous Wasting Disease0medium153
Horse Diseases0low30
Horton Disease0low20
Horton Giant Cell Arteritis0low20
Horton's Disease0low20
Horton's Giant Cell Arteritis0low20
Hospital Infections0low10
Hospital-Acquired Condition0low40
HPV Infection0low20
HTLV-III Infections0low40
HTLV-III-LAV Infections0low40
Hughes Syndrome0low10
Human Flu0low30
Human Influenza0low30
Human Mammary Carcinoma0low320
Human Papillomavirus Infection0low20
Human Transmissible Spongiform Encephalopathies, Inherited0low40
Hunermann-Conradi Syndrome0low10
Hydrocephalus0low20
Hydrocephalus Ex-Vacuo0low20
Hydrocephaly0low20
Hydrophobia0low10
Hydrophthalmos0low10
Hydrops0low120
Hygroma, Subdural0low20
Hyperalgesia0low10
Hyperalgesia, Mechanical0low10
Hyperalgesia, Primary0low10
Hyperalgesia, Secondary0low10
Hyperalgesia, Tactile0low10
Hyperalgesia, Thermal0low10
Hyperalgesic Sensations0low10
Hyperalgia0low10
Hyperalgia, Mechanical0low10
Hyperalgia, Primary0low10
Hyperalgia, Secondary0low10
Hyperbilirubinemic Encephalopathy0low10
Hypercapnia0low20
Hyperemia0medium62
Hyperglycemia0low50
Hyperglycemia, Postprandial0low50
Hypergonadotropic Ovarian Failure, X-Linked0low10
Hyperhomocysteinemia0low10
Hypernephroma0medium21
Hyperplasia0low40
Hypersensitivity0low30
Hypersensitivity, Atopic0low10
Hypersensitivity, Contact0low30
Hypersensitivity, Drug0medium183
Hypersensitivity, Food0low10
Hypersensitivity, Immediate0low10
Hypersensitivity, Type I0low10
Hypertension0medium101
Hypertension-Edema-Proteinuria Gestosis0low30
Hypertension, Ocular0low90
Hypertension, Pulmonary0low10
Hypertensive Retinopathy0low10
Hyperthermia0low10
Hyperthyroid0low10
Hyperthyroidism0low10
Hyperthyroidism, Autoimmune0low10
Hypertrophic Neuropathy of Dejerine-Sottas0low10
Hypertrophy0low20
Hypertyrosinemia0low20
Hypertyrosinemia, Type I0low20
Hypesthesia0low20
Hypesthesia, Tactile0low20
Hypesthesia, Thermal0low20
Hypoacusis0low10
Hypocapnia0low10
Hypoesthesia0low20
Hypogammaglobulinemia0low10
Hypoglycemia0low10
Hypomineralization, Tooth0low40
Hyponatremia0low10
Hyposalivation0low10
Hypospadias0low10
Hypotension0low40
Hypotension, Vascular0low40
Hypothermia0low10
Hypothermia, Accidental0low10
Hypovolemic Shock0low50
Hypoxemia0medium223
Hypoxia0medium223
Hypoxia-Ischemia, Brain0low10
Hypoxia-Ischemia, Cerebral0low10
Hypoxia, Brain0low10
Hypoxia, Cerebral0low10
Hypoxic Brain Damage0low10
Hypoxic Encephalopathy0low10
Hypoxic-Ischemic Encephalopathy0low10
Iatrogenic Disease0low40
Icterus0low50
Icterus Gravis Neonatorum0low10
IDDM0medium408
Idiopathic Autoimmune Hemolytic Anemia0low10
Idiopathic Duct-centric Pancreatitis0low10
Idiopathic Parkinson Disease0low10
Idiopathic Parkinson's Disease0low10
Idiopathic Proctocolitis0medium113
Idiopathic Thrombocytopenic Purpura0low10
IgE-Mediated Hypersensitivity0low10
IgG4-related Pancreatitis0low10
Ileitis, Regional0medium92
Ileitis, Terminal0medium92
Ileocolitis0medium92
Immune Diseases0low30
Immune Disorders0low30
Immune System Diseases0low30
Immune System Disorders0low30
Immune Thrombocytopenia0low10
Immune Thrombocytopenic Purpura0low10
Immunodeficiency Syndrome, Acquired0low30
Immunodeficiency Syndrome, Severe Combined0low10
Immunodeficiency, Severe Combined0low10
Immunologic Deficiency Syndrome, Acquired0low30
Immunologic Deficiency, Severe Combined0low10
Immunologic Diseases0low30
Immunological Diseases0low30
Impaired Sensation0low20
Inadequate Sleep0low20
Incontinentia Pigmenti0low10
Incontinentia Pigmenti Achromians0medium41
Increased Intracranial Pressure-Associated Papilledema0low30
Infant, Newborn, Diseases0low10
Infant, Premature, Diseases0low20
Infantile Gaucher Disease0low10
Infarct0low10
Infarction0low10
Infarction, Anterior Cerebral Circulation0low20
Infarction, Anterior Circulation, Brain0low20
Infarction, Brain, Anterior Circulation0low20
Infarction, Brain, Posterior Circulation0low20
Infarction, Cerebral0low20
Infarction, Cerebral, Left Hemisphere0low20
Infarction, Cerebral, Right Hemisphere0low20
Infarction, Left Hemisphere, Cerebral0low20
Infarction, Middle Cerebral Artery0low60
Infarction, Posterior Circulation, Brain0low20
Infarction, Right Hemisphere, Cerebral0low20
Infection0low20
Infection and Infestation0low20
Infection, Cross0low10
Infection, Postoperative Wound0low30
Infection, Surgical Wound0low30
Infection, Toxoplasma gondii0low40
Infection, Wound0low10
Infections0low20
Infections and Infestations0low20
Infections, Actinobacillus0low10
Infections, Alphavirus0low10
Infections, Atypical Mycobacterium0low10
Infections, Bacterial Eye0low80
Infections, Bacterial Ocular0low80
Infections, Bartonella0low10
Infections, Borrelia0low10
Infections, Bunyaviridae0low10
Infections, Bunyavirus0low10
Infections, Chlamydia0low30
Infections, Coronavirus0low30
Infections, Coxsackie Virus0low10
Infections, Coxsackievirus0low10
Infections, E coli0low30
Infections, Escherichia coli0low30
Infections, Flavivirus0low10
Infections, Gram-Negative Bacterial0low10
Infections, Helicobacter0low20
Infections, Herpesviridae0low10
Infections, Herpesvirus0low10
Infections, Hospital0low10
Infections, Neisseriaceae0medium11
Infections, Nosocomial0low10
Infections, Orthomyxoviridae0low10
Infections, Orthomyxovirus0low10
Infections, Plasmodium0low10
Infections, Pseudomonas0low80
Infections, Respiratory Syncytial Virus0low10
Infections, Rochalimaea0low10
Infections, Staphylococcal0low30
Infections, Trichomonas0low10
Infections, Tumor Virus0low30
Infectious Encephalomyelitis, Viral0low10
Infectious Endophthalmitis0low40
Infectious Keratoconjunctivitis0medium11
Inferior Dislocation0low20
Infertility, Male0low20
Inflammation0medium251
Inflammation, Brain0low20
Inflammatory Bowel Disease 10medium92
Inflammatory Bowel Disease, Ulcerative Colitis Type0medium113
Inflammatory Bowel Diseases0low20
Inflammatory Encephalomyelitis0low10
Influenza0low30
Influenza in Humans0low30
Influenza, Human0low30
Infratentorial Cancer0low30
Infratentorial Neoplasms0low30
Infratentorial Neoplasms, Benign0low30
Infratentorial Neoplasms, Malignant0low30
Infratentorial Tumors0low30
Inherited Human Transmissible Spongiform Encephalopathies0low40
Iniencephaly0low10
Injuries0medium21
Injuries and Wounds0medium21
Injuries, Abdominal0low10
Injuries, Acute Brain0low40
Injuries, Blunt0low40
Injuries, Brain0low40
Injuries, Carotid Artery0low10
Injuries, Cranial Nerve VII0low10
Injuries, Craniocerebral0low30
Injuries, Experimental Radiation0low50
Injuries, Eye0medium172
Injuries, Head0low30
Injuries, Heart0low10
Injuries, Leg0low10
Injuries, Multiple0low10
Injuries, Nonpenetrating0low40
Injuries, Penetrating Eye0low20
Injuries, Radiation0low30
Injuries, Seventh Cranial Nerve0low10
Injuries, Soft Tissue0low10
Injuries, Spinal Cord0low30
Injuries, Surgical0medium152
Injuries, Wounds0medium21
Injury, Facial Nerve0low10
Injury, Ischemia-Reperfusion0low190
Injury, Reperfusion0low190
Innate Inflammatory Response0medium251
Inner Ear Disease0low10
Insufficient Sleep0low20
Insufficient Sleep Syndrome0low20
Insulin-Dependent Diabetes Mellitus 10medium408
Insulinoma0low10
Insuloma0low10
Intermittent Claudication0medium21
Internal Carotid Artery Diseases0low30
Internal Carotid Artery Stenosis0low10
Internal Nerve Compression Syndromes0low10
Interstitial Cystitis0low30
Interstitial Cystitis, Chronic0low30
Interstitial Lung Disease0low10
Interstitial Lung Diseases0low10
Intestinal Diseases0low20
Intestinal Obstruction0low10
Intestinal Perforation0low10
Intestinal Polyps0low10
Intoxication, Alcoholic0low10
Intracapillary Glomerulosclerosis0medium61
Intracerebral Hemorrhage0low10
Intracranial Aneurysm0low140
Intracranial Arteriovenous Malformation, Ruptured0low30
Intracranial Arteriovenous Malformations0low30
Intracranial Arteriovenous Malformations, Congenital0low30
Intracranial Astrocytoma0low110
Intracranial Central Nervous System Disorders0low60
Intracranial CNS Disorders0low60
Intracranial Edema0low140
Intracranial Embolism0low10
Intracranial Embolism and Thrombosis0low10
Intracranial Hypotension0low10
Intracranial Hypotension, Essential0low10
Intracranial Hypotension, Secondary0low10
Intracranial Hypotension, Spontaneous0low10
Intracranial Meningeal Neoplasms0low80
Intracranial Meningioma0low80
Intracranial Neoplasms0medium1391
Intracranial Vascular Disorders0low40
Intradural-Extramedullary Spinal Cord Neoplasms0low80
Intraepithelial Neoplasms0medium32
Intramedullary Spinal Cord Neoplasms0low80
Intramedullary Spinal Cord Neoplasms, Primary0low80
Intraocular Pressure0medium7717
Intraoperative Complications0medium152
Intraorbital Meningioma0low80
Intrauterine Growth Restriction0low10
Intrauterine Growth Retardation0low10
Intravascular Hemolysis0low90
Intraventricular Meningioma0low80
Intraventricular Neoplasms0low10
Intraventricular Septal Defects0low40
Invasiveness, Neoplasm0low10
Iris Diseases0low20
Iron Overload0low20
Iron Storage Disorder0low10
Iron-Deficiency Anemia0low10
Iron-Deficiency Anemias0low10
Irvine-Gass Syndrome0medium232
Ischaemic Stroke0low20
Ischemia0medium383
Ischemia-Anoxia, Brain0low10
Ischemia-Anoxia, Cerebral0low10
Ischemia-Hypoxia, Brain0low10
Ischemia-Hypoxia, Cerebral0low10
Ischemia-Reperfusion Injury0low190
Ischemia, Cerebral0low110
Ischemia, Myocardial0low20
Ischemic Attack, Transient0low10
Ischemic Encephalopathy0low110
Ischemic Heart Disease0low20
Ischemic Optic Neuropathy0low20
Ischemic Stroke0low20
Ischemic-Hypoxic Encephalopathy0low10
Itching0low40
Ito Syndrome0medium41
Jacksonian Seizure0low100
Jail Fever0low10
Jaundice0low50
Jaundice, Cholestatic0low10
Jaundice, Hemolytic0low50
Jaundice, Mechanical0low10
Jaundice, Neonatal0low10
Jaundice, Obstructive0low10
Joint Dislocations0low20
Joint Subluxations0low20
Joseph Azorean Disease0low10
Joseph Disease0low10
Juvenile Absence Epilepsy0low10
Juvenile Hereditary Epithelial Dystrophy0low10
Juvenile Pilocytic Astrocytoma0low110
Juvenile Temporal Arteritis0low20
Juvenile-Onset Diabetes0medium408
Kahler Disease0low40
Kala-Azar0low10
Kaposi Disease0low10
Kaposi Sarcoma0low10
Kaposi's Disease0low10
Kaposi's Sarcoma0low10
Kawasaki Disease0low10
Kawasaki Syndrome0low10
Kerasin Histiocytosis0low10
Kerasin Lipoidosis0low10
Kerasin thesaurismosis0low10
Keratitis0medium194
Keratitis, Acanthamoeba0low20
Keratitis, Dendritic0low40
Keratitis, Furrow0low40
Keratitis, Herpetic0low80
Keratitis, Ulcerative0medium152
Keratoconjunctivitis0low80
Keratoconjunctivitis Sicca0medium336
Keratoconjunctivitis, Infectious0medium11
Keratoconjunctivitis, Vernal0low110
Keratoconus0medium61
Keratosis Palmoplantaris with Corneal Dystrophy0low20
Kernicterus0low10
Keskushermoston sairaudet@fi0low10
Kidney Calculi0low10
Kidney Cancer0medium21
Kidney Diseases0low10
Kidney Failure0low20
Kidney Failure, Acute0low30
Kidney Failure, Chronic0medium31
Kidney Insufficiency0low20
Kidney Insufficiency, Acute0low30
Kidney Insufficiency, Chronic0low30
Kidney Neoplasms0medium21
Kidney Scarring0low10
Kidney Stones0low10
Kimmelstiel-Wilson Disease0medium61
Kimmelstiel-Wilson Syndrome0medium61
Koch's Disease0low30
Kochs Disease0low30
Kussmaul Aphasia0low10
Kussmaul's Aphasia0low10
Labyrinth Diseases0low10
Lacerations0low60
Lacrimal Apparatus Diseases0medium242
Lacrimal Duct Obstruction0medium376
Lambdoid Synostosis0low10
Laryngeal Cancer0low20
Laryngeal Neoplasms0low20
Laryngopharyngeal Reflux0low10
Larynx Cancer0low20
Larynx Neoplasms0low20
Late Onset Alzheimer Disease0low30
Leakage, Dental0low10
Leakages, Dental0low10
Left Hemisphere, Cerebral Infarction0low20
Left Hemisphere, Infarction, Cerebral0low20
Left Main Coronary Artery Disease0medium11
Left Main Coronary Disease0medium11
Left Main Disease0medium11
Left Middle Cerebral Artery Infarction0low60
Leg Injuries0low10
Leiomyoma0medium11
Leiomyoma, Uterine0medium11
Leishmaniasis, Visceral0low10
Lens Diseases0low10
Lens Opacities0low120
Leptomeningeal Neoplasms0low80
Leptospira Canicola Infection0low10
Leptospira Infection0low10
Leptospirosis0low10
Leptospirosis Canicola0low10
Lesion of Sciatic Nerve0low10
Leucocythaemia0low40
Leucocythemia0low40
Leukemia0low40
Leukemia L 12100low20
Leukemia L12100low20
Leukemia, Acute Lymphoblastic0low10
Leukemia, Acute Myelogenous0low10
Leukemia, Acute Myeloid0low10
Leukemia, Acute Promyelocytic0low20
Leukemia, Basophilic, Acute0low10
Leukemia, Chronic Myelogenous0low10
Leukemia, Chronic Myeloid0low10
Leukemia, Erythroblastic, Acute0low20
Leukemia, Granulocytic0low10
Leukemia, Granulocytic, Chronic0low10
Leukemia, Lymphoblastic0low10
Leukemia, Lymphoblastic, Acute0low10
Leukemia, Lymphoblastic, Acute, L10low10
Leukemia, Lymphoblastic, Acute, L20low10
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive0low10
Leukemia, Lymphoblastic, Burkitt-Type0low20
Leukemia, Lymphocytic0low10
Leukemia, Lymphocytic, Acute0low10
Leukemia, Lymphocytic, Acute, L10low10
Leukemia, Lymphocytic, Acute, L20low10
Leukemia, Lymphocytic, L30low20
Leukemia, Lymphoid0low10
Leukemia, Lymphoid, Acute0low10
Leukemia, Monocytic, Chronic0low10
Leukemia, Myeloblastic, Acute0low10
Leukemia, Myelocytic0low10
Leukemia, Myelocytic, Acute0low10
Leukemia, Myelocytic, Chronic0low10
Leukemia, Myelogenous0low10
Leukemia, Myelogenous, Acute0low10
Leukemia, Myelogenous, Chronic0low10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive0low10
Leukemia, Myelogenous, Ph1 Positive0low10
Leukemia, Myelogenous, Ph1-Positive0low10
Leukemia, Myeloid0low10
Leukemia, Myeloid, Acute0low10
Leukemia, Myeloid, Acute, M10low10
Leukemia, Myeloid, Acute, M20low10
Leukemia, Myeloid, Acute, M30low20
Leukemia, Myeloid, Acute, M60low20
Leukemia, Myeloid, Chronic0low10
Leukemia, Myeloid, Ph1 Positive0low10
Leukemia, Myeloid, Ph1-Positive0low10
Leukemia, Myeloid, Philadelphia Positive0low10
Leukemia, Myeloid, Philadelphia-Positive0low10
Leukemia, Nonlymphoblastic, Acute0low10
Leukemia, Nonlymphocytic, Acute0low10
Leukemia, Progranulocytic0low20
Leukemia, Promyelocytic, Acute0low20
Leukoma0low60
Lewy Body Parkinson Disease0low10
Lewy Body Parkinson's Disease0low10
Libman-Sacks Disease0low60
Lice Infestations0low30
Linear Skull Fracture0low30
Lipoid Histiocytosis (Kerasin Type)0low10
Liver Cancer0low170
Liver Cancer, Adult0low90
Liver Cell Carcinoma0low90
Liver Cell Carcinoma, Adult0low90
Liver Cirrhoses, Experimental0low20
Liver Cirrhosis, Experimental0low20
Liver Diseases0low20
Liver Diseases, Parasitic0low10
Liver Dysfunction0low20
Liver Injury, Drug-Induced0low10
Liver Injury, Drug-Induced, Acute0low10
Liver Neoplasms0low170
Liver Neoplasms, Experimental0low20
Liver Steatosis0low10
Livor Mortis0low10
Local Neoplasm Recurrence0low110
Local Neoplasm Recurrences0low110
Locoregional Neoplasm Recurrence0low110
Louse-Borne Typhus0low10
Low Blood Pressure0low40
Lower Extremity Paresis0low10
Lower Motor Neuron Facial Palsy0low30
Lung Adenocarcinoma0low10
Lung Cancer0low80
Lung Diseases, Interstitial0low10
Lung Neoplasms0low80
Lupus Erythematosus Disseminatus0low60
Lupus Erythematosus, Systemic0low60
Lupus Meningoencephalitis0low10
Lupus Vasculitis, Central Nervous System0low10
Luxatio Erecta0low20
Lyell's Syndrome0low20
Lymph Node Metastasis0low30
Lymph Node Syndrome, Mucocutaneous0low10
Lymphadenopathy Syndrome0low10
Lymphangitis0low10
Lymphatic Metastasis0low30
Lymphatic Sarcoma0low10
Lymphedema0low30
Lymphedema, Early-Onset0low30
Lymphedema, Hereditary, Ia0low30
Lymphoblastic Leukemia0low10
Lymphoblastic Leukemia, Acute0low10
Lymphoblastic Leukemia, Acute, Adult0low10
Lymphoblastic Leukemia, Acute, Childhood0low10
Lymphoblastic Leukemia, Acute, L10low10
Lymphoblastic Leukemia, Acute, L20low10
Lymphoblastic Lymphoma0low10
Lymphocytic Leukemia0low10
Lymphocytic Leukemia, Acute0low10
Lymphocytic Leukemia, L10low10
Lymphocytic Leukemia, L20low10
Lymphocytic Leukemia, L30low20
Lymphoid Leukemia0low10
Lymphoma0low110
Lymphoma of Mucosa-Associated Lymphoid Tissue0low10
Lymphoma, Atypical Diffuse Small Lymphoid0low10
Lymphoma, B-Cell0low10
Lymphoma, B-Cell, Marginal Zone0low10
Lymphoma, Burkitt0low20
Lymphoma, Diffuse0low10
Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic0low10
Lymphoma, High-Grade0low10
Lymphoma, Intermediate-Grade0low10
Lymphoma, Low-Grade0low10
Lymphoma, Lymphoblastic0low10
Lymphoma, Malignant0low110
Lymphoma, Mixed0low10
Lymphoma, Mixed Cell, Diffuse0low10
Lymphoma, Mixed Lymphocytic-Histiocytic0low10
Lymphoma, Mixed Small and Large Cell, Diffuse0low10
Lymphoma, Mixed-Cell0low10
Lymphoma, Mixed-Cell, Diffuse0low10
Lymphoma, Mucosa-Associated Lymphoid Tissue0low10
Lymphoma, Non-Hodgkin0low10
Lymphoma, Non-Hodgkin, Familial0low10
Lymphoma, Non-Hodgkin's0low10
Lymphoma, Non-Hodgkins0low10
Lymphoma, Nonhodgkin's0low10
Lymphoma, Nonhodgkins0low10
Lymphoma, Pleomorphic0low10
Lymphoma, Small and Large Cleaved-Cell, Diffuse0low10
Lymphoma, Small Cleaved Cell, Diffuse0low10
Lymphoma, Small Cleaved-Cell, Diffuse0low10
Lymphoma, Small Non-Cleaved-Cell0low10
Lymphoma, Small Noncleaved-Cell0low10
Lymphoma, T-Cell0low20
Lymphoma, Undifferentiated0low10
Lymphoma, Undifferentiated, Diffuse0low10
Lymphosarcoma0low10
Lyssa0low10
M3 ANLL0low20
Machado-Joseph Azorean Disease0low10
Machado-Joseph Disease0low10
Machado-Joseph Disease Type I0low10
Machado-Joseph Disease Type II0low10
Machado-Joseph Disease Type III0low10
Machado-Joseph Disease Type IV0low10
Macropsia0low80
Macular Degeneration0medium286
Macular Degeneration, Age-Related0medium286
Macular Dystrophy0medium286
Macular Dystrophy, Corneal0low60
Macular Dystrophy, Dominant Cystoid0medium232
Macular Edema0medium232
Macular Edema, Cystoid0medium232
Macular Holes0low70
Maculopapular Drug Eruption0low30
Maculopapular Exanthem0low30
Maculopathies, Age-Related0medium286
Maculopathy0medium286
Maculopathy, Age-Related0medium286
Major Motor Seizure Disorder0low20
Maladie du systu00E8me nerveux central@fr0low10
Malaria0low10
Malaria Meningitis0low20
Malaria, Cerebral0low20
Malaria, Falciparum0low20
Malaria, Vivax0medium11
Malattie del sistema nervoso centrale@it0low10
Male Pattern Baldness0low10
Malformations of Cerebral Cortex Development0low20
Malformations of Cortical Development0low20
Malignancy0low670
Malignant Cerebellar Neoplasms0low10
Malignant Epithelial Neoplasms0medium91
Malignant Glioma0low650
Malignant Infratentorial Neoplasms0low30
Malignant Melanoma0low80
Malignant Meningeal Neoplasms0low80
Malignant Meningioma0low80
Malignant Mesothelioma0low10
Malignant Neoplasm of Breast0low320
Malignant Neoplasms0low670
Malignant Neoplasms, Brain0medium1391
Malignant Pleural Mesothelioma0low10
Malignant Primary Brain Neoplasms0medium1391
Malignant Primary Brain Tumors0medium1391
Malignant Supratentorial Neoplasms0low80
Malignant Tumor of Breast0low320
Malignant Tumor of Urinary Bladder0low50
MALT Lymphoma0low10
Mammary Cancer0low320
Mammary Carcinoma, Animal0low10
Mammary Carcinoma, Human0low320
Mammary Neoplasm, Human0low320
Mammary Neoplasms0low10
Mammary Neoplasms, Animal0low10
Mammary Neoplasms, Experimental0low30
Mammary Neoplasms, Human0low320
Mange0low10
Marasmus0low10
Marchiafava-Micheli Syndrome0low10
Marginal Mandibular Nerve Injuries0low10
Marginal Mandibular Nerve Injury0low10
Marginal Ulcer0low10
Marginal Zone B-Cell Lymphoma0low10
Margins of Excision0low30
Marsh Fever0low10
Mastocytoma, Skin0low10
Maturity-Onset Diabetes0medium181
Maturity-Onset Diabetes Mellitus0medium181
Mayaro Virus Infection0low10
MCA Infarct0low60
MCA Infarction0low60
MCTD0low10
Measles0low10
Mechanical Allodynia0low10
Mechanical Hyperalgesia0low10
Medullary Neoplasms0low30
Medullary Tumors0low30
Medulloblastoma0low10
Medulloblastoma, Adult0low10
Medulloblastoma, Childhood0low10
Medulloblastoma, Desmoplastic0low10
Medullomyoblastoma0low10
Meesmann Corneal Dystrophy0low10
Meesmann Corneal Epithelial Dystrophy0low10
Meesmann Epithelial Corneal Dystrophy0low10
Meibomian Gland Dysfunction0medium167
Melancholia0low10
Melanocytic Medulloblastoma0low10
Melanocytic Vestibular Schwannoma0low30
Melanoma0low80
Melanoma, Amelanotic0low10
Melanoma, B160low40
Melanoma, Cloudman S910low40
Melanoma, Experimental0low40
Melanoma, Harding-Passey0low40
Melanomas, Experimental0low40
Memory Deficits0low10
Memory Disorder, Semantic0low10
Memory Disorder, Spatial0low10
Memory Disorders0low10
Memory Disorders, Age-Related0low10
Memory Loss0low10
Meningeal Cancer0low80
Meningeal Neoplasms0low80
Meningeal Neoplasms, Benign0low80
Meningeal Neoplasms, Intracranial0low80
Meningeal Neoplasms, Malignant0low80
Meningeal Plague0low10
Meningeal Tumors0low80
Meningioma0low80
Meningiomas, Multiple0low80
Meningiomatosis0low80
Meningitis0low40
Meningitis, Tuberculous0low40
Meningoencephalitis0low10
Meningomyelocele0low10
Meningotheliomatous Meningioma0low80
Mental Deterioration0low20
MERS (Middle East Respiratory Syndrome)0low30
Mesencephalic Neoplasms0low30
Mesenteric Vascular Occlusion0low60
Mesothelioma0low10
Mesothelioma, Malignant0low10
Mesothelioma, Malignant Pleural0low10
Metabolic Acidosis0low20
Metamorphopsia0low80
Metaplasia0medium61
Metastase0medium31
Metastases, Neoplasm0medium31
Metastasis0medium31
Metastasis, Neoplasm0medium31
Metopic Synostosis0low10
MG Dysfunction0medium167
Microaneurysm0low10
Microangiopathic Hemolytic Anemia0low10
Microangiopathy, Diabetic0low60
Microcystic Meningioma0low80
Micropsia0low80
Midbrain Neoplasms0low30
Midbrain Tumors0low30
Middle Cerebral Artery Aneurysm0low140
Middle Cerebral Artery Circulation Infarction0low60
Middle Cerebral Artery Embolic Infarction0low60
Middle Cerebral Artery Embolus0low60
Middle Cerebral Artery Infarction0low60
Middle Cerebral Artery Occlusion0low60
Middle Cerebral Artery Stroke0low60
Middle Cerebral Artery Syndrome0low60
Middle Cerebral Artery Thrombosis0low60
Middle Cerebral Artery Thrombotic Infarction0low60
Middle Ear Inflammation0low10
Middle East Respiratory Syndrome0low30
Mild Cognitive Impairment0low20
Mild Neurocognitive Disorder0low20
Mild Traumatic Brain Injury0low10
Miliary Aneurysm0low10
Milroy Disease0low30
Milroy's Disease0low30
Minimal Disease, Residual0low70
Minimal Residual Disease0low70
Miosis0low10
Miosis, Persistent0low10
Mite Infestations0low10
Mitochondrial Diseases0low10
Mitochondrial Disorders0low10
Mitochondrial Electron Transport Chain Deficiencies0low10
Mitochondrial Respiratory Chain Deficiencies0low10
Mixed Connective Tissue Disease0low10
Mixed Glioma0low650
Mixed Oligodendroglioma-Astrocytoma0low10
Mixed Oligodendroglioma-Ependymoma0low10
Mixed Small and Large Cell Lymphoma, Diffuse0low10
Mixed-Cell Lymphoma0low10
Mixed-Cell Lymphoma, Diffuse0low10
MODY0medium181
Molluscum Fibrosum0low10
Mongolism0low10
Moniliasis, Oral0low10
Monkey Diseases0low10
Monochromatopsia0low10
Monocytic Leukemia, Chronic0low10
Mononeuropathy, Diabetic0low20
Monoparesis0low10
Morbilliform Drug Reaction0low30
Morbilliform Exanthem0low30
Mouth Cancer0low30
Mouth Dryness0low10
Mouth Neoplasms0low30
Mouth Ulcer0low10
Moya-Moya Disease0low10
Moyamoya Disease0low10
Moyamoya Disease, Classic0low10
Moyamoya Disease, Primary0low10
Moyamoya Disease, Secondary0low10
Moyamoya Syndrome0low10
Mucocutaneous Lymph Node Syndrome0low10
Mucosa-Associated Lymphoid Tissue Lymphoma0low10
Mucous Membrane Pemphigoid, Benign0low40
Mucoviscidosis0low60
Mud Fever0low10
Multiple Abnormalities0low10
Multiple Head Injuries0low30
Multiple Hemangioblastomas0low10
Multiple Idiopathic Pigmented Hemangiosarcoma0low10
Multiple Injuries0low10
Multiple Myeloma0low40
Multiple Neurofibromas0low10
Multiple Trauma0low10
Mumps0low20
Muscle Contraction0low120
Muscle Disorders0low20
Muscle Paresis0low10
Muscle Spasm0low20
Muscle Weakness0low10
Muscular Diseases0low20
Muscular Dystrophy Pseudohypertrophic Progressive, Becker Type0low20
Muscular Dystrophy, Becker0low20
Muscular Dystrophy, Becker Type0low20
Muscular Dystrophy, Childhood, Pseudohypertrophic0low20
Muscular Dystrophy, Duchenne0low20
Muscular Dystrophy, Duchenne and Becker Types0low20
Muscular Dystrophy, Duchenne Type0low20
Muscular Dystrophy, Pseudohypertrophic0low20
Muscular Dystrophy, Pseudohypertrophic Progressive, Becker Type0low20
Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type0low20
Muscular Dystrophy, Pseudohypertrophic, Childhood0low20
Muscular Paresis0low10
Muscular Spasm0low20
Muscular Weakness0low10
Mutism0low10
Mutism, Conversion0low10
Mutism, Elective0low10
Mutism, Organic0low10
Mutism, Selective0low10
Mutism, Voluntary0low10
Mycobacterium abscessus Infection0low10
Mycobacterium Infections, Atypical0low10
Mycobacterium Infections, Nontuberculous0low10
Mycobacterium tuberculosis Infection0low30
Mycoplasma-Induced Stevens Johnson Syndrome0low20
Mycoplasma-Induced Stevens-Johnson Syndrome0low20
Mycoses0low20
Mycosis, Ocular0low20
Mycotic Aneurysm, Intracranial0low140
Mycotic Infections, Ocular0low20
Myeloblastic Leukemia, Acute0low10
Myelocele0low10
Myelocytic Leukemia0low10
Myelocytic Leukemia, Acute0low10
Myelocytic Leukemia, Chronic0low10
Myeloencephalitis0low10
Myelogenous Leukemia0low10
Myelogenous Leukemia, Acute0low10
Myelogenous Leukemia, Chronic0low10
Myelogenous Leukemia, Ph1-Positive0low10
Myeloid Leukemia0low10
Myeloid Leukemia, Acute0low10
Myeloid Leukemia, Acute, M10low10
Myeloid Leukemia, Acute, M20low10
Myeloid Leukemia, Acute, M30low20
Myeloid Leukemia, Acute, M60low20
Myeloid Leukemia, Chronic0low10
Myeloid Leukemia, Ph1-Positive0low10
Myeloid Leukemia, Philadelphia-Positive0low10
Myeloma-Multiple0low40
Myeloma, Multiple0low40
Myeloma, Plasma-Cell0low40
Myelomatosis0low40
Myelomeningocele0low10
Myelomeningocele, Acquired0low10
Myelopathy, Traumatic0low30
Myocardial Infarct0low60
Myocardial Infarction0low60
Myocardial Ischemia0low20
Myoclonic Seizure0low100
Myoclonic Seizures0low100
Myodystrophia Fetalis Deformans0low10
Myoepithelial Tumor0low10
Myoepithelioma0low10
Myofascial Pain Syndrome, Diffuse0low10
Myopathic Conditions0low20
Myopathic Ophthalmopathy0low30
Myopathies0low20
Myopia0medium213
Myopia, Degenerative0low10
Myopia, Pathological0low10
Myopia, Progressive0low10
Myotonia Atrophica0medium21
Myotonia Dystrophica0medium21
Myotonic Dystrophy0medium21
Myotonic Dystrophy 10medium21
Myotonic Dystrophy 20medium21
Myotonic Dystrophy, Congenital0medium21
Myotonic Myopathy, Proximal0medium21
Myotonic Pupil0low10
Myxoid Cyst0low10
Nagana0low10
Nail Fungus0medium21
NAION0low20
Nasal Cancer0low10
Nasal Catarrh0medium21
Nasal Neoplasms0low10
Nasal Polyps0medium21
Nasolacrimal Duct Obstruction0medium376
Nasopharyngeal Cancer0low10
Nasopharyngeal Carcinoma0low10
Nasopharyngeal Neoplasms0low10
Nasopharynx Cancer0low10
Nasopharynx Neoplasms0low10
Nausea0medium113
Nearsightedness0medium213
Neck Cancer0low60
Neck Neoplasm0low60
Neck Neoplasms0low60
Necrosis0medium251
Necrotizing Enterocolitis0low20
Necrotizing Pancreatitis, Acute0low10
Necrotizing Scleritis0low10
Negative Surgical Margins0low30
Neisseria gonorrhoeae Infection0low10
Neisseriaceae Infections0medium11
nemoci centru00E1lnu00EDho nervovu00E9ho systu00E9mu@cs0low10
Neonatal Diseases0low10
Neonatal Jaundice0low10
Neoplasia0low670
Neoplasm0low670
Neoplasm Circulating Cells0low20
Neoplasm Invasion0low10
Neoplasm Invasiveness0low10
Neoplasm Metastases0medium31
Neoplasm Metastasis0medium31
Neoplasm Recurrence, Local0low110
Neoplasm Recurrence, Locoregional0low110
Neoplasm Recurrences, Local0low110
Neoplasm, Residual0low70
Neoplasms0low670
Neoplasms, Adrenal Gland0low10
Neoplasms, Benign0low670
Neoplasms, Bladder0low50
Neoplasms, Bone0low40
Neoplasms, Brain0medium1391
Neoplasms, Brain Stem0low30
Neoplasms, Brain, Benign0medium1391
Neoplasms, Brain, Malignant0medium1391
Neoplasms, Brain, Primary0medium1391
Neoplasms, Brainstem0low30
Neoplasms, Brainstem, Primary0low30
Neoplasms, Breast0low320
Neoplasms, Bronchial0low20
Neoplasms, Central Nervous System0low50
Neoplasms, Cerebellar0low10
Neoplasms, Cerebellar, Benign0low10
Neoplasms, Cerebellar, Malignant0low10
Neoplasms, Cerebellar, Primary0low10
Neoplasms, Cerebral Ventricle0low10
Neoplasms, Cerebroventricular0low10
Neoplasms, Cervical0low50
Neoplasms, Cervix0low50
Neoplasms, Colonic0medium223
Neoplasms, Colorectal0medium122
Neoplasms, Digestive System0low10
Neoplasms, Esophageal0medium31
Neoplasms, Experimental0low150
Neoplasms, Experimental Liver0low20
Neoplasms, Experimental Mammary0low30
Neoplasms, Eye0low40
Neoplasms, Gastric0medium101
Neoplasms, Gastrointestinal0low10
Neoplasms, Head0low60
Neoplasms, Head and Neck0low60
Neoplasms, Hepatic0low170
Neoplasms, Infratentorial0low30
Neoplasms, Intracranial0medium1391
Neoplasms, Intraepithelial0medium32
Neoplasms, Intraventricular0low10
Neoplasms, Kidney0medium21
Neoplasms, Laryngeal0low20
Neoplasms, Leptomeningeal0low80
Neoplasms, Liver0low170
Neoplasms, Lung0low80
Neoplasms, Malignant Epithelial0medium91
Neoplasms, Mammary0low10
Neoplasms, Medullary0low30
Neoplasms, Meningeal0low80
Neoplasms, Mesencephalic0low30
Neoplasms, Midbrain0low30
Neoplasms, Mouth0low30
Neoplasms, Nasopharyngeal0low10
Neoplasms, Neck0low60
Neoplasms, Nerve Sheath0low10
Neoplasms, Nervous System0low10
Neoplasms, Neuroepithelial0low10
Neoplasms, Nose0low10
Neoplasms, Oral0low30
Neoplasms, Oropharyngeal0low10
Neoplasms, Ovarian0low80
Neoplasms, Pancreatic0low30
Neoplasms, Paranasal Sinus0low10
Neoplasms, Pharyngeal0low20
Neoplasms, Pharynx0low20
Neoplasms, Pontine0low30
Neoplasms, Posterior Fossa0low30
Neoplasms, Prostate0low150
Neoplasms, Prostatic0low150
Neoplasms, Pulmonary0low80
Neoplasms, Rectal0low20
Neoplasms, Retinal0low30
Neoplasms, Skin0low70
Neoplasms, Skull0low10
Neoplasms, Skull Base0low20
Neoplasms, Spinal Cord0low80
Neoplasms, Squamous Cell0low10
Neoplasms, Stomach0medium101
Neoplasms, Supratentorial0low80
Neoplasms, Thyroid0low10
Neoplasms, Tongue0low10
Neoplasms, Upper Aerodigestive Tract0low60
Neoplasms, Uterine0medium21
Neoplasms, Uterus0medium21
Neoplasms, Ventricular, Brain0low10
Neoplasms, Vulvar0low20
Neoplastic Cell Transformation0low30
Neoplastic Cells, Circulating0low20
Neoplastic Transformation, Cell0low30
Neovascularization, Choroid0medium275
Neovascularization, Choroidal0medium275
Neovascularization, Optic Disc0low120
Neovascularization, Pathologic0medium271
Neovascularization, Pathological0medium271
Neovascularization, Retinal0low120
Nephritis0low10
Nephroblastoma0low10
Nephroid Carcinoma0medium21
Nephrolith0low10
Nephrosis0low10
Nerve Compression Syndromes0low10
Nerve Compression Syndromes, External0low10
Nerve Compression Syndromes, Internal0low10
Nerve Degeneration0low40
Nerve Entrapments0low10
Nerve Injury, Facial0low10
Nerve Pain0low20
Nerve Sheath Neoplasm0low10
Nerve Sheath Neoplasms0low10
Nerve Sheath Tumor0low10
Nerve Sheath Tumors0low10
Nerve Sheath Tumors, Peripheral0low10
Nervous System Azorean Disease0low10
Nervous System Degenerative Diseases0low20
Nervous System Diseases0low10
Nervous System Disorders0low10
Nervous System Neoplasms0low10
Nervous System Paraneoplastic Syndromes0low10
Nervous System Poisoning0low20
Nervous System Tumors0low10
Nervus Cranialis Disorders0medium21
Neural Tube Defects0low10
Neural Tube Developmental Defects0low10
Neural-Optical Lesion0low60
Neuralgia0low20
Neuralgia-Neuritis, Sciatic Nerve0low10
Neuralgia, Atypical0low20
Neuralgia, Diabetic0low20
Neuralgia, Iliohypogastric Nerve0low20
Neuralgia, Ilioinguinal0low20
Neuralgia, Perineal0low20
Neuralgia, Stump0low20
Neuralgia, Supraorbital0low20
Neuralgia, Vidian0low20
Neurenteric Cyst0low10
Neurilemmoma0low50
Neurilemmoma, Acoustic0low30
Neurilemoma0low50
Neurilemoma, Acoustic0low30
Neurinoma0low50
Neurinoma of the Acoustic Nerve0low30
Neurinoma, Acoustic0low30
Neuritic Plaques0low20
Neuritis0low10
Neuritis, Motor0low10
Neuritis, Peripheral0low10
Neuritis, Sensory0low10
Neuroblastoma0low60
Neurodegenerative Diseases0low20
Neurodegenerative Disorders0low20
Neurodermatitis, Atopic0low60
Neurodermatitis, Disseminated0low60
Neurodynia0low20
Neuroenteric Cyst0low10
Neuroepithelial Neoplasms0low10
Neuroepithelial Tumors0low10
Neurofibroma, Plexiform0low10
Neurofibromatoses0low10
Neurofibromatosis0low10
Neurofibromatosis 10low10
Neurofibromatosis 30low10
Neurofibromatosis I0low10
Neurofibromatosis Syndrome0low10
Neurofibromatosis Type 10low10
Neurofibromatosis Type 30low10
Neurofibromatosis Type I0low10
Neurofibromatosis, Peripheral Type0low10
Neurofibromatosis, Peripheral, NF 10low10
Neurofibromatosis, Peripheral, NF10low10
Neurofibromatosis, Type 10low10
Neurofibromatosis, Type I0low10
Neurologic Degenerative Conditions0low20
Neurologic Degenerative Diseases0low20
Neurologic Diseases, Degenerative0low20
Neurologic Disorders0low10
Neurological Disorders0low10
Neuroma, Acoustic0low30
Neuroma, Acoustic, Unilateral0low30
Neuromas, Plexiform0low10
Neuron Degeneration0low40
Neuronopathic Gaucher Disease0low10
Neuropathic Pain0low20
Neuropathies, Cranial0medium21
Neuropathies, Hereditary Motor and Sensory0low10
Neuropsychiatric Systemic Lupus Erythematosus0low10
Neuroretinitis0low30
Neurosis, Depressive0low10
Neurotoxic Disorders0low20
Neurotoxicity Syndromes0low20
Neurotoxin Diseases0low20
Neurotoxin Disorders0low20
Nevi, Melanocytic0low10
Nevi, Pigmented0low10
Nevus, Melanocytic0low10
Nevus, Pigmented0low10
NF1 (Neurofibromatosis 1)0low10
NIDDM0medium181
Nigrospinodentatal Degeneration0low10
Nodular Glomerulosclerosis0medium61
Non-Convulsive Status Epilepticus0low40
Non-Depressed Skull Fracture0low30
Non-Epileptic Seizure0low100
Non-Epileptic Seizures0low100
Non-Hodgkin Lymphoma0low10
Non-Hodgkin's Lymphoma0low10
Non-Neuronopathic Gaucher Disease0low10
Non-Small Cell Lung Cancer0low30
Non-Small Cell Lung Carcinoma0low30
Non-Small-Cell Lung Carcinoma0low30
Nonarteritic Anterior Ischemic Optic Neuropathy0low20
Nonepileptic Seizure0low100
Nonepileptic Seizures0low100
Noninsulin-Dependent Diabetes Mellitus0medium181
Nonlymphoblastic Leukemia, Acute0low10
Nonlymphocytic Leukemia, Acute0low10
Nonne-Milroy Disease0low30
Nonne-Milroy Lymphedema0low30
Nonne-Milroy-Meige Disease0low30
Nonpenetrating Injuries0low40
Nonsmall Cell Lung Cancer0low30
Nonstaphylococcal Scalded Skin Syndrome0low20
Nose Cancer0low10
Nose Neoplasms0low10
Nosocomial Infections0low10
Numbness0low20
O'nyong-nyong Virus Infection0low10
Obesity0low20
Obstructive Hydrocephalus0low20
Occipital Region Trauma0low30
Occipital Trauma0low30
Occlusion, Middle Cerebral Artery0low60
Occult Spinal Dysraphism0low10
Occult Spinal Dysraphism Sequence0low10
Occupational Diseases0low30
Occupational Illnesses0low30
Ocular Cicatricial Pemphigoid0low40
Ocular Coloboma0low10
Ocular Headache0low50
Ocular Herpes Simplex0low80
Ocular Hypertension0low90
Ocular Hypotension0low50
Ocular Hypotony0low50
Ocular Infections, Bacterial0low80
Ocular Infections, Fungal0low20
Ocular Infections, Parasitic0low10
Ocular Infections, Viral0low40
Ocular Rosacea0low10
Ocular Toxoplasmosis0low10
Oculomycosis0low20
Old Silk Route Disease0low10
Olfactory Groove Meningioma0low80
Oligoastrocytoma, Mixed0low110
Oligodendroblastoma0low10
Oligodendroglioma0low10
Oligodendroglioma, Adult0low10
Oligodendroglioma, Childhood0low10
Oligodendroglioma, Well-Differentiated0low10
Omenn Syndrome0low10
Omenn's Syndrome0low10
Onychomycosis0medium21
Open Head Injury0low30
Open-Angle Glaucoma0medium213
Ophthalmia0low40
Ophthalmopathies, Thyroid-Associated0low30
Ophthalmopathy, Infiltrative0low30
Ophthalmopathy, Thyroid-Associated0low30
Opportunistic Infections, AIDS-Related0low10
Opportunistic Infections, HIV-Related0low10
Optic Atrophies, Hereditary0low20
Optic Atrophy, Hereditary0low20
Optic Disc Disorders0low60
Optic Disc Drusen0low10
Optic Disc Edema0low30
Optic Disc Neovascularization0low120
Optic Disk Disorders0low60
Optic Disk Drusen0low10
Optic Disk Edema0low30
Optic Disk Neovascularization0low120
Optic Ischaemic Neuropathy0low20
Optic Ischemic Neuropathy0low20
Optic Nerve Diseases0low60
Optic Nerve Ischemia0low20
Optic Nerve Papillitis0low30
Optic Neuropathy0low60
Optic Neuropathy, Anterior Ischemic0low20
Optic Neuropathy, Ischemic0low20
Optic Neuropathy, Posterior Ischemic0low20
Optic Papilla Edema0low30
Oral Cancer0low30
Oral Neoplasms0low30
Oral Ulcer0low10
Orbital Neoplasms0low10
Oregon Type Tyrosinemia0low20
Ornithosis0low10
Oropharyngeal Cancer0low10
Oropharyngeal Neoplasms0low10
Oropharynx Cancer0low10
Oropharynx Neoplasms0low10
Oropouche Fever0low10
Oropouche Infection0low10
Oropouche Orthobunyavirus Infection0low10
Oropouche Virus Infection0low10
Oroya Fever0low10
Orthobunyavirus Infections0low10
Orthomyxoviridae Infections0low10
Orthomyxovirus Infections0low10
Orthostatic Headache0low50
Osler-Rendu Disease0low10
Osler-Rendu-Weber Disease0low10
Osler-Weber-Rendu Syndrome0low10
Osler's Disease0low10
Osteoarthritis0low10
Osteoarthrosis0low10
Osteoarthrosis Deformans0low10
Osteoclastic Bone Loss0low10
Osteogenic Sarcoma0low70
Osteoporosis0low20
Osteoporosis, Age-Related0low20
Osteoporosis, Involutional0low20
Osteoporosis, Post-Traumatic0low20
Osteoporosis, Senile0low20
Osteosarcoma0low70
Osteosarcoma Tumor0low70
Otitis Media0low10
Otologic Diseases0low20
Otological Diseases0low20
Otorrhea, Cerebrospinal Fluid, Post-Traumatic0low110
Otorrhea, Cerebrospinal Fluid, Spontaneous0low110
Otorrhea, Cerebrospinal Fluid, Traumatic0low110
Otorrhea, Post-Traumatic, Cerebrospinal Fluid0low110
Otorrhea, Spontaneous, Cerebrospinal Fluid0low110
Otorrhea, Traumatic Cerebrospinal Fluid0low110
Otto Syndrome0low10
Ovarian Cancer0low80
Ovarian Failure, Premature0low10
Ovarian Neoplasms0low80
Ovary Cancer0low80
Ovary Neoplasms0low80
Overinclusion0low10
Ovine Diseases0low10
Oxidative Phosphorylation Deficiencies0low10
Oxycephaly0low10
Oxygen Deficiency0medium223
Pachydermatocele0low10
Pachymeningitis0low40
Paget Disease Extramammary0low20
Paget Disease, Extra-Mammary0low20
Paget Disease, Extramammary0low20
Paget's Disease, Extra-Mammary0low20
Paget's Disease, Extramammary0low20
Pain0medium91
Pain, Burning0medium91
Pain, Crushing0medium91
Pain, Migratory0medium91
Pain, Radiating0medium91
Pain, Splitting0medium91
Painful Bladder Syndrome0low30
Palatal Neoplasms0low10
Palmoplantaris Pustulosis0low20
Palsy0low30
Paludism0low10
Pancreas Cancer0low30
Pancreas Neoplasms0low30
Pancreatic Cancer0low30
Pancreatic Cyst0low20
Pancreatic Cystic Fibrosis0low60
Pancreatic Diseases0low30
Pancreatic Insufficiency0low30
Pancreatic Necrosis0low10
Pancreatic Neoplasms0low30
Pancreatic Parenchyma with Edema0low30
Pancreatic Parenchymal Edema0low30
Pancreatic Pseudocyst0low10
Pancreatitis0low30
Pancreatitis Necrotising0low10
Pancreatitis Necrotizing0low10
Pancreatitis, Acute0low30
Pancreatitis, Acute Edematous0low30
Pancreatitis, Acute Necrotizing0low10
Papillary Ependymoma0low40
Papillary Meningioma0low80
Papillary Renal Cell Carcinoma0medium21
Papilledema0low30
Papilledema Associated with Decreased Intraocular Pressure0low30
Papilledema Associated with Increased Intracranial Pressure0low30
Papillitis0low30
Papillitis, Optic0low30
Papilloma0low10
Papilloma, Inverted0low10
Papilloma, Shope0low30
Papilloma, Squamous Cell0low10
Papillomatosis0low10
Papillomavirus Infections0low20
Papulopustular Rosacea0low10
Parageusia0low10
Paralysis0low30
Paralysis Agitans0low10
Paranasal Sinus Cancer0low10
Paranasal Sinus Diseases0low10
Paranasal Sinus Neoplasms0low10
Paraneoplastic Autonomic Dysfunction0low10
Paraneoplastic Encephalomyelitis0low10
Paraneoplastic Neurologic Syndromes0low10
Paraneoplastic Syndromes, Nervous System0low10
Parasagittal Meningioma0low80
Parasitic Eye Infections0low10
Parasitic Liver Diseases0low10
Parenterally-Transmitted Non-A, Non-B Hepatitis0low10
Paresis0low10
Paresthesia0low10
Paresthesia, Distal0low10
Paresthesia, Painful0low10
Parietal Region Trauma0low30
Parkinson Disease0low10
Parkinson Disease, Idiopathic0low10
Parkinson's Disease0low10
Parkinson's Disease, Idiopathic0low10
Parkinson's Disease, Lewy Body0low10
Parotitis, Epidemic0low20
Paroxysmal Atrial Fibrillation0low10
Paroxysmal Cold Hemoglobinuria0low10
Paroxysmal Hemoglobinuria0low10
Paroxysmal Hemoglobinuria, Cold0low10
Paroxysmal Hemoglobinuria, Nocturnal0low10
Paroxysmal Nerve Pain0low20
Paroxysmal Nocturnal Hemoglobinuria0low10
Partial Seizure0low100
Partial Seizures0low100
Partial Trisomy 21 Down Syndrome0low10
Passive Hyperemia0medium62
Pathologic Angiogenesis0medium271
Pathologic Constriction0low10
Pathologic Dilatation0low10
Pathologic Dilatations0low10
Pathologic Neovascularization0medium271
Pattern Baldness0low10
Pediculosis0low30
Pemphigoid0low10
Pemphigoid, Benign Mucous Membrane0low40
Pemphigoid, Bullous0low10
Pemphigoid, Cicatricial0low40
Pemphigoid, Ocular Cicatricial0low40
Pemphigus0low10
Pemphigus Foliaceus0low10
Pemphigus Vulgaris0low10
Penetrating Eye Injuries0low20
Peptic Ulcer0low10
Peptic Ulcer Hemorrhage0low10
Periapical Diseases0low10
Perinatal Subarachnoid Hemorrhage0low10
Perineurioma0low10
Periodontal Pocket0medium11
Periorbital Headache0low50
Peripancreatic Fat Necrosis0low30
Peripheral Angiopathies0low160
Peripheral Arterial Disease0low30
Peripheral Arterial Diseases0low30
Peripheral Artery Disease0low30
Peripheral Nerve Diseases0medium21
Peripheral Nerve Injuries0low10
Peripheral Nerve Injury0low10
Peripheral Nerve Neoplasms0low20
Peripheral Nerve Neoplasms, Benign0low20
Peripheral Nerve Neoplasms, Malignant0low20
Peripheral Nerve Neoplastic Infiltration0low20
Peripheral Nerve Sheath Tumor0low10
Peripheral Nerve Sheath Tumors0low10
Peripheral Nerve Tumors0low20
Peripheral Nervous System Benign Neoplasms0low20
Peripheral Nervous System Disease0medium21
Peripheral Nervous System Diseases0medium21
Peripheral Nervous System Disorders0medium21
Peripheral Nervous System Malignant Neoplasms0low20
Peripheral Nervous System Neoplasms0low20
Peripheral Neurofibromatosis0low10
Peripheral Neuropathies0medium21
Peripheral Vascular Diseases0low160
Peritoneal Carcinomatosis0low30
Peritoneal Neoplasms0low30
Peritoneal Surface Malignancy0low30
Peritonitis0low20
Peroperative Complications0medium152
Persistent Atrial Fibrillation0low10
Pertussis0medium11
Petit Mal Convulsion0low100
Petit Mal Epilepsy0low10
Petit Mal Status0low40
Pharnyx Cancer0low20
Pharyngeal Cancer0low20
Pharyngeal Neoplasms0low20
Pharynx Neoplasms0low20
Phlebothrombosis0low10
Phlegmon0low10
Photodermatitis0low10
Photosensitivity Disorders0low10
Photosensitization0low10
Phototoxic Contact Dermatitis0low20
Phototoxic Dermatitis0low20
Phototoxicity0low20
Phymatous Rosacea0low10
Physiological Neonatal Jaundice0low10
Pie Torcido0low10
Pigmentary Cirrhosis0low10
Pigmentary Retinopathy0medium81
Pigmentation Disorders0medium41
Pigmented Moles0low10
Pilocytic Astrocytoma0low110
Pink Eye0medium21
Plagiocephaly, Craniosynostosis0low10
Plagiocephaly, Synostotic0low10
Plague0low10
Plaque, Amyloid0low20
Plaque, Atherosclerotic0low20
Plaque, Dental0medium137
Plaque, Ulcerating, Carotid Artery0low10
Plaques, Amyloid0low20
Plasma Cell Myeloma0low40
Plasmodium falciparum Malaria0low20
Plasmodium Infections0low10
Plasmodium vivax Malaria0medium11
Plegia0low30
Pleural Diseases0low10
Pleural Effusion0low10
Pneumonia, Interstitial0low10
Pneumonia, Viral0low30
Pneumonic Plague0low10
Pneumonitis, Interstitial0low10
Pneumothorax0medium41
Pneumothorax, Primary Spontaneous0medium41
PNS (Peripheral Nervous System) Diseases0medium21
PNS Diseases0medium21
Pocket, Periodontal0medium11
Poisoning0low30
Poisoning, Blood0low40
Poisoning, Nervous System0low20
Pollen Allergy0low10
Pollinosis0low10
Polyarthritis0low10
Polyneuritis0low10
Polyneuropathies0low10
Polyneuropathy, Acquired0low10
Polyneuropathy, Critical Illness0low10
Polyneuropathy, Familial0low10
Polyneuropathy, Inherited0low10
Polyneuropathy, Motor0low10
Polyopsia0medium21
Polytrauma0low10
Pontine Neoplasms0low30
Pontine Tumors0low30
Positive Surgical Margins0low30
Post-Traumatic Cerebrospinal Fluid Otorrhea0low110
Post-Traumatic Cerebrospinal Fluid Rhinorrhea0medium481
Post-Traumatic Hydrocephalus0low20
Post-Traumatic Myelopathy0low30
Post-Traumatic Otorrhea, Cerebrospinal Fluid0low110
Post-Traumatic Rhinorrhea, Cerebrospinal Fluid0medium481
Postabsorptive Hypoglycemia0low10
Posterior Cerebral Artery Aneurysm0low140
Posterior Choroidal Artery Infarction0low20
Posterior Circulation Brain Infarction0low20
Posterior Circulation Infarction, Brain0low20
Posterior Circulation Transient Ischemic Attack0low10
Posterior Communicating Artery Aneurysm0low140
Posterior Fossa Meningioma0low80
Posterior Fossa Neoplasms0low30
Posterior Fossa Tumors0low30
Posterior Ischemic Optic Neuropathy0low20
Postmortem Changes0low10
Postoperative Complications0medium444
Postoperative Wound Infection0low30
Postprandial Hyperglycemia0low50
Postprandial Hypoglycemia0low10
Postzoster Arteritis0low10
Poultry Diseases0low10
Pre-Eclampsia0low30
Precancerous Conditions0medium51
Precordial Catch0low10
Precordial Catch Syndrome0low10
Precursor Cell Lymphoblastic Leukemia-Lymphoma0low10
Predisposition, Genetic0low10
Preeclampsia0low30
Preeclampsia Eclampsia 10low30
Pregnancy0medium361
Pregnancy Complications0low30
Pregnancy Toxemias0low30
Premature Ovarian Failure0low10
Premature Ovarian Failure 10low10
Premature Ovarian Failure, X-Linked0low10
Preneoplastic Condition0medium51
Preneoplastic Conditions0medium51
Presbyopia0low10
Presenile Alzheimer Dementia0low30
Pressure Pneumothorax0medium41
Presyncope0low10
Primary Brain Neoplasms0medium1391
Primary Brain Stem Neoplasms0low30
Primary Brainstem Neoplasms0low30
Primary Central Nervous System Neoplasm0low50
Primary Central Nervous System Neoplasms0low50
Primary Central Nervous System Vasculitis0low10
Primary CNS Vasculitis0low10
Primary Congenital Lymphedema0low30
Primary Hemochromatosis0low10
Primary Hyperthyroidism0low10
Primary Intramedullary Spinal Cord Neoplasms0low80
Primary Malignant Brain Neoplasms0medium1391
Primary Malignant Brain Tumors0medium1391
Primary Neoplasms, Cerebellum0low10
Primary Open Angle Glaucoma0medium213
Primary Ovarian Insufficiency0low10
Primary Ovarian Insufficiency, Fragile X-Associated0low10
Primary Parkinsonism0low10
Primary Peritonitis0low20
Primary Senile Degenerative Dementia0low30
Primary Spinal Cord Neoplasms, Intramedullary0low80
Primary Spontaneous Pneumothorax0medium41
Primary Supratentorial Neoplasms0low80
Prion Disease0low40
Prion Diseases0low40
Prion Protein Diseases0low40
Prion-Associated Disorders0low40
Prion-Induced Disorder0low40
Prion-Induced Disorders0low40
Progranulocytic Leukemia0low20
Progressive Intracranial Occlusive Arteropathy (Moyamoya)0low10
Progressive Muscular Dystrophy, Duchenne Type0low20
Prolapse0low20
Proliferative Vitreoretinopathy0low30
PROMM (Proximal Myotonic Myopathy)0medium21
Promyelocytic Leukemia, Acute0low20
Proptosis0low20
Prostate Cancer0low150
Prostate Neoplasms0low150
Prostatic Adenoma0low10
Prostatic Cancer0low150
Prostatic Hyperplasia0low10
Prostatic Hyperplasia, Benign0low10
Prostatic Hypertrophy0low10
Prostatic Hypertrophy, Benign0low10
Prostatic Neoplasms0low150
Prostatitis0low10
Prosthesis Durability0low30
Prosthesis Failure0low30
Prosthesis Loosening0low30
Prosthesis Migration0low30
Prosthesis Survival0low30
Protan Defect0low10
Protein-Calorie Malnutrition0low10
Protein-Energy Malnutrition0low10
Proteinuria0low20
Proteinuria-Edema-Hypertension Gestosis0low30
Proximal Myotonic Myopathy0medium21
Pruritis0low40
Pruritus0low40
Psammomatous Meningioma0low80
Pseudo-Exfoliation Syndrome0low20
Pseudoaphakia0low120
Pseudocoma0medium31
Pseudoexfoliation Of The Lens0low20
Pseudoexfoliation Syndrome0low20
Pseudohypertrophic Childhood Muscular Dystrophy0low20
Pseudohypertrophic Muscular Dystrophy, Childhood0low20
Pseudomonas aeruginosa Infection0low80
Pseudomonas Infections0low80
Pseudopelade0low10
Pseudophakia0low20
Pseudoxanthoma Elasticum0low10
Pseudoxanthoma Elasticum, Autosomal Dominant0low10
Pseudoxanthoma Elasticum, Forme Fruste0low10
Pseudoxanthoma Elasticum, Incomplete0low10
Psittacosis0low10
Psoriasis0low20
PT-NANBH0low10
Pterygium0low20
Pulmonary Cancer0low80
Pulmonary Consumption0low10
Pulmonary Cystic Fibrosis0low60
Pulmonary Disease, Chronic Obstructive0medium21
Pulmonary Edema0low10
Pulmonary Edemas0low10
Pulmonary Embolism0low60
Pulmonary Embolisms0low60
Pulmonary Hypertension0low10
Pulmonary Neoplasms0low80
Pulmonary Phthisis0low10
Pulmonary Thromboembolism0low60
Pulmonary Thromboembolisms0low60
Pulmonary Tuberculoses0low10
Pulmonary Tuberculosis0low10
Pulmonic Plague0low10
Pulmonic Stenosis with Cafe-au-Lait Spots0low10
Pulsatile Tinnitus0low10
Pupil Diameter Unequal0low10
Pupil, Tonic0low10
Pupillary Miosis0low10
Pupillary Size Inequality0low10
Pupillotonia0low10
Purpura, Thrombocytopenic, Autoimmune0low10
Purpura, Thrombocytopenic, Idiopathic0low10
Pustular Psoriasis of Palms and Soles0low20
Pustulosis of Palms and Soles0low20
Pustulosis Palmaris et Plantaris0low20
Pyaemia0low40
Pyemia0low40
Pykno-Epilepsy0low10
Pyknolepsy0low10
Pyohemia0low40
Pyrexia0low30
Rabies0low10
Radiation Injuries0low30
Radiation Injuries, Experimental0low50
Radiation Sickness0low30
Radiation Syndrome0low30
Raeder Paratrigeminal Syndrome0low20
Rash0low40
Rasmussen Encephalitis0low20
Rasmussen Syndrome0low20
Rasmussen's Syndrome0low20
Raynaud Disease0low30
Raynaud Phenomenon0low30
Raynaud's Disease0low30
Reactive Hyperemia0medium62
Reactive Hypoglycemia0low10
Recklinghausen Disease of Nerve0low10
Recklinghausen Disease, Nerve0low10
Recklinghausen's Disease of Nerve0low10
Recklinghausens Disease of Nerve0low10
Recrudescence0medium161
Rectal Cancer0low20
Rectal Neoplasms0low20
Rectal Tumors0low20
Rectum Cancer0low20
Rectum Neoplasms0low20
Recurrence0medium161
Recurrence, Local Neoplasm0low110
Recurrence, Locoregional Neoplasm0low110
Recurrences, Local Neoplasm0low110
Reduced Sensation0low20
Refractive Disorders0medium62
Refractive Errors0medium62
Regional Enteritis0medium92
Regurgitation, Gastric0low10
Relapse0medium161
REM Sleep Deprivation0low20
Remission, Spontaneous0low30
Remittent Fever0low10
Renal Calculi0low10
Renal Calculus0low10
Renal Cancer0medium21
Renal Carcinoma0medium21
Renal Cell Cancer0medium21
Renal Cell Carcinoma0medium21
Renal Cell Carcinoma, Papillary0medium21
Renal Collecting Duct Carcinoma0medium21
Renal Disease, End-Stage0medium31
Renal Failure0low20
Renal Failure, Acute0low30
Renal Failure, Chronic0medium31
Renal Failure, End-Stage0medium31
Renal Insufficiency0low20
Renal Insufficiency, Acute0low30
Renal Insufficiency, Chronic0low30
Renal Neoplasms0medium21
Rendu-Osler-Weber Disease0low10
Reperfusion Damage0low190
Reperfusion Injury0low190
Research-Related Injuries0medium21
Resection Margin0low30
Residual Cancer0low70
Residual Disease, Minimal0low70
Residual Neoplasm0low70
Residual Tumor0low70
Residual Tumour0low70
Resistant Ovary Syndrome0low10
Respiration Disorders0low10
Respiratory Chain Deficiencies, Mitochondrial0low10
Respiratory Syncytial Virus Infection0low10
Respiratory Syncytial Virus Infections0low10
Respiratory Tract Diseases0low10
Retained Surgical Instruments0low20
Retained Surgical Items0low20
Retained Surgical Needle0low20
Retained Surgical Sponge0low20
Retained Surgical Tools0low20
Retention Disorders, Cognitive0low10
Reticuloendotheliosis, Familial0low10
Reticulolymphosarcoma0low110
Reticulosarcoma0low10
Reticulum Cell Sarcoma0low10
Reticulum-Cell Sarcoma0low10
Retinal Artery Occlusion0low30
Retinal Branch Vein Occlusion0low120
Retinal Breaks0low70
Retinal Cancer0low30
Retinal Degeneration0low60
Retinal Detachment0low270
Retinal Dialyses0low70
Retinal Diseases0medium423
Retinal Drusen0low40
Retinal Edema0low30
Retinal Hemorrhage0low80
Retinal Holes0low70
Retinal Microaneurysm0low10
Retinal Neoplasms0low30
Retinal Neovascularization0low120
Retinal Perforations0low70
Retinal Pigment Epithelial Detachment0low270
Retinal Tears0low70
Retinal Telangiectasis0low10
Retinal Tumors0low30
Retinal Vasculitis0low10
Retinal Vein Occlusion0low120
Retinal Vein Thrombosis0low120
Retinitis0low30
Retinitis Pigmentosa0medium81
Retinitis, Cytomegalovirus0low10
Retinocochleocerebral Vasculopathy0low20
Retinopathy of Prematurity0low60
Retro-Ocular Headache0low50
Retrolental Fibroplasia0low60
Rheumatism, Muscular0low10
Rheumatoid Arthritis0low50
Rhinitis0medium21
Rhinitis, Allergic, Nonseasonal0low10
Rhinitis, Allergic, Perennial0low10
Rhinitis, Allergic, Seasonal0low10
Rhinorrhea, Cerebrospinal Fluid, Post-Traumatic0medium481
Rhinorrhea, Cerebrospinal Fluid, Spontaneous0medium481
Rhinorrhea, Cerebrospinal Fluid, Traumatic0medium481
Rhinorrhea, Post-Traumatic, Cerebrospinal Fluid0medium481
Rhinorrhea, Spontaneous Cerebrospinal Fluid0medium481
Rhinorrhea, Traumatic Cerebrospinal Fluid0medium481
Rice-Field Fever0low10
Richner-Hanhart Syndrome0low20
Richner-Hanhart Syndrome, Tyrosinosis, Oculocutaneous Type0low20
Ricker Syndrome0medium21
Rickettsia prowazekii Infection0low10
Rida0low30
Right Hemisphere, Cerebral Infarction0low20
Right Hemisphere, Infarction, Cerebral0low20
Right Middle Cerebral Artery Infarction0low60
Ringing-Buzzing-Tinnitus0low10
Rochalimaea Infections0low10
Rocher-Sheldon Syndrome0low10
Rodent Ulcer0low30
Root Caries0low30
Rosacea0low10
Ross River Virus Infection0low10
Rossi Syndrome0low10
Rubeola0low10
Runt Disease0medium153
Rupture0medium31
Rupture, Spontaneous0low30
Ruptured Aneurysm0low40
Ruptured Intracranial Arteriovenous Malformation0low30
Saccular Aneurysm0low120
Sagittal Synostosis0low10
SAH (Subarachnoid Hemorrhage)0low10
SAIDS0low10
Salmonella typhi Infection0low30
Sarcoidosis0low30
Sarcoma0low40
Sarcoma 1800low10
Sarcoma 180, Crocker0low10
Sarcoma, Cerebellar, Circumscribed Arachnoidal0low10
Sarcoma, Engelbreth-Holm-Swarm0low30
Sarcoma, Epithelioid0low40
Sarcoma, Experimental0low30
Sarcoma, Germinoblastic0low110
Sarcoma, Jensen0low30
Sarcoma, Kaposi0low10
Sarcoma, Lymphatic0low10
Sarcoma, Osteogenic0low70
Sarcoma, Reticulum-Cell0low10
Sarcoma, Soft Tissue0low40
Sarcoma, Spindle Cell0low40
Sarcomas, Experimental0low30
Sarcomatoid Renal Cell Carcinoma0medium21
SARS Coronavirus 2 Infection0low80
SARS-CoV-2 Infection0low80
Scalded Skin Syndrome, Nonstaphylococcal0low20
Scaphocephaly0low10
Scar0medium41
Scarring0medium41
Scars0medium41
Schamberg Disease0medium41
Schamberg's Disease0medium41
Schaumann Disease0low30
Schaumann Syndrome0low30
Schaumann's Syndrome0low30
Schistosoma mansoni Infection0low20
Schistosomiasis mansoni0low20
Schistosomiasis, Intestinal0low20
Schwannoma0low50
Schwannoma, Acoustic0low30
Schwannoma, Vestibular0low30
Schwannomatosis, Plexiform0low50
Sciatic Nerve Diseases0low10
Sciatic Nerve Palsy0low10
Sciatic Neuritis0low10
Sciatic Neuropathy0low10
Sclera Diseases0low10
Scleral Diseases0low10
Scleritis0low10
Scleroderma, Systemic0medium71
Sclerosis, Systemic0medium71
Scotoma0low10
Scotoma, Altitudinal0low10
Scotoma, Arcuate0low10
Scotoma, Bjerrum0low10
Scotoma, Central0low10
Scotoma, Centrocecal0low10
Scotoma, Paracecal0low10
Scotoma, Paracentral0low10
Scotoma, Peripheral0low10
Scotoma, Ring0low10
Scotoma, Scintillating0low10
Scotoma, Sector0low10
Scrapie0low30
Sea Fan Neovascularization0low120
Seasonal Allergic Rhinitis0low10
Seborrhea0low10
Seborrheic Dermatitis0low10
Second Cranial Nerve Diseases0low60
Secondary CNS Vasculitis0low10
Secondary Open Angle Glaucoma0medium213
Secondary Peritonitis0low20
Secretory Meningioma0low80
Segond Fracture0low10
Seizure0low100
Seizure Disorder0low10
Seizure Disorder, Absence0low10
Seizure Disorder, Grand Mal0low20
Seizure Disorder, Major Motor0low20
Seizure Disorder, Tonic Clonic0low20
Seizures0low100
Seizures, Auditory0low100
Seizures, Clonic0low100
Seizures, Convulsive0low100
Seizures, Epileptic0low100
Seizures, Focal0low100
Seizures, Generalized0low100
Seizures, Gustatory0low100
Seizures, Motor0low100
Seizures, Olfactory0low100
Seizures, Sensory0low100
Seizures, Somatosensory0low100
Seizures, Tonic0low100
Seizures, Tonic-Clonic0low100
Seizures, Vertiginous0low100
Seizures, Vestibular0low100
Seizures, Visual0low100
Selective Mutism0low10
Semantic Memory Disorder0low10
Senile Dementia, Acute Confusional0low30
Senile Dementia, Alzheimer Type0low30
Senile Osteoporosis0low20
Senile Paranoid Dementia0low10
Senile Plaques0low20
Sensation Disorders0low10
Sensitivity and Specificity0medium23218
Sensitivity, Contact0low30
Sensorineural Hearing Loss0low10
Sensory Disorders0low10
Sepsis0low40
Septicemia0low40
Septicemic Plague0low10
Seventh Cranial Nerve Injuries0low10
Severe Combined Immune Deficiency0low10
Severe Combined Immunodeficiency0low10
Severe Combined Immunodeficiency Syndrome0low10
Severe Combined Immunologic Deficiency0low10
Severe Jaundice in Neonate0low10
Severe Jaundice in Newborn0low10
Severe Sepsis0low40
Sharp Headache0low50
Sharp Syndrome0low10
Sheep Diseases0low10
Shingles0low10
Shock0low50
Shock, Anaphylactic0medium232
Shock, Hemorrhagic0low30
Shock, Traumatic0low20
Sicca Syndrome0medium4210
Side Effects of Drugs0medium21
Signet Ring Cell Carcinoma0low10
Silicosis0low10
Simian Acquired Immune Deficiency Syndrome0low10
Simian Acquired Immuno-Deficiency Syndrome0low10
Simian Acquired Immunodeficiency Syndrome0low10
Simian AIDS0low10
Simple Partial Status Epilepticus0low40
Single Seizure0low100
Sinus Infections0medium42
Sinusitis0medium42
Sjogren Syndrome0medium4210
Sjogren's Syndrome0medium4210
Skin Aging0low30
Skin and Subcutaneous Tissue Disorders0low50
Skin Cancer0low70
Skin Diseases0low50
Skin Fistula0low10
Skin Mastocytoma0low10
Skin Neoplasms0low70
Skin Rash0low40
Skin Ulcer0low20
Skull Base Neoplasms0low20
Skull Fracture, Basilar0low10
Skull Fracture, Basilar, Childhood0low10
Skull Fracture, Frontobasilar0low10
Skull Fracture, Linear0low30
Skull Fracture, Non-Depressed0low30
Skull Fracture, Transphenoid Basilar0low10
Skull Fractures0low30
Skull Neoplasms0low10
Sleep Debt0low20
Sleep Deprivation0low20
Sleep Fragmentation0low20
Sleep Insufficiency0low20
Small Cleaved-Cell Lymphoma, Diffuse0low10
Small Non-Cleaved-Cell Lymphoma0low10
Small Noncleaved-Cell Lymphoma0low10
Small Pupil0low10
Smear Layer0low20
Sneezing0low10
Soft Tissue Injuries0low10
Soft Tissue Neoplasms0low10
Solitary Mastocytoma of Skin0low10
Spasm0low20
Spasm, Ciliary Body0low20
Spasm, Generalized0low20
Spasm, Hemifacial0low10
Spatial Memory Disorder0low10
Special Senses Disorders0low10
Sphenoid Wing Meningioma0low80
Spider Veins0low20
Spinal Cerebrospinal Fluid Leak0low180
Spinal Cerebrospinal Fluid Leak, Post-Traumatic0low180
Spinal Cerebrospinal Fluid Leak, Spontaneous0low180
Spinal Cerebrospinal Fluid Leak, Traumatic0low180
Spinal Cord Contusion0low30
Spinal Cord Injuries0low30
Spinal Cord Laceration0low30
Spinal Cord Myelodysplasia0low10
Spinal Cord Neoplasms0low80
Spinal Cord Neoplasms, Benign0low80
Spinal Cord Neoplasms, Intradural-Extramedullary0low80
Spinal Cord Neoplasms, Intramedullary0low80
Spinal Cord Neoplasms, Malignant0low80
Spinal Cord Neoplasms, Primary Intramedullary0low80
Spinal Cord Transection0low30
Spinal Cord Trauma0low30
Spinal Diseases0low10
Spinal Meningeal Neoplasms0low80
Spinal Meningioma0low80
Spinocerebellar Ataxia 30low10
Spinocerebellar Ataxia Type 30low10
Spinocerebellar Ataxia-30low10
Spinocerebellar Atrophy III0low10
Spinocerebellar Atrophy Type 30low10
Spiral Fractures0low10
Splenic Diseases0low10
Spongiform Encephalopathies, Transmissible0low40
Spongioblastoma, Polar0low10
Spontaneous Cerebrospinal Fluid Otorrhea0low110
Spontaneous Cerebrospinal Fluid Rhinorrhea0medium481
Spontaneous Oto-Acoustic Emission Tinnitus0low10
Spontaneous Otorrhea, Cerebrospinal Fluid0low110
Spontaneous Pneumothorax0medium41
Spontaneous Rhinorrhea, Cerebrospinal Fluid0medium481
Spontaneous Vertebral Artery Dissection0low10
Sprue0low10
Sprue, Celiac0low10
Sprue, Nontropical0low10
Squamous Cell Cancer0low10
Squamous Cell Carcinoma0low120
Squamous Cell Neoplasms0low10
Squamous Intraepithelial Lesions of the Cervix0low10
SREDIu0160NJI u017DIVu010CANI SUSTAV, BOLESTI@hr0low10
Staphylococcal Infections0low30
Staphylococcus aureus Infection0low30
Status Epilepticus0low40
Status Epilepticus, Complex Partial0low40
Status Epilepticus, Electrographic0low40
Status Epilepticus, Generalized0low40
Status Epilepticus, Generalized Convulsive0low40
Status Epilepticus, Grand Mal0low40
Status Epilepticus, Non-Convulsive0low40
Status Epilepticus, Simple Partial0low40
Status Epilepticus, Subclinical0low40
Steatohepatitis0low10
Steatosis of Liver0low10
Steinert Disease0medium21
Steinert Myotonic Dystrophy0medium21
Steinert's Disease0medium21
Stenosis0low10
Stenosis, Common Carotid Artery0low10
Stenosis, External Carotid Artery0low10
Sterility, Male0low20
Stevens Johnson Syndrome Toxic Epidermal Necrolysis0low20
Stevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum0low20
Stevens-Johnson Syndrome0low20
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis0low20
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum0low20
Stippled Epiphyses0low10
Stomach Cancer0medium101
Stomach Diseases0low10
Stomach Neoplasms0medium101
Stomach Ulcer0low10
Stomatitis, Denture0low10
Streptozocin Diabetes0low110
Streptozotocin Diabetes0low110
Striatonigral Degeneration, Autosomal Dominant0low10
Stricture0low10
Stroke0low30
Stroke, Acute0low30
Stroke, Middle Cerebral Artery0low60
Stromal Dystrophies, Corneal0low60
Stuttgart Disease0low10
Sub-Fertility, Male0low20
Subacute Neuronopathic Gaucher Disease0low10
Subarachnoid Hemorrhage0low10
Subarachnoid Hemorrhage, Aneurysmal0low10
Subarachnoid Hemorrhage, Intracranial0low10
Subarachnoid Hemorrhage, Spontaneous0low10
Subcortical Infarction0low20
Subdural Cerebrospinal Fluid Effusion0low20
Subdural Cerebrospinal Fluid Leakage0low20
Subdural Effusion0low20
Subdural Empyema0low10
Subdural Hematoma0low10
Subdural Hematoma, Traumatic0low10
Subependymal Giant Cell Astrocytoma0low110
Subfertility, Male0low20
Sudden Deafness0low10
Sudden Death0low10
Sudden Hearing Loss0low10
Sudden Visual Loss0low10
Suffering, Physical0medium91
Suffocation0low20
Superficial Head Injury0low30
Supraesophageal Gastric Reflux0low10
Supraesophageal Gastric Reflux (SEGR)0low10
Supratentorial Neoplasms0low80
Supratentorial Neoplasms, Benign0low80
Supratentorial Neoplasms, Malignant0low80
Supratentorial Neoplasms, Primary0low80
Supratentorial Tumors0low80
Surgical Blood Loss0low10
Surgical Hemorrhage0low10
Surgical Injuries0medium152
Surgical Margins0low30
Surgical Site Infection0low30
Surgical Wound Dehiscence0low40
Surgical Wound Infection0low30
Susac Syndrome0low20
Susac's Syndrome0low20
Susceptibility, Disease0low10
Susceptibility, Genetic0low10
Swine Diseases0low10
Swine Influenza0low10
Swineherd's Disease0low10
Sykdommer i sentralnervesystemet@no0low10
Symmetric Diabetic Proximal Motor Neuropathy0low20
Symptom Cluster0low70
Symptomatic Tonic-Clonic Epilepsy0low20
Syncopal Episode0low10
Syncopal Vertigo0low10
Syncope0low10
Syncope, Cardiogenic0low10
Syncope, Carotid Sinus0low10
Syncope, Convulsive0low10
Syncope, Deglutitional0low10
Syncope, Effort0low10
Syncope, Hyperventilation0low10
Syncope, Micturition0low10
Syncope, Postural0low10
Syncope, Situational0low10
Syncope, Stokes-Adams0low10
Syncope, Tussive0low10
Syndrome0low70
Syndrome, VKH (Vogt Koyanagi Harada)0low40
Syndrome, Vogt Koyanagi Harada0low40
Synostotic Anterior Plagiocephaly0low10
Synostotic Posterior Plagiocephaly0low10
Syphilis0low10
Systemic Capillary Leak Syndrome0low20
Systemic Lupus Erythematosis, Central Nervous System0low10
Systemic Lupus Erythematosus0low60
Systemic Scleroderma0medium71
Systemic Sclerosis0medium71
T-Cell Lymphoma0low20
T-Lymphotropic Virus Type III Infections, Human0low40
Tachyarrhythmia0low10
Tachycardia0low10
Tactile Allodynia0low10
Talipes Equinovarus0low10
Tapetoretinal Degeneration0medium81
Taste Disorder, Anterior Tongue0low10
Taste Disorder, Posterior Tongue0low10
Taste Disorder, Primary0low10
Taste Disorder, Primary, Bitter0low10
Taste Disorder, Primary, Salt0low10
Taste Disorder, Primary, Sweet0low10
Taste Disorder, Secondary0low10
Taste Disorder, Secondary, Bitter0low10
Taste Disorder, Secondary, Salt0low10
Taste Disorder, Secondary, Sweet0low10
Taste Disorders0low10
Taste Dysfunction0low10
Taste, Altered0low10
Taste, Distorted0low10
Taste, Metallic0low10
Tat Deficiency0low20
TB Meningitis0low40
Tear Duct Obstruction0medium376
Telangiectasia0low20
Telangiectasia, Hereditary Hemorrhagic0low10
Telangiectasia, Hereditary Hemorrhagic, of Rendu, Osler, and Weber0low10
Telangiectasia, Hereditary Hemorrhagic, Type 10low10
Telangiectasis0low20
Temporal Arteritis0low20
Temporal Region Trauma0low30
Tendinitis0low10
Tendinopathy0low10
Tendinosis0low10
Tendonitis0low10
Tendonopathy0low10
Tendonosis0low10
Tension Pneumothorax0medium41
Tensor Palatini Induced Tinnitus0low10
Tensor Tympani Induced Tinnitus0low10
Teratocarcinoma0low10
Tethered Cord Syndrome0low10
Tethered Spinal Cord Syndrome0low10
Texidor's Twinge0low10
Textiloma0low20
Thermal Allodynia0low10
Throbbing Headache0low50
Thromboangiitis Obliterans0low10
Thromboangitis Obliterans0low10
Thrombocytopathy0low30
Thrombocytopenia0low20
Thrombocytopenic Purpura, Autoimmune0low10
Thromboembolism0low10
Thromboembolism, Pulmonary0low60
Thromboembolisms, Pulmonary0low60
Thrombopenia0low20
Thrombosis0low180
Thrombosis, Deep Vein0low10
Thrombosis, Middle Cerebral Artery0low60
Thrombosis, Retinal Vein0low120
Thrombosis, Venous0low10
Thrombotic Infarction, Middle Cerebral Artery0low60
Thrombus0low180
Thrush0low10
Thyroid Adenoma0low10
Thyroid Cancer0low10
Thyroid Carcinoma0low10
Thyroid Neoplasms0low10
Thyroid-Associated Ophthalmopathies0low30
Thyroid-Associated Ophthalmopathy0low30
Thyrotoxicosis0low10
TIA (Transient Ischemic Attack)0low10
Tibial Fractures0low10
Tillaux Fracture0low10
Tinea Unguium0medium21
Tinnitus0low10
Tinnitus of Vascular Origin0low10
Tinnitus, Clicking0low10
Tinnitus, Leudet0low10
Tinnitus, Leudet's0low10
Tinnitus, Noise Induced0low10
Tinnitus, Objective0low10
Tinnitus, Spontaneous Oto-Acoustic Emission0low10
Tinnitus, Subjective0low10
Tinnitus, Tensor Palatini Induced0low10
Tinnitus, Tensor Tympani Induced0low10
Todd Paralysis0low30
Todd's Paralysis0low30
Toddler's Fracture0low10
Tongue Cancer0low10
Tongue Neoplasms0low10
Tonic Clonic Convulsions0low20
Tonic Clonic Seizure0low100
Tonic Pupil0low10
Tonic Pupil, Local0low10
Tonic Pupil, Neuropathic0low10
Tonic Seizure0low100
Tonic Seizures0low100
Tonic-Clonic Convulsion Disorder0low20
Tonic-Clonic Convulsion Syndrome0low20
Tonic-Clonic Seizure0low100
Tonic-Clonic Seizure Disorder0low20
Tonic-Clonic Seizure Syndrome0low20
Tonic-Clonic Seizures0low100
Tooth Demineralization0low40
Tooth Erosion0medium11
Tooth Hypomineralization0low40
Tooth Sensitivity0low10
Torsion Abnormality0low10
Torsion Fractures0low10
Toxemia Of Pregnancy0low30
Toxemias, Pregnancy0low30
Toxic Encephalitis0low20
Toxic Epidermal Necrolysis0low20
Toxic Epidermal Necrolysis Stevens Johnson Syndrome0low20
Toxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum0low20
Toxic Epidermal Necrolysis Stevens-Johnson Syndrome0low20
Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum0low20
Toxic Hepatitis0low10
Toxicity, Drug0medium21
Toxoplasma gondii Infection0low40
Toxoplasmosis0low40
Toxoplasmosis, Ocular0low10
Tracheal Neoplasms0low10
Transformation, Neoplastic Cell0low30
Transformation, Viral Cell0low10
Transient Ischemic Attack0low10
Transient Ischemic Attack, Anterior Circulation0low10
Transient Ischemic Attack, Brain Stem0low10
Transient Ischemic Attack, Brainstem0low10
Transient Ischemic Attack, Carotid Circulation0low10
Transient Ischemic Attack, Posterior Circulation0low10
Transient Ischemic Attack, Vertebrobasilar Circulation0low10
Transient Ischemic Attacks, Crescendo0low10
Transitional Meningioma0low80
Transitory Hearing Loss0low10
Translocation, Chromosomal0low30
Translocation, Genetic0low30
Transmissible Dementias0low40
Transmissible Spongiform Encephalopathies0low40
Trauma0medium21
Trauma, Carotid Artery0low10
Trauma, Head0low30
Trauma, Multiple0low10
Traumatic Cerebrospinal Fluid Otorrhea0low110
Traumatic Cerebrospinal Fluid Rhinorrhea0medium481
Traumatic Otorrhea, Cerebrospinal Fluid0low110
Traumatic Rhinorrhea, Cerebrospinal Fluid0medium481
Traumatic Vertebral Artery Dissection0low10
Trichomonas Infections0low10
Trichomoniasis0low10
Trigeminal Nerve Diseases0low20
Trigeminal Nerve Disorders0low20
Trigeminal Neuropathy0low20
Trigeminal Neuropathy, Idiopathic0low20
Trigonocephaly0low10
Triple Symptom Complex0low10
Triple-Symptom Complex0low10
Trisomy 210low10
Trisomy 21, Meiotic Nondisjunction0low10
Trisomy 21, Mitotic Nondisjunction0low10
Trisomy G0low10
Tritan Defect0low10
Troisier-Hanot-Chauffard Syndrome0low10
Trypanosomiasis, African0low10
Tubercular Meningitis0low40
Tuberculoses, Pulmonary0low10
Tuberculosis0low30
Tuberculosis Meningitis0low40
Tuberculosis, Meningeal0low40
Tuberculosis, Pulmonary0low10
Tuberculous Hypertrophic Pachymeningitis0low40
Tumor Cells, Embolic0low20
Tumor Royale0low10
Tumor Virus Infections0low30
Tumor-Free Margins0low30
Tumorigenic Transformation0low30
Tumors0low670
Tumors of the Nerve Sheath0low10
Tumors of the Nervous System0low10
Tumors, Breast0low320
Tumors, Central Nervous System0low50
Tumors, Retinal0low30
Tumors, Spinal Cord0low80
Type 1 AIP0low10
Type 1 Autoimmune Pancreatitis0low10
Type 1 Diabetes0medium408
Type 1 Diabetes Mellitus0medium408
Type 1 Gaucher Disease0low10
Type 2 AIP0low10
Type 2 Autoimmune Pancreatitis0low10
Type 2 Diabetes0medium181
Type 2 Diabetes Mellitus0medium181
Type 2 Gaucher Disease0low10
Type 3 Gaucher Disease0low10
Type 3 Spinocerebellar Ataxia0low10
Type I Hypersensitivity0low10
Type I Machado-Joseph Disease0low10
Type II Machado-Joseph Disease0low10
Type III Machado-Joseph Disease0low10
Type IV Machado-Joseph Disease0low10
Typhoid0low30
Typhoid Fever0low30
Typhus0low10
Typhus, Abdominal0low30
Typhus, Epidemic Louse-Borne0low10
Tyrosine Aminotransferase Deficiency0low20
Tyrosine Transaminase Deficiency0low20
Tyrosine Transaminase Deficiency Disease0low20
Tyrosinemia0low20
Tyrosinemia Type 10low20
Tyrosinemia, Type 20low20
Tyrosinemia, Type I0low20
Tyrosinemia, Type II0low20
Tyrosinemia, Type III0low20
Tyrosinemias0low20
Tyrosinemias, Hereditary0low20
Tyrosinosis, Oculocutaneous Type0low20
u041Du0415u0420u0412u041Du041Eu0419 u0421u0418u0421u0422u0415u041Cu042B u0426u0415u041Du0422u0420u0410u041Bu042Cu041Du041Eu0419 u0411u041Eu041Bu0415u0417u041Du0418@ru0low10
u4E2Du67A2u795Eu7D4Cu7CFBu75BEu60A3@ja0low10
UADT Neoplasm0low60
UADT Neoplasms0low60
Ulcer0medium41
Ulcer, Rodent0low30
Ulcerating Plaque, Carotid Artery0low10
Ulcerative Colitis0medium113
Undifferentiated Lymphoma0low10
Unilateral Blindness0low10
Unilateral Coronal Synostosis0low10
Unilateral Headache0low50
Unipolar Depression0low10
Upper Aerodigestive Tract Neoplasm0low60
Upper Aerodigestive Tract Neoplasms0low60
Upper Extremity Paresis0low10
Upper Motor Neuron Facial Palsy0low30
Ureteral Obstruction0medium21
Urinary Bladder Cancer0low50
Urinary Bladder Diseases0low10
Urinary Bladder Neoplasms0low50
Urinary Incontinence0medium11
Urinary Retention0medium11
Urinary Tract Diseases0low10
Urinary Tract Infections0medium31
Urologic Diseases0low10
Urological Diseases0low10
Urticaria0low90
Uterine Bleeding0medium11
Uterine Cancer0medium21
Uterine Cervical Cancer0low50
Uterine Cervical Dysplasia0low20
Uterine Cervical Neoplasms0low50
Uterine Cervicitis0low10
Uterine Diseases0low10
Uterine Hemorrhage0medium11
Uterine Neoplasms0medium21
Uterine Prolapse0medium11
Uterus Cancer0medium21
Uterus Neoplasms0medium21
Uveal Diseases0low20
Uveitis0medium111
Uveitis, Anterior0low30
Uveitis, Posterior0low30
Uveomeningoencephalitic Syndrome0low40
Uveomeningoencephalitis0low40
Uveoretinal Coloboma0low10
Vaginal Bleeding0medium11
Vaginal Prolapse0medium11
Vascular Accident, Brain0low30
Vascular Calcification0low10
Vascular Calcinosis0low10
Vascular Diseases0low190
Vascular Diseases, Intracranial0low40
Vascular Diseases, Peripheral0low160
Vascular Hypotension0low40
Vascular Origin Tinnitus0low10
Vasculitis0low10
Vasculitis, Central Nervous System0low10
Vasculitis, CNS, Secondary0low10
Vasculitis, Retinal0low10
Vasogenic Brain Edema0low140
Vasogenic Cerebral Edema0low140
Venous Congestion0medium62
Venous Engorgement0medium62
Venous Infarction, Brain0low20
Venous Insufficiency0low10
Venous Thrombosis0low10
Ventricular Dysfunction0low10
Ventricular Fibrillation0low10
Ventricular Neoplasms, Brain0low10
Ventricular Septal Defect0low40
Ventricular Septal Defects0low40
Ventricular Tumors, Brain0low10
Verruga Peruana0low10
Vertebral Artery Dissection0low10
Vertebral Artery Dissection, Spontaneous0low10
Vertebral Artery Dissection, Traumatic0low10
Vertebrobasilar Circulation Transient Ischemic Attack0low10
Vertex Headache0low50
Vesication0medium41
Vestibular Schwannoma0low30
Vibrio cholerae Infection0low10
Viral Cell Transformation0low10
Viral Conjunctivitis0low10
Viral Diseases0low20
Viral Encephalitis0low10
Viral Eye Infections0low40
Viral Hepatitis, Human0low10
Viral Infections0low20
Virus Diseases0low20
Virus Infections0low20
Visceral Steatosis0low10
Vision Disability0low80
Vision Disorders0low80
Visual Disorders0low80
Visual Fatigue0medium11
Visual Impairment0low80
Vitamin D Deficiency0low10
Vitamin E Deficiency0low10
Vitiligo0low10
Vitreoretinopathy Neovascular Inflammatory0low30
Vitreoretinopathy, Proliferative0low30
Vitreous Hemorrhage0low20
VKH (Vogt Koyanagi Harada) Syndrome0low40
VKH Syndrome0low40
Vogt-Koyanagi-Harada Disease0low40
Vogt-Koyanagi-Harada Syndrome0low40
Vomiting0medium81
Von Recklenhausen-Applebaum Disease0low10
von Recklinghausen Disease0low10
von Recklinghausen's Disease0low10
Vulva Cancer0low20
Vulva Neoplasms0low20
Vulvar Cancer0low20
Vulvar Neoplasms0low20
Wake-up Stroke0low20
Wallerian Degeneration0low10
Water-Electrolyte Imbalance0low10
Watson Syndrome0low10
Weber-Osler Disease0low10
Weber-Osler Syndrome0low10
Weight Gain0low30
Weight Loss0low10
Weight Reduction0low10
Well-Differentiated Oligodendroglioma0low10
Werlhof Disease0low10
Werlhof's Disease0low10
Wet Lung0low10
Wet Macular Degeneration0medium41
White Spot, Dental0low60
White Spots, Dental0low60
Whooping Cough0medium11
Wilms Tumor0low10
Wilms Tumor 10low10
Wilms' Tumor0low10
Wound Dehiscence, Surgical0low40
Wound Infection0low10
Wound Infection, Postoperative0low30
Wound Infection, Surgical0low30
Wounds0medium21
Wounds and Injuries0medium21
Wounds and Injury0medium21
Wounds, Gunshot0low30
Wounds, Injury0medium21
Wounds, Multiple0low10
Wounds, Nonpenetrating0low40
Wounds, Penetrating0low20
X-Linked Chondrodysplasia Punctata 20low10
X-Linked Chronic Granulomatous Disease0low10
X-Linked Dominant Chondrodysplasia Punctata0low10
X-Linked Familial Exudative Vitreoretinopathy0low10
X-Linked Hypergonadotropic Ovarian Failure0low10
Xanthomatous Meningioma0low80
Xeroderma Pigmentosum0low10
Xerophthalmia0low60
Xerostomia0low10
XL-FEVR0low10
Yersinia pestis Infection0low10
Zentralnervensystemkrankheiten@de0low10
Ziekte, centraalzenuwstelsel-@nl0low10
Zona0low10
Zoonoses0low10
Zoonotic Diseases0low10
Zoonotic Infections0low10
Zoonotic Infectious Diseases0low10
Zoonotic Spillover0low10
Zoster0low10

Research Highlights

Safety/Toxicity (72)

ArticleYear
Safety and efficacy of cyclosporine (0.05% versus 0.09%) in dry eye disease. Is it the strength of cyclosporin that really matters?
Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH, Volume: 14, Issue: 28		2022
Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre.
Indian journal of ophthalmology, Volume: 71, Issue: 4		2023
Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial.
JAMA ophthalmology, 05-01, Volume: 141, Issue: 5		2023
Efficacy and Safety of Amniotic Membrane Transplantation Combined with Closure of Tenon Capsule and Bulbar Conjunctival Space in the Treatment of Primary Pterygium.
Contrast media & molecular imaging, Volume: 2022		2022
Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial.
Clinical therapeutics, Volume: 44, Issue: 9		2022
Efficacy and Safety of the Long-Acting Diquafosol Ophthalmic Solution DE-089C in Patients with Dry Eye: A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study.
Advances in therapy, Volume: 39, Issue: 8		2022
The efficacy and safety of intrathecal fluorescein in endoscopic cerebrospinal fluid leak repair -a systematic review.
Auris, nasus, larynx, Volume: 49, Issue: 6		2022
Supratentorial high-grade gliomas: maximal safe anatomical resection guided by augmented reality high-definition fiber tractography and fluorescein.
Neurosurgical focus, Volume: 51, Issue: 2		2021
The Effectiveness and Safety of Intrathecal Fluorescein in the Management of Cerebrospinal Fluid Leaks.
American journal of rhinology & allergy, Volume: 35, Issue: 6		2021
Intra-operative fluorescein videoangiography-related nephrotoxicity in intracranial aneurysm surgery: Single center, observational cohort study.
Clinical neurology and neurosurgery, Volume: 203		2021
A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease.
Cornea, Sep-01, Volume: 40, Issue: 9		2021
Targeted acetylcholinesterase-responsive drug carriers with long duration of drug action and reduced hepatotoxicity.
International journal of nanomedicine, Volume: 14		2019
Corneal histomorphometric analysis: The depth of damage induced in the bovine cornea correlates with the severity of the ocular toxicity.
Toxicology in vitro : an international journal published in association with BIBRA, Volume: 61		2019
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters.
Nature communications, 06-18, Volume: 10, Issue: 1		2019
Surgery of malignant motor-eloquent gliomas guided by sodium-fluorescein and navigated transcranial magnetic stimulation: a novel technique to increase the maximal safe resection.
Journal of neurosurgical sciences, Volume: 63, Issue: 6		2019
How Safe is the Use of Intrathecal Fluorescein? An Experimental Study.
Turkish neurosurgery, Volume: 29, Issue: 4		2019
A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease.
Ophthalmology, Volume: 126, Issue: 6		2019
Safety and feasibility of low-dose fluorescein-guided resection of glioblastoma.
Clinical neurology and neurosurgery, Volume: 175		2018
One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease.
European journal of ophthalmology, Nov-08, Volume: 27, Issue: 6		2017
An Observational Study to Determine Whether Routinely Sending Patients Home With a 24-Hour Supply of Topical Tetracaine From the Emergency Department for Simple Corneal Abrasion Pain Is Potentially Safe.
Annals of emergency medicine, Volume: 71, Issue: 6		2018
Safe intrathecal fluorescein use for identification of cerebrospinal fluid leaks: Case-report and perioperative algorithm description.
Revista espanola de anestesiologia y reanimacion, Volume: 64, Issue: 9		2017
Fluorescent Formazans and Tetrazolium Salts - Towards Fluorescent Cytotoxicity Assays.
Combinatorial chemistry & high throughput screening, Volume: 19, Issue: 5		2016
Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease.
Scientific reports, Feb-11, Volume: 6		2016
SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model.
Advances in therapy, Volume: 33, Issue: 1		2016
Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
American journal of ophthalmology, Volume: 163		2016
Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome.
Advances in therapy, Volume: 32, Issue: 12		2015
Efficacy and Safety of Topical Atorvastatin for the Treatment of Dry Eye Associated with Blepharitis: A Pilot Study.
Ophthalmic research, Volume: 54, Issue: 1		2015
Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials.
Cornea, Volume: 34, Issue: 6		2015
Thromboembolic injury and systemic toxicity induced by nicotine in mice.
General physiology and biophysics, Volume: 33, Issue: 3		2014
Safety and efficacy of oral fluorescein angiography in detecting macular edema in comparison with spectral-domain optical coherence tomography.
Retina (Philadelphia, Pa.), Volume: 33, Issue: 8		2013
Halogenation generates effective modulators of amyloid-Beta aggregation and neurotoxicity.
PloS one, Volume: 8, Issue: 2		2013
Flow cytometric evaluation of nanoparticles using side-scattered light and reactive oxygen species-mediated fluorescence-correlation with genotoxicity.
Environmental science & technology, Jul-17, Volume: 46, Issue: 14		2012
EXTEND III: efficacy and safety of ranibizumab in South Korean and Taiwanese patients with subfoveal CNV secondary to AMD.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, Volume: 250, Issue: 10		2012
Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
Eye & contact lens, Volume: 38, Issue: 2		2012
[Safety evaluation of new anticancer chemotherapy administration system: compared to the results from a former study-].
Gan to kagaku ryoho. Cancer & chemotherapy, Volume: 38, Issue: 9		2011
Utilization of fluorescein for identification and preservation of the facial nerve and semicircular canals for safe mastoidectomy: a proof of concept laboratory cadaveric study.
Neurosurgery, Volume: 66, Issue: 1		2010
Toxicity of organic fluorophores used in molecular imaging: literature review.
Molecular imaging, Volume: 8, Issue: 6		2009
Inhibition of Abeta aggregation and neurotoxicity by the 39-kDa receptor-associated protein.
Journal of neurochemistry, Volume: 112, Issue: 5		2010
The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract.
Alimentary pharmacology & therapeutics, Volume: 31, Issue: 5		2010
Cytotoxicity testing of multipurpose contact lens solutions using monolayer and stratified cultures of human corneal epithelial cells.
Eye & contact lens, Volume: 35, Issue: 6		2009
Visible light induced photodegradation and phototoxicity of phloxine B and uranine.
Biomedical and environmental sciences : BES, Volume: 21, Issue: 5		2008
Evaluation of the side effects and image quality during fluorescein angiography comparing 2 mL and 5 mL sodium fluorescein.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, Volume: 43, Issue: 5		2008
Corneal epithelial testing strategies for safety evaluation of ophthalmic formulations.
Cutaneous and ocular toxicology, Volume: 26, Issue: 4		2007
Adverse effect of cyclosporin A on barrier functions of cerebral microvascular endothelial cells after hypoxia-reoxygenation damage in vitro.
Cellular and molecular neurobiology, Volume: 27, Issue: 7		2007
Safety of low-dose intrathecal fluorescein in endoscopic cranial base surgery.
Neurosurgery, Volume: 61, Issue: 3 Suppl		2007
Solution toxicity in soft contact lens daily wear is associated with corneal inflammation.
Optometry and vision science : official publication of the American Academy of Optometry, Volume: 84, Issue: 4		2007
Anaerobic glycolysis protection against 1-methy-4-phenylpyridinium (MPP+) toxicity in C6 glioma cells.
Neurochemical research, Volume: 32, Issue: 6		2007
In vitro assessment of medical device toxicity: interactions of benzalkonium chloride with silicone-containing and p-hema-containing hydrogel contact lens materials.
Eye & contact lens, Volume: 33, Issue: 1		2007
Safety of sodium fluorescein for in vivo study of skin.
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), Volume: 12, Issue: 3		2006
Pharmacological profile and toxicity of fluorescein-labelled sinistrin, a novel marker for GFR measurements.
Naunyn-Schmiedeberg's archives of pharmacology, Volume: 373, Issue: 3		2006
Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, Volume: 243, Issue: 6		2005
Comparison of dyes for cataract surgery. Part 1: cytotoxicity to corneal endothelial cells in a rabbit model.
Journal of cataract and refractive surgery, Volume: 31, Issue: 4		2005
Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Cornea, Volume: 23, Issue: 8		2004
Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity.
Pharmaceutical research, Volume: 21, Issue: 5		2004
Water-soluble polycationic dendrimers with a phosphoramidothioate backbone: preliminary studies of cytotoxicity and oligonucleotide/plasmid delivery in human cell culture.
Oligonucleotides, Volume: 13, Issue: 4		2003
Intravitreal sodium fluorescein enhances visualization of clear vitreous during vitreous surgery for macular hole: a safety and efficacy study.
Clinical & experimental ophthalmology, Volume: 32, Issue: 1		2004
A simple corneal perfusion chamber for drug penetration and toxicity studies.
The British journal of ophthalmology, Volume: 85, Issue: 4		2001
Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity.
International journal of pharmaceutics, Dec-15, Volume: 211, Issue: 1-2		2000
Cyclosporine toxicity in renal transplant recipients detected by nailfold capillaroscopy with Na-fluorescein.
Kidney international, Volume: 58, Issue: 6		2000
Phototoxicity from systemic sodium fluorescein.
Retina (Philadelphia, Pa.), Volume: 20, Issue: 4		2000
Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed-dose ophthalmic solution: a randomized, comparative, controlled study in healthy volunteers.
Methods and findings in experimental and clinical pharmacology, Volume: 21, Issue: 3		1999
Efficacy and safety of fluorescein angiography with orally administered sodium fluorescein.
American journal of ophthalmology, Volume: 126, Issue: 4		1998
Acute toxicity of fluorescein to turbot (Scophthalmus maximus).
Veterinary and human toxicology, Volume: 37, Issue: 6		1995
Effect of sodium fluorescein on neurite outgrowth from the retinal explant culture: an in vitro model for retinal toxicity.
Brain research, Volume: 313, Issue: 1		1983
A permeability test for acute corneal toxicity.
Toxicology letters, Volume: 31, Issue: 2		1986
Microcytotoxicity assay for platelet antibodies using fresh and frozen fluorescein-labeled target platelets.
Diagnostic and clinical immunology, Volume: 5, Issue: 2		1987
[Fluorescein and its adverse effects].
Ceskoslovenska oftalmologie, Volume: 45, Issue: 5		1989
Oral fluorescein angiography: reassessment of its relative safety and evaluation of optimum conditions with use of capsules.
The British journal of ophthalmology, Volume: 74, Issue: 8		1990
The safety of intravenous fluorescein administration.
Annals of plastic surgery, Volume: 26, Issue: 6		1991
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Long-term Use (6)

ArticleYear
The Effect of Long-Term Use of an Eyewash Solution on the Ocular Surface Mucin Layer.
International journal of molecular sciences, Oct-13, Volume: 20, Issue: 20		2019
Colored and fluorescent nanofibrous silk as a physically transient chemosensor and vitamin deliverer.
Scientific reports, 07-14, Volume: 7, Issue: 1		2017
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Optometry and vision science : official publication of the American Academy of Optometry, Volume: 92, Issue: 4 Suppl 1		2015
Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophages in chronic obstructive pulmonary disease subjects.
Respirology (Carlton, Vic.), Volume: 17, Issue: 5		2012
Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
Ophthalmology, Volume: 106, Issue: 4		1999
Effect of continued treatment with timolol maleate on corneal endothelium: a fluorophotometric study.
Cornea, Volume: 17, Issue: 6		1998
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (72)

ArticleYear
Quantitative intravitreal pharmacokinetics in mouse as a step towards inter-species translation.
Experimental eye research, Volume: 235		2023
Fluorescein clearance kinetics in blood and bile indicates hepatic ischemia-reperfusion injury in rats.
American journal of physiology. Gastrointestinal and liver physiology, 08-01, Volume: 323, Issue: 2		2022
The Role of Different Tear Volume Detection Methods in the Evaluation and Diagnosis of Mild Dry Eye Disease.
Translational vision science & technology, 03-02, Volume: 11, Issue: 3		2022
Single-photon peak event detection (SPEED): a computational method for fast photon counting in fluorescence lifetime imaging microscopy.
Optics express, Nov-08, Volume: 29, Issue: 23		2021
Broad-Band Spectrum, High-Sensitivity Absorbance Spectroscopy in Picoliter Volumes.
Analytical chemistry, 06-01, Volume: 93, Issue: 21		2021
Pharmacokinetics of intravitreal macromolecules: Scaling between rats and rabbits.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Apr-01, Volume: 159		2021
Highly Sensitive Analysis in Capillary Electrophoresis Using Large-volume Sample Stacking with an Electroosmotic Flow Pump Combined with Field-amplified Sample Injection.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, Aug-10, Volume: 35, Issue: 8		2019
Photography-based method for assessing fluorescein clearance test in dogs.
BMC veterinary research, Sep-03, Volume: 14, Issue: 1		2018
Evaluating tear clearance rate with optical coherence tomography.
Contact lens & anterior eye : the journal of the British Contact Lens Association, Volume: 41, Issue: 1		2018
Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance.
Acta biomaterialia, 10-01, Volume: 61		2017
Minimising instilled volume reduces the impact of fluorescein on clinical measurements of tear film stability.
Contact lens & anterior eye : the journal of the British Contact Lens Association, Volume: 40, Issue: 3		2017
Clearance Kinetics and Clearance Routes of Molecules From the Suprachoroidal Space After Microneedle Injection.
Investigative ophthalmology & visual science, 01-01, Volume: 58, Issue: 1		2017
Visualization of Tear Clearance Using Anterior Segment Optical Coherence Tomography and Polymethylmethacrylate Particles.
Cornea, Volume: 35 Suppl 1		2016
Effects of Pringle maneuver and partial hepatectomy on the pharmacokinetics and blood-brain barrier permeability of sodium fluorescein in rats.
Brain research, Aug-27, Volume: 1618		2015
A novel technique of contrast-enhanced optical coherence tomography imaging in evaluation of clearance of lipids in human tears.
PloS one, Volume: 9, Issue: 11		2014
Basal values, intra-day and inter-day variations in tear film osmolarity and tear fluorescein clearance.
Current eye research, Volume: 39, Issue: 7		2014
New method for evaluation of early phase tear clearance by anterior segment optical coherence tomography.
Acta ophthalmologica, Volume: 92, Issue: 2		2014
Toward 10,000-fold sensitivity improvement of oligosaccharides in capillary electrophoresis using large-volume sample stacking with an electroosmotic flow pump combined with field-amplified sample injection.
Electrophoresis, Volume: 34, Issue: 16		2013
Fluorescent dye imaging of the volume sampled by single well forced-gradient tracer tests evaluated in a laboratory-scale aquifer physical model.
Journal of contaminant hydrology, Feb-01, Volume: 128, Issue: 1-4		2012
Mixing subattolitre volumes in a quantitative and highly parallel manner with soft matter nanofluidics.
Nature nanotechnology, Oct-30, Volume: 7, Issue: 1		2011
Pharmacokinetics and organ distribution of fluorescein in experimental pigs: an input study for confocal laser endomicroscopy of the gastrointestinal tract.
Neuro endocrinology letters, Volume: 31 Suppl 2		2010
Flow injection small-volume fiber-optic pH sensor based on evanescent wave excitation and fluorescence determination.
Journal of fluorescence, Volume: 21, Issue: 3		2011
Thoracoscopic findings and pharmacokinetics of inhaled fluorescein in a pig model.
Respiration; international review of thoracic diseases, Volume: 80, Issue: 3		2010
Episcleral clearance of sodium fluorescein from a bioerodible sub-tenon's implant in the rat.
Experimental eye research, Volume: 90, Issue: 4		2010
Gradient, contact-free volume transfers minimize compound loss in dose-response experiments.
Journal of biomolecular screening, Volume: 15, Issue: 1		2010
Double sample preconcentration by in-line coupled large volume single drop microextraction and sweeping in capillary electrophoresis.
Electrophoresis, Volume: 30, Issue: 11		2009
Effect of ocular surface reconstruction by using amniotic membrane transplant for symptomatic conjunctivochalasis on fluorescein clearance test results.
Cornea, Volume: 27, Issue: 6		2008
Blood volume is normal after pre-operative overnight fasting.
Acta anaesthesiologica Scandinavica, Volume: 52, Issue: 4		2008
Experience with sodium fluorescein flow cytometry in the determination of red cell volume.
International journal of laboratory hematology, Volume: 31, Issue: 2		2009
Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops.
European journal of clinical pharmacology, Volume: 64, Issue: 5		2008
Delayed tear clearance in patients with conjunctivochalasis is associated with punctal occlusion.
Cornea, Volume: 26, Issue: 3		2007
Parallel mixing of photolithographically defined nanoliter volumes using elastomeric microvalve arrays.
Electrophoresis, Volume: 26, Issue: 19		2005
The Effect of instilled fluorescein solution volume on the values and repeatability of TBUT measurements.
Cornea, Volume: 24, Issue: 7		2005
Small-volume rapid-mix device for subsecond kinetic analysis in flow cytometry.
Cytometry. Part A : the journal of the International Society for Analytical Cytology, Volume: 67, Issue: 1		2005
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
American journal of ophthalmology, Volume: 138, Issue: 3		2004
Validation of an ocular microdialysis technique in rabbits with permanently implanted vitreous probes: systemic and intravitreal pharmacokinetics of fluorescein.
International journal of pharmaceutics, Aug-20, Volume: 281, Issue: 1-2		2004
Effect of linoleic acid and gamma-linolenic acid on tear production, tear clearance and on the ocular surface after photorefractive keratectomy.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, Volume: 241, Issue: 7		2003
Extracellular glutamate increases in the lateral hypothalamus during meal initiation, and GABA peaks during satiation: microdialysis measurements every 30 s.
Behavioral neuroscience, Volume: 117, Issue: 2		2003
Changes of cell volume and nitric oxide concentration in macula densa cells caused by changes in luminal NaCl concentration.
Journal of the American Society of Nephrology : JASN, Volume: 13, Issue: 11		2002
Quantitative in vitro comparison of fluorescein delivery to the eye via impregnated paper strip and volumetric techniques.
Optometry and vision science : official publication of the American Academy of Optometry, Volume: 79, Issue: 7		2002
[Changes in blood volume during acute normovolemic hemodilution with 5% albumin or 6% hydroxyethylstarch and intraoperative retransfusion].
Der Anaesthesist, Volume: 50, Issue: 8		2001
Delayed tear clearance in contact lens associated papillary conjunctivitis.
Current eye research, Volume: 22, Issue: 4		2001
Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface.
Ophthalmology, Volume: 108, Issue: 7		2001
The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects.
American journal of ophthalmology, Volume: 131, Issue: 3		2001
Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique.
Experimental eye research, Volume: 72, Issue: 3		2001
Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease.
Archives of ophthalmology (Chicago, Ill. : 1960), Volume: 118, Issue: 12		2000
A standardized visual scale for evaluation of tear fluorescein clearance.
Ophthalmology, Volume: 107, Issue: 7		2000
Effects of ethanol volume percent on fluorescein-labeled spinach apo- and holocalmodulin.
Analytical chemistry, Jan-01, Volume: 72, Issue: 1		2000
Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea.
Investigative ophthalmology & visual science, Volume: 40, Issue: 11		1999
Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
Ophthalmology, Volume: 106, Issue: 4		1999
First clinical implications of perioperative red cell volume measurement with a nonradioactive marker (sodium fluorescein).
Anesthesia and analgesia, Volume: 87, Issue: 6		1998
Plasma clearance of cholyl-lysyl-fluorescein: a pilot study in humans.
Journal of hepatology, Volume: 27, Issue: 6		1997
Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume.
Current eye research, Volume: 16, Issue: 7		1997
The LightCycler: a microvolume multisample fluorimeter with rapid temperature control.
BioTechniques, Volume: 22, Issue: 1		1997
Fluorescence-based classification of microsatellites using a single-wavelength semiautomatic sequencer: genotype assignment and identity tests by analysis of comigrating peak profiles.
Electrophoresis, Volume: 16, Issue: 10		1995
Internal fluorescence labeling with fluorescent deoxynucleotides in two-label peak-height encoded DNA sequencing by capillary electrophoresis.
Nucleic acids research, Sep-25, Volume: 22, Issue: 19		1994
Blood volume determination with sodium fluorescein and radioactive chromium--a clinical comparison of methods.
Infusionstherapie und Transfusionsmedizin, Volume: 21, Issue: 3		1994
The effect of fluorescein volume on lacrimal outflow transit time.
Ophthalmic plastic and reconstructive surgery, Volume: 10, Issue: 4		1994
Pharmacokinetics of fluorescein-labelled glycosaminoglycans and of their lipoprotein lipase-inducing activity in the rat.
Arzneimittel-Forschung, Volume: 32, Issue: 8		1982
Some aspects of the pharmacokinetics of fluorescein in normal and in diabetic subjects.
International journal of microcirculation, clinical and experimental, Volume: 2, Issue: 3		1983
Plasma pharmacokinetics and interstitial diffusion of macromolecules in a capillary bed.
The American journal of physiology, Volume: 246, Issue: 1 Pt 2		1984
Two-compartment model for plasma pharmacokinetics in individual blood vessels.
Journal of pharmacokinetics and biopharmaceutics, Volume: 12, Issue: 4		1984
Pharmacokinetics and distribution of a fluoresceinated glycosaminoglycan, sulodexide, in rats. Part I: Pharmacokinetics in rats.
Arzneimittel-Forschung, Volume: 35, Issue: 10		1985
Studies on the pharmacokinetics of fluorescein and its dilaurate ester under the conditions of the fluorescein dilaurate test.
Arzneimittel-Forschung, Volume: 35, Issue: 3		1985
Clearance of a topically applied fluorescein gel from periodontal pockets.
Journal of clinical periodontology, Volume: 17, Issue: 9		1990
Clearance of fluorescein incorporated into microspheres from the cornea and aqueous after subconjunctival injection.
Ophthalmic surgery, Volume: 21, Issue: 12		1990
Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection.
Ophthalmic surgery, Volume: 22, Issue: 3		1991
[A new method for the determination of circulating blood volume--erythrocyte marking with sodium fluorescein].
Infusionstherapie (Basel, Switzerland), Volume: 18, Issue: 3		1991
Effect of eledoisin on tear volume and tear flow in humans as assessed by fluorophotometry.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, Volume: 229, Issue: 6		1991
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (37)

ArticleYear
Oil-free eye drops containing Cyclosporine A/cyclodextrin/PVA supramolecular complex as a treatment modality for dry eye disease.
Carbohydrate polymers, Dec-01, Volume: 297		2022
Drug delivery of 6-bromoindirubin-3'-glycerol-oxime ether employing poly(D,L-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents.
Journal of nanobiotechnology, Jan-04, Volume: 20, Issue: 1		2022
Fluorescein Isothiocyanate Chitosan Nanoparticles in Oral Drug Delivery Studies.
Trends in pharmacological sciences, Volume: 41, Issue: 10		2020
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology, Volume: 96, Issue: 5		2019
Chitosan-based nanomicelle as a novel platform for targeted delivery of methotrexate.
International journal of biological macromolecules, Apr-01, Volume: 126		2019
En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries.
Journal of visualized experiments : JoVE, Feb-25, Issue: 108		2016
A New Spray Device to Deliver Topical Ocular Medication: Penetration of Fluorescein to the Anterior Segment.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, Volume: 31, Issue: 9		2015
Cell penetrating peptide (CPP)-conjugated desferrioxamine for enhanced neuroprotection: synthesis and in vitro evaluation.
Bioconjugate chemistry, Nov-19, Volume: 25, Issue: 11		2014
Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, Volume: 88, Issue: 1		2014
Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry.
PloS one, Volume: 7, Issue: 10		2012
Controlled delivery of nanosuspensions from osmotic pumps: zero order and non-zero order kinetics.
Journal of controlled release : official journal of the Controlled Release Society, Mar-28, Volume: 158, Issue: 3		2012
Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
Drug delivery, Volume: 18, Issue: 6		2011
Online monitoring of transepithelial electrical resistance (TEER) in an apparatus for combined dissolution and permeation testing.
International journal of pharmaceutics, Jun-15, Volume: 392, Issue: 1-2		2010
Increased NO bioavailability in aging male rats by genistein and exercise training: using 4, 5-diaminofluorescein diacetate.
Reproductive biology and endocrinology : RB&E, Sep-07, Volume: 7		2009
5-Aminolaevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy.
Molecular cancer therapeutics, Volume: 7, Issue: 6		2008
Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops.
European journal of clinical pharmacology, Volume: 64, Issue: 5		2008
[Bioavailability and influncing factors of self-designed powder needleless injection system on rabbits].
Yao xue xue bao = Acta pharmaceutica Sinica, Volume: 42, Issue: 4		2007
Transport kinetics of iron chelators and their chelates in Caco-2 cells.
Pharmaceutical research, Volume: 23, Issue: 2		2006
Control of pulmonary absorption of water-soluble compounds by various viscous vehicles.
International journal of pharmaceutics, Sep-10, Volume: 282, Issue: 1-2		2004
Characterization of TAT-mediated transport of detachable kinase substrates.
Biochemistry, Jul-06, Volume: 43, Issue: 26		2004
The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Volume: 21, Issue: 2-3		2004
Bioavailability of fluorescein from a new drug delivery system in human eyes.
The British journal of ophthalmology, Volume: 88, Issue: 1		2004
Fractional contribution of lung, nasal and gastrointestinal absorption to the systemic level following nose-only aerosol exposure in rats: a case study of 3.7- micro m fluorescein aerosols.
Archives of toxicology, Volume: 77, Issue: 6		2003
A comparative bioavailability study of three conventional eye drops versus a single lyophilisate.
The British journal of ophthalmology, Volume: 87, Issue: 4		2003
Transepithelial transport of fluorescein in Caco-2 cell monolayers and use of such transport in in vitro evaluation of phenolic acid availability.
Bioscience, biotechnology, and biochemistry, Volume: 66, Issue: 11		2002
Lyophilisates for drug delivery in ophthalmology: pharmacokinetics of fluorescein in the human anterior segment.
The British journal of ophthalmology, Volume: 86, Issue: 10		2002
Matrix metalloproteinase (2, 9, and 14) expression, localization, and activity in ovine corpora lutea throughout the estrous cycle.
Biology of reproduction, Volume: 66, Issue: 4		2002
Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres.
Journal of controlled release : official journal of the Controlled Release Society, Nov-09, Volume: 77, Issue: 1-2		2001
Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity.
International journal of pharmaceutics, Dec-15, Volume: 211, Issue: 1-2		2000
Simultaneous use of sodium deoxycholate and dipotassium glycyrrhizinate enhances the cellular transport of poorly absorbed compounds across Caco-2 cell monolayers.
The Journal of pharmacy and pharmacology, Volume: 51, Issue: 1		1999
Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?
Chemistry & biology, Volume: 6, Issue: 3		1999
Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Volume: 6, Issue: 2		1998
Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume.
Current eye research, Volume: 16, Issue: 7		1997
In situ measurement of fluorescein release by collagen shields in human eyes.
Current eye research, Volume: 13, Issue: 4		1994
Studies on the pharmacokinetics of fluorescein and its dilaurate ester under the conditions of the fluorescein dilaurate test.
Arzneimittel-Forschung, Volume: 35, Issue: 3		1985
Effect of intracanalicular collagen implants on the absorption of topically applied sodium fluorescein.
Cornea, Volume: 10, Issue: 6		1991
Use of fluorometry in assessing the efficacy of a cation-sensitive gel as an ophthalmic vehicle: comparison with scintigraphy.
Journal of pharmaceutical sciences, Volume: 81, Issue: 7		1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (79)

ArticleYear
Results of Intraoperative Sodium Fluorescein Video Angiography and Its Repeated Use in a Series of Brain Aneurysm Surgeries.
Turkish neurosurgery, Volume: 33, Issue: 5		2023
A phase 2a, double-masked, randomized, vehicle-controlled trial of VVN001 in subjects with dry eye disease.
The ocular surface, Volume: 28		2023
Efficacy and Safety of the Long-Acting Diquafosol Ophthalmic Solution DE-089C in Patients with Dry Eye: A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study.
Advances in therapy, Volume: 39, Issue: 8		2022
The efficacy and safety of intrathecal fluorescein in endoscopic cerebrospinal fluid leak repair -a systematic review.
Auris, nasus, larynx, Volume: 49, Issue: 6		2022
A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease.
Cornea, Sep-01, Volume: 40, Issue: 9		2021
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters.
Nature communications, 06-18, Volume: 10, Issue: 1		2019
A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease.
Ophthalmology, Volume: 126, Issue: 6		2019
Fluorescein sodium-guided resection of a cerebellar lymphoma: case report and literature review.
British journal of neurosurgery, Volume: 37, Issue: 4		2023
Combined Fluorescence Using 5-Aminolevulinic Acid and Fluorescein Sodium at Glioblastoma Border: Intraoperative Findings and Histopathologic Data About 3 Newly Diagnosed Consecutive Cases.
World neurosurgery, Volume: 122		2019
Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma.
Journal of neurosurgery, 09-07, Volume: 131, Issue: 3		2018
Fluorescent Detection of Merlin-deficient Schwann Cells and Primary Human Vestibular Schwannoma Cells Using Sodium Fluorescein.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, Volume: 39, Issue: 8		2018
Distribution of fluorescein sodium and triamcinolone acetonide in the simulated liquefied and vitrectomized Vitreous Model with simulated eye movements.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Nov-15, Volume: 109		2017
Precision Ocular Drug Delivery Via Aerosol Ring Vortices.
Pharmaceutical research, Volume: 34, Issue: 11		2017
Safe intrathecal fluorescein use for identification of cerebrospinal fluid leaks: Case-report and perioperative algorithm description.
Revista espanola de anestesiologia y reanimacion, Volume: 64, Issue: 9		2017
Intravenous fluorescein angiography-associated adverse reactions.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, Volume: 51, Issue: 5		2016
Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.
Biochemical pharmacology, Oct-15, Volume: 118		2016
A lower dose of fluorescein sodium is more suitable for confocal laser endomicroscopy: a feasibility study.
Gastrointestinal endoscopy, Volume: 84, Issue: 6		2016
A new hexapeptide from the leader peptide of rMnSOD enters cells through the oestrogen receptor to deliver therapeutic molecules.
Scientific reports, Jan-04, Volume: 6		2016
A novel approach of optical biopsy using probe-based confocal laser endomicroscopy for peritoneal metastasis.
Surgical endoscopy, Volume: 30, Issue: 8		2016
Sensitivity and specificity of intrathecal fluorescein and white light excitation for detecting intraoperative cerebrospinal fluid leak in endoscopic skull base surgery: a prospective study.
Journal of neurosurgery, Volume: 124, Issue: 3		2016
The Effects of Increasing Ocular Surface Stimulation on Blinking and Tear Secretion.
Investigative ophthalmology & visual science, Volume: 56, Issue: 8		2015
Fused-filament 3D printing (3DP) for fabrication of tablets.
International journal of pharmaceutics, Dec-10, Volume: 476, Issue: 1-2		2014
Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.
Molecular vision, Volume: 19		2013
Generation of chemical concentration gradients in mobile droplet arrays via fragmentation of long immiscible diluting plugs.
Analytical chemistry, Feb-19, Volume: 85, Issue: 4		2013
The exogenous fluorophore, fluorescein, enables in vivo assessment of the gastrointestinal mucosa via confocal endomicroscopy: optimization of intravenous dosing in the dog model.
Journal of veterinary pharmacology and therapeutics, Volume: 36, Issue: 5		2013
Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry.
PloS one, Volume: 7, Issue: 10		2012
Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Ophthalmology, Volume: 119, Issue: 12		2012
Determining rates of epithelial solute transport by optical measurement of fluorochrome concentration gradients in the unstirred layer.
The Journal of experimental biology, Sep-01, Volume: 215, Issue: Pt 17		2012
Effect of topically applied epithelial sodium channel inhibitors on tear production in normal mice and in mice with induced aqueous tear deficiency.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, Volume: 28, Issue: 4		2012
Cross-linking with ultraviolet-a and riboflavin reduces corneal permeability.
Investigative ophthalmology & visual science, Nov-29, Volume: 52, Issue: 12		2011
A simultaneous iris angiography technique in pigmented rabbits.
Ophthalmic research, Volume: 47, Issue: 2		2012
Fl-DFO molecules@mesoporous silica materials: highly sensitive and selective nanosensor for dosing with iron ions.
Journal of colloid and interface science, Jun-01, Volume: 358, Issue: 1		2011
Smart polymeric nanofibers for topical delivery of levothyroxine.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, Volume: 13, Issue: 3		2010
Development of a PDMS-based microchip electrophoresis device for continuous online in vivo monitoring of microdialysis samples.
Electrophoresis, Volume: 31, Issue: 8		2010
Gradient, contact-free volume transfers minimize compound loss in dose-response experiments.
Journal of biomolecular screening, Volume: 15, Issue: 1		2010
High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen.
Cornea, Volume: 28, Issue: 10		2009
Inhibition of anti-fluorescent probe monoclonal antibody by long-chain amphiphiles.
Colloids and surfaces. B, Biointerfaces, Jan-01, Volume: 75, Issue: 1		2010
Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
Cancer research, Dec-01, Volume: 68, Issue: 23		2008
Italian multicentre study on intrathecal fluorescein for craniosinusal fistulae.
Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, Volume: 28, Issue: 4		2008
Comparison of in vitro eye irritation potential by bovine corneal opacity and permeability (BCOP) assay to erythema scores in human eye sting test of surfactant-based formulations.
Cutaneous and ocular toxicology, Volume: 27, Issue: 2		2008
Quantitating the concentration of Py-Im polyamide-fluorescein conjugates in live cells.
Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue: 22		2008
ORAC-fluorescein assay to determine the oxygen radical absorbance capacity of resveratrol complexed in cyclodextrins.
Journal of agricultural and food chemistry, Mar-26, Volume: 56, Issue: 6		2008
Ophthalmic cyclosporine use in ocular GVHD.
Cornea, Volume: 25, Issue: 6		2006
Comparative in vivo mucoadhesion studies of thiomer formulations using magnetic resonance imaging and fluorescence detection.
Journal of controlled release : official journal of the Controlled Release Society, Sep-28, Volume: 115, Issue: 1		2006
Pharmacological profile and toxicity of fluorescein-labelled sinistrin, a novel marker for GFR measurements.
Naunyn-Schmiedeberg's archives of pharmacology, Volume: 373, Issue: 3		2006
In vitro bioassay of endotoxin using fluorescein as a pH indicator in a macrophage cell culture system.
Yonsei medical journal, Apr-30, Volume: 46, Issue: 2		2005
A prototype microfluidic platform for miniaturization and automation of serial dilution and dose-response assays.
Assay and drug development technologies, Volume: 1, Issue: 1 Pt 1		2002
[Complications of lumbar administration of 5% sodium fluorescein solution for detection of cerebrospinal fluid fistula].
Laryngo- rhino- otologie, Volume: 82, Issue: 12		2003
Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects.
Journal of glaucoma, Volume: 12, Issue: 6		2003
Tolerance of ocular iontophoresis in healthy volunteers.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, Volume: 19, Issue: 2		2003
How well can a T-cell epitope replace its parent carrier protein? A dose-response study.
Pharmaceutical research, Volume: 20, Issue: 4		2003
Highly enhanced permeability of blood-brain barrier induced by repeated administration of endothelin-1 in dogs and rats.
Pharmacology & toxicology, Volume: 92, Issue: 1		2003
Isolation of a peptide for targeted drug delivery into human head and neck solid tumors.
Cancer research, Dec-01, Volume: 60, Issue: 23		2000
Insecticidal activity of photoactive dyes to American and migratory grasshoppers (Orthoptera: Acrididae).
Journal of economic entomology, Volume: 93, Issue: 3		2000
A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal-tension glaucoma patients.
Ophthalmology, Volume: 107, Issue: 3		2000
Oral dosage forms fabricated by three dimensional printing.
Journal of controlled release : official journal of the Controlled Release Society, May-03, Volume: 66, Issue: 1		2000
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
Archives of ophthalmology (Chicago, Ill. : 1960), Volume: 117, Issue: 9		1999
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
Archives of ophthalmology (Chicago, Ill. : 1960), Volume: 117, Issue: 9		1999
Dose-dependent increase of transcapillary diffusion of sodium fluorescein after histamine microinjections.
VASA. Zeitschrift fur Gefasskrankheiten, Volume: 28, Issue: 2		1999
Fatal anaphylactic shock during a fluorescein angiography.
Forensic science international, Mar-15, Volume: 100, Issue: 1-2		1999
The effect of fluorescein on the accuracy of blood glucose determination by glucose meters.
Acta ophthalmologica Scandinavica, Volume: 77, Issue: 2		1999
Cerebrospinal fluid fistulae in a canine model.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, Volume: 117, Issue: 5		1997
Fluorophotometry with a small animal adapter.
Japanese journal of ophthalmology, Volume: 40, Issue: 3		1996
Tetrandrine inhibits breakdown of blood-aqueous barrier induced by endotoxin and interleukin-1 alpha in rats.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics,Fall, Volume: 12, Issue: 3		1996
Dose-response effects of radiation on the permeability of endothelial cells in culture.
Radiation research, Volume: 146, Issue: 3		1996
Quantitative flow cytometry reveals a hierarchy of glucocorticoid effect on cell surface mouse mammary tumor virus gp52.
The Journal of steroid biochemistry and molecular biology, Volume: 57, Issue: 1-2		1996
The validation of a new vascular damage assay for photodynamic therapy agents.
Photochemistry and photobiology, Volume: 62, Issue: 5		1995
The effect of oral dexamethasone on the circadian rhythm of aqueous humor flow in humans.
Investigative ophthalmology & visual science, Volume: 35, Issue: 3		1994
Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic Arg-Gly-Asp peptide.
Thrombosis research, Mar-15, Volume: 77, Issue: 6		1995
Development of a colon delivery capsule and the pharmacological activity of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in beagle dogs.
The Journal of pharmacy and pharmacology, Volume: 47, Issue: 6		1995
Pharmacokinetics of fluorescein-labelled glycosaminoglycans and of their lipoprotein lipase-inducing activity in the rat.
Arzneimittel-Forschung, Volume: 32, Issue: 8		1982
Pharmacokinetics and distribution of a fluoresceinated glycosaminoglycan, sulodexide, in rats. Part II: Organ distribution in rats.
Arzneimittel-Forschung, Volume: 35, Issue: 10		1985
Quantitation of antigen in tissue by immunofluorescence image analysis.
Journal of immunological methods, Nov-13, Volume: 124, Issue: 1		1989
Permeabilized hepatocyte couplets. Adenosine triphosphate-dependent bile canalicular contractions and a circumferential pericanalicular microfilament belt demonstrated.
Laboratory investigation; a journal of technical methods and pathology, Volume: 65, Issue: 2		1991
Oral fluorescein angiography and fluoroscopy: determination of plasma fluorescein levels and clinical application.
Optometry and vision science : official publication of the American Academy of Optometry, Volume: 69, Issue: 12		1992
[The effect of dosage on oral fluorescein angiography of the fundus].
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology, Volume: 28, Issue: 3		1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Interactions (10)

ArticleYear
Efficacy and Safety of Amniotic Membrane Transplantation Combined with Closure of Tenon Capsule and Bulbar Conjunctival Space in the Treatment of Primary Pterygium.
Contrast media & molecular imaging, Volume: 2022		2022
An investigation into the effects of ocular nebulization combined with meibomian gland massage on ocular surface status and corneal higher-order aberrations for the treatment of meibomian gland dysfunction.
Acta ophthalmologica, Volume: 100, Issue: 3		2022
Application of fluorescein combined with methylene blue in sentinel lymph node biopsy of breast cancer.
Scientific reports, 06-09, Volume: 11, Issue: 1		2021
Highly Sensitive Analysis in Capillary Electrophoresis Using Large-volume Sample Stacking with an Electroosmotic Flow Pump Combined with Field-amplified Sample Injection.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, Aug-10, Volume: 35, Issue: 8		2019
The Role of Drug-Drug Interactions in Hydrogel Delivery Systems: Experimental and Model Study.
Chemphyschem : a European journal of chemical physics and physical chemistry, Jun-03, Volume: 17, Issue: 11		2016
Effectiveness of Autologous Serum Eye Drops Combined With Punctal Plugs for the Treatment of Sjögren Syndrome-Related Dry Eye.
Cornea, Volume: 34, Issue: 10		2015
Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study.
JAMA ophthalmology, Volume: 131, Issue: 6		2013
Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
Die Pharmazie, Volume: 63, Issue: 3		2008
Food-drug interaction between ferulic acid and nateglinide involving the fluorescein/H+ cotransport system.
Journal of agricultural and food chemistry, Apr-06, Volume: 53, Issue: 7		2005
Intravenous hydroxyethylrutosides combined with long-term oral anticoagulation in atherosclerotic nonreconstructable critical leg ischemia: a retrospective study.
Angiology, Volume: 50, Issue: 6		1999
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Natural Sources (1)

ArticleYear
Dissolvable microneedles based on Panax notoginseng polysaccharide for transdermal drug delivery and skin dendritic cell activation.
Carbohydrate polymers, Sep-15, Volume: 268		2021
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]